null dep=None lb1=Coadministration lb1=of lib=and lib=drugs lib=primarily lib=metabolized lib=by lib=CYP3A lib=(e.g., la2=) la2=may la2=result la2=in la2=increased la2=plasma la2=concentrations la2=of la2=the la2=other la2=drug la2=that la2=could la2=increase la2=or la2=prolong la2=both la2=its la2=therapeutic la2=and la2=adverse la2=effects.
null dep=None lb1=Coadministration lb1=of lib=and lib=drugs lib=that lib=induce lib=CYP3A lib=may lib=decrease la2=plasma la2=concentrations la2=and la2=reduce la2=its la2=therapeutic la2=effect.
null dep=None lb1=Coadministration lb1=of lib=and lib=drugs lib=that lib=inhibit lib=CYP3A lib=may lib=increase la2=plasma la2=concentrations.
null dep=conj lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lib=and la2=, la2=trimethoprim/sulfamethoxazole, la2=clarithromycin, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole. 2under1
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lib=and lib=dapsone, la2=/sulfamethoxazole, la2=clarithromycin, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lib=and lib=dapsone, lib=trimethoprim/ la2=, la2=clarithromycin, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole.
null dep=conj lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lib=and lib=dapsone, lib=trimethoprim/sulfamethoxazole, la2=, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole. 2under1
null dep=conj lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lib=and lib=dapsone, lib=trimethoprim/sulfamethoxazole, lib=clarithromycin, la2=, la2=itraconazole la2=or la2=fluconazole. 2under1
null dep=conj lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lib=and lib=dapsone, lib=trimethoprim/sulfamethoxazole, lib=clarithromycin, lib=erythromycin, la2=or la2=fluconazole. 2under1
null dep=conj lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lib=and lib=dapsone, lib=trimethoprim/sulfamethoxazole, lib=clarithromycin, lib=erythromycin, lib=itraconazole lib=or la2=. 2under1
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lib=, la2=/sulfamethoxazole, la2=clarithromycin, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lib=, lib=trimethoprim/ la2=, la2=clarithromycin, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lib=, lib=trimethoprim/sulfamethoxazole, la2=, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lib=, lib=trimethoprim/sulfamethoxazole, lib=clarithromycin, la2=, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lib=, lib=trimethoprim/sulfamethoxazole, lib=clarithromycin, lib=erythromycin, la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lib=, lib=trimethoprim/sulfamethoxazole, lib=clarithromycin, lib=erythromycin, lib=itraconazole lib=or la2=.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lib=/ la2=, la2=clarithromycin, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lib=/sulfamethoxazole, la2=, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lib=/sulfamethoxazole, lib=clarithromycin, la2=, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lib=/sulfamethoxazole, lib=clarithromycin, lib=erythromycin, la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lib=/sulfamethoxazole, lib=clarithromycin, lib=erythromycin, lib=itraconazole lib=or la2=.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/ lib=, la2=, la2=erythromycin, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/ lib=, lib=clarithromycin, la2=, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/ lib=, lib=clarithromycin, lib=erythromycin, la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/ lib=, lib=clarithromycin, lib=erythromycin, lib=itraconazole lib=or la2=.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/sulfamethoxazole, lib=, la2=, la2=itraconazole la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/sulfamethoxazole, lib=, lib=erythromycin, la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/sulfamethoxazole, lib=, lib=erythromycin, lib=itraconazole lib=or la2=.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/sulfamethoxazole, lb1=clarithromycin, lib=, la2=or la2=fluconazole.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/sulfamethoxazole, lb1=clarithromycin, lib=, lib=itraconazole lib=or la2=.
null dep=None lb1=Based lb1=on lb1=known lb1=metabolic lb1=profiles, lb1=clinically lb1=significant lb1=drug lb1=interactions lb1=are lb1=not lb1=expected lb1=between lb1=VIRACEPT lb1=and lb1=dapsone, lb1=trimethoprim/sulfamethoxazole, lb1=clarithromycin, lb1=erythromycin, lib=or la2=.
advise dep=compound lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With la2=: la2=amiodarone, la2=quinidine la2=Antihistamines: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 1under2
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: la2=, la2=quinidine la2=Antihistamines: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, la2=Antihistamines: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine la2=: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine lib=Antihistamines: la2=, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives la2=: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride
advise dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lib=Antiarrhythmics: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents:
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: la2=, la2=quinidine la2=Antihistamines: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, la2=Antihistamines: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine la2=: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine lib=Antihistamines: la2=, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives la2=: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lib=: lib=amiodarone, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents:
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, la2=Antihistamines: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=appos lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine la2=: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=dep lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine lib=Antihistamines: la2=, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine lib=Antihistamines: lib=astemizole, la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives la2=: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lib=, lib=quinidine lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents: 2under1
null dep=compound lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, la2=: la2=astemizole, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 1under2
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lib=Antihistamines: la2=, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lib=Antihistamines: lib=astemizole, la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives la2=: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lib=Antihistamines: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents:
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lib=: la2=, la2=terfenadine la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lib=: lib=astemizole, la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lib=: lib=astemizole, lib=terfenadine lib=Antimigraine: la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lib=: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives la2=: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lib=: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lib=: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lib=: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lib=: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lib=: lib=astemizole, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents:
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lib=, la2=Antimigraine: la2=ergot la2=derivatives la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lib=, lib=terfenadine lib=Antimigraine: la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lib=, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives la2=: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lib=, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lib=, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lib=, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lib=, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lib=, lib=terfenadine lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents: 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lib=Antimigraine: la2=Antimycobacterial la2=agents: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lib=Antimigraine: lib=ergot lib=derivatives la2=: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lib=Antimigraine: lib=ergot lib=derivatives lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents:
null dep=compound lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: la2=: la2=rifampin la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lib=Antimycobacterial lib=agents: la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lib=Antimycobacterial lib=agents: lib=rifampin la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lib=Antimycobacterial lib=agents: lib=rifampin lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents:
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lib=: la2=Benzodiazepines la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lib=: lib=rifampin la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=dep lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lib=: lib=rifampin lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=compound lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lib=: lib=rifampin lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lib=: lib=rifampin lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents:
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: la2=midazolam, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride
null dep=compound lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: lib=Benzodiazepines la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 1under2
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: lib=Benzodiazepines lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: lib=Benzodiazepines lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents:
null dep=compound lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: lb1=rifampin la2=, la2=triazolam la2=GI la2=motility la2=agents: la2=cisapride 1under2
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: lb1=rifampin lib=midazolam, la2=GI la2=motility la2=agents: la2=cisapride
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: lb1=rifampin lib=midazolam, lib=triazolam lib=GI lib=motility lib=agents:
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: lb1=rifampin lb1=Benzodiazepines lib=, la2=GI la2=motility la2=agents: la2=cisapride 2under1
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: lb1=rifampin lb1=Benzodiazepines lib=, lib=triazolam lib=GI lib=motility lib=agents:
null dep=None lb1=Drugs lb1=That lb1=Should lb1=Not lb1=Be lb1=Coadministered lb1=With lb1=VIRACEPT lb1=Antiarrhythmics: lb1=amiodarone, lb1=quinidine lb1=Antihistamines: lb1=astemizole, lb1=terfenadine lb1=Antimigraine: lb1=ergot lb1=derivatives lb1=Antimycobacterial lb1=agents: lb1=rifampin lb1=Benzodiazepines lb1=midazolam, lib=GI lib=motility lib=agents:
advise dep=compound lb1=Drugs lb1=Which lb1=Require lb1=a lb1=Dose lb1=Reduction lb1=When lb1=Coadminstered lb1=With la2=: la2=rifabutin 1under2
advise dep=None lb1=Drugs lb1=Which lb1=Require lb1=a lb1=Dose lb1=Reduction lb1=When lb1=Coadminstered lb1=With lib=Antimycobacterial lib=agents:
null dep=None lb1=Drugs lb1=Which lb1=Require lb1=a lb1=Dose lb1=Reduction lb1=When lb1=Coadminstered lb1=With lb1=VIRACEPT lib=:
null dep=None lb1=* lb1=This lb1=table lb1=is lb1=not lb1=all lb1=inclusive lb1=** lib=may lib=not lib=be lib=effective lib=due lib=to lib=decreased la2=plasma la2=concentrations la2=in la2=patients la2=taking la2=these la2=agents la2=concomitantly
null dep=None lib=: lib=Administration lib=of la2=with la2=VIRACEPT la2=resulted la2=in la2=the la2=appearance la2=of la2=unchanged la2=terfenadine la2=in la2=plasma; 2under1
null dep=None lib=: lib=Administration lib=of lib=terfenadine lib=with la2=resulted la2=in la2=the la2=appearance la2=of la2=unchanged la2=terfenadine la2=in la2=plasma; 2under1
null dep=None lib=: lib=Administration lib=of la2=with la2=VIRACEPT la2=resulted la2=in la2=the la2=appearance la2=of la2=unchanged la2=terfenadine la2=in la2=plasma; 2under1
null dep=None lb1=Terfenadine: lb1=Administration lb1=of lib=with la2=resulted la2=in la2=the la2=appearance la2=of la2=unchanged la2=terfenadine la2=in la2=plasma;
null dep=None lb1=Terfenadine: lb1=Administration lb1=of lib=with lib=VIRACEPT lib=resulted lib=in lib=the lib=appearance lib=of lib=unchanged la2=with la2=VIRACEPT la2=resulted la2=in la2=the la2=appearance la2=of la2=unchanged la2=terfenadine la2=in la2=plasma;
null dep=None lb1=Terfenadine: lb1=Administration lb1=of lb1=terfenadine lb1=with lib=resulted lib=in lib=the lib=appearance lib=of lib=unchanged la2=with la2=VIRACEPT la2=resulted la2=in la2=the la2=appearance la2=of la2=unchanged la2=terfenadine la2=in la2=plasma;
advise dep=None lb1=therefore, lib=should lib=not lib=be lib=administered lib=concurrently lib=with la2=because la2=of la2=the la2=potential la2=for la2=serious la2=and/or la2=life-threatening la2=cardiac la2=arrhythmias.
advise dep=None lb1=Because lb1=a lb1=similar lb1=interaction lb1=is lb1=likely, lib=should lib=also lib=not lib=be lib=administered lib=concurrently lib=with la2=.
null dep=None lib=: lib=Coadministration lib=of la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=83% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=indinavir lib=with la2=resulted la2=in la2=an la2=83% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=indinavir lib=with lib=VIRACEPT lib=resulted lib=in lib=an lib=83% lib=increase lib=in la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=83% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C. 2under1
mechanism dep=None lb1=Indinavir: lb1=Coadministration lb1=of lib=with la2=resulted la2=in la2=an la2=83% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C.
null dep=None lb1=Indinavir: lb1=Coadministration lb1=of lib=with lib=VIRACEPT lib=resulted lib=in lib=an lib=83% lib=increase lib=in la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C.
null dep=None lb1=Indinavir: lb1=Coadministration lb1=of lib=with lib=VIRACEPT lib=resulted lib=in lib=an lib=83% lib=increase lib=in lib=nelfinavir lib=plasma lib=AUC lib=and lib=a lib=51% lib=increase lib=in la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=83% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C.
null dep=None lb1=Indinavir: lb1=Coadministration lb1=of lb1=indinavir lb1=with lib=resulted lib=in lib=an lib=83% lib=increase lib=in la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C.
null dep=None lb1=Indinavir: lb1=Coadministration lb1=of lb1=indinavir lb1=with lib=resulted lib=in lib=an lib=83% lib=increase lib=in lib=nelfinavir lib=plasma lib=AUC lib=and lib=a lib=51% lib=increase lib=in la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=83% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C.
null dep=None lb1=Indinavir: lb1=Coadministration lb1=of lb1=indinavir lb1=with lb1=VIRACEPT lb1=resulted lb1=in lb1=an lb1=83% lb1=increase lb1=in lib=plasma lib=AUC lib=and lib=a lib=51% lib=increase lib=in la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=83% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=51% la2=increase la2=in la2=indinavir la2=plasma la2=A.C.
null dep=None lib=: lib=Coadministration lib=of la2=with la2=VIRACEPT la2=resulted la2=in la2=a la2=152% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=ritonavir lib=with la2=resulted la2=in la2=a la2=152% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=ritonavir lib=with lib=VIRACEPT lib=resulted lib=in lib=a lib=152% lib=increase lib=in la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of la2=with la2=VIRACEPT la2=resulted la2=in la2=a la2=152% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C. 2under1
mechanism dep=None lb1=Ritonavir: lb1=Coadministration lb1=of lib=with la2=resulted la2=in la2=a la2=152% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C.
null dep=None lb1=Ritonavir: lb1=Coadministration lb1=of lib=with lib=VIRACEPT lib=resulted lib=in lib=a lib=152% lib=increase lib=in la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C.
null dep=None lb1=Ritonavir: lb1=Coadministration lb1=of lib=with lib=VIRACEPT lib=resulted lib=in lib=a lib=152% lib=increase lib=in lib=nelfinavir lib=plasma lib=AUC lib=and lib=very lib=little lib=change lib=in la2=with la2=VIRACEPT la2=resulted la2=in la2=a la2=152% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C.
null dep=None lb1=Ritonavir: lb1=Coadministration lb1=of lb1=ritonavir lb1=with lib=resulted lib=in lib=a lib=152% lib=increase lib=in la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C.
null dep=None lb1=Ritonavir: lb1=Coadministration lb1=of lb1=ritonavir lb1=with lib=resulted lib=in lib=a lib=152% lib=increase lib=in lib=nelfinavir lib=plasma lib=AUC lib=and lib=very lib=little lib=change lib=in la2=with la2=VIRACEPT la2=resulted la2=in la2=a la2=152% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C.
null dep=None lb1=Ritonavir: lb1=Coadministration lb1=of lb1=ritonavir lb1=with lb1=VIRACEPT lb1=resulted lb1=in lb1=a lb1=152% lb1=increase lb1=in lib=plasma lib=AUC lib=and lib=very lib=little lib=change lib=in la2=with la2=VIRACEPT la2=resulted la2=in la2=a la2=152% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=very la2=little la2=change la2=in la2=ritonavir la2=plasma la2=A.C.
null dep=None lib=: lib=Coadministration lib=of la2=(using la2=an la2=experimental la2=soft-gelatin la2=capsule la2=formulation la2=of la2=saquinavir la2=1200mg) la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of la2=(using la2=an la2=experimental la2=soft-gelatin la2=capsule la2=formulation la2=of la2=saquinavir la2=1200mg) la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=saquinavir lib=(using lib=an lib=experimental lib=soft-gelatin lib=capsule lib=formulation lib=of lib=saquinavir lib=1200mg) lib=with la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=saquinavir lib=(using lib=an lib=experimental lib=soft-gelatin lib=capsule lib=formulation lib=of lib=saquinavir lib=1200mg) lib=with lib=VIRACEPT lib=resulted lib=in lib=an lib=18% lib=increase lib=in la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of la2=(using la2=an la2=experimental la2=soft-gelatin la2=capsule la2=formulation la2=of la2=saquinavir la2=1200mg) la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C. 2under1
null dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lib=(using lib=an lib=experimental lib=soft-gelatin lib=capsule lib=formulation lib=of la2=(using la2=an la2=experimental la2=soft-gelatin la2=capsule la2=formulation la2=of la2=saquinavir la2=1200mg) la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
mechanism dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lib=(using lib=an lib=experimental lib=soft-gelatin lib=capsule lib=formulation lib=of lib=saquinavir lib=1200mg) lib=with la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
null dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lib=(using lib=an lib=experimental lib=soft-gelatin lib=capsule lib=formulation lib=of lib=saquinavir lib=1200mg) lib=with lib=VIRACEPT lib=resulted lib=in lib=an lib=18% lib=increase lib=in la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
null dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lib=(using lib=an lib=experimental lib=soft-gelatin lib=capsule lib=formulation lib=of la2=(using la2=an la2=experimental la2=soft-gelatin la2=capsule la2=formulation la2=of la2=saquinavir la2=1200mg) la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
null dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lib=(using lib=an lib=experimental lib=soft-gelatin lib=capsule lib=formulation lib=of lib=saquinavir lib=1200mg) lib=with la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
null dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lib=(using lib=an lib=experimental lib=soft-gelatin lib=capsule lib=formulation lib=of lib=saquinavir lib=1200mg) lib=with lib=VIRACEPT lib=resulted lib=in lib=an lib=18% lib=increase lib=in la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
null dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lib=(using lib=an lib=experimental lib=soft-gelatin lib=capsule lib=formulation lib=of la2=(using la2=an la2=experimental la2=soft-gelatin la2=capsule la2=formulation la2=of la2=saquinavir la2=1200mg) la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
null dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lb1=saquinavir lb1=(using lb1=an lb1=experimental lb1=soft-gelatin lb1=capsule lb1=formulation lb1=of lb1=saquinavir lb1=1200mg) lb1=with lib=resulted lib=in lib=an lib=18% lib=increase lib=in la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
null dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lb1=saquinavir lb1=(using lb1=an lb1=experimental lb1=soft-gelatin lb1=capsule lb1=formulation lb1=of lb1=saquinavir lb1=1200mg) lb1=with lib=resulted lib=in lib=an lib=18% lib=increase lib=in lib=nelfinavir lib=plasma lib=AUC lib=and lib=a lib=4-fold lib=increase lib=in la2=(using la2=an la2=experimental la2=soft-gelatin la2=capsule la2=formulation la2=of la2=saquinavir la2=1200mg) la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
null dep=None lb1=Saquinavir: lb1=Coadministration lb1=of lb1=saquinavir lb1=(using lb1=an lb1=experimental lb1=soft-gelatin lb1=capsule lb1=formulation lb1=of lb1=saquinavir lb1=1200mg) lb1=with lb1=VIRACEPT lb1=resulted lb1=in lb1=an lb1=18% lb1=increase lb1=in lib=plasma lib=AUC lib=and lib=a lib=4-fold lib=increase lib=in la2=(using la2=an la2=experimental la2=soft-gelatin la2=capsule la2=formulation la2=of la2=saquinavir la2=1200mg) la2=with la2=VIRACEPT la2=resulted la2=in la2=an la2=18% la2=increase la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=4-fold la2=increase la2=in la2=saquinavir la2=plasma la2=A.C.
null dep=None lib=: lib=Coadministration lib=of la2=with la2=VIRACEPT la2=resulted la2=in la2=a la2=35% la2=increase la2=in la2=nelfinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=ketoconazole lib=with la2=resulted la2=in la2=a la2=35% la2=increase la2=in la2=nelfinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=ketoconazole lib=with lib=VIRACEPT lib=resulted lib=in lib=a lib=35% lib=increase lib=in la2=plasma la2=A.C. 2under1
mechanism dep=None lb1=Ketoconazole: lb1=Coadministration lb1=of lib=with la2=resulted la2=in la2=a la2=35% la2=increase la2=in la2=nelfinavir la2=plasma la2=A.C.
null dep=None lb1=Ketoconazole: lb1=Coadministration lb1=of lib=with lib=VIRACEPT lib=resulted lib=in lib=a lib=35% lib=increase lib=in la2=plasma la2=A.C.
null dep=None lb1=Ketoconazole: lb1=Coadministration lb1=of lb1=ketoconazole lb1=with lib=resulted lib=in lib=a lib=35% lib=increase lib=in la2=plasma la2=A.C.
null dep=conj lb1=This lb1=change lb1=was lb1=not lb1=considered lb1=clinically lb1=significant lb1=and lb1=no lb1=dose lb1=adjustment lb1=is lb1=needed lb1=when lib=and la2=are la2=coadministered. 2under1
null dep=None lib=: lib=It lib=is lib=recommended lib=that la2=be la2=administered la2=on la2=an la2=empty la2=stomach; 2under1
advise dep=None lb1=therefore, lib=should lib=be lib=administered lib=(with lib=food) lib=one lib=hour lib=after lib=or lib=more lib=than lib=two lib=hours lib=before la2=.
advise dep=None lb1=A lb1=dose lb1=adjustment lb1=is lb1=not lb1=needed lb1=when lib=is lib=administered lib=with la2=.
null dep=None lb1=Little lb1=or lb1=no lb1=change lb1=in lb1=the lb1=pharmacokinetics lb1=of lb1=either lb1=drug lb1=was lb1=observed lb1=when lib=was lib=coadministered lib=with la2=or la2=stavudine.
null dep=None lb1=Little lb1=or lb1=no lb1=change lb1=in lb1=the lb1=pharmacokinetics lb1=of lb1=either lb1=drug lb1=was lb1=observed lb1=when lib=was lib=coadministered lib=with lib=lamivudine lib=or la2=.
null dep=conj lb1=Little lb1=or lb1=no lb1=change lb1=in lb1=the lb1=pharmacokinetics lb1=of lb1=either lb1=drug lb1=was lb1=observed lb1=when lb1=VIRACEPT lb1=was lb1=coadministered lb1=with lib=or la2=. 2under1
null dep=None lib=: lib=Coadministration lib=of la2=and la2=VIRACEPT la2=resulted la2=in la2=a la2=32% la2=decrease la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=rifabutin lib=and la2=resulted la2=in la2=a la2=32% la2=decrease la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=rifabutin lib=and lib=VIRACEPT lib=resulted lib=in lib=a lib=32% lib=decrease lib=in la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of la2=and la2=VIRACEPT la2=resulted la2=in la2=a la2=32% la2=decrease la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C. 2under1
mechanism dep=None lb1=Rifabutin: lb1=Coadministration lb1=of lib=and la2=resulted la2=in la2=a la2=32% la2=decrease la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C.
null dep=None lb1=Rifabutin: lb1=Coadministration lb1=of lib=and lib=VIRACEPT lib=resulted lib=in lib=a lib=32% lib=decrease lib=in la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C.
null dep=None lb1=Rifabutin: lb1=Coadministration lb1=of lib=and lib=VIRACEPT lib=resulted lib=in lib=a lib=32% lib=decrease lib=in lib=nelfinavir lib=plasma lib=AUC lib=and lib=a lib=207% lib=increase lib=in la2=and la2=VIRACEPT la2=resulted la2=in la2=a la2=32% la2=decrease la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C.
null dep=None lb1=Rifabutin: lb1=Coadministration lb1=of lb1=rifabutin lb1=and lib=resulted lib=in lib=a lib=32% lib=decrease lib=in la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C.
null dep=None lb1=Rifabutin: lb1=Coadministration lb1=of lb1=rifabutin lb1=and lib=resulted lib=in lib=a lib=32% lib=decrease lib=in lib=nelfinavir lib=plasma lib=AUC lib=and lib=a lib=207% lib=increase lib=in la2=and la2=VIRACEPT la2=resulted la2=in la2=a la2=32% la2=decrease la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C.
null dep=None lb1=Rifabutin: lb1=Coadministration lb1=of lb1=rifabutin lb1=and lb1=VIRACEPT lb1=resulted lb1=in lb1=a lb1=32% lb1=decrease lb1=in lib=plasma lib=AUC lib=and lib=a lib=207% lib=increase lib=in la2=and la2=VIRACEPT la2=resulted la2=in la2=a la2=32% la2=decrease la2=in la2=nelfinavir la2=plasma la2=AUC la2=and la2=a la2=207% la2=increase la2=in la2=rifabutin la2=plasma la2=A.C.
advise dep=None lb1=It lb1=is lb1=recommended lb1=that lb1=the lb1=dose lb1=of lib=be lib=reduced lib=to lib=one-half lib=the lib=usual lib=dose lib=when lib=administered lib=with la2=.
null dep=None lib=: lib=Coadministration lib=of la2=and la2=VIRACEPT la2=resulted la2=in la2=an la2=82% la2=decrease la2=in la2=nelfinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=rifampin lib=and la2=resulted la2=in la2=an la2=82% la2=decrease la2=in la2=nelfinavir la2=plasma la2=A.C. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=rifampin lib=and lib=VIRACEPT lib=resulted lib=in lib=an lib=82% lib=decrease lib=in la2=plasma la2=A.C. 2under1
mechanism dep=None lb1=Rifampin: lb1=Coadministration lb1=of lib=and la2=resulted la2=in la2=an la2=82% la2=decrease la2=in la2=nelfinavir la2=plasma la2=A.C.
null dep=None lb1=Rifampin: lb1=Coadministration lb1=of lib=and lib=VIRACEPT lib=resulted lib=in lib=an lib=82% lib=decrease lib=in la2=plasma la2=A.C.
null dep=None lb1=Rifampin: lb1=Coadministration lb1=of lb1=rifampin lb1=and lib=resulted lib=in lib=an lib=82% lib=decrease lib=in la2=plasma la2=A.C.
advise dep=conj lib=and la2=should la2=not la2=be la2=coadministered. 2under1
null dep=conj lib=and la2=: la2=Coadministration la2=of la2=VIRACEPT la2=with la2=OVCON-35 la2=resulted la2=in la2=a la2=47% la2=decrease la2=in la2=ethinyl la2=estradiol la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations. 2under1
null dep=None lib=and lib=Norethindrone: lib=Coadministration lib=of la2=with la2=OVCON-35 la2=resulted la2=in la2=a la2=47% la2=decrease la2=in la2=ethinyl la2=estradiol la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations. 2under1
null dep=None lib=and lib=Norethindrone: lib=Coadministration lib=of lib=VIRACEPT lib=with la2=resulted la2=in la2=a la2=47% la2=decrease la2=in la2=ethinyl la2=estradiol la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations. 2under1
null dep=case lib=and lib=Norethindrone: lib=Coadministration lib=of lib=VIRACEPT lib=with lib=OVCON-35 lib=resulted lib=in lib=a lib=47% lib=decrease lib=in la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations.
null dep=None lib=and lib=Norethindrone: lib=Coadministration lib=of lib=VIRACEPT lib=with lib=OVCON-35 lib=resulted lib=in lib=a lib=47% lib=decrease lib=in lib=ethinyl lib=estradiol lib=and lib=an lib=18% lib=decrease lib=in la2=plasma la2=concentrations. 2under1
null dep=None lb1=Ethinyl lb1=Estradiol lb1=and lib=: lib=Coadministration lib=of la2=with la2=OVCON-35 la2=resulted la2=in la2=a la2=47% la2=decrease la2=in la2=ethinyl la2=estradiol la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations.
null dep=None lb1=Ethinyl lb1=Estradiol lb1=and lib=: lib=Coadministration lib=of lib=VIRACEPT lib=with la2=resulted la2=in la2=a la2=47% la2=decrease la2=in la2=ethinyl la2=estradiol la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations.
null dep=case lb1=Ethinyl lb1=Estradiol lb1=and lib=: lib=Coadministration lib=of lib=VIRACEPT lib=with lib=OVCON-35 lib=resulted lib=in lib=a lib=47% lib=decrease lib=in la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations.
null dep=None lb1=Ethinyl lb1=Estradiol lb1=and lib=: lib=Coadministration lib=of lib=VIRACEPT lib=with lib=OVCON-35 lib=resulted lib=in lib=a lib=47% lib=decrease lib=in lib=ethinyl lib=estradiol lib=and lib=an lib=18% lib=decrease lib=in la2=plasma la2=concentrations.
mechanism dep=None lb1=Ethinyl lb1=Estradiol lb1=and lb1=Norethindrone: lb1=Coadministration lb1=of lib=with la2=resulted la2=in la2=a la2=47% la2=decrease la2=in la2=ethinyl la2=estradiol la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations.
null dep=None lb1=Ethinyl lb1=Estradiol lb1=and lb1=Norethindrone: lb1=Coadministration lb1=of lib=with lib=OVCON-35 lib=resulted lib=in lib=a lib=47% lib=decrease lib=in la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations.
null dep=None lb1=Ethinyl lb1=Estradiol lb1=and lb1=Norethindrone: lb1=Coadministration lb1=of lib=with lib=OVCON-35 lib=resulted lib=in lib=a lib=47% lib=decrease lib=in lib=ethinyl lib=estradiol lib=and lib=an lib=18% lib=decrease lib=in la2=plasma la2=concentrations.
null dep=None lb1=Ethinyl lb1=Estradiol lb1=and lb1=Norethindrone: lb1=Coadministration lb1=of lb1=VIRACEPT lb1=with lib=resulted lib=in lib=a lib=47% lib=decrease lib=in la2=and la2=an la2=18% la2=decrease la2=in la2=norethindrone la2=plasma la2=concentrations.
null dep=None lb1=Ethinyl lb1=Estradiol lb1=and lb1=Norethindrone: lb1=Coadministration lb1=of lb1=VIRACEPT lb1=with lib=resulted lib=in lib=a lib=47% lib=decrease lib=in lib=ethinyl lib=estradiol lib=and lib=an lib=18% lib=decrease lib=in la2=plasma la2=concentrations.
null dep=case lb1=Ethinyl lb1=Estradiol lb1=and lb1=Norethindrone: lb1=Coadministration lb1=of lb1=VIRACEPT lb1=with lb1=OVCON-35 lb1=resulted lb1=in lb1=a lb1=47% lb1=decrease lb1=in lib=and lib=an lib=18% lib=decrease lib=in la2=plasma la2=concentrations.
null dep=compound lb1=- lib=, la2=, la2=or la2=narcotics: la2=Potentiation la2=of la2=otthostatic la2=hypotension la2=may la2=occur 1under2
null dep=None lb1=- lib=, lib=barbiturates, lib=or la2=: la2=Potentiation la2=of la2=otthostatic la2=hypotension la2=may la2=occur
null dep=conj lb1=- lb1=Alcohol, lib=, lib=or la2=: la2=Potentiation la2=of la2=otthostatic la2=hypotension la2=may la2=occur 2under1
null dep=None lb1=- lib=: lib=(Oral lib=agents lib=and la2=) la2=Dosage la2=adjustment la2=of la2=the la2=antidiabetic la2=drug la2=may la2=be la2=required 2under1
null dep=amod lb1=- lib=: lib=(Oral lib=agents lib=and lib=insulin) lib=Dosage lib=adjustment lib=of lib=the la2=may la2=be la2=required
null dep=None lb1=- lb1=Antidiabetic lb1=drugs: lb1=(Oral lb1=agents lb1=and lib=) lib=Dosage lib=adjustment lib=of lib=the la2=may la2=be la2=required
null dep=conj lb1=- lib=and la2=resins: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 2under1
null dep=compound lb1=- lib=and lib=colestipol la2=: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 1under2
null dep=None lb1=- lib=and lib=colestipol lib=resins: la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=conj lb1=- lib=and la2=resins: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 2under1
null dep=compound lb1=- lib=and lib=colestipol la2=: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 1under2
null dep=None lb1=- lib=and lib=colestipol lib=resins: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lib=and lib=colestipol lib=resins: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding lib=thiazide la2=s la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lb1=Cholestyramine lb1=and la2=: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 1under2
null dep=conj lb1=- lb1=Cholestyramine lb1=and lib=resins: la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 1under2
null dep=None lb1=- lb1=Cholestyramine lb1=and lib=resins: lib=Cholestytamine lib=and la2=resins: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lb1=Cholestyramine lb1=and la2=: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 1under2
null dep=None lb1=- lb1=Cholestyramine lb1=and lib=resins: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lb1=Cholestyramine lb1=and lib=resins: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding lib=thiazide la2=s la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=compound lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lib=: la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 2under1
null dep=None lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lib=: lib=Cholestytamine lib=and la2=resins: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 2under1
null dep=None lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lib=: lib=Cholestytamine lib=and lib=colestipol la2=: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 2under1
null dep=None lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lib=: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lib=: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding lib=thiazide la2=s la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 2under1
null dep=conj lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lb1=resins: lib=and la2=resins: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 2under1
null dep=compound lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lb1=resins: lib=and lib=colestipol la2=: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 1under2
mechanism dep=None lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lb1=resins: lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lb1=resins: lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding lib=thiazide la2=s la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lb1=Cholestyramine lb1=and la2=: la2=Cholestytamine la2=and la2=colestipol la2=resins la2=have la2=the la2=potential la2=of la2=binding la2=thiazide la2=diuretics la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 1under2
mechanism dep=None lb1=- lb1=Cholestyramine lb1=and lib=resins: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lb1=Cholestyramine lb1=and lib=resins: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding lib=thiazide la2=s la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lib=: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lib=: lib=Cholestytamine lib=and lib=colestipol lib=resins lib=have lib=the lib=potential lib=of lib=binding lib=thiazide la2=s la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract 2under1
null dep=None lb1=- lb1=Cholestyramine lb1=and lb1=colestipol lb1=resins: lb1=Cholestytamine lb1=and lb1=colestipol lb1=resins lb1=have lb1=the lb1=potential lb1=of lb1=binding lib=and lib=reducing la2=s la2=and la2=reducing la2=diuretic la2=absorption la2=from la2=the la2=gastrointestinal la2=tract
null dep=None lb1=- lib=, la2=: la2=Intensified la2=electrolyte la2=depletion, la2=particularly la2=hypokalemia 2under1
null dep=None lb1=- lib=, lib=nondepolarizing lib=(e.g., la2=): la2=Possible la2=increased la2=responsiveness la2=to la2=the la2=muscle la2=relaxant 2under1
null dep=compound lb1=- lib=, lib=nondepolarizing lib=(e.g., lib=tubocurarine): lib=Possible lib=increased lib=responsiveness lib=to lib=the la2=s, la2=nondepolarizing la2=(e.g., la2=tubocurarine): la2=Possible la2=increased la2=responsiveness la2=to la2=the la2=muscle la2=relaxant
null dep=None lb1=- lb1=Skeletal lb1=muscle lb1=relaxants, lb1=nondepolarizing lb1=(e.g., lib=): lib=Possible lib=increased lib=responsiveness lib=to lib=the la2=s, la2=nondepolarizing la2=(e.g., la2=tubocurarine): la2=Possible la2=increased la2=responsiveness la2=to la2=the la2=muscle la2=relaxant
advise dep=None lb1=- lib=: lib=Generally lib=should lib=not lib=be lib=given lib=with la2=.
mechanism dep=None lib=reduce lib=the lib=renal lib=clearance lib=of la2=and la2=add la2=a la2=high la2=risk la2=of la2=lithium la2=toxicity.
mechanism dep=None lib=reduce lib=the lib=renal lib=clearance lib=of la2=and la2=add la2=a la2=high la2=risk la2=of la2=lithium la2=toxicity.
null dep=None lb1=Diuretic lb1=agents lb1=reduce lb1=the lb1=renal lb1=clearance lb1=of lib=and lib=add lib=a lib=high lib=risk lib=of la2=and la2=add la2=a la2=high la2=risk la2=of la2=lithium la2=toxicity.
advise dep=None lb1=Refer lb1=to lb1=the lb1=package lb1=insert lb1=for lib=preparations lib=before lib=use lib=of lib=such lib=preparations lib=with
null dep=root lb1=- lib=: lib=In lib=some lib=patients, lib=the lib=administration lib=of lib=a la2=can la2=reduce la2=the la2=diuretic, la2=natriuretic, la2=and la2=antihypertensive la2=effects la2=of la2=loop, la2=potassium-sparing la2=and la2=thiazide la2=diuretics.
null dep=None lb1=-
null dep=root lb1=-
null dep=None lb1=- lib=: lib=In lib=some lib=patients, lib=the lib=administration lib=of lib=a lib=non-steroidal lib=anti-inflammatory lib=agent lib=can lib=reduce lib=the lib=diuretic, lib=natriuretic, lib=and lib=antihypertensive lib=effects lib=of lib=loop, lib=potassium-sparing lib=and la2=.
effect dep=None lb1=- lb1=Non-steroidal lb1=Anti-inflammatory lb1=Drugs: lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lb1=a
effect dep=det lb1=- lb1=Non-steroidal lb1=Anti-inflammatory lb1=Drugs: lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lb1=a
effect dep=det lb1=- lb1=Non-steroidal lb1=Anti-inflammatory lb1=Drugs: lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lb1=a lib=can lib=reduce lib=the lib=diuretic, lib=natriuretic, lib=and lib=antihypertensive lib=effects lib=of lib=loop, lib=potassium-sparing lib=and la2=.
null dep=conj lb1=- lb1=Non-steroidal lb1=Anti-inflammatory lb1=Drugs: lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lb1=a lb1=non-steroidal lb1=anti-inflammatory lb1=agent lb1=can lb1=reduce lb1=the lb1=diuretic, lb1=natriuretic, lb1=and lb1=antihypertensive lb1=effects lb1=of lb1=loop, lb1=potassium-sparing lb1=and lb1=thiazide lb1=diuretics.
null dep=conj lb1=- lb1=Non-steroidal lb1=Anti-inflammatory lb1=Drugs: lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lb1=a lb1=non-steroidal lb1=anti-inflammatory lb1=agent lb1=can lb1=reduce lb1=the lb1=diuretic, lb1=natriuretic, lb1=and lb1=antihypertensive lb1=effects lb1=of lb1=loop, lb1=potassium-sparing lb1=and lb1=thiazide lb1=diuretics. la2=.
null dep=amod lb1=- lb1=Non-steroidal lb1=Anti-inflammatory lb1=Drugs: lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lb1=a lb1=non-steroidal lb1=anti-inflammatory lb1=agent lb1=can lb1=reduce lb1=the lb1=diuretic, lb1=natriuretic, lb1=and lb1=antihypertensive lb1=effects lb1=of lb1=loop, lb1=potassium-sparing lb1=and lb1=thiazide lb1=diuretics. la2=.
advise dep=conj lb1=Therefore, lb1=when lib=and la2=are la2=used la2=concomitantly, la2=the la2=patient la2=should la2=be la2=observed la2=closely la2=to la2=determine la2=if la2=the la2=desired la2=effect la2=of la2=the la2=diuretic la2=is la2=obtained
null dep=None lb1=Therefore, lb1=when lib=and lib=non-steroidal lib=anti-inflammatory lib=agents lib=are lib=used lib=concomitantly, lib=the lib=patient lib=should lib=be lib=observed lib=closely lib=to lib=determine lib=if lib=the lib=desired lib=effect lib=of lib=the la2=is la2=obtained
null dep=None lb1=Therefore, lb1=when lb1=chlorothiazide lb1=and lib=are lib=used lib=concomitantly, lib=the lib=patient lib=should lib=be lib=observed lib=closely lib=to lib=determine lib=if lib=the lib=desired lib=effect lib=of lib=the la2=is la2=obtained
mechanism dep=None lib=: lib=May lib=increase lib=plasma lib=concentration lib=of la2=, la2=possibly la2=by la2=inhibiting la2=conjugation.
mechanism dep=None lb1=Combination lib=may lib=also lib=decrease lib=the lib=plasma lib=concentration lib=of la2=.
effect dep=None lib=: lib=Interferes lib=with lib=the lib=contraceptive lib=effect lib=of lib=microdosed la2=-containing la2=minipill la2=preparations.
mechanism dep=None lib=: lib=May lib=increase lib=CYP lib=metabolism lib=of la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
null dep=dep lib=( la2=, la2=tetracycline): la2=Pregnancy la2=has la2=been la2=reported la2=following la2=concomitant la2=use, la2=however, la2=pharmacokinetic la2=studies la2=have la2=not la2=shown la2=consistent la2=effects la2=with la2=these la2=antibiotics la2=on la2=plasma la2=concentrations la2=of la2=synthetic la2=steroids. 2under1
null dep=None lib=(ampicillin, la2=): la2=Pregnancy la2=has la2=been la2=reported la2=following la2=concomitant la2=use, la2=however, la2=pharmacokinetic la2=studies la2=have la2=not la2=shown la2=consistent la2=effects la2=with la2=these la2=antibiotics la2=on la2=plasma la2=concentrations la2=of la2=synthetic la2=steroids. 2under1
null dep=None lib=(ampicillin, lib=tetracycline): lib=Pregnancy lib=has lib=been lib=reported lib=following lib=concomitant lib=use, lib=however, lib=pharmacokinetic lib=studies lib=have lib=not lib=shown lib=consistent lib=effects lib=with lib=these la2=on la2=plasma la2=concentrations la2=of la2=synthetic la2=steroids. 2under1
null dep=None lib=(ampicillin, lib=tetracycline): lib=Pregnancy lib=has lib=been lib=reported lib=following lib=concomitant lib=use, lib=however, lib=pharmacokinetic lib=studies lib=have lib=not lib=shown lib=consistent lib=effects lib=with lib=these lib=antibiotics lib=on lib=plasma lib=concentrations lib=of la2=.
null dep=appos lb1=Antibiotics lb1=( lib=, la2=): la2=Pregnancy la2=has la2=been la2=reported la2=following la2=concomitant la2=use, la2=however, la2=pharmacokinetic la2=studies la2=have la2=not la2=shown la2=consistent la2=effects la2=with la2=these la2=antibiotics la2=on la2=plasma la2=concentrations la2=of la2=synthetic la2=steroids. 2under1
null dep=None lb1=Antibiotics lb1=( lib=, lib=tetracycline): lib=Pregnancy lib=has lib=been lib=reported lib=following lib=concomitant lib=use, lib=however, lib=pharmacokinetic lib=studies lib=have lib=not lib=shown lib=consistent lib=effects lib=with lib=these la2=on la2=plasma la2=concentrations la2=of la2=synthetic la2=steroids.
null dep=None lb1=Antibiotics lb1=( lib=, lib=tetracycline): lib=Pregnancy lib=has lib=been lib=reported lib=following lib=concomitant lib=use, lib=however, lib=pharmacokinetic lib=studies lib=have lib=not lib=shown lib=consistent lib=effects lib=with lib=these lib=antibiotics lib=on lib=plasma lib=concentrations lib=of la2=.
null dep=None lb1=Antibiotics lb1=(ampicillin, lib=): lib=Pregnancy lib=has lib=been lib=reported lib=following lib=concomitant lib=use, lib=however, lib=pharmacokinetic lib=studies lib=have lib=not lib=shown lib=consistent lib=effects lib=with lib=these la2=on la2=plasma la2=concentrations la2=of la2=synthetic la2=steroids.
null dep=None lb1=Antibiotics lb1=(ampicillin, lib=): lib=Pregnancy lib=has lib=been lib=reported lib=following lib=concomitant lib=use, lib=however, lib=pharmacokinetic lib=studies lib=have lib=not lib=shown lib=consistent lib=effects lib=with lib=these lib=antibiotics lib=on lib=plasma lib=concentrations lib=of la2=.
null dep=None lb1=Antibiotics lb1=(ampicillin, lb1=tetracycline): lb1=Pregnancy lb1=has lb1=been lb1=reported lb1=following lb1=concomitant lb1=use, lb1=however, lb1=pharmacokinetic lb1=studies lb1=have lb1=not lb1=shown lb1=consistent lb1=effects lb1=with lb1=these lib=on lib=plasma lib=concentrations lib=of la2=.
null dep=None lib=: lib=Combination la2=may la2=increase la2=or la2=decrease la2=the la2=effects la2=of la2=coumarin la2=derivatives.
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=increase lib=or lib=decrease lib=the lib=effects lib=of la2=.
effect dep=None lb1=Anticoagulants: lb1=Combination lib=may lib=increase lib=or lib=decrease lib=the lib=effects lib=of la2=.
null dep=dep lib=( la2=, la2=felbamate, la2=phenobarbital, la2=phenytoin, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
null dep=None lib=(carbamazepine, la2=, la2=phenobarbital, la2=phenytoin, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
null dep=None lib=(carbamazepine, lib=felbamate, la2=, la2=phenytoin, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
null dep=None lib=(carbamazepine, lib=felbamate, lib=phenobarbital, la2=, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
null dep=None lib=(carbamazepine, lib=felbamate, lib=phenobarbital, lib=phenytoin, la2=): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
mechanism dep=None lib=(carbamazepine, lib=felbamate, lib=phenobarbital, lib=phenytoin, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lib=(carbamazepine, lib=felbamate, lib=phenobarbital, lib=phenytoin, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and/or lib=some la2=, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
null dep=conj lb1=Anticonvulsants lb1=( lib=, la2=, la2=phenobarbital, la2=phenytoin, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
null dep=conj lb1=Anticonvulsants lb1=( lib=, lib=felbamate, la2=, la2=phenytoin, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
null dep=conj lb1=Anticonvulsants lb1=( lib=, lib=felbamate, lib=phenobarbital, la2=, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
null dep=appos lb1=Anticonvulsants lb1=( lib=, lib=felbamate, lib=phenobarbital, lib=phenytoin, la2=): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness. 2under1
mechanism dep=None lb1=Anticonvulsants lb1=( lib=, lib=felbamate, lib=phenobarbital, lib=phenytoin, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lb1=Anticonvulsants lb1=( lib=, lib=felbamate, lib=phenobarbital, lib=phenytoin, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and/or lib=some la2=, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
null dep=None lb1=Anticonvulsants lb1=(carbamazepine, lib=, la2=, la2=phenytoin, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
null dep=None lb1=Anticonvulsants lb1=(carbamazepine, lib=, lib=phenobarbital, la2=, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
null dep=None lb1=Anticonvulsants lb1=(carbamazepine, lib=, lib=phenobarbital, lib=phenytoin, la2=): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lb1=Anticonvulsants lb1=(carbamazepine, lib=, lib=phenobarbital, lib=phenytoin, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lb1=Anticonvulsants lb1=(carbamazepine, lib=, lib=phenobarbital, lib=phenytoin, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and/or lib=some la2=, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
null dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lib=, la2=, la2=topiramate): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
null dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lib=, lib=phenytoin, la2=): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lib=, lib=phenytoin, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lib=, lib=phenytoin, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and/or lib=some la2=, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
null dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lb1=phenobarbital, lib=, la2=): la2=Increase la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lb1=phenobarbital, lib=, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lb1=phenobarbital, lib=, lib=topiramate): lib=Increase lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and/or lib=some la2=, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lb1=phenobarbital, lb1=phenytoin, lib=): lib=Increase lib=the lib=metabolism lib=of la2=and/or la2=some la2=progestins, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
mechanism dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lb1=phenobarbital, lb1=phenytoin, lib=): lib=Increase lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and/or lib=some la2=, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
null dep=None lb1=Anticonvulsants lb1=(carbamazepine, lb1=felbamate, lb1=phenobarbital, lb1=phenytoin, lb1=topiramate): lb1=Increase lb1=the lb1=metabolism lb1=of lib=and/or lib=some la2=, la2=leading la2=to la2=possible la2=decrease la2=in la2=contraceptive la2=effectiveness.
null dep=amod lib=: lib=Doses lib=of la2=(vitamin la2=C) la2=1 la2=g/day la2=have la2=been la2=reported la2=to la2=increase la2=plasma la2=concentration la2=of la2=synthetic la2=estrogens la2=by la2=~47%, la2=possibly la2=by la2=inhibiting la2=conjugation;
null dep=appos lib=: lib=Doses lib=of lib=ascorbic lib=acid lib=( la2=) la2=1 la2=g/day la2=have la2=been la2=reported la2=to la2=increase la2=plasma la2=concentration la2=of la2=synthetic la2=estrogens la2=by la2=~47%, la2=possibly la2=by la2=inhibiting la2=conjugation;
null dep=None lib=: lib=Doses lib=of lib=ascorbic lib=acid lib=(vitamin lib=C) lib=1 lib=g/day lib=have lib=been lib=reported lib=to lib=increase lib=plasma lib=concentration lib=of la2=by la2=~47%, la2=possibly la2=by la2=inhibiting la2=conjugation;
null dep=appos lb1=Ascorbic lb1=acid: lb1=Doses lb1=of lib=( la2=) la2=1 la2=g/day la2=have la2=been la2=reported la2=to la2=increase la2=plasma la2=concentration la2=of la2=synthetic la2=estrogens la2=by la2=~47%, la2=possibly la2=by la2=inhibiting la2=conjugation;
mechanism dep=None lb1=Ascorbic lb1=acid: lb1=Doses lb1=of lib=(vitamin lib=C) lib=1 lib=g/day lib=have lib=been lib=reported lib=to lib=increase lib=plasma lib=concentration lib=of la2=by la2=~47%, la2=possibly la2=by la2=inhibiting la2=conjugation;
mechanism dep=None lb1=Ascorbic lb1=acid: lb1=Doses lb1=of lb1=ascorbic lb1=acid lb1=( lib=) lib=1 lib=g/day lib=have lib=been lib=reported lib=to lib=increase lib=plasma lib=concentration lib=of la2=by la2=~47%, la2=possibly la2=by la2=inhibiting la2=conjugation;
null dep=None lib=: la2=: la2=Atorvastatin la2=increases la2=the la2=AUC la2=for la2=norethindrone la2=and la2=ethinyl la2=estradiol. 2under1
null dep=None lib=: lib=Atorvastatin lib=increases lib=the lib=AUC lib=for la2=and la2=ethinyl la2=estradiol. 2under1
null dep=None lib=: lib=Atorvastatin lib=increases lib=the lib=AUC lib=for lib=norethindrone lib=and la2=.
mechanism dep=None lib=: lib=Atorvastatin lib=increases lib=the lib=AUC lib=for la2=and la2=ethinyl la2=estradiol. 2under1
mechanism dep=None lib=: lib=Atorvastatin lib=increases lib=the lib=AUC lib=for lib=norethindrone lib=and la2=.
null dep=conj lb1=Atorvastatin: lb1=Atorvastatin lb1=increases lb1=the lb1=AUC lb1=for lib=and la2=.
null dep=None lib=: lib=Combination la2=may la2=decrease la2=the la2=clearance la2=of la2=some la2=benzodiazepines la2=(alprazolam, la2=chlordiazepoxide, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam).
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=decrease lib=the lib=clearance lib=of lib=some la2=(alprazolam, la2=chlordiazepoxide, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam). 2under1
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=( la2=, la2=chlordiazepoxide, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam). 2under1
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, la2=, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam). 2under1
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, lib=chlordiazepoxide, la2=) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam). 2under1
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=( la2=, la2=oxazepam, la2=temazepam). 2under1
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, la2=, la2=temazepam). 2under1
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, lib=oxazepam, la2=). 2under1
mechanism dep=None lb1=Benzodiazepines: lb1=Combination lib=may lib=decrease lib=the lib=clearance lib=of lib=some la2=(alprazolam, la2=chlordiazepoxide, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam).
mechanism dep=None lb1=Benzodiazepines: lb1=Combination lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=( la2=, la2=chlordiazepoxide, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam).
mechanism dep=None lb1=Benzodiazepines: lb1=Combination lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, la2=, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam).
mechanism dep=None lb1=Benzodiazepines: lb1=Combination lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, lib=chlordiazepoxide, la2=) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam).
mechanism dep=None lb1=Benzodiazepines: lb1=Combination lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=( la2=, la2=oxazepam, la2=temazepam).
mechanism dep=None lb1=Benzodiazepines: lb1=Combination lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, la2=, la2=temazepam).
mechanism dep=None lb1=Benzodiazepines: lb1=Combination lib=may lib=decrease lib=the lib=clearance lib=of lib=some lib=benzodiazepines lib=(alprazolam, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, lib=oxazepam, la2=).
null dep=dep lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lib=( la2=, la2=chlordiazepoxide, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam). 2under1
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lib=(alprazolam, la2=, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam). 2under1
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lib=(alprazolam, lib=chlordiazepoxide, la2=) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam). 2under1
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lib=(alprazolam, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=( la2=, la2=oxazepam, la2=temazepam).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lib=(alprazolam, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, la2=, la2=temazepam).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lib=(alprazolam, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, lib=oxazepam, la2=).
null dep=appos lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=( lib=, la2=, la2=diazepam) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam). 2under1
null dep=appos lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=( lib=, lib=chlordiazepoxide, la2=) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam). 2under1
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=( lib=, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=( la2=, la2=oxazepam, la2=temazepam).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=( lib=, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, la2=, la2=temazepam).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=( lib=, lib=chlordiazepoxide, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, lib=oxazepam, la2=).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lib=, la2=) la2=and la2=increase la2=the la2=clearance la2=of la2=others la2=(lorazepam, la2=oxazepam, la2=temazepam).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lib=, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=( la2=, la2=oxazepam, la2=temazepam).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lib=, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, la2=, la2=temazepam).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lib=, lib=diazepam) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, lib=oxazepam, la2=).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lb1=chlordiazepoxide, lib=) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=( la2=, la2=oxazepam, la2=temazepam).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lb1=chlordiazepoxide, lib=) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, la2=, la2=temazepam).
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lb1=chlordiazepoxide, lib=) lib=and lib=increase lib=the lib=clearance lib=of lib=others lib=(lorazepam, lib=oxazepam, la2=).
null dep=appos lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lb1=chlordiazepoxide, lb1=diazepam) lb1=and lb1=increase lb1=the lb1=clearance lb1=of lb1=others lb1=( lib=, la2=, la2=temazepam). 2under1
null dep=appos lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lb1=chlordiazepoxide, lb1=diazepam) lb1=and lb1=increase lb1=the lb1=clearance lb1=of lb1=others lb1=( lib=, lib=oxazepam, la2=). 2under1
null dep=None lb1=Benzodiazepines: lb1=Combination lb1=hormonal lb1=contraceptives lb1=may lb1=decrease lb1=the lb1=clearance lb1=of lb1=some lb1=benzodiazepines lb1=(alprazolam, lb1=chlordiazepoxide, lb1=diazepam) lb1=and lb1=increase lb1=the lb1=clearance lb1=of lb1=others lb1=(lorazepam, lib=, la2=).
null dep=None lib=: lib=Combination la2=may la2=increase la2=the la2=clearance la2=of la2=clofibric la2=acid.
null dep=amod lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=increase lib=the lib=clearance lib=of la2=.
mechanism dep=None lb1=Clofibric lb1=acid: lb1=Combination lib=may lib=increase lib=the lib=clearance lib=of la2=.
null dep=None lib=: lib=Combination la2=may la2=inhibit la2=the la2=metabolism la2=of la2=cyclosporine, la2=leading la2=to la2=increased la2=plasma la2=concentrations;
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=inhibit lib=the lib=metabolism lib=of la2=, la2=leading la2=to la2=increased la2=plasma la2=concentrations; 2under1
mechanism dep=None lb1=Cyclosporine: lb1=Combination lib=may lib=inhibit lib=the lib=metabolism lib=of la2=, la2=leading la2=to la2=increased la2=plasma la2=concentrations;
null dep=conj lb1=Example lb1=inducers lb1=include lib=, la2=, la2=nafcillin, la2=nevirapine, la2=phenobarbital, la2=phenytoin, la2=and la2=rifamycins. 2under1
null dep=conj lb1=Example lb1=inducers lb1=include lib=, lib=carbamazepine, la2=, la2=nevirapine, la2=phenobarbital, la2=phenytoin, la2=and la2=rifamycins. 2under1
null dep=conj lb1=Example lb1=inducers lb1=include lib=, lib=carbamazepine, lib=nafcillin, la2=, la2=phenobarbital, la2=phenytoin, la2=and la2=rifamycins. 2under1
null dep=conj lb1=Example lb1=inducers lb1=include lib=, lib=carbamazepine, lib=nafcillin, lib=nevirapine, la2=, la2=phenytoin, la2=and la2=rifamycins. 2under1
null dep=conj lb1=Example lb1=inducers lb1=include lib=, lib=carbamazepine, lib=nafcillin, lib=nevirapine, lib=phenobarbital, la2=, la2=and la2=rifamycins. 2under1
null dep=conj lb1=Example lb1=inducers lb1=include lib=, lib=carbamazepine, lib=nafcillin, lib=nevirapine, lib=phenobarbital, lib=phenytoin, lib=and la2=. 2under1
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lib=, la2=, la2=nevirapine, la2=phenobarbital, la2=phenytoin, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lib=, lib=nafcillin, la2=, la2=phenobarbital, la2=phenytoin, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lib=, lib=nafcillin, lib=nevirapine, la2=, la2=phenytoin, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lib=, lib=nafcillin, lib=nevirapine, lib=phenobarbital, la2=, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lib=, lib=nafcillin, lib=nevirapine, lib=phenobarbital, lib=phenytoin, lib=and la2=.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lib=, la2=, la2=phenobarbital, la2=phenytoin, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lib=, lib=nevirapine, la2=, la2=phenytoin, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lib=, lib=nevirapine, lib=phenobarbital, la2=, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lib=, lib=nevirapine, lib=phenobarbital, lib=phenytoin, lib=and la2=.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lb1=nafcillin, lib=, la2=, la2=phenytoin, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lb1=nafcillin, lib=, lib=phenobarbital, la2=, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lb1=nafcillin, lib=, lib=phenobarbital, lib=phenytoin, lib=and la2=.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lb1=nafcillin, lb1=nevirapine, lib=, la2=, la2=and la2=rifamycins.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lb1=nafcillin, lb1=nevirapine, lib=, lib=phenytoin, lib=and la2=.
null dep=None lb1=Example lb1=inducers lb1=include lb1=aminoglutethimide, lb1=carbamazepine, lb1=nafcillin, lb1=nevirapine, lb1=phenobarbital, lib=, lib=and la2=.
null dep=None lib=: la2=: la2=Griseofulvin la2=may la2=induce la2=the la2=metabolism la2=of la2=combination la2=hormonal la2=contraceptives la2=causing la2=menstrual la2=changes; 2under1
null dep=case lib=: lib=Griseofulvin lib=may lib=induce lib=the lib=metabolism lib=of la2=causing la2=menstrual la2=changes;
mechanism dep=case lib=: lib=Griseofulvin lib=may lib=induce lib=the lib=metabolism lib=of la2=causing la2=menstrual la2=changes;
null dep=None lib=: lib=Combination la2=may la2=increase la2=the la2=clearance la2=of la2=morphine.
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=increase lib=the lib=clearance lib=of la2=. 2under1
mechanism dep=None lb1=Morphine: lb1=Combination lib=may lib=increase lib=the lib=clearance lib=of la2=.
null dep=appos lib=( la2=): la2=Nevirapine la2=may la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives; 2under1
null dep=None lib=(NNRTIs): la2=may la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives; 2under1
null dep=None lib=(NNRTIs): lib=Nevirapine lib=may lib=decrease lib=plasma lib=levels lib=of la2=;
null dep=None lb1=Non-nucleoside lb1=reverse lb1=transcriptase lb1=inhibitors lb1=( lib=): la2=may la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives;
null dep=None lb1=Non-nucleoside lb1=reverse lb1=transcriptase lb1=inhibitors lb1=( lib=): lib=Nevirapine lib=may lib=decrease lib=plasma lib=levels lib=of la2=;
mechanism dep=None lb1=Non-nucleoside lb1=reverse lb1=transcriptase lb1=inhibitors lb1=(NNRTIs): lib=may lib=decrease lib=plasma lib=levels lib=of la2=;
null dep=None lib=: la2=may la2=inhibit la2=the la2=metabolism la2=of la2=prednisolone, la2=leading la2=to la2=increased la2=plasma la2=concentrations.
null dep=None lib=: lib=Ethinyl lib=estradiol lib=may lib=inhibit lib=the lib=metabolism lib=of la2=, la2=leading la2=to la2=increased la2=plasma la2=concentrations. 2under1
mechanism dep=None lb1=Prednisolone: lib=may lib=inhibit lib=the lib=metabolism lib=of la2=, la2=leading la2=to la2=increased la2=plasma la2=concentrations.
null dep=None lib=: la2=, la2=lopinavir, la2=nelfinavir, la2=and la2=ritonavir la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives; 2under1
null dep=None lib=: lib=Amprenavir, la2=, la2=nelfinavir, la2=and la2=ritonavir la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives; 2under1
null dep=None lib=: lib=Amprenavir, lib=lopinavir, la2=, la2=and la2=ritonavir la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives; 2under1
null dep=None lib=: lib=Amprenavir, lib=lopinavir, lib=nelfinavir, lib=and la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives; 2under1
null dep=None lib=: lib=Amprenavir, lib=lopinavir, lib=nelfinavir, lib=and lib=ritonavir lib=have lib=been lib=shown lib=to lib=decrease lib=plasma lib=levels lib=of la2=;
null dep=conj lb1=Protease lb1=inhibitors: lib=, la2=, la2=nelfinavir, la2=and la2=ritonavir la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives; 2under1
null dep=conj lb1=Protease lb1=inhibitors: lib=, lib=lopinavir, la2=, la2=and la2=ritonavir la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives; 2under1
null dep=conj lb1=Protease lb1=inhibitors: lib=, lib=lopinavir, lib=nelfinavir, lib=and la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives; 2under1
mechanism dep=None lb1=Protease lb1=inhibitors: lib=, lib=lopinavir, lib=nelfinavir, lib=and lib=ritonavir lib=have lib=been lib=shown lib=to lib=decrease lib=plasma lib=levels lib=of la2=;
null dep=None lb1=Protease lb1=inhibitors: lb1=Amprenavir, lib=, la2=, la2=and la2=ritonavir la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives;
null dep=None lb1=Protease lb1=inhibitors: lb1=Amprenavir, lib=, lib=nelfinavir, lib=and la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives;
mechanism dep=None lb1=Protease lb1=inhibitors: lb1=Amprenavir, lib=, lib=nelfinavir, lib=and lib=ritonavir lib=have lib=been lib=shown lib=to lib=decrease lib=plasma lib=levels lib=of la2=;
null dep=None lb1=Protease lb1=inhibitors: lb1=Amprenavir, lb1=lopinavir, lib=, lib=and la2=have la2=been la2=shown la2=to la2=decrease la2=plasma la2=levels la2=of la2=combination la2=hormonal la2=contraceptives;
mechanism dep=None lb1=Protease lb1=inhibitors: lb1=Amprenavir, lb1=lopinavir, lib=, lib=and lib=ritonavir lib=have lib=been lib=shown lib=to lib=decrease lib=plasma lib=levels lib=of la2=;
mechanism dep=None lb1=Protease lb1=inhibitors: lb1=Amprenavir, lb1=lopinavir, lb1=nelfinavir, lb1=and lib=have lib=been lib=shown lib=to lib=decrease lib=plasma lib=levels lib=of la2=;
mechanism dep=None lib=has lib=been lib=shown lib=to lib=increase lib=plasma lib=levels lib=of la2=.
null dep=None lib=: la2=: la2=Rifampin la2=increases la2=the la2=metabolism la2=of la2=ethinyl la2=estradiol la2=and la2=some la2=progestins la2=(norethindrone) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities. 2under1
null dep=None lib=: lib=Rifampin lib=increases lib=the lib=metabolism lib=of la2=and la2=some la2=progestins la2=(norethindrone) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities.
null dep=None lib=: lib=Rifampin lib=increases lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and lib=some la2=(norethindrone) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities. 2under1
null dep=None lib=: lib=Rifampin lib=increases lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and lib=some lib=progestins lib=( la2=) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities. 2under1
mechanism dep=None lib=: lib=Rifampin lib=increases lib=the lib=metabolism lib=of la2=and la2=some la2=progestins la2=(norethindrone) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities.
mechanism dep=None lib=: lib=Rifampin lib=increases lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and lib=some la2=(norethindrone) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities. 2under1
mechanism dep=None lib=: lib=Rifampin lib=increases lib=the lib=metabolism lib=of lib=ethinyl lib=estradiol lib=and lib=some lib=progestins lib=( la2=) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities. 2under1
null dep=None lb1=Rifampin: lb1=Rifampin lb1=increases lb1=the lb1=metabolism lb1=of lib=and lib=some la2=(norethindrone) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities.
null dep=None lb1=Rifampin: lb1=Rifampin lb1=increases lb1=the lb1=metabolism lb1=of lib=and lib=some lib=progestins lib=( la2=) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities.
null dep=appos lb1=Rifampin: lb1=Rifampin lb1=increases lb1=the lb1=metabolism lb1=of lb1=ethinyl lb1=estradiol lb1=and lb1=some lib=( la2=) la2=resulting la2=in la2=decreased la2=contraceptive la2=effectiveness la2=and la2=increased la2=menstrual la2=irregularities. 2under1
null dep=None lib=: lib=Combination la2=may la2=increase la2=the la2=clearance la2=of la2=salicylic la2=acid.
null dep=amod lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=increase lib=the lib=clearance lib=of la2=.
mechanism dep=None lb1=Salicylic lb1=acid: lb1=Combination lib=may lib=increase lib=the lib=clearance lib=of la2=.
null dep=None lib=: la2=may la2=increase la2=the la2=serum la2=concentration la2=of la2=selegiline.
null dep=None lib=: lib=Combination lib=hormonal lib=contraceptives lib=may lib=increase lib=the lib=serum lib=concentration lib=of la2=. 2under1
mechanism dep=None lb1=Selegiline: lib=may lib=increase lib=the lib=serum lib=concentration lib=of la2=.
null dep=None lib=: la2=may la2=inhibit la2=the la2=metabolism la2=of la2=theophylline, la2=leading la2=to la2=increased la2=plasma la2=concentrations.
null dep=None lib=: lib=Ethinyl lib=estradiol lib=may lib=inhibit lib=the lib=metabolism lib=of la2=, la2=leading la2=to la2=increased la2=plasma la2=concentrations. 2under1
mechanism dep=None lb1=Theophylline: lib=may lib=inhibit lib=the lib=metabolism lib=of la2=, la2=leading la2=to la2=increased la2=plasma la2=concentrations.
null dep=dep lib=( la2=, la2=imipramine, la2=nortriptyline): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant; 2under1
null dep=None lib=(amitriptyline, la2=, la2=nortriptyline): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant; 2under1
null dep=None lib=(amitriptyline, lib=imipramine, la2=): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant; 2under1
mechanism dep=None lib=(amitriptyline, lib=imipramine, lib=nortriptyline): lib=Metabolism lib=may lib=be lib=inhibited lib=by la2=, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant;
null dep=None lib=(amitriptyline, lib=imipramine, lib=nortriptyline): lib=Metabolism lib=may lib=be lib=inhibited lib=by lib=combination lib=hormonal lib=contraceptives, lib=increasing lib=plasma lib=levels lib=of la2=s la2=(amitriptyline, la2=imipramine, la2=nortriptyline): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant; 2under1
null dep=appos lb1=Tricyclic lb1=antidepressants lb1=( lib=, la2=, la2=nortriptyline): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant; 2under1
null dep=appos lb1=Tricyclic lb1=antidepressants lb1=( lib=, lib=imipramine, la2=): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant; 2under1
mechanism dep=None lb1=Tricyclic lb1=antidepressants lb1=( lib=, lib=imipramine, lib=nortriptyline): lib=Metabolism lib=may lib=be lib=inhibited lib=by la2=, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant;
null dep=None lb1=Tricyclic lb1=antidepressants lb1=( lib=, lib=imipramine, lib=nortriptyline): lib=Metabolism lib=may lib=be lib=inhibited lib=by lib=combination lib=hormonal lib=contraceptives, lib=increasing lib=plasma lib=levels lib=of la2=s la2=(amitriptyline, la2=imipramine, la2=nortriptyline): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant;
null dep=None lb1=Tricyclic lb1=antidepressants lb1=(amitriptyline, lib=, la2=): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant;
mechanism dep=None lb1=Tricyclic lb1=antidepressants lb1=(amitriptyline, lib=, lib=nortriptyline): lib=Metabolism lib=may lib=be lib=inhibited lib=by la2=, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant;
null dep=None lb1=Tricyclic lb1=antidepressants lb1=(amitriptyline, lib=, lib=nortriptyline): lib=Metabolism lib=may lib=be lib=inhibited lib=by lib=combination lib=hormonal lib=contraceptives, lib=increasing lib=plasma lib=levels lib=of la2=s la2=(amitriptyline, la2=imipramine, la2=nortriptyline): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant;
mechanism dep=None lb1=Tricyclic lb1=antidepressants lb1=(amitriptyline, lb1=imipramine, lib=): lib=Metabolism lib=may lib=be lib=inhibited lib=by la2=, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant;
null dep=None lb1=Tricyclic lb1=antidepressants lb1=(amitriptyline, lb1=imipramine, lib=): lib=Metabolism lib=may lib=be lib=inhibited lib=by lib=combination lib=hormonal lib=contraceptives, lib=increasing lib=plasma lib=levels lib=of la2=s la2=(amitriptyline, la2=imipramine, la2=nortriptyline): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant;
null dep=None lb1=Tricyclic lb1=antidepressants lb1=(amitriptyline, lb1=imipramine, lb1=nortriptyline): lb1=Metabolism lb1=may lb1=be lb1=inhibited lb1=by lib=, lib=increasing lib=plasma lib=levels lib=of la2=s la2=(amitriptyline, la2=imipramine, la2=nortriptyline): la2=Metabolism la2=may la2=be la2=inhibited la2=by la2=combination la2=hormonal la2=contraceptives, la2=increasing la2=plasma la2=levels la2=of la2=antidepressant;
null dep=None lib=/ lib=NUTRITION lib=/ lib=HERB lib=INTERACTIONS: lib=Food: lib=CNS lib=effects lib=of la2=may la2=be la2=enhanced la2=if la2=combination la2=hormonal la2=contraceptives la2=are la2=used la2=concurrently la2=with la2=caffeine.
null dep=None lib=/ lib=NUTRITION lib=/ lib=HERB lib=INTERACTIONS: lib=Food: lib=CNS lib=effects lib=of lib=caffeine lib=may lib=be lib=enhanced lib=if la2=are la2=used la2=concurrently la2=with la2=caffeine.
null dep=None lib=/ lib=NUTRITION lib=/ lib=HERB lib=INTERACTIONS: lib=Food: lib=CNS lib=effects lib=of la2=may la2=be la2=enhanced la2=if la2=combination la2=hormonal la2=contraceptives la2=are la2=used la2=concurrently la2=with la2=caffeine.
null dep=None lb1=ETHANOL lb1=/ lb1=NUTRITION lb1=/ lb1=HERB lb1=INTERACTIONS: lb1=Food: lb1=CNS lb1=effects lb1=of lib=may lib=be lib=enhanced lib=if la2=are la2=used la2=concurrently la2=with la2=caffeine.
null dep=None lb1=ETHANOL lb1=/ lb1=NUTRITION lb1=/ lb1=HERB lb1=INTERACTIONS: lb1=Food: lb1=CNS lb1=effects lb1=of lib=may lib=be lib=enhanced lib=if lib=combination lib=hormonal lib=contraceptives lib=are lib=used lib=concurrently lib=with la2=may la2=be la2=enhanced la2=if la2=combination la2=hormonal la2=contraceptives la2=are la2=used la2=concurrently la2=with la2=caffeine.
effect dep=None lb1=ETHANOL lb1=/ lb1=NUTRITION lb1=/ lb1=HERB lb1=INTERACTIONS: lb1=Food: lb1=CNS lb1=effects lb1=of lb1=caffeine lb1=may lb1=be lb1=enhanced lb1=if lib=are lib=used lib=concurrently lib=with la2=may la2=be la2=enhanced la2=if la2=combination la2=hormonal la2=contraceptives la2=are la2=used la2=concurrently la2=with la2=caffeine.
null dep=None lb1=Grapefruit lb1=juice lb1=increases lib=concentrations lib=and lib=would lib=be lib=expected lib=to lib=increase la2=serum la2=levels la2=as la2=well;
null dep=conj lb1=In lb1=patients lb1=receiving lb1=a lb1=potent lb1=CYP3A4 lb1=inducer lb1=such lb1=as lib=or la2=, la2=a la2=dose la2=increase la2=to la2=500 la2=mg la2=daily la2=should la2=be la2=considered la2=in la2=the la2=absence la2=of la2=severe la2=adverse la2=drug la2=reaction, la2=and la2=clinical la2=response la2=and la2=adverse la2=events la2=should la2=be la2=carefully la2=monitored la2=(see la2=CLINICAL la2=PHARMACOLOGY-Pharmacokinetics-Drug-Drug la2=Interactions la2=and la2=DOSAGE la2=AND la2=ADMINISTRATION-Dosage la2=Adjustment la2=sections). 2under1
effect dep=None lb1=International lb1=Normalized lb1=Ratio lb1=(INR) lb1=elevations lb1=and/or lb1=bleeding lb1=events lb1=have lb1=been lb1=reported lb1=in lb1=some lb1=patients lb1=taking lib=while lib=on la2=therapy.
null dep=conj lb1=Substances lb1=that lb1=are lb1=potent lb1=inhibitors lb1=of lb1=CYP3A4 lb1=activity lb1=(eg, lib=and la2=) la2=decrease la2=gefitinib la2=metabolism la2=and la2=increase la2=gefitinib la2=plasma la2=concentrations. 2under1
mechanism dep=None lb1=Substances lb1=that lb1=are lb1=potent lb1=inhibitors lb1=of lb1=CYP3A4 lb1=activity lb1=(eg, lib=and lib=itraconazole) lib=decrease la2=metabolism la2=and la2=increase la2=gefitinib la2=plasma la2=concentrations.
mechanism dep=None lb1=Substances lb1=that lb1=are lb1=potent lb1=inhibitors lb1=of lb1=CYP3A4 lb1=activity lb1=(eg, lib=and lib=itraconazole) lib=decrease la2=metabolism la2=and la2=increase la2=gefitinib la2=plasma la2=concentrations.
mechanism dep=None lb1=Substances lb1=that lb1=are lb1=potent lb1=inhibitors lb1=of lb1=CYP3A4 lb1=activity lb1=(eg, lb1=ketoconazole lb1=and lib=) lib=decrease la2=metabolism la2=and la2=increase la2=gefitinib la2=plasma la2=concentrations.
mechanism dep=None lb1=Substances lb1=that lb1=are lb1=potent lb1=inhibitors lb1=of lb1=CYP3A4 lb1=activity lb1=(eg, lb1=ketoconazole lb1=and lib=) lib=decrease la2=metabolism la2=and la2=increase la2=gefitinib la2=plasma la2=concentrations.
null dep=None lb1=Substances lb1=that lb1=are lb1=potent lb1=inhibitors lb1=of lb1=CYP3A4 lb1=activity lb1=(eg, lb1=ketoconazole lb1=and lb1=itraconazole) lb1=decrease lib=metabolism lib=and lib=increase la2=metabolism la2=and la2=increase la2=gefitinib la2=plasma la2=concentrations.
null dep=nmod lb1=Drugs lb1=that lb1=cause lb1=significant lb1=sustained lb1=elevation lb1=in lb1=gastric lb1=pH lb1=( lib=such lib=as la2=or la2=cimetidine) la2=may la2=reduce la2=plasma la2=concentrations la2=of la2=IRESSA la2=and la2=therefore la2=potentially la2=may la2=reduce la2=efficacy. 2under1
null dep=None lb1=Drugs lb1=that lb1=cause lb1=significant lb1=sustained lb1=elevation lb1=in lb1=gastric lb1=pH lb1=( lib=such lib=as lib=ranitidine lib=or la2=) la2=may la2=reduce la2=plasma la2=concentrations la2=of la2=IRESSA la2=and la2=therefore la2=potentially la2=may la2=reduce la2=efficacy. 2under1
mechanism dep=None lb1=Drugs lb1=that lb1=cause lb1=significant lb1=sustained lb1=elevation lb1=in lb1=gastric lb1=pH lb1=( lib=such lib=as lib=ranitidine lib=or lib=cimetidine) lib=may lib=reduce lib=plasma lib=concentrations lib=of la2=and la2=therefore la2=potentially la2=may la2=reduce la2=efficacy.
null dep=conj lb1=Drugs lb1=that lb1=cause lb1=significant lb1=sustained lb1=elevation lb1=in lb1=gastric lb1=pH lb1=(histamine lb1=H2-receptor lb1=antagonists lb1=such lb1=as lib=or la2=) la2=may la2=reduce la2=plasma la2=concentrations la2=of la2=IRESSA la2=and la2=therefore la2=potentially la2=may la2=reduce la2=efficacy. 2under1
mechanism dep=None lb1=Drugs lb1=that lb1=cause lb1=significant lb1=sustained lb1=elevation lb1=in lb1=gastric lb1=pH lb1=(histamine lb1=H2-receptor lb1=antagonists lb1=such lb1=as lib=or lib=cimetidine) lib=may lib=reduce lib=plasma lib=concentrations lib=of la2=and la2=therefore la2=potentially la2=may la2=reduce la2=efficacy.
mechanism dep=None lb1=Drugs lb1=that lb1=cause lb1=significant lb1=sustained lb1=elevation lb1=in lb1=gastric lb1=pH lb1=(histamine lb1=H2-receptor lb1=antagonists lb1=such lb1=as lb1=ranitidine lb1=or lib=) lib=may lib=reduce lib=plasma lib=concentrations lib=of la2=and la2=therefore la2=potentially la2=may la2=reduce la2=efficacy.
null dep=conj lb1=Phase lb1=II lb1=clinical lb1=trial lb1=data, lb1=where lib=and la2=have la2=been la2=used la2=concomitantly, la2=indicate la2=that la2=IRESSA la2=may la2=exacerbate la2=the la2=neutropenic la2=effect la2=of la2=vinorelbine. 2under1
null dep=None lb1=Phase lb1=II lb1=clinical lb1=trial lb1=data, lb1=where lib=and lib=vinorelbine lib=have lib=been lib=used lib=concomitantly, lib=indicate lib=that la2=and la2=vinorelbine la2=have la2=been la2=used la2=concomitantly, la2=indicate la2=that la2=IRESSA la2=may la2=exacerbate la2=the la2=neutropenic la2=effect la2=of la2=vinorelbine.
null dep=conj lb1=Phase lb1=II lb1=clinical lb1=trial lb1=data, lb1=where lib=and la2=have la2=been la2=used la2=concomitantly, la2=indicate la2=that la2=IRESSA la2=may la2=exacerbate la2=the la2=neutropenic la2=effect la2=of la2=vinorelbine. 2under1
null dep=conj lb1=Phase lb1=II lb1=clinical lb1=trial lb1=data, lb1=where lb1=IRESSA lb1=and lib=have lib=been lib=used lib=concomitantly, lib=indicate lib=that la2=and la2=vinorelbine la2=have la2=been la2=used la2=concomitantly, la2=indicate la2=that la2=IRESSA la2=may la2=exacerbate la2=the la2=neutropenic la2=effect la2=of la2=vinorelbine. 1under2
null dep=None lb1=Phase lb1=II lb1=clinical lb1=trial lb1=data, lb1=where lb1=IRESSA lb1=and lib=have lib=been lib=used lib=concomitantly, lib=indicate lib=that lib=IRESSA lib=may lib=exacerbate lib=the lib=neutropenic lib=effect lib=of la2=have la2=been la2=used la2=concomitantly, la2=indicate la2=that la2=IRESSA la2=may la2=exacerbate la2=the la2=neutropenic la2=effect la2=of la2=vinorelbine.
effect dep=conj lb1=Phase lb1=II lb1=clinical lb1=trial lb1=data, lb1=where lib=and la2=have la2=been la2=used la2=concomitantly, la2=indicate la2=that la2=IRESSA la2=may la2=exacerbate la2=the la2=neutropenic la2=effect la2=of la2=vinorelbine. 2under1
null dep=appos lb1=The lb1=behavioral lb1=effects lb1=of lb1=the lb1=stereoisomers lb1=of lib=( la2=) la2=were la2=compared la2=with la2=those la2=of la2=phencyclidine la2=(PCP) la2=in la2=pigeons la2=and la2=squirrel la2=monkeys la2=responding la2=under la2=a la2=multiple la2=fixed-interval la2=fixed-ratio la2=(FI la2=FR) la2=schedule la2=of la2=food la2=presentation. 2under1
null dep=None lb1=The lb1=behavioral lb1=effects lb1=of lb1=the lb1=stereoisomers lb1=of lib=(NANM) lib=were lib=compared lib=with lib=those lib=of la2=(PCP) la2=in la2=pigeons la2=and la2=squirrel la2=monkeys la2=responding la2=under la2=a la2=multiple la2=fixed-interval la2=fixed-ratio la2=(FI la2=FR) la2=schedule la2=of la2=food la2=presentation.
null dep=None lb1=The lb1=behavioral lb1=effects lb1=of lb1=the lb1=stereoisomers lb1=of lib=(NANM) lib=were lib=compared lib=with lib=those lib=of lib=phencyclidine lib=( la2=) la2=in la2=pigeons la2=and la2=squirrel la2=monkeys la2=responding la2=under la2=a la2=multiple la2=fixed-interval la2=fixed-ratio la2=(FI la2=FR) la2=schedule la2=of la2=food la2=presentation.
null dep=None lb1=The lb1=behavioral lb1=effects lb1=of lb1=the lb1=stereoisomers lb1=of lb1=N-allylnormetazocine lb1=( lib=) lib=were lib=compared lib=with lib=those lib=of la2=(PCP) la2=in la2=pigeons la2=and la2=squirrel la2=monkeys la2=responding la2=under la2=a la2=multiple la2=fixed-interval la2=fixed-ratio la2=(FI la2=FR) la2=schedule la2=of la2=food la2=presentation.
null dep=None lb1=The lb1=behavioral lb1=effects lb1=of lb1=the lb1=stereoisomers lb1=of lb1=N-allylnormetazocine lb1=( lib=) lib=were lib=compared lib=with lib=those lib=of lib=phencyclidine lib=( la2=) la2=in la2=pigeons la2=and la2=squirrel la2=monkeys la2=responding la2=under la2=a la2=multiple la2=fixed-interval la2=fixed-ratio la2=(FI la2=FR) la2=schedule la2=of la2=food la2=presentation.
null dep=appos lb1=The lb1=behavioral lb1=effects lb1=of lb1=the lb1=stereoisomers lb1=of lb1=N-allylnormetazocine lb1=(NANM) lb1=were lb1=compared lb1=with lb1=those lb1=of lib=( la2=) la2=in la2=pigeons la2=and la2=squirrel la2=monkeys la2=responding la2=under la2=a la2=multiple la2=fixed-interval la2=fixed-ratio la2=(FI la2=FR) la2=schedule la2=of la2=food la2=presentation. 2under1
null dep=conj lb1=Intermediate lb1=doses lb1=of lib=or la2=produced la2=transient la2=increases la2=in la2=FI la2=responding la2=in la2=monkeys la2=and la2=sustained la2=increases la2=in la2=FI la2=responding la2=in la2=pigeons;
null dep=dep lb1=In lb1=monkeys, lib=was lib=about lib=10 lib=times lib=more lib=potent lib=than la2=in la2=decreasing la2=responding, la2=whereas la2=in la2=pigeons la2=(-)-NANM la2=was la2=about la2=equipotent la2=with la2=(+)-NANM.
null dep=punct lb1=In lb1=monkeys, lib=was lib=about lib=10 lib=times lib=more lib=potent lib=than lib=(+)-NANM lib=in lib=decreasing lib=responding, lib=whereas lib=in lib=pigeons la2=was la2=about la2=10 la2=times la2=more la2=potent la2=than la2=(+)-NANM la2=in la2=decreasing la2=responding, la2=whereas la2=in la2=pigeons la2=(-)-NANM la2=was la2=about la2=equipotent la2=with la2=(+)-NANM.
null dep=dep lb1=In lb1=monkeys, lib=was lib=about lib=10 lib=times lib=more lib=potent lib=than la2=in la2=decreasing la2=responding, la2=whereas la2=in la2=pigeons la2=(-)-NANM la2=was la2=about la2=equipotent la2=with la2=(+)-NANM.
null dep=dep lb1=In lb1=monkeys, lb1=(-)-NANM lb1=was lb1=about lb1=10 lb1=times lb1=more lb1=potent lb1=than lib=in lib=decreasing lib=responding, lib=whereas lib=in lib=pigeons la2=was la2=about la2=10 la2=times la2=more la2=potent la2=than la2=(+)-NANM la2=in la2=decreasing la2=responding, la2=whereas la2=in la2=pigeons la2=(-)-NANM la2=was la2=about la2=equipotent la2=with la2=(+)-NANM.
null dep=dep lb1=In lb1=monkeys, lb1=(-)-NANM lb1=was lb1=about lb1=10 lb1=times lb1=more lb1=potent lb1=than lib=in lib=decreasing lib=responding, lib=whereas lib=in lib=pigeons lib=(-)-NANM lib=was lib=about lib=equipotent lib=with la2=in la2=decreasing la2=responding, la2=whereas la2=in la2=pigeons la2=(-)-NANM la2=was la2=about la2=equipotent la2=with la2=(+)-NANM.
null dep=dep lb1=In lb1=monkeys, lib=was lib=about lib=10 lib=times lib=more lib=potent lib=than la2=in la2=decreasing la2=responding, la2=whereas la2=in la2=pigeons la2=(-)-NANM la2=was la2=about la2=equipotent la2=with la2=(+)-NANM.
null dep=punct lb1=In lb1=both lb1=species, lib=, lib=but lib=not la2=, la2=antagonized la2=the la2=rate-decreasing la2=effects la2=of la2=morphine la2=on la2=FI la2=and la2=FR la2=responding.
effect dep=None lb1=In lb1=both lb1=species, lib=, lib=but lib=not lib=(+)-NANM, lib=antagonized lib=the lib=rate-decreasing lib=effects lib=of la2=on la2=FI la2=and la2=FR la2=responding.
null dep=None lb1=In lb1=both lb1=species, lb1=(-)-NANM, lb1=but lb1=not lib=, lib=antagonized lib=the lib=rate-decreasing lib=effects lib=of la2=on la2=FI la2=and la2=FR la2=responding.
null dep=punct lb1=In lb1=monkeys, lb1=the lb1=effects lb1=of lib=, lib=but lib=not la2=or la2=PCP, la2=were la2=antagonized la2=by la2=naloxone;
null dep=conj lb1=In lb1=monkeys, lb1=the lb1=effects lb1=of lib=, lib=but lib=not lib=(+)-NANM lib=or la2=, la2=were la2=antagonized la2=by la2=naloxone;
effect dep=None lb1=In lb1=monkeys, lb1=the lb1=effects lb1=of lib=, lib=but lib=not lib=(+)-NANM lib=or lib=PCP, lib=were lib=antagonized lib=by la2=;
null dep=conj lb1=In lb1=monkeys, lb1=the lb1=effects lb1=of lb1=(-)-NANM, lb1=but lb1=not lib=or la2=, la2=were la2=antagonized la2=by la2=naloxone;
null dep=None lb1=In lb1=monkeys, lb1=the lb1=effects lb1=of lb1=(-)-NANM, lb1=but lb1=not lib=or lib=PCP, lib=were lib=antagonized lib=by la2=;
null dep=None lb1=In lb1=monkeys, lb1=the lb1=effects lb1=of lb1=(-)-NANM, lb1=but lb1=not lb1=(+)-NANM lb1=or lib=, lib=were lib=antagonized lib=by la2=;
effect dep=None lb1=the lb1=doses lb1=of lib=required lib=to lib=antagonize lib=the lib=effects lib=of la2=were la2=more la2=than la2=100 la2=times la2=higher la2=than la2=those la2=required la2=to la2=antagonize la2=the la2=effects la2=of la2=morphine.
effect dep=None lb1=the lb1=doses lb1=of lib=required lib=to lib=antagonize lib=the lib=effects lib=of lib=(-)-NANM lib=were lib=more lib=than lib=100 lib=times lib=higher lib=than lib=those lib=required lib=to lib=antagonize lib=the lib=effects lib=of la2=.
null dep=None lb1=the lb1=doses lb1=of lb1=naloxone lb1=required lb1=to lb1=antagonize lb1=the lb1=effects lb1=of lib=were lib=more lib=than lib=100 lib=times lib=higher lib=than lib=those lib=required lib=to lib=antagonize lib=the lib=effects lib=of la2=.
null dep=None lb1=In lb1=pigeons, lib=did lib=not lib=systematically lib=alter lib=the lib=effects lib=of la2=, la2=(+)-NANM la2=or la2=PCP.
null dep=None lb1=In lb1=pigeons, lib=did lib=not lib=systematically lib=alter lib=the lib=effects lib=of lib=(-)-NANM, la2=or la2=PCP.
null dep=None lb1=In lb1=pigeons, lib=did lib=not lib=systematically lib=alter lib=the lib=effects lib=of lib=(-)-NANM, lib=(+)-NANM lib=or la2=.
null dep=punct lb1=In lb1=pigeons, lb1=naloxone lb1=did lb1=not lb1=systematically lb1=alter lb1=the lb1=effects lb1=of lib=, la2=or la2=PCP.
null dep=conj lb1=In lb1=pigeons, lb1=naloxone lb1=did lb1=not lb1=systematically lb1=alter lb1=the lb1=effects lb1=of lib=, lib=(+)-NANM lib=or la2=.
null dep=conj lb1=In lb1=pigeons, lb1=naloxone lb1=did lb1=not lb1=systematically lb1=alter lb1=the lb1=effects lb1=of lb1=(-)-NANM, lib=or la2=.
effect dep=None lib=reduced lib=or lib=eliminated lib=the lib=increases lib=in lib=FI lib=responding lib=produced lib=by lib=intermediate lib=doses lib=of lib=either la2=or la2=PCP la2=in la2=pigeons, la2=but la2=did la2=not la2=antagonize la2=the la2=decreases la2=in la2=FI la2=or la2=FR la2=responding la2=produced la2=by la2=high la2=doses la2=of la2=PCP la2=or la2=either la2=stereoisomer la2=of la2=NANM.
effect dep=None lib=reduced lib=or lib=eliminated lib=the lib=increases lib=in lib=FI lib=responding lib=produced lib=by lib=intermediate lib=doses lib=of lib=either lib=(+)-NANM lib=or la2=in la2=pigeons, la2=but la2=did la2=not la2=antagonize la2=the la2=decreases la2=in la2=FI la2=or la2=FR la2=responding la2=produced la2=by la2=high la2=doses la2=of la2=PCP la2=or la2=either la2=stereoisomer la2=of la2=NANM.
null dep=None lib=reduced lib=or lib=eliminated lib=the lib=increases lib=in lib=FI lib=responding lib=produced lib=by lib=intermediate lib=doses lib=of lib=either lib=(+)- la2=or la2=PCP la2=in la2=pigeons, la2=but la2=did la2=not la2=antagonize la2=the la2=decreases la2=in la2=FI la2=or la2=FR la2=responding la2=produced la2=by la2=high la2=doses la2=of la2=PCP la2=or la2=either la2=stereoisomer la2=of la2=NANM.
null dep=conj lb1=Haloperidol lb1=reduced lb1=or lb1=eliminated lb1=the lb1=increases lb1=in lb1=FI lb1=responding lb1=produced lb1=by lb1=intermediate lb1=doses lb1=of lb1=either lib=or la2=in la2=pigeons, la2=but la2=did la2=not la2=antagonize la2=the la2=decreases la2=in la2=FI la2=or la2=FR la2=responding la2=produced la2=by la2=high la2=doses la2=of la2=PCP la2=or la2=either la2=stereoisomer la2=of la2=NANM.
null dep=conj lb1=Haloperidol lb1=reduced lb1=or lb1=eliminated lb1=the lb1=increases lb1=in lb1=FI lb1=responding lb1=produced lb1=by lb1=intermediate lb1=doses lb1=of lb1=either lib=or lib=PCP lib=in lib=pigeons, lib=but lib=did lib=not lib=antagonize lib=the lib=decreases lib=in lib=FI lib=or lib=FR lib=responding lib=produced lib=by lib=high lib=doses lib=of lib=PCP lib=or lib=either lib=stereoisomer lib=of la2=or la2=PCP la2=in la2=pigeons, la2=but la2=did la2=not la2=antagonize la2=the la2=decreases la2=in la2=FI la2=or la2=FR la2=responding la2=produced la2=by la2=high la2=doses la2=of la2=PCP la2=or la2=either la2=stereoisomer la2=of la2=NANM.
null dep=conj lb1=Haloperidol lb1=reduced lb1=or lb1=eliminated lb1=the lb1=increases lb1=in lb1=FI lb1=responding lb1=produced lb1=by lb1=intermediate lb1=doses lb1=of lb1=either lb1=(+)-NANM lb1=or lib=in lib=pigeons, lib=but lib=did lib=not lib=antagonize lib=the lib=decreases lib=in lib=FI lib=or lib=FR lib=responding lib=produced lib=by lib=high lib=doses lib=of lib=PCP lib=or lib=either lib=stereoisomer lib=of la2=or la2=PCP la2=in la2=pigeons, la2=but la2=did la2=not la2=antagonize la2=the la2=decreases la2=in la2=FI la2=or la2=FR la2=responding la2=produced la2=by la2=high la2=doses la2=of la2=PCP la2=or la2=either la2=stereoisomer la2=of la2=NANM. 1under2
null dep=conj lb1=The lb1=effects lb1=of lib=, la2=and la2=cocaine la2=on la2=bar-press la2=behavior la2=in la2=normal la2=and la2=genetically la2=nervous la2=dogs. 2under1
null dep=conj lb1=The lb1=effects lb1=of lib=, lib=amphetamine lib=and la2=on la2=bar-press la2=behavior la2=in la2=normal la2=and la2=genetically la2=nervous la2=dogs. 2under1
null dep=None lb1=The lb1=effects lb1=of lb1=chlordiazepoxide, lib=and la2=on la2=bar-press la2=behavior la2=in la2=normal la2=and la2=genetically la2=nervous la2=dogs.
null dep=det lb1=Studies lb1=on lb1=two lb1=strains lb1=of lb1=pointer lb1=dogs lb1=have lb1=demonstrated lb1=that lb1=administration lb1=of lb1=a lib=( la2=) la2=facilitates la2=acquisition la2=of la2=goal-directed la2=behavior la2=in la2="genetically la2=nervous" 2under1
null dep=conj lb1=The lb1=concomitant lb1=administration lb1=of lb1=either lib=or la2=, la2=compounds la2=which la2=inhibit la2=neuronal la2=reuptake la2=of la2=norepinephrine, la2=disrupts la2=the la2=behavioral la2=response la2=of la2=the la2=genetically la2=nervous la2=E-strain la2=subjects la2=to la2=a la2=far la2=greater la2=extent la2=than la2=the la2=stable la2=A-strain la2=subjects. 2under1
null dep=None lb1=METHODS: lb1=Clinical lb1=studies, lb1=case lb1=reports, lb1=and lb1=commentaries lb1=and lb1=editorials lb1=concerning lib=published lib=in lib=the lib=international lib=literature lib=between lib=January lib=1999 lib=and lib=August lib=2000 lib=were lib=identified lib=through lib=searches lib=of lib=MEDLINE, lib=PREMEDLINE, lib=and lib=International lib=Pharmaceutical lib=Abstracts, lib=using lib=the lib=terms la2=published la2=in la2=the la2=international la2=literature la2=between la2=January la2=1999 la2=and la2=August la2=2000 la2=were la2=identified la2=through la2=searches la2=of la2=MEDLINE, la2=PREMEDLINE, la2=and la2=International la2=Pharmaceutical la2=Abstracts, la2=using la2=the la2=terms la2=sildenafil, la2=Viagra, la2=and la2=erectile la2=dysfunction.
null dep=conj lb1=METHODS: lb1=Clinical lb1=studies, lb1=case lb1=reports, lb1=and lb1=commentaries lb1=and lb1=editorials lb1=concerning lib=published lib=in lib=the lib=international lib=literature lib=between lib=January lib=1999 lib=and lib=August lib=2000 lib=were lib=identified lib=through lib=searches lib=of lib=MEDLINE, lib=PREMEDLINE, lib=and lib=International lib=Pharmaceutical lib=Abstracts, lib=using lib=the lib=terms lib=sildenafil, la2=, la2=and la2=erectile la2=dysfunction.
null dep=conj lb1=METHODS: lb1=Clinical lb1=studies, lb1=case lb1=reports, lb1=and lb1=commentaries lb1=and lb1=editorials lb1=concerning lib=published lib=in lib=the lib=international lib=literature lib=between lib=January lib=1999 lib=and lib=August lib=2000 lib=were lib=identified lib=through lib=searches lib=of lib=MEDLINE, lib=PREMEDLINE, lib=and lib=International lib=Pharmaceutical lib=Abstracts, lib=using lib=the lib=terms lib=sildenafil, la2=, la2=and la2=erectile la2=dysfunction.
null dep=None lb1=RESULTS: lib=has lib=demonstrated lib=effectiveness lib=in lib=men lib=with lib=erectile lib=dysfunction lib=associated lib=with lib=prostatectomy, lib=radiation lib=therapy, lib=diabetes lib=mellitus, lib=certain lib=neurologic lib=disorders, lib=and lib=drug lib=therapy lib=(eg, la2=[SSRIs]).
null dep=None lb1=RESULTS: lib=has lib=demonstrated lib=effectiveness lib=in lib=men lib=with lib=erectile lib=dysfunction lib=associated lib=with lib=prostatectomy, lib=radiation lib=therapy, lib=diabetes lib=mellitus, lib=certain lib=neurologic lib=disorders, lib=and lib=drug lib=therapy lib=(eg, lib=selective lib=serotonin lib=reuptake lib=inhibitors lib=[ la2=]).
null dep=appos lb1=RESULTS: lb1=Sildenafil lb1=has lb1=demonstrated lb1=effectiveness lb1=in lb1=men lb1=with lb1=erectile lb1=dysfunction lb1=associated lb1=with lb1=prostatectomy, lb1=radiation lb1=therapy, lb1=diabetes lb1=mellitus, lb1=certain lb1=neurologic lb1=disorders, lb1=and lb1=drug lb1=therapy lb1=(eg, lib=[ la2=]). 2under1
effect dep=None lb1=however, lb1=patients lb1=with lb1=moderate lb1=to lb1=severe lb1=cardiovascular lb1=disease lb1=or lb1=those lb1=taking lib=therapy lib=are lib=at lib=increased lib=risk lib=for lib=potentially lib=serious lib=cardiovascular lib=adverse lib=effects lib=with la2=therapy.
null dep=None lb1=In lb1=addition, lb1=patients lb1=taking lb1=drugs lb1=that lb1=inhibit lb1=the lb1=cytochrome lb1=P450 lb1=3A4 lb1=isozyme, lb1=which lb1=metabolizes lib=, lib=may lib=experience lib=increased lib=drug lib=concentrations lib=and lib=possible lib=toxicity lib=from lib=normal lib=doses lib=of la2=, la2=may la2=experience la2=increased la2=drug la2=concentrations la2=and la2=possible la2=toxicity la2=from la2=normal la2=doses la2=of la2=sildenafil.
null dep=dep lib=( la2=- la2=or la2=magnesium-containing): la2=Concomitant la2=administration la2=of la2=300-mg la2=cefdinir la2=capsules la2=with la2=30 la2=mL la2=Maalox la2=TC la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%. 2under1
null dep=None lib=(aluminum- lib=or la2=-containing): la2=Concomitant la2=administration la2=of la2=300-mg la2=cefdinir la2=capsules la2=with la2=30 la2=mL la2=Maalox la2=TC la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%.
null dep=None lib=(aluminum- lib=or lib=magnesium-containing): lib=Concomitant lib=administration lib=of lib=300-mg la2=capsules la2=with la2=30 la2=mL la2=Maalox la2=TC la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%. 2under1
null dep=None lib=(aluminum- lib=or lib=magnesium-containing): lib=Concomitant lib=administration lib=of lib=300-mg lib=cefdinir lib=capsules lib=with lib=30 lib=mL la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%.
null dep=None lb1=Antacids lb1=( lib=- lib=or la2=-containing): la2=Concomitant la2=administration la2=of la2=300-mg la2=cefdinir la2=capsules la2=with la2=30 la2=mL la2=Maalox la2=TC la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%.
null dep=None lb1=Antacids lb1=( lib=- lib=or lib=magnesium-containing): lib=Concomitant lib=administration lib=of lib=300-mg la2=capsules la2=with la2=30 la2=mL la2=Maalox la2=TC la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%.
null dep=None lb1=Antacids lb1=( lib=- lib=or lib=magnesium-containing): lib=Concomitant lib=administration lib=of lib=300-mg lib=cefdinir lib=capsules lib=with lib=30 lib=mL la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%.
null dep=None lb1=Antacids lb1=(aluminum- lb1=or lib=-containing): lib=Concomitant lib=administration lib=of lib=300-mg la2=capsules la2=with la2=30 la2=mL la2=Maalox la2=TC la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%.
null dep=None lb1=Antacids lb1=(aluminum- lb1=or lib=-containing): lib=Concomitant lib=administration lib=of lib=300-mg lib=cefdinir lib=capsules lib=with lib=30 lib=mL la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%.
mechanism dep=None lb1=Antacids lb1=(aluminum- lb1=or lb1=magnesium-containing): lb1=Concomitant lb1=administration lb1=of lb1=300-mg lib=capsules lib=with lib=30 lib=mL la2=suspension la2=reduces la2=the la2=rate la2=(Cmax) la2=and la2=extent la2=(AUC) la2=of la2=absorption la2=by la2=approximately la2=40%.
null dep=None lb1=There lb1=are lb1=no lb1=significant lb1=effects lb1=on lib=pharmacokinetics lib=if lib=the la2=is la2=administered la2=2 la2=hours la2=before la2=or la2=2 la2=hours la2=after la2=cefdinir.
null dep=None lb1=There lb1=are lb1=no lb1=significant lb1=effects lb1=on lib=pharmacokinetics lib=if lib=the lib=antacid lib=is lib=administered lib=2 lib=hours lib=before lib=or lib=2 lib=hours lib=after la2=pharmacokinetics la2=if la2=the la2=antacid la2=is la2=administered la2=2 la2=hours la2=before la2=or la2=2 la2=hours la2=after la2=cefdinir.
null dep=None lb1=There lb1=are lb1=no lb1=significant lb1=effects lb1=on lb1=cefdinir lb1=pharmacokinetics lb1=if lb1=the lib=is lib=administered lib=2 lib=hours lib=before lib=or lib=2 lib=hours lib=after la2=pharmacokinetics la2=if la2=the la2=antacid la2=is la2=administered la2=2 la2=hours la2=before la2=or la2=2 la2=hours la2=after la2=cefdinir.
null dep=None lb1=If lib=are lib=required lib=during la2=therapy, la2=OMNICEF la2=should la2=be la2=taken la2=at la2=least la2=2 la2=hours la2=before la2=or la2=after la2=the la2=antacid.
null dep=None lb1=If lib=are lib=required lib=during la2=therapy, la2=OMNICEF la2=should la2=be la2=taken la2=at la2=least la2=2 la2=hours la2=before la2=or la2=after la2=the la2=antacid.
null dep=None lb1=If lib=are lib=required lib=during lib=OMNICEF lib=therapy, lib=OMNICEF lib=should lib=be lib=taken lib=at lib=least lib=2 lib=hours lib=before lib=or lib=after lib=the la2=s la2=are la2=required la2=during la2=OMNICEF la2=therapy, la2=OMNICEF la2=should la2=be la2=taken la2=at la2=least la2=2 la2=hours la2=before la2=or la2=after la2=the la2=antacid.
null dep=None lb1=If lb1=antacids lb1=are lb1=required lb1=during lib=therapy, la2=therapy, la2=OMNICEF la2=should la2=be la2=taken la2=at la2=least la2=2 la2=hours la2=before la2=or la2=after la2=the la2=antacid.
null dep=None lb1=If lb1=antacids lb1=are lb1=required lb1=during lib=therapy, lib=OMNICEF lib=should lib=be lib=taken lib=at lib=least lib=2 lib=hours lib=before lib=or lib=after lib=the la2=s la2=are la2=required la2=during la2=OMNICEF la2=therapy, la2=OMNICEF la2=should la2=be la2=taken la2=at la2=least la2=2 la2=hours la2=before la2=or la2=after la2=the la2=antacid.
advise dep=None lb1=If lb1=antacids lb1=are lb1=required lb1=during lib=therapy, lib=OMNICEF lib=should lib=be lib=taken lib=at lib=least lib=2 lib=hours lib=before lib=or lib=after lib=the la2=s la2=are la2=required la2=during la2=OMNICEF la2=therapy, la2=OMNICEF la2=should la2=be la2=taken la2=at la2=least la2=2 la2=hours la2=before la2=or la2=after la2=the la2=antacid.
null dep=None lib=: lib=As lib=with lib=other la2=, la2=probenecid la2=inhibits la2=the la2=renal la2=excretion la2=of la2=cefdinir, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life.
null dep=None lib=: lib=As lib=with lib=other lib=b-lactam lib=antibiotics, la2=inhibits la2=the la2=renal la2=excretion la2=of la2=cefdinir, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life. 2under1
null dep=None lib=: lib=As lib=with lib=other lib=b-lactam lib=antibiotics, lib=probenecid lib=inhibits lib=the lib=renal lib=excretion lib=of la2=, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life. 2under1
null dep=None lib=: lib=As lib=with lib=other lib=b-lactam lib=antibiotics, lib=probenecid lib=inhibits lib=the lib=renal lib=excretion lib=of la2=, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life. 2under1
null dep=None lb1=Probenecid: lb1=As lb1=with lb1=other lib=, la2=inhibits la2=the la2=renal la2=excretion la2=of la2=cefdinir, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life.
mechanism dep=None lb1=Probenecid: lb1=As lb1=with lb1=other lib=, lib=probenecid lib=inhibits lib=the lib=renal lib=excretion lib=of la2=, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life.
null dep=None lb1=Probenecid: lb1=As lb1=with lb1=other lib=, lib=probenecid lib=inhibits lib=the lib=renal lib=excretion lib=of la2=, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life.
mechanism dep=None lb1=Probenecid: lb1=As lb1=with lb1=other lb1=b-lactam lb1=antibiotics, lib=inhibits lib=the lib=renal lib=excretion lib=of la2=, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life.
null dep=None lb1=Probenecid: lb1=As lb1=with lb1=other lb1=b-lactam lb1=antibiotics, lib=inhibits lib=the lib=renal lib=excretion lib=of la2=, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life.
null dep=None lb1=Probenecid: lb1=As lb1=with lb1=other lb1=b-lactam lb1=antibiotics, lb1=probenecid lb1=inhibits lb1=the lb1=renal lb1=excretion lb1=of lib=, lib=resulting lib=in lib=an lib=approximate lib=doubling lib=in lib=A.C. lib=a lib=54% lib=increase lib=in lib=peak la2=, la2=resulting la2=in la2=an la2=approximate la2=doubling la2=in la2=A.C. la2=a la2=54% la2=increase la2=in la2=peak la2=cefdinir la2=plasma la2=levels, la2=and la2=a la2=50% la2=prolongation la2=in la2=the la2=apparent la2=elimination la2=half-life.
null dep=compound lib=and lib=Foods lib=Fortified lib=With la2=Supplements la2=and la2=Foods la2=Fortified la2=With la2=Iron la2=Concomitant la2=administration la2=of la2=cefdinir la2=with la2=a la2=therapeutic la2=iron la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively. 2under1
null dep=None lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of la2=with la2=a la2=therapeutic la2=iron la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of lib=cefdinir lib=with lib=a lib=therapeutic la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of lib=cefdinir lib=with lib=a lib=therapeutic la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of lib=cefdinir lib=with lib=a lib=therapeutic lib=iron lib=supplement lib=containing lib=60 lib=mg lib=of lib=elemental lib=iron lib=(as lib=FeSO4) lib=or la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of lib=cefdinir lib=with lib=a lib=therapeutic la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lib=Supplements lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of la2=with la2=a la2=therapeutic la2=iron la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lib=Supplements lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of lib=cefdinir lib=with lib=a lib=therapeutic la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lib=Supplements lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of lib=cefdinir lib=with lib=a lib=therapeutic la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lib=Supplements lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of lib=cefdinir lib=with lib=a lib=therapeutic lib=iron lib=supplement lib=containing lib=60 lib=mg lib=of lib=elemental lib=iron lib=(as lib=FeSO4) lib=or la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lib=Supplements lib=and lib=Foods lib=Fortified lib=With lib=Iron lib=Concomitant lib=administration lib=of lib=cefdinir lib=with lib=a lib=therapeutic la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lib=with lib=a lib=therapeutic la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
mechanism dep=None lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lib=with lib=a lib=therapeutic la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lib=with lib=a lib=therapeutic lib=iron lib=supplement lib=containing lib=60 lib=mg lib=of lib=elemental lib=iron lib=(as lib=FeSO4) lib=or la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
mechanism dep=None lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lib=with lib=a lib=therapeutic la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=compound lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lb1=cefdinir lb1=with lb1=a lb1=therapeutic lib=containing lib=60 lib=mg lib=of lib=elemental la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=det lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lb1=cefdinir lb1=with lb1=a lb1=therapeutic lib=containing lib=60 lib=mg lib=of lib=elemental lib=iron lib=(as lib=FeSO4) lib=or la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=compound lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lb1=cefdinir lb1=with lb1=a lb1=therapeutic lib=containing lib=60 lib=mg lib=of lib=elemental la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lb1=cefdinir lb1=with lb1=a lb1=therapeutic lib=supplement lib=containing lib=60 lib=mg lib=of lib=elemental lib=iron lib=(as lib=FeSO4) lib=or la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively. 1under2
null dep=None lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lb1=cefdinir lb1=with lb1=a lb1=therapeutic lib=supplement lib=containing lib=60 lib=mg lib=of lib=elemental la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively.
null dep=None lb1=Iron lb1=Supplements lb1=and lb1=Foods lb1=Fortified lb1=With lb1=Iron lb1=Concomitant lb1=administration lb1=of lb1=cefdinir lb1=with lb1=a lb1=therapeutic lb1=iron lb1=supplement lb1=containing lb1=60 lb1=mg lb1=of lb1=elemental lb1=iron lb1=(as lb1=FeSO4) lb1=or lib=supplemented lib=with lib=10 lib=mg lib=of lib=elemental la2=supplement la2=containing la2=60 la2=mg la2=of la2=elemental la2=iron la2=(as la2=FeSO4) la2=or la2=vitamins la2=supplemented la2=with la2=10 la2=mg la2=of la2=elemental la2=iron la2=reduced la2=extent la2=of la2=absorption la2=by la2=80% la2=and la2=31%, la2=respectively. 2under1
null dep=None lb1=If lib=are lib=required lib=during la2=therapy, la2=OMNICEF la2=should la2=be la2=taken la2=at la2=least la2=2 la2=hours la2=before la2=or la2=after la2=the la2=supplement.
advise dep=None lb1=If lib=are lib=required lib=during la2=therapy, la2=OMNICEF la2=should la2=be la2=taken la2=at la2=least la2=2 la2=hours la2=before la2=or la2=after la2=the la2=supplement.
null dep=None lb1=If lb1=iron lb1=supplements lb1=are lb1=required lb1=during lib=therapy, la2=therapy, la2=OMNICEF la2=should la2=be la2=taken la2=at la2=least la2=2 la2=hours la2=before la2=or la2=after la2=the la2=supplement.
null dep=None lb1=The lb1=effect lb1=of lb1=foods lb1=highly lb1=fortified lb1=with lb1=elemental lib=(primarily la2=(primarily la2=iron-fortified la2=breakfast la2=cereals) la2=on la2=cefdinir la2=absorption la2=has la2=not la2=been la2=studied.
null dep=None lb1=The lb1=effect lb1=of lb1=foods lb1=highly lb1=fortified lb1=with lb1=elemental lib=(primarily lib=iron-fortified lib=breakfast lib=cereals) lib=on la2=absorption la2=has la2=not la2=been la2=studied. 2under1
null dep=None lb1=The lb1=effect lb1=of lb1=foods lb1=highly lb1=fortified lb1=with lb1=elemental lib=(primarily lib=iron-fortified lib=breakfast lib=cereals) lib=on la2=absorption la2=has la2=not la2=been la2=studied. 2under1
null dep=None lb1=Concomitantly lb1=administered lib=-fortified lib=infant lib=formula lib=(2.2 lib=mg lib=elemental la2=-fortified la2=infant la2=formula la2=(2.2 la2=mg la2=elemental la2=iron/6 la2=oz) la2=has la2=no la2=significant la2=effect la2=on la2=cefdinir la2=pharmacokinetics.
null dep=None lb1=Concomitantly lb1=administered lib=-fortified lib=infant lib=formula lib=(2.2 lib=mg lib=elemental lib=iron/6 lib=oz) lib=has lib=no lib=significant lib=effect lib=on la2=pharmacokinetics.
null dep=None lb1=Concomitantly lb1=administered lib=-fortified lib=infant lib=formula lib=(2.2 lib=mg lib=elemental lib=iron/6 lib=oz) lib=has lib=no lib=significant lib=effect lib=on la2=pharmacokinetics.
null dep=None lb1=Therefore, lib=for lib=Oral lib=Suspension lib=can lib=be lib=administered lib=with la2=-fortified la2=infant la2=formula.
mechanism dep=conj lb1=The lb1=reddish lb1=color lb1=is lb1=due lb1=to lb1=the lb1=formation lb1=of lb1=a lb1=nonabsorbable lb1=complex lb1=between lib=or lib=its lib=breakdown lib=products lib=and la2=in la2=the la2=gastrointestinal la2=tract. 2under1
null dep=None lb1=Drug/Laboratory lb1=Test lb1=Interactions lb1=A lb1=false-positive lb1=reaction lb1=for lb1=ketones lb1=in lb1=the lb1=urine lb1=may lb1=occur lb1=with lb1=tests lb1=using lib=, lib=but lib=not lib=with lib=those lib=using la2=.
null dep=None lb1=The lb1=administration lb1=of lb1=local lib=containing la2=or la2=norepinephrine la2=to la2=patients la2=receiving la2=monoamine la2=oxidase la2=inhibitors la2=or la2=tricyclic la2=antidepressants la2=may la2=produce la2=severe, la2=prolonged la2=hypertension. 2under1
null dep=None lb1=The lb1=administration lb1=of lb1=local lib=containing lib=epinephrine lib=or la2=to la2=patients la2=receiving la2=monoamine la2=oxidase la2=inhibitors la2=or la2=tricyclic la2=antidepressants la2=may la2=produce la2=severe, la2=prolonged la2=hypertension. 2under1
null dep=None lb1=The lb1=administration lb1=of lb1=local lib=containing lib=epinephrine lib=or lib=norepinephrine lib=to lib=patients lib=receiving la2=or la2=tricyclic la2=antidepressants la2=may la2=produce la2=severe, la2=prolonged la2=hypertension.
null dep=None lb1=The lb1=administration lb1=of lb1=local lib=containing lib=epinephrine lib=or lib=norepinephrine lib=to lib=patients lib=receiving lib=monoamine lib=oxidase lib=inhibitors lib=or la2=may la2=produce la2=severe, la2=prolonged la2=hypertension.
null dep=cc lb1=The lb1=administration lb1=of lb1=local lb1=anesthetic lb1=solutions lb1=containing lib=or la2=to la2=patients la2=receiving la2=monoamine la2=oxidase la2=inhibitors la2=or la2=tricyclic la2=antidepressants la2=may la2=produce la2=severe, la2=prolonged la2=hypertension. 2under1
effect dep=cc lb1=The lb1=administration lb1=of lb1=local lb1=anesthetic lb1=solutions lb1=containing lib=or lib=norepinephrine lib=to lib=patients lib=receiving la2=or la2=tricyclic la2=antidepressants la2=may la2=produce la2=severe, la2=prolonged la2=hypertension.
effect dep=None lb1=The lb1=administration lb1=of lb1=local lb1=anesthetic lb1=solutions lb1=containing lib=or lib=norepinephrine lib=to lib=patients lib=receiving lib=monoamine lib=oxidase lib=inhibitors lib=or la2=may la2=produce la2=severe, la2=prolonged la2=hypertension.
effect dep=cc lb1=The lb1=administration lb1=of lb1=local lb1=anesthetic lb1=solutions lb1=containing lb1=epinephrine lb1=or lib=to lib=patients lib=receiving la2=or la2=tricyclic la2=antidepressants la2=may la2=produce la2=severe, la2=prolonged la2=hypertension.
effect dep=None lb1=The lb1=administration lb1=of lb1=local lb1=anesthetic lb1=solutions lb1=containing lb1=epinephrine lb1=or lib=to lib=patients lib=receiving lib=monoamine lib=oxidase lib=inhibitors lib=or la2=may la2=produce la2=severe, la2=prolonged la2=hypertension.
null dep=conj lb1=The lb1=administration lb1=of lb1=local lb1=anesthetic lb1=solutions lb1=containing lb1=epinephrine lb1=or lb1=norepinephrine lb1=to lb1=patients lb1=receiving lib=or la2=may la2=produce la2=severe, la2=prolonged la2=hypertension.
null dep=conj lib=and la2=may la2=reduce la2=or la2=reverse la2=the la2=pressor la2=effect la2=of la2=epinephrine. 2under1
effect dep=None lib=and lib=butyrophenones lib=may lib=reduce lib=or lib=reverse lib=the lib=pressor lib=effect lib=of la2=.
effect dep=None lb1=Phenothiazines lb1=and lib=may lib=reduce lib=or lib=reverse lib=the lib=pressor lib=effect lib=of la2=.
null dep=compound lb1=Concurrent lb1=administration lb1=of lib=(for lib=the lib=treatment lib=of lib=hypotension lib=related lib=to lib=obstetric lib=blocks) lib=and la2=may la2=cause la2=severe, la2=persistent la2=hypertension la2=or la2=cerebrovascular la2=accidents.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lib=, la2=, la2=niacin la2=(nicotinic la2=acid), la2=erythromycin, la2=azole la2=antifungals.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lib=, lib=fibric lib=acid lib=derivatives, la2=(nicotinic la2=acid), la2=erythromycin, la2=azole la2=antifungals.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lib=, lib=fibric lib=acid lib=derivatives, lib=niacin lib=( la2=), la2=erythromycin, la2=azole la2=antifungals.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lib=, lib=fibric lib=acid lib=derivatives, lib=niacin lib=(nicotinic lib=acid), la2=, la2=azole la2=antifungals.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lib=, lib=fibric lib=acid lib=derivatives, lib=niacin lib=(nicotinic lib=acid), lib=erythromycin, la2=.
null dep=appos lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lib=, la2=(nicotinic la2=acid), la2=erythromycin, la2=azole la2=antifungals.
null dep=compound lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lib=, lib=niacin lib=( la2=), la2=erythromycin, la2=azole la2=antifungals.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lib=, lib=niacin lib=(nicotinic lib=acid), la2=, la2=azole la2=antifungals.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lib=, lib=niacin lib=(nicotinic lib=acid), lib=erythromycin, la2=.
null dep=appos lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lb1=fibric lb1=acid lb1=derivatives, lib=( la2=), la2=erythromycin, la2=azole la2=antifungals.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lb1=fibric lb1=acid lb1=derivatives, lib=(nicotinic lib=acid), la2=, la2=azole la2=antifungals.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lb1=fibric lb1=acid lb1=derivatives, lib=(nicotinic lib=acid), lib=erythromycin, la2=.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lb1=fibric lb1=acid lb1=derivatives, lb1=niacin lb1=( lib=), la2=, la2=azole la2=antifungals.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lb1=fibric lb1=acid lb1=derivatives, lb1=niacin lb1=( lib=), lib=erythromycin, la2=.
null dep=None lb1=The lb1=risk lb1=of lb1=myopathy lb1=during lb1=treatment lb1=with lb1=drugs lb1=of lb1=this lb1=class lb1=is lb1=increased lb1=with lb1=concurrent lb1=administration lb1=of lb1=cyclosporine, lb1=fibric lb1=acid lb1=derivatives, lb1=niacin lb1=(nicotinic lb1=acid), lib=, la2=.
null dep=None lib=: lib=When la2=and la2=Maalox la2=TC la2=suspension la2=were la2=coadministered, la2=plasma la2=concentrations la2=of la2=atorvastatin la2=decreased la2=approximately la2=35%. 2under1
null dep=None lib=: lib=When lib=atorvastatin lib=and la2=suspension la2=were la2=coadministered, la2=plasma la2=concentrations la2=of la2=atorvastatin la2=decreased la2=approximately la2=35%.
null dep=None lib=: lib=When la2=and la2=Maalox la2=TC la2=suspension la2=were la2=coadministered, la2=plasma la2=concentrations la2=of la2=atorvastatin la2=decreased la2=approximately la2=35%. 2under1
mechanism dep=None lb1=Antacid: lb1=When lib=and la2=suspension la2=were la2=coadministered, la2=plasma la2=concentrations la2=of la2=atorvastatin la2=decreased la2=approximately la2=35%.
null dep=None lb1=Antacid: lb1=When lib=and lib=Maalox lib=TC lib=suspension lib=were lib=coadministered, lib=plasma lib=concentrations lib=of la2=and la2=Maalox la2=TC la2=suspension la2=were la2=coadministered, la2=plasma la2=concentrations la2=of la2=atorvastatin la2=decreased la2=approximately la2=35%.
null dep=None lb1=Antacid: lb1=When lb1=atorvastatin lb1=and lib=suspension lib=were lib=coadministered, lib=plasma lib=concentrations lib=of la2=and la2=Maalox la2=TC la2=suspension la2=were la2=coadministered, la2=plasma la2=concentrations la2=of la2=atorvastatin la2=decreased la2=approximately la2=35%.
null dep=None lib=: lib=Because la2=does la2=not la2=affect la2=the la2=pharmacokinetics la2=of la2=antipyrine, la2=interactions la2=with la2=other la2=drugs la2=metabolized la2=via la2=the la2=same la2=cytochrome la2=isozymes la2=are la2=not la2=expected. 2under1
null dep=None lib=: lib=Because lib=atorvastatin lib=does lib=not lib=affect lib=the lib=pharmacokinetics lib=of la2=, la2=interactions la2=with la2=other la2=drugs la2=metabolized la2=via la2=the la2=same la2=cytochrome la2=isozymes la2=are la2=not la2=expected. 2under1
null dep=None lib=: lib=Because lib=atorvastatin lib=does lib=not lib=affect lib=the lib=pharmacokinetics lib=of lib=antipyrine, lib=interactions lib=with lib=other la2=metabolized la2=via la2=the la2=same la2=cytochrome la2=isozymes la2=are la2=not la2=expected. 2under1
null dep=None lb1=Antipyrine: lb1=Because lib=does lib=not lib=affect lib=the lib=pharmacokinetics lib=of la2=, la2=interactions la2=with la2=other la2=drugs la2=metabolized la2=via la2=the la2=same la2=cytochrome la2=isozymes la2=are la2=not la2=expected.
null dep=None lb1=Antipyrine: lb1=Because lib=does lib=not lib=affect lib=the lib=pharmacokinetics lib=of lib=antipyrine, lib=interactions lib=with lib=other la2=metabolized la2=via la2=the la2=same la2=cytochrome la2=isozymes la2=are la2=not la2=expected.
null dep=None lb1=Antipyrine: lb1=Because lb1=atorvastatin lb1=does lb1=not lb1=affect lb1=the lb1=pharmacokinetics lb1=of lib=, lib=interactions lib=with lib=other la2=metabolized la2=via la2=the la2=same la2=cytochrome la2=isozymes la2=are la2=not la2=expected. 2under1
null dep=None lib=: lib=Plasma lib=concentrations lib=of la2=decreased la2=approximately la2=25% la2=when la2=colestipol la2=and la2=atorvastatin la2=were la2=coadministered. 2under1
null dep=None lib=: lib=Plasma lib=concentrations lib=of lib=atorvastatin lib=decreased lib=approximately lib=25% lib=when la2=and la2=atorvastatin la2=were la2=coadministered. 2under1
null dep=None lib=: lib=Plasma lib=concentrations lib=of la2=decreased la2=approximately la2=25% la2=when la2=colestipol la2=and la2=atorvastatin la2=were la2=coadministered. 2under1
null dep=conj lb1=Colestipol: lb1=Plasma lb1=concentrations lb1=of lib=decreased lib=approximately lib=25% lib=when la2=and la2=atorvastatin la2=were la2=coadministered. 1under2
null dep=None lb1=Colestipol: lb1=Plasma lb1=concentrations lb1=of lib=decreased lib=approximately lib=25% lib=when lib=colestipol lib=and la2=decreased la2=approximately la2=25% la2=when la2=colestipol la2=and la2=atorvastatin la2=were la2=coadministered.
mechanism dep=conj lb1=Colestipol: lb1=Plasma lb1=concentrations lb1=of lb1=atorvastatin lb1=decreased lb1=approximately lb1=25% lb1=when lib=and la2=decreased la2=approximately la2=25% la2=when la2=colestipol la2=and la2=atorvastatin la2=were la2=coadministered. 2under1
effect dep=conj lb1=However, lb1=LDL-C lb1=reduction lb1=was lb1=greater lb1=when lib=and la2=were la2=coadministered la2=than la2=when la2=either la2=drug la2=was la2=given la2=alone. 2under1
null dep=None lib=: la2=plasma la2=concentrations la2=and la2=LDL-C la2=reduction la2=were la2=not la2=altered la2=by la2=coadministration la2=of la2=cimetidine. 2under1
null dep=None lib=: lib=Atorvastatin lib=plasma lib=concentrations lib=and lib=LDL-C lib=reduction lib=were lib=not lib=altered lib=by lib=coadministration lib=of la2=. 2under1
null dep=None lb1=Cimetidine: lib=plasma lib=concentrations lib=and lib=LDL-C lib=reduction lib=were lib=not lib=altered lib=by lib=coadministration lib=of la2=.
null dep=None lib=: lib=When lib=multiple lib=doses lib=of la2=and la2=digoxin la2=were la2=coadministered, la2=steady-state la2=plasma la2=digoxin la2=concentrations la2=increased la2=by la2=approximately la2=20%. 2under1
null dep=None lib=: lib=When lib=multiple lib=doses lib=of lib=atorvastatin lib=and la2=were la2=coadministered, la2=steady-state la2=plasma la2=digoxin la2=concentrations la2=increased la2=by la2=approximately la2=20%. 2under1
null dep=None lib=: lib=When lib=multiple lib=doses lib=of lib=atorvastatin lib=and la2=were la2=coadministered, la2=steady-state la2=plasma la2=digoxin la2=concentrations la2=increased la2=by la2=approximately la2=20%. 2under1
mechanism dep=conj lb1=Digoxin: lb1=When lb1=multiple lb1=doses lb1=of lib=and la2=were la2=coadministered, la2=steady-state la2=plasma la2=digoxin la2=concentrations la2=increased la2=by la2=approximately la2=20%. 2under1
null dep=conj lb1=Digoxin: lb1=When lb1=multiple lb1=doses lb1=of lib=and la2=were la2=coadministered, la2=steady-state la2=plasma la2=digoxin la2=concentrations la2=increased la2=by la2=approximately la2=20%. 2under1
null dep=None lb1=Digoxin: lb1=When lb1=multiple lb1=doses lb1=of lb1=atorvastatin lb1=and lib=were lib=coadministered, lib=steady-state lib=plasma la2=were la2=coadministered, la2=steady-state la2=plasma la2=digoxin la2=concentrations la2=increased la2=by la2=approximately la2=20%.
null dep=None lib=: lib=In lib=healthy lib=individuals, lib=plasma lib=concentrations lib=of la2=increased la2=approximately la2=40% la2=with la2=coadministration la2=of la2=atorvastatin la2=and la2=erythromycin, la2=a la2=known la2=inhibitor la2=of la2=cytochrome la2=P450 la2=3A4. 2under1
null dep=None lib=: lib=In lib=healthy lib=individuals, lib=plasma lib=concentrations lib=of la2=increased la2=approximately la2=40% la2=with la2=coadministration la2=of la2=atorvastatin la2=and la2=erythromycin, la2=a la2=known la2=inhibitor la2=of la2=cytochrome la2=P450 la2=3A4. 2under1
null dep=None lib=: lib=In lib=healthy lib=individuals, lib=plasma lib=concentrations lib=of lib=atorvastatin lib=increased lib=approximately lib=40% lib=with lib=coadministration lib=of lib=atorvastatin lib=and la2=, la2=a la2=known la2=inhibitor la2=of la2=cytochrome la2=P450 la2=3A4. 2under1
null dep=None lb1=Erythromycin: lb1=In lb1=healthy lb1=individuals, lb1=plasma lb1=concentrations lb1=of lib=increased lib=approximately lib=40% lib=with lib=coadministration lib=of la2=increased la2=approximately la2=40% la2=with la2=coadministration la2=of la2=atorvastatin la2=and la2=erythromycin, la2=a la2=known la2=inhibitor la2=of la2=cytochrome la2=P450 la2=3A4.
null dep=conj lb1=Erythromycin: lb1=In lb1=healthy lb1=individuals, lb1=plasma lb1=concentrations lb1=of lib=increased lib=approximately lib=40% lib=with lib=coadministration lib=of lib=atorvastatin lib=and la2=, la2=a la2=known la2=inhibitor la2=of la2=cytochrome la2=P450 la2=3A4.
mechanism dep=conj lb1=Erythromycin: lb1=In lb1=healthy lb1=individuals, lb1=plasma lb1=concentrations lb1=of lib=increased lib=approximately lib=40% lib=with lib=coadministration lib=of lib=atorvastatin lib=and la2=, la2=a la2=known la2=inhibitor la2=of la2=cytochrome la2=P450 la2=3A4.
null dep=None lb1=Oral lib=: lib=Coadministration lib=of la2=and la2=an la2=oral la2=contraceptive la2=increased la2=AUC la2=values la2=for la2=norethindrone la2=and la2=ethinyl la2=estradiol la2=by la2=approximately la2=30% la2=and la2=20%. 2under1
null dep=None lb1=Oral lib=: lib=Coadministration lib=of lib=atorvastatin lib=and lib=an lib=oral la2=increased la2=AUC la2=values la2=for la2=norethindrone la2=and la2=ethinyl la2=estradiol la2=by la2=approximately la2=30% la2=and la2=20%. 2under1
null dep=None lb1=Oral lib=: lib=Coadministration lib=of lib=atorvastatin lib=and lib=an lib=oral lib=contraceptive lib=increased lib=AUC lib=values lib=for la2=and la2=ethinyl la2=estradiol la2=by la2=approximately la2=30% la2=and la2=20%. 2under1
null dep=None lb1=Oral lib=: lib=Coadministration lib=of lib=atorvastatin lib=and lib=an lib=oral lib=contraceptive lib=increased lib=AUC lib=values lib=for lib=norethindrone lib=and la2=by la2=approximately la2=30% la2=and la2=20%.
mechanism dep=None lb1=Oral lb1=Contraceptives: lb1=Coadministration lb1=of lib=and lib=an lib=oral la2=increased la2=AUC la2=values la2=for la2=norethindrone la2=and la2=ethinyl la2=estradiol la2=by la2=approximately la2=30% la2=and la2=20%.
mechanism dep=None lb1=Oral lb1=Contraceptives: lb1=Coadministration lb1=of lib=and lib=an lib=oral lib=contraceptive lib=increased lib=AUC lib=values lib=for la2=and la2=ethinyl la2=estradiol la2=by la2=approximately la2=30% la2=and la2=20%.
mechanism dep=None lb1=Oral lb1=Contraceptives: lb1=Coadministration lb1=of lib=and lib=an lib=oral lib=contraceptive lib=increased lib=AUC lib=values lib=for lib=norethindrone lib=and la2=by la2=approximately la2=30% la2=and la2=20%.
null dep=None lb1=Oral lb1=Contraceptives: lb1=Coadministration lb1=of lb1=atorvastatin lb1=and lb1=an lb1=oral lib=increased lib=AUC lib=values lib=for la2=and la2=ethinyl la2=estradiol la2=by la2=approximately la2=30% la2=and la2=20%.
null dep=None lb1=Oral lb1=Contraceptives: lb1=Coadministration lb1=of lb1=atorvastatin lb1=and lb1=an lb1=oral lib=increased lib=AUC lib=values lib=for lib=norethindrone lib=and la2=by la2=approximately la2=30% la2=and la2=20%.
null dep=conj lb1=Oral lb1=Contraceptives: lb1=Coadministration lb1=of lb1=atorvastatin lb1=and lb1=an lb1=oral lb1=contraceptive lb1=increased lb1=AUC lb1=values lb1=for lib=and la2=by la2=approximately la2=30% la2=and la2=20%.
advise dep=None lb1=These lb1=increases lb1=should lb1=be lb1=considered lb1=when lb1=selecting lb1=an lb1=oral lib=for lib=a lib=woman lib=taking la2=. 2under1
null dep=None lib=: la2=had la2=no la2=clinically la2=significant la2=effect la2=on la2=prothrombin la2=time la2=when la2=administered la2=to la2=patients la2=receiving la2=chronic la2=warfarin la2=treatment. 2under1
null dep=None lib=: lib=Atorvastatin lib=had lib=no lib=clinically lib=significant lib=effect lib=on lib=prothrombin lib=time lib=when lib=administered lib=to lib=patients lib=receiving lib=chronic la2=treatment. 2under1
null dep=None lb1=Warfarin: lib=had lib=no lib=clinically lib=significant lib=effect lib=on lib=prothrombin lib=time lib=when lib=administered lib=to lib=patients lib=receiving lib=chronic la2=treatment.
advise dep=None lb1=Caution lb1=should lb1=be lb1=exercised lb1=if lb1=an lib=is lib=administered lib=concomitantly lib=with lib=drugs lib=that lib=may lib=decrease lib=the lib=levels lib=or lib=activity lib=of lib=endogenous lib=steroid lib=hormones, lib=such lib=as la2=, la2=spironolactone, la2=and la2=cimetidine.
advise dep=None lb1=Caution lb1=should lb1=be lb1=exercised lb1=if lb1=an lib=is lib=administered lib=concomitantly lib=with lib=drugs lib=that lib=may lib=decrease lib=the lib=levels lib=or lib=activity lib=of lib=endogenous lib=steroid lib=hormones, lib=such lib=as lib=ketoconazole, la2=, la2=and la2=cimetidine.
advise dep=None lb1=Caution lb1=should lb1=be lb1=exercised lb1=if lb1=an lib=is lib=administered lib=concomitantly lib=with lib=drugs lib=that lib=may lib=decrease lib=the lib=levels lib=or lib=activity lib=of lib=endogenous lib=steroid lib=hormones, lib=such lib=as lib=ketoconazole, lib=spironolactone, lib=and la2=.
null dep=conj lb1=Caution lb1=should lb1=be lb1=exercised lb1=if lb1=an lb1=HMG-CoA lb1=reductase lb1=inhibitor lb1=is lb1=administered lb1=concomitantly lb1=with lb1=drugs lb1=that lb1=may lb1=decrease lb1=the lb1=levels lb1=or lb1=activity lb1=of lb1=endogenous lb1=steroid lb1=hormones, lb1=such lb1=as lib=, la2=, la2=and la2=cimetidine. 2under1
null dep=conj lb1=Caution lb1=should lb1=be lb1=exercised lb1=if lb1=an lb1=HMG-CoA lb1=reductase lb1=inhibitor lb1=is lb1=administered lb1=concomitantly lb1=with lb1=drugs lb1=that lb1=may lb1=decrease lb1=the lb1=levels lb1=or lb1=activity lb1=of lb1=endogenous lb1=steroid lb1=hormones, lb1=such lb1=as lib=, lib=spironolactone, lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=exercised lb1=if lb1=an lb1=HMG-CoA lb1=reductase lb1=inhibitor lb1=is lb1=administered lb1=concomitantly lb1=with lb1=drugs lb1=that lb1=may lb1=decrease lb1=the lb1=levels lb1=or lb1=activity lb1=of lb1=endogenous lb1=steroid lb1=hormones, lb1=such lb1=as lb1=ketoconazole, lib=, lib=and la2=.
advise dep=conj lb1=Co-administration lb1=of lib=and la2=or la2=other la2=agents la2=interfering la2=with la2=neuromuscular la2=transmission la2=(e.g., la2=curare-like la2=compounds) la2=should la2=only la2=be la2=performed la2=with la2=caution la2=as la2=the la2=effect la2=of la2=the la2=toxin la2=may la2=be la2=potentiated. 2under1
advise dep=None lb1=Co-administration lb1=of lib=and lib=aminoglycosides lib=or lib=other lib=agents lib=interfering lib=with lib=neuromuscular lib=transmission lib=(e.g., la2=) la2=should la2=only la2=be la2=performed la2=with la2=caution la2=as la2=the la2=effect la2=of la2=the la2=toxin la2=may la2=be la2=potentiated.
null dep=None lb1=Co-administration lb1=of lib=and lib=aminoglycosides lib=or lib=other lib=agents lib=interfering lib=with lib=neuromuscular lib=transmission lib=(e.g., lib=curare-like lib=compounds) lib=should lib=only lib=be lib=performed lib=with lib=caution lib=as lib=the lib=effect lib=of lib=the la2=may la2=be la2=potentiated.
null dep=None lb1=Co-administration lb1=of lb1=MYOBLOC lb1=and lib=or lib=other lib=agents lib=interfering lib=with lib=neuromuscular lib=transmission lib=(e.g., la2=) la2=should la2=only la2=be la2=performed la2=with la2=caution la2=as la2=the la2=effect la2=of la2=the la2=toxin la2=may la2=be la2=potentiated.
null dep=None lb1=Co-administration lb1=of lb1=MYOBLOC lb1=and lib=or lib=other lib=agents lib=interfering lib=with lib=neuromuscular lib=transmission lib=(e.g., lib=curare-like lib=compounds) lib=should lib=only lib=be lib=performed lib=with lib=caution lib=as lib=the lib=effect lib=of lib=the la2=may la2=be la2=potentiated.
null dep=None lb1=Co-administration lb1=of lb1=MYOBLOC lb1=and lb1=aminoglycosides lb1=or lb1=other lb1=agents lb1=interfering lb1=with lb1=neuromuscular lb1=transmission lb1=(e.g., lib=) lib=should lib=only lib=be lib=performed lib=with lib=caution lib=as lib=the lib=effect lib=of lib=the la2=may la2=be la2=potentiated.
null dep=appos lib=, lib=other, lib=especially la2=, la2=or la2=preanesthetic la2=and la2=anesthetic la2=agents la2=used la2=in la2=surgery la2=or la2=skeletal-muscle la2=relaxants, la2=nondepolarizing, la2=used la2=in la2=surgery 2under1
null dep=None lib=, lib=other, lib=especially lib=diazoxide, lib=or lib=pre la2=and la2=anesthetic la2=agents la2=used la2=in la2=surgery la2=or la2=skeletal-muscle la2=relaxants, la2=nondepolarizing, la2=used la2=in la2=surgery 2under1
null dep=None lib=, lib=other, lib=especially lib=diazoxide, lib=or lib=preanesthetic lib=and lib=anesthetic lib=agents lib=used lib=in lib=surgery lib=or la2=, la2=nondepolarizing, la2=used la2=in la2=surgery
null dep=None lb1=Antihypertensive lb1=medications, lb1=other, lb1=especially lib=, lib=or lib=pre la2=and la2=anesthetic la2=agents la2=used la2=in la2=surgery la2=or la2=skeletal-muscle la2=relaxants, la2=nondepolarizing, la2=used la2=in la2=surgery 2under1
null dep=None lb1=Antihypertensive lb1=medications, lb1=other, lb1=especially lib=, lib=or lib=preanesthetic lib=and lib=anesthetic lib=agents lib=used lib=in lib=surgery lib=or la2=, la2=nondepolarizing, la2=used la2=in la2=surgery
null dep=None lb1=Antihypertensive lb1=medications, lb1=other, lb1=especially lb1=diazoxide, lb1=or lb1=pre lib=and lib=anesthetic lib=agents lib=used lib=in lib=surgery lib=or la2=, la2=nondepolarizing, la2=used la2=in la2=surgery
null dep=cc lib=or la2=or la2=Corticotropin la2=(ACTH) 2under1
null dep=cc lib=or lib=Corticosteroids lib=or la2=(ACTH) 2under1
null dep=None lib=or lib=Corticosteroids lib=or lib=Corticotropin lib=( la2=) 2under1
null dep=None lb1=Amphotericin lb1=B lb1=or lib=or la2=(ACTH)
null dep=None lb1=Amphotericin lb1=B lb1=or lib=or lib=Corticotropin lib=( la2=)
null dep=appos lb1=Amphotericin lb1=B lb1=or lb1=Corticosteroids lb1=or lib=( la2=) 2under1
effect dep=None lb1=(Concurrent lb1=use lb1=with lib=may lib=enhance lib=the lib=possibility lib=of la2=toxicity la2=associated la2=with la2=hypokalemia.)
advise dep=None lb1=for lb1=adult-onset lb1=diabetics, lb1=dosage lb1=adjustment lb1=of lib=may lib=be lib=necessary lib=during lib=and lib=after la2=therapy;
null dep=None lb1=(Concurrent lb1=use lb1=with lib=is lib=not lib=recommended, lib=as lib=they lib=may lib=provoke la2=toxicity la2=because la2=of la2=reduced la2=renal la2=clearance.)
effect dep=None lb1=(In lb1=some lb1=patients, lb1=the
effect dep=None lb1=(In lb1=some lb1=patients, lb1=the
effect dep=None lb1=(In lb1=some lb1=patients, lb1=the lib=can lib=reduce lib=the lib=diuretic, lib=natriuretic, lib=and lib=antihypertensive lib=effects lib=of lib=loop, lib=potassium lib=sparing, lib=and la2=.
null dep=conj lb1=(In lb1=some lb1=patients, lb1=the lb1=steroidal lb1=anti-inflammatory lb1=agent lb1=can lb1=reduce lb1=the lb1=diuretic, lb1=natriuretic, lb1=and lb1=antihypertensive lb1=effects lb1=of lb1=loop, lb1=potassium lb1=sparing, lb1=and lb1=thiazide lb1=diuretics.
null dep=conj lb1=(In lb1=some lb1=patients, lb1=the lb1=steroidal lb1=anti-inflammatory lb1=agent lb1=can lb1=reduce lb1=the lb1=diuretic, lb1=natriuretic, lb1=and lb1=antihypertensive lb1=effects lb1=of lb1=loop, lb1=potassium lb1=sparing, lb1=and lb1=thiazide lb1=diuretics. la2=.
null dep=amod lb1=(In lb1=some lb1=patients, lb1=the lb1=steroidal lb1=anti-inflammatory lb1=agent lb1=can lb1=reduce lb1=the lb1=diuretic, lb1=natriuretic, lb1=and lb1=antihypertensive lb1=effects lb1=of lb1=loop, lb1=potassium lb1=sparing, lb1=and lb1=thiazide lb1=diuretics. la2=.
advise dep=conj lb1=Therefore, lb1=when lib=and la2=are la2=used la2=concomitantly, la2=the la2=patient la2=should la2=be la2=observed la2=closely la2=to la2=determine la2=if la2=the la2=desired la2=effect la2=of la2=the la2=diuretic la2=is la2=obtained.)
null dep=case lb1=Therefore, lb1=when lib=and lib=nonsteroidal lib=anti-inflammatory lib=agents lib=are lib=used lib=concomitantly, lib=the lib=patient lib=should lib=be lib=observed lib=closely lib=to lib=determine lib=if lib=the lib=desired lib=effect lib=of lib=the la2=is la2=obtained.)
null dep=None lb1=Therefore, lb1=when lb1=hydroflumethiazide lb1=and lib=are lib=used lib=concomitantly, lib=the lib=patient lib=should lib=be lib=observed lib=closely lib=to lib=determine lib=if lib=the lib=desired lib=effect lib=of lib=the la2=is la2=obtained.)
effect dep=None lb1=( lib=may lib=decrease lib=arterial lib=responsiveness lib=to la2=.
effect dep=None lb1=( lib=may lib=increase lib=the lib=responsiveness lib=to la2=.)
null dep=None lib=/ la2=, la2=Macrolides, la2=Including la2=Erythromycin
null dep=None lib=/Itraconazole, la2=, la2=Including la2=Erythromycin
null dep=None lib=/Itraconazole, lib=Macrolides, lib=Including
null dep=None lb1=Ketoconazole/ lib=, la2=, la2=Including la2=Erythromycin
null dep=None lb1=Ketoconazole/ lib=, lib=Macrolides, lib=Including
null dep=None lb1=Ketoconazole/Itraconazole, lib=, lib=Including
effect dep=cc lb1=Nephrotoxicity lb1=has lb1=been lb1=reported lb1=following lb1=concomitant lb1=administration lb1=of lib=with la2=or la2=potent la2=diuretics la2=such la2=as la2=furosemide.
effect dep=None lb1=Nephrotoxicity lb1=has lb1=been lb1=reported lb1=following lb1=concomitant lb1=administration lb1=of lib=with lib=aminoglycoside lib=antibiotics lib=or lib=potent la2=such la2=as la2=furosemide.
effect dep=None lb1=Nephrotoxicity lb1=has lb1=been lb1=reported lb1=following lb1=concomitant lb1=administration lb1=of lib=with lib=aminoglycoside lib=antibiotics lib=or lib=potent lib=diuretics lib=such lib=as la2=.
null dep=conj lb1=Nephrotoxicity lb1=has lb1=been lb1=reported lb1=following lb1=concomitant lb1=administration lb1=of lb1=cephalosporins lb1=with lib=or lib=potent la2=such la2=as la2=furosemide. 2under1
null dep=None lb1=Nephrotoxicity lb1=has lb1=been lb1=reported lb1=following lb1=concomitant lb1=administration lb1=of lb1=cephalosporins lb1=with lib=or lib=potent lib=diuretics lib=such lib=as la2=. 2under1
null dep=nmod lb1=Nephrotoxicity lb1=has lb1=been lb1=reported lb1=following lb1=concomitant lb1=administration lb1=of lb1=cephalosporins lb1=with lb1=aminoglycoside lb1=antibiotics lb1=or lb1=potent lib=such lib=as la2=. 2under1
null dep=None lb1=Renal lb1=function lb1=should lb1=be lb1=carefully lb1=monitored, lb1=especially lb1=if lb1=higher lb1=dosages lb1=of lb1=the lib=are lib=to lib=be lib=administered lib=or lib=if lib=therapy lib=is lib=prolonged, lib=because lib=of lib=the lib=potential lib=nephrotoxicity lib=and lib=ototoxicity lib=of la2=.
effect dep=None lib=has lib=been lib=shown lib=to lib=be lib=antagonistic lib=to la2=, la2=including la2=ceftazidime, la2=based la2=on la2=in la2=vitro la2=studies la2=and la2=time la2=kill la2=curves la2=with la2=enteric la2=gram-negative la2=bacilli.
effect dep=None lib=has lib=been lib=shown lib=to lib=be lib=antagonistic lib=to lib=beta-lactam lib=antibiotics, lib=including la2=, la2=based la2=on la2=in la2=vitro la2=studies la2=and la2=time la2=kill la2=curves la2=with la2=enteric la2=gram-negative la2=bacilli.
null dep=nmod lb1=Chloramphenicol lb1=has lb1=been lb1=shown lb1=to lb1=be lb1=antagonistic lb1=to lib=, lib=including la2=, la2=based la2=on la2=in la2=vitro la2=studies la2=and la2=time la2=kill la2=curves la2=with la2=enteric la2=gram-negative la2=bacilli. 2under1
null dep=None lb1=Concomitantly lb1=given lib=did lib=not lib=interfere lib=with lib=the lib=absorption lib=of lib=a lib=tablet lib=of la2=.
mechanism dep=None lb1=Milk, lb1=milk lb1=products, lb1=and lib=-rich lib=foods lib=or lib=drugs lib=may lib=impair lib=the lib=absorption lib=of la2=.
null dep=None lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lib=: lib=The lib=addition lib=of la2=to la2=antiepileptic la2=drugs la2=(AEDs) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs.
null dep=None lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lib=: lib=The lib=addition lib=of lib=Felbatol lib=to la2=(AEDs) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs.
null dep=None lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lib=: lib=The lib=addition lib=of lib=Felbatol lib=to lib=antiepileptic lib=drugs lib=( la2=) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs.
null dep=None lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lib=: lib=The lib=addition lib=of lib=Felbatol lib=to lib=antiepileptic lib=drugs lib=( la2=) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs.
mechanism dep=case lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lb1=Antiepileptic lb1=Drugs: lb1=The lb1=addition lb1=of lib=to la2=(AEDs) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs.
mechanism dep=None lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lb1=Antiepileptic lb1=Drugs: lb1=The lb1=addition lb1=of lib=to lib=antiepileptic lib=drugs lib=( la2=) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs.
null dep=None lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lb1=Antiepileptic lb1=Drugs: lb1=The lb1=addition lb1=of lib=to lib=antiepileptic lib=drugs lib=( la2=) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs.
null dep=appos lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lb1=Antiepileptic lb1=Drugs: lb1=The lb1=addition lb1=of lb1=Felbatol lb1=to lib=( la2=) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs. 2under1
null dep=appos lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lb1=Antiepileptic lb1=Drugs: lb1=The lb1=addition lb1=of lb1=Felbatol lb1=to lib=( la2=) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs. 2under1
null dep=None lb1=Use lb1=in lb1=Conjunction lb1=with lb1=Other lb1=Antiepileptic lb1=Drugs: lb1=The lb1=addition lb1=of lb1=Felbatol lb1=to lb1=antiepileptic lb1=drugs lb1=( lib=) lib=affects lib=the lib=steady-state lib=plasma lib=concentrations lib=of la2=) la2=affects la2=the la2=steady-state la2=plasma la2=concentrations la2=of la2=AEDs.
null dep=None lb1=The lb1=net lb1=effect lb1=of lb1=these lb1=interactions lb1=is lb1=summarized lb1=in lb1=the lb1=following lb1=table: la2=AED la2=Felbatol
null dep=compound lb1=The lb1=net lb1=effect lb1=of lb1=these lb1=interactions lb1=is lb1=summarized lb1=in lb1=the lb1=following lb1=table: lib=AED 1under2
null dep=compound lb1=The lb1=net lb1=effect lb1=of lb1=these lb1=interactions lb1=is lb1=summarized lb1=in lb1=the lb1=following lb1=table: lib=AED 1under2
null dep=appos lib=( la2=) 2under1
null dep=None lb1=Specific lb1=Effects lb1=of lib=on lib=Other la2=Phenytoin: la2=Felbatol la2=causes la2=an la2=increase la2=in la2=steady-state la2=phenytoin la2=plasma la2=concentrations.
null dep=None lb1=Specific lb1=Effects lb1=of lib=on lib=Other lib=Antiepileptic lib=Drugs la2=: la2=Felbatol la2=causes la2=an la2=increase la2=in la2=steady-state la2=phenytoin la2=plasma la2=concentrations.
null dep=None lb1=Specific lb1=Effects lb1=of lib=on lib=Other lib=Antiepileptic lib=Drugs lib=Phenytoin: la2=on la2=Other la2=Antiepileptic la2=Drugs la2=Phenytoin: la2=Felbatol la2=causes la2=an la2=increase la2=in la2=steady-state la2=phenytoin la2=plasma la2=concentrations.
null dep=None lb1=Specific lb1=Effects lb1=of lib=on lib=Other lib=Antiepileptic lib=Drugs lib=Phenytoin: lib=Felbatol lib=causes lib=an lib=increase lib=in lib=steady-state la2=plasma la2=concentrations.
null dep=amod lb1=Specific lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Other la2=: la2=Felbatol la2=causes la2=an la2=increase la2=in la2=steady-state la2=phenytoin la2=plasma la2=concentrations.
null dep=None lb1=Specific lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Other lib=Phenytoin: la2=on la2=Other la2=Antiepileptic la2=Drugs la2=Phenytoin: la2=Felbatol la2=causes la2=an la2=increase la2=in la2=steady-state la2=phenytoin la2=plasma la2=concentrations.
null dep=None lb1=Specific lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Other lib=Phenytoin: lib=Felbatol lib=causes lib=an lib=increase lib=in lib=steady-state la2=plasma la2=concentrations.
null dep=None lb1=Specific lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Other lb1=Antiepileptic lb1=Drugs lib=: la2=on la2=Other la2=Antiepileptic la2=Drugs la2=Phenytoin: la2=Felbatol la2=causes la2=an la2=increase la2=in la2=steady-state la2=phenytoin la2=plasma la2=concentrations.
null dep=None lb1=Specific lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Other lb1=Antiepileptic lb1=Drugs lib=: lib=Felbatol lib=causes lib=an lib=increase lib=in lib=steady-state la2=plasma la2=concentrations.
mechanism dep=None lb1=Specific lb1=Effects lb1=of lib=on lib=Other lib=Antiepileptic lib=Drugs lib=Phenytoin: lib=Felbatol lib=causes lib=an lib=increase lib=in lib=steady-state la2=plasma la2=concentrations.
null dep=None lb1=In lb1=10 lb1=otherwise lb1=healthy lb1=subjects lb1=with lb1=epilepsy lb1=ingesting lib=, lib=the lib=steadystate lib=trough lib=(Cmin) la2=, la2=the la2=steadystate la2=trough la2=(Cmin) la2=phenytoin la2=plasma la2=concentration la2=was la2=17 la2=5 la2=micrograms/mL.
mechanism dep=None lb1=Increasing lb1=the lib=dose lib=to lib=1800 lib=mg/day lib=in lib=six lib=of lib=these lib=subjects lib=increased lib=the lib=steady-state la2=Cmin la2=to la2=25 la2=7 la2=micrograms/mL.
null dep=None lb1=In lb1=order lb1=to lb1=maintain lib=levels, lib=limit lib=adverse lib=experiences, lib=and lib=achieve lib=the la2=dose la2=of la2=3600 la2=mg/day, la2=a la2=phenytoin la2=dose la2=reduction la2=of la2=approximately la2=40% la2=was la2=necessary la2=for la2=eight la2=of la2=these la2=10 la2=subjects.
null dep=None lb1=In lb1=order lb1=to lb1=maintain lib=levels, lib=limit lib=adverse lib=experiences, lib=and lib=achieve lib=the lib=felbamate lib=dose lib=of lib=3600 lib=mg/day, lib=a la2=levels, la2=limit la2=adverse la2=experiences, la2=and la2=achieve la2=the la2=felbamate la2=dose la2=of la2=3600 la2=mg/day, la2=a la2=phenytoin la2=dose la2=reduction la2=of la2=approximately la2=40% la2=was la2=necessary la2=for la2=eight la2=of la2=these la2=10 la2=subjects.
advise dep=None lb1=In lb1=order lb1=to lb1=maintain lb1=phenytoin lb1=levels, lb1=limit lb1=adverse lb1=experiences, lb1=and lb1=achieve lb1=the lib=dose lib=of lib=3600 lib=mg/day, lib=a la2=levels, la2=limit la2=adverse la2=experiences, la2=and la2=achieve la2=the la2=felbamate la2=dose la2=of la2=3600 la2=mg/day, la2=a la2=phenytoin la2=dose la2=reduction la2=of la2=approximately la2=40% la2=was la2=necessary la2=for la2=eight la2=of la2=these la2=10 la2=subjects.
null dep=None lb1=In lb1=a lb1=controlled lb1=clinical lb1=trial, lb1=a lb1=20% lb1=reduction lb1=of lb1=the lib=dose lib=at lib=the lib=initiation lib=of la2=therapy la2=resulted la2=in la2=phenytoin la2=levels la2=comparable la2=to la2=those la2=prior la2=to la2=Felbatol la2=administration.
null dep=None lb1=In lb1=a lb1=controlled lb1=clinical lb1=trial, lb1=a lb1=20% lb1=reduction lb1=of lb1=the lib=dose lib=at lib=the lib=initiation lib=of lib=Felbatol lib=therapy lib=resulted lib=in la2=dose la2=at la2=the la2=initiation la2=of la2=Felbatol la2=therapy la2=resulted la2=in la2=phenytoin la2=levels la2=comparable la2=to la2=those la2=prior la2=to la2=Felbatol la2=administration.
null dep=None lb1=In lb1=a lb1=controlled lb1=clinical lb1=trial, lb1=a lb1=20% lb1=reduction lb1=of lb1=the lib=dose lib=at lib=the lib=initiation lib=of la2=therapy la2=resulted la2=in la2=phenytoin la2=levels la2=comparable la2=to la2=those la2=prior la2=to la2=Felbatol la2=administration.
null dep=None lb1=In lb1=a lb1=controlled lb1=clinical lb1=trial, lb1=a lb1=20% lb1=reduction lb1=of lb1=the lb1=phenytoin lb1=dose lb1=at lb1=the lb1=initiation lb1=of lib=therapy lib=resulted lib=in la2=dose la2=at la2=the la2=initiation la2=of la2=Felbatol la2=therapy la2=resulted la2=in la2=phenytoin la2=levels la2=comparable la2=to la2=those la2=prior la2=to la2=Felbatol la2=administration.
null dep=None lb1=In lb1=a lb1=controlled lb1=clinical lb1=trial, lb1=a lb1=20% lb1=reduction lb1=of lb1=the lb1=phenytoin lb1=dose lb1=at lb1=the lb1=initiation lb1=of lib=therapy lib=resulted lib=in lib=phenytoin lib=levels lib=comparable lib=to lib=those lib=prior lib=to la2=therapy la2=resulted la2=in la2=phenytoin la2=levels la2=comparable la2=to la2=those la2=prior la2=to la2=Felbatol la2=administration.
null dep=None lb1=In lb1=a lb1=controlled lb1=clinical lb1=trial, lb1=a lb1=20% lb1=reduction lb1=of lb1=the lib=dose lib=at lib=the lib=initiation lib=of la2=therapy la2=resulted la2=in la2=phenytoin la2=levels la2=comparable la2=to la2=those la2=prior la2=to la2=Felbatol la2=administration.
null dep=None lib=: la2=causes la2=a la2=decrease la2=in la2=the la2=steady-state la2=carbamazepine la2=plasma la2=concentrations la2=and la2=an la2=increase la2=in la2=the la2=steady-state la2=carbamazepine la2=epoxide la2=plasma la2=concentration. 2under1
null dep=None lib=: lib=Felbatol lib=causes lib=a lib=decrease lib=in lib=the lib=steady-state la2=plasma la2=concentrations la2=and la2=an la2=increase la2=in la2=the la2=steady-state la2=carbamazepine la2=epoxide la2=plasma la2=concentration. 2under1
null dep=None lib=: lib=Felbatol lib=causes lib=a lib=decrease lib=in lib=the lib=steady-state lib=carbamazepine lib=plasma lib=concentrations lib=and lib=an lib=increase lib=in lib=the lib=steady-state la2=plasma la2=concentration.
mechanism dep=None lb1=Carbamazepine: lib=causes lib=a lib=decrease lib=in lib=the lib=steady-state la2=plasma la2=concentrations la2=and la2=an la2=increase la2=in la2=the la2=steady-state la2=carbamazepine la2=epoxide la2=plasma la2=concentration.
null dep=None lb1=Carbamazepine: lib=causes lib=a lib=decrease lib=in lib=the lib=steady-state lib=carbamazepine lib=plasma lib=concentrations lib=and lib=an lib=increase lib=in lib=the lib=steady-state la2=plasma la2=concentration.
null dep=None lb1=Carbamazepine: lb1=Felbatol lb1=causes lb1=a lb1=decrease lb1=in lb1=the lb1=steady-state lib=plasma lib=concentrations lib=and lib=an lib=increase lib=in lib=the lib=steady-state la2=plasma la2=concentration.
null dep=None lb1=In lb1=nine lb1=otherwise lb1=healthy lb1=subjects lb1=with lb1=epilepsy lb1=ingesting lib=, lib=the lib=steady-state lib=trough lib=(Cmin) la2=, la2=the la2=steady-state la2=trough la2=(Cmin) la2=carbamazepine la2=concentration la2=was la2=8 la2=2 la2=micrograms/mL.
mechanism dep=None lb1=The lib=steady-state lib=Cmin lib=decreased lib=31% lib=to lib=5 lib=1 lib=micrograms/mL lib=when la2=(3000 la2=mg/day, la2=divided la2=into la2=three la2=doses) la2=was la2=coadministered.
null dep=None lib=steady-state lib=Cmin lib=concentrations lib=increased lib=57% lib=from lib=1.0 lib=0.3 lib=to lib=1.6 lib=0.4 lib=micrograms/mL lib=with lib=the lib=addition lib=of la2=.
null dep=case lb1=In lb1=clinical lb1=trials, lb1=similar lb1=changes lb1=in lib=and la2=were la2=seen. 1under2
null dep=None lib=: la2=causes la2=an la2=increase la2=in la2=steady-state la2=valproate la2=concentrations. 2under1
null dep=None lib=: lib=Felbatol lib=causes lib=an lib=increase lib=in lib=steady-state la2=concentrations. 2under1
mechanism dep=None lb1=Valproate: lib=causes lib=an lib=increase lib=in lib=steady-state la2=concentrations.
null dep=None lb1=In lb1=four lb1=subjects lb1=with lb1=epilepsy lb1=ingesting lib=, lib=the lib=steady-state lib=trough lib=(Cmin) la2=, la2=the la2=steady-state la2=trough la2=(Cmin) la2=valproate la2=plasma la2=concentration la2=was la2=63 la2=16 la2=micrograms/mL.
mechanism dep=None lb1=Increasing lb1=the lib=dose lib=to lib=2400 lib=mg/day lib=increased lib=the lib=steadystate la2=Cmin la2=to la2=96 la2=25 la2=micrograms/mL.
null dep=None lb1=Corresponding lb1=values lb1=for lb1=free lib=Cmin lib=concentrations lib=were lib=7 lib=3, lib=9 lib=4, lib=and lib=11 lib=6 lib=micrograms/mL lib=for lib=0, lib=1200, lib=and lib=2400 lib=mg/day la2=, la2=respectively.
null dep=None lb1=The lb1=ratios lb1=of lb1=the lb1=AUCs lb1=of lb1=unbound lib=to lib=the lib=AUCs lib=of lib=the lib=total la2=to la2=the la2=AUCs la2=of la2=the la2=total la2=valproate la2=were la2=11.1 la2=%, la2=13.0%, la2=and la2=11.5%, la2=with la2=coadministration la2=of la2=0, la2=1200, la2=and la2=2400 la2=mg/day la2=of la2=Felbatol la2=, la2=respectively.
null dep=None lb1=The lb1=ratios lb1=of lb1=the lb1=AUCs lb1=of lb1=unbound lib=to lib=the lib=AUCs lib=of lib=the lib=total lib=valproate lib=were lib=11.1 lib=%, lib=13.0%, lib=and lib=11.5%, lib=with lib=coadministration lib=of lib=0, lib=1200, lib=and lib=2400 lib=mg/day lib=of la2=, la2=respectively.
null dep=None lb1=The lb1=ratios lb1=of lb1=the lb1=AUCs lb1=of lb1=unbound lib=to lib=the lib=AUCs lib=of lib=the lib=total lib=valproate lib=were lib=11.1 lib=%, lib=13.0%, lib=and lib=11.5%, lib=with lib=coadministration lib=of lib=0, lib=1200, lib=and lib=2400 lib=mg/day lib=of la2=, la2=respectively.
null dep=None lib=: lib=Coadministration lib=of la2=with la2=phenobarbital la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=felbamate lib=with la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=felbamate lib=with la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=felbamate lib=with la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lib=: lib=Coadministration lib=of lib=felbamate lib=with la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
mechanism dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lib=with la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL.
null dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lib=with la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL.
null dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lib=with la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL.
null dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lib=with la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL.
null dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lb1=felbamate lb1=with lib=causes lib=an lib=increase lib=in la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lb1=felbamate lb1=with lib=causes lib=an lib=increase lib=in la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lb1=felbamate lb1=with lib=causes lib=an lib=increase lib=in la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lb1=felbamate lb1=with lib=causes lib=an lib=increase lib=in la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lb1=felbamate lb1=with lib=causes lib=an lib=increase lib=in la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lb1=Phenobarbital: lb1=Coadministration lb1=of lb1=felbamate lb1=with lib=causes lib=an lib=increase lib=in la2=causes la2=an la2=increase la2=in la2=phenobarbital la2=plasma la2=concentrations, la2=In la2=12 la2=otherwise la2=healthy la2=male la2=volunteers la2=ingesting la2=phenobarbital, la2=the la2=steady-state la2=trough la2=(Cmin) la2=phenobarbital la2=concentration la2=was la2=14.2 la2=micrograms/mL. 2under1
null dep=None lb1=Effects lb1=of lb1=Other lib=on la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lib=on lib=Felbatol la2=: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lib=on lib=Felbatol la2=: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lib=on la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lib=on lib=Felbatol lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=( la2=) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lib=on lib=Felbatol lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=(felbamate) lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lib=on la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lib=on la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=compound lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on la2=: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 1under2
null dep=compound lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on la2=: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 1under2
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=appos lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=( la2=) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=(felbamate) lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: la2=: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=compound lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=( la2=) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=(felbamate) lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=compound lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=compound lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
mechanism dep=compound lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
mechanism dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=( la2=) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=(felbamate) lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=compound lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=compound lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lib=: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=appos lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=( la2=) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of lib=Felbatol lib=(felbamate) lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lb1=Phenytoin: lb1=Phenytoin lb1=causes lb1=an lb1=approximate lb1=doubling lb1=of lb1=the lb1=clearance lb1=of lb1=Felbatol lb1=( lib=) lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=appos lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lb1=Phenytoin: lb1=Phenytoin lb1=causes lb1=an lb1=approximate lb1=doubling lb1=of lb1=the lb1=clearance lb1=of lb1=Felbatol lb1=( lib=) lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of lib=phenytoin lib=causes lib=an lib=approximate lib=45% lib=decrease lib=in lib=the lib=steady-state lib=trough lib=concentrations lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 1under2
null dep=appos lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lb1=Phenytoin: lb1=Phenytoin lb1=causes lb1=an lb1=approximate lb1=doubling lb1=of lb1=the lb1=clearance lb1=of lb1=Felbatol lb1=( lib=) lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of lib=phenytoin lib=causes lib=an lib=approximate lib=45% lib=decrease lib=in lib=the lib=steady-state lib=trough lib=concentrations lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 1under2
mechanism dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lb1=Phenytoin: lb1=Phenytoin lb1=causes lb1=an lb1=approximate lb1=doubling lb1=of lb1=the lb1=clearance lb1=of lb1=Felbatol lb1=(felbamate) lb1=at lb1=steady lb1=state lb1=and, lb1=therefore, lb1=the lb1=addition lb1=of lib=causes lib=an lib=approximate lib=45% lib=decrease lib=in lib=the lib=steady-state lib=trough lib=concentrations lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lb1=Felbatol lb1=Phenytoin: lb1=Phenytoin lb1=causes lb1=an lb1=approximate lb1=doubling lb1=of lb1=the lb1=clearance lb1=of lb1=Felbatol lb1=(felbamate) lb1=at lb1=steady lb1=state lb1=and, lb1=therefore, lb1=the lb1=addition lb1=of lib=causes lib=an lib=approximate lib=45% lib=decrease lib=in lib=the lib=steady-state lib=trough lib=concentrations lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Effects lb1=of lb1=Other lb1=Antiepileptic lb1=Drugs lb1=on lib=Phenytoin: lib=Phenytoin lib=causes lib=an lib=approximate lib=doubling lib=of lib=the lib=clearance lib=of la2=Phenytoin: la2=Phenytoin la2=causes la2=an la2=approximate la2=doubling la2=of la2=the la2=clearance la2=of la2=Felbatol la2=(felbamate) la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=phenytoin la2=causes la2=an la2=approximate la2=45% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lib=: la2=: la2=Carbamazepine la2=causes la2=an la2=approximate la2=50% la2=increase la2=in la2=the la2=clearance la2=of la2=Felbatol la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lib=: lib=Carbamazepine lib=causes lib=an lib=approximate lib=50% lib=increase lib=in lib=the lib=clearance lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lib=: lib=Carbamazepine lib=causes lib=an lib=approximate lib=50% lib=increase lib=in lib=the lib=clearance lib=of lib=Felbatol lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lib=: lib=Carbamazepine lib=causes lib=an lib=approximate lib=50% lib=increase lib=in lib=the lib=clearance lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lib=: lib=Carbamazepine lib=causes lib=an lib=approximate lib=50% lib=increase lib=in lib=the lib=clearance lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
mechanism dep=None lib=: lib=Carbamazepine lib=causes lib=an lib=approximate lib=50% lib=increase lib=in lib=the lib=clearance lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lib=: lib=Carbamazepine lib=causes lib=an lib=approximate lib=50% lib=increase lib=in lib=the lib=clearance lib=of lib=Felbatol lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lib=: lib=Carbamazepine lib=causes lib=an lib=approximate lib=50% lib=increase lib=in lib=the lib=clearance lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lib=: lib=Carbamazepine lib=causes lib=an lib=approximate lib=50% lib=increase lib=in lib=the lib=clearance lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy. 2under1
null dep=None lb1=Carbamazepine: lb1=Carbamazepine lb1=causes lb1=an lb1=approximate lb1=50% lb1=increase lb1=in lb1=the lb1=clearance lb1=of lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Carbamazepine: lb1=Carbamazepine lb1=causes lb1=an lb1=approximate lb1=50% lb1=increase lb1=in lb1=the lb1=clearance lb1=of lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of lib=carbamazepine lib=results lib=in lib=an lib=approximate lib=40% lib=decrease lib=in lib=the lib=steady-state lib=trough lib=concentrations lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Carbamazepine: lb1=Carbamazepine lb1=causes lb1=an lb1=approximate lb1=50% lb1=increase lb1=in lb1=the lb1=clearance lb1=of lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of lib=carbamazepine lib=results lib=in lib=an lib=approximate lib=40% lib=decrease lib=in lib=the lib=steady-state lib=trough lib=concentrations lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
mechanism dep=None lb1=Carbamazepine: lb1=Carbamazepine lb1=causes lb1=an lb1=approximate lb1=50% lb1=increase lb1=in lb1=the lb1=clearance lb1=of lb1=Felbatol lb1=at lb1=steady lb1=state lb1=and, lb1=therefore, lb1=the lb1=addition lb1=of lib=results lib=in lib=an lib=approximate lib=40% lib=decrease lib=in lib=the lib=steady-state lib=trough lib=concentrations lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Carbamazepine: lb1=Carbamazepine lb1=causes lb1=an lb1=approximate lb1=50% lb1=increase lb1=in lb1=the lb1=clearance lb1=of lb1=Felbatol lb1=at lb1=steady lb1=state lb1=and, lb1=therefore, lb1=the lb1=addition lb1=of lib=results lib=in lib=an lib=approximate lib=40% lib=decrease lib=in lib=the lib=steady-state lib=trough lib=concentrations lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lb1=Carbamazepine: lb1=Carbamazepine lb1=causes lb1=an lb1=approximate lb1=50% lb1=increase lb1=in lb1=the lb1=clearance lb1=of lib=at lib=steady lib=state lib=and, lib=therefore, lib=the lib=addition lib=of lib=carbamazepine lib=results lib=in lib=an lib=approximate lib=40% lib=decrease lib=in lib=the lib=steady-state lib=trough lib=concentrations lib=of la2=at la2=steady la2=state la2=and, la2=therefore, la2=the la2=addition la2=of la2=carbamazepine la2=results la2=in la2=an la2=approximate la2=40% la2=decrease la2=in la2=the la2=steady-state la2=trough la2=concentrations la2=of la2=Felbatol la2=as la2=compared la2=to la2=the la2=same la2=dose la2=of la2=Felbatol la2=given la2=as la2=monotherapy.
null dep=None lib=: lib=Available lib=data lib=suggest lib=that lib=there lib=is lib=no lib=significant lib=effect lib=of la2=on la2=the la2=clearance la2=of la2=Felbatol la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations. 2under1
null dep=None lib=: lib=Available lib=data lib=suggest lib=that lib=there lib=is lib=no lib=significant lib=effect lib=of lib=valproate lib=on lib=the lib=clearance lib=of la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations. 2under1
null dep=None lib=: lib=Available lib=data lib=suggest lib=that lib=there lib=is lib=no lib=significant lib=effect lib=of la2=on la2=the la2=clearance la2=of la2=Felbatol la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations. 2under1
null dep=None lib=: lib=Available lib=data lib=suggest lib=that lib=there lib=is lib=no lib=significant lib=effect lib=of lib=valproate lib=on lib=the lib=clearance lib=of la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations. 2under1
null dep=None lib=: lib=Available lib=data lib=suggest lib=that lib=there lib=is lib=no lib=significant lib=effect lib=of lib=valproate lib=on lib=the lib=clearance lib=of lib=Felbatol lib=at lib=steady lib=state, lib=Therefore, lib=the lib=addition lib=of lib=valproate lib=is lib=not lib=expected lib=to lib=cause lib=a lib=clinically lib=important lib=effect lib=on lib=Felbatol lib=( la2=) la2=plasma la2=concentrations. 2under1
null dep=None lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lib=on lib=the lib=clearance lib=of la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations.
null dep=None lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lib=on lib=the lib=clearance lib=of lib=Felbatol lib=at lib=steady lib=state, lib=Therefore, lib=the lib=addition lib=of la2=on la2=the la2=clearance la2=of la2=Felbatol la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations.
null dep=None lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lib=on lib=the lib=clearance lib=of la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations.
null dep=None lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lib=on lib=the lib=clearance lib=of lib=Felbatol lib=at lib=steady lib=state, lib=Therefore, lib=the lib=addition lib=of lib=valproate lib=is lib=not lib=expected lib=to lib=cause lib=a lib=clinically lib=important lib=effect lib=on lib=Felbatol lib=( la2=) la2=plasma la2=concentrations.
null dep=None lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lb1=valproate lb1=on lb1=the lb1=clearance lb1=of lib=at lib=steady lib=state, lib=Therefore, lib=the lib=addition lib=of la2=on la2=the la2=clearance la2=of la2=Felbatol la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations.
null dep=None lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lb1=valproate lb1=on lb1=the lb1=clearance lb1=of lib=at lib=steady lib=state, lib=Therefore, lib=the lib=addition lib=of lib=valproate lib=is lib=not lib=expected lib=to lib=cause lib=a lib=clinically lib=important lib=effect lib=on la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations.
null dep=appos lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lb1=valproate lb1=on lb1=the lb1=clearance lb1=of lib=at lib=steady lib=state, lib=Therefore, lib=the lib=addition lib=of lib=valproate lib=is lib=not lib=expected lib=to lib=cause lib=a lib=clinically lib=important lib=effect lib=on lib=Felbatol lib=( la2=) la2=plasma la2=concentrations.
null dep=None lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lib=on lib=the lib=clearance lib=of la2=at la2=steady la2=state, la2=Therefore, la2=the la2=addition la2=of la2=valproate la2=is la2=not la2=expected la2=to la2=cause la2=a la2=clinically la2=important la2=effect la2=on la2=Felbatol la2=(felbamate) la2=plasma la2=concentrations.
null dep=None lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lib=on lib=the lib=clearance lib=of lib=Felbatol lib=at lib=steady lib=state, lib=Therefore, lib=the lib=addition lib=of lib=valproate lib=is lib=not lib=expected lib=to lib=cause lib=a lib=clinically lib=important lib=effect lib=on lib=Felbatol lib=( la2=) la2=plasma la2=concentrations.
null dep=appos lb1=Valproate: lb1=Available lb1=data lb1=suggest lb1=that lb1=there lb1=is lb1=no lb1=significant lb1=effect lb1=of lb1=valproate lb1=on lb1=the lb1=clearance lb1=of lib=at lib=steady lib=state, lib=Therefore, lib=the lib=addition lib=of lib=valproate lib=is lib=not lib=expected lib=to lib=cause lib=a lib=clinically lib=important lib=effect lib=on lib=Felbatol lib=( la2=) la2=plasma la2=concentrations.
null dep=None lib=: lib=It lib=appears lib=that la2=may la2=reduce la2=plasma la2=felbamate la2=concentrations. 2under1
null dep=None lib=: lib=It lib=appears lib=that lib=phenobarbital lib=may lib=reduce lib=plasma la2=concentrations. 2under1
mechanism dep=None lb1=Phenobarbital: lb1=It lb1=appears lb1=that lib=may lib=reduce lib=plasma la2=concentrations.
null dep=None lb1=Steady-state lb1=plasma lib=concentrations lib=were lib=found lib=to lib=be lib=29% lib=lower lib=than lib=the lib=mean lib=concentrations lib=of lib=a lib=group lib=of lib=newly lib=diagnosed lib=subjects lib=with lib=epilepsy lib=also lib=receiving lib=2400 lib=mg lib=of la2=concentrations la2=were la2=found la2=to la2=be la2=29% la2=lower la2=than la2=the la2=mean la2=concentrations la2=of la2=a la2=group la2=of la2=newly la2=diagnosed la2=subjects la2=with la2=epilepsy la2=also la2=receiving la2=2400 la2=mg la2=of la2=felbamate la2=a la2=day.
null dep=None lb1=Effects lb1=of lib=on la2=The la2=rate la2=and la2=extent la2=of la2=absorption la2=of la2=a la2=2400 la2=mg la2=dose la2=of la2=Felbatol la2=as la2=monotherapy la2=given la2=as la2=tablets la2=was la2=not la2=affected la2=when la2=coadministered la2=with la2=antacids.
null dep=None lb1=Effects lb1=of lib=on la2=The la2=rate la2=and la2=extent la2=of la2=absorption la2=of la2=a la2=2400 la2=mg la2=dose la2=of la2=Felbatol la2=as la2=monotherapy la2=given la2=as la2=tablets la2=was la2=not la2=affected la2=when la2=coadministered la2=with la2=antacids.
null dep=None lb1=Effects lb1=of lib=on lib=Felbatol lib=The lib=rate lib=and lib=extent lib=of lib=absorption lib=of lib=a lib=2400 lib=mg lib=dose lib=of lib=Felbatol lib=as lib=monotherapy lib=given lib=as lib=tablets lib=was lib=not lib=affected lib=when lib=coadministered lib=with la2=.
null dep=None lb1=Effects lb1=of lb1=Antacids lb1=on lib=The lib=rate lib=and lib=extent lib=of lib=absorption lib=of lib=a lib=2400 lib=mg lib=dose lib=of la2=The la2=rate la2=and la2=extent la2=of la2=absorption la2=of la2=a la2=2400 la2=mg la2=dose la2=of la2=Felbatol la2=as la2=monotherapy la2=given la2=as la2=tablets la2=was la2=not la2=affected la2=when la2=coadministered la2=with la2=antacids.
null dep=None lb1=Effects lb1=of lb1=Antacids lb1=on lib=The lib=rate lib=and lib=extent lib=of lib=absorption lib=of lib=a lib=2400 lib=mg lib=dose lib=of lib=Felbatol lib=as lib=monotherapy lib=given lib=as lib=tablets lib=was lib=not lib=affected lib=when lib=coadministered lib=with la2=.
null dep=None lb1=Effects lb1=of lb1=Antacids lb1=on lib=The lib=rate lib=and lib=extent lib=of lib=absorption lib=of lib=a lib=2400 lib=mg lib=dose lib=of lib=Felbatol lib=as lib=monotherapy lib=given lib=as lib=tablets lib=was lib=not lib=affected lib=when lib=coadministered lib=with la2=.
null dep=None lb1=Effects lb1=of lib=on la2=The la2=coadministration la2=of la2=erythromycin la2=(1000 la2=mg/day) la2=for la2=10 la2=days la2=did la2=not la2=alter la2=the la2=pharmacokinetic la2=parameters la2=of la2=Cmax, la2=Cmin, la2=AUC, la2=CI/kg la2=or la2=tmax la2=at la2=felbamate la2=daily la2=doses la2=of la2=3000 la2=or la2=3600 la2=mg/day la2=in la2=10 la2=otherwise la2=healthy la2=subjects la2=with la2=epilepsy.
null dep=None lb1=Effects lb1=of lib=on lib=Felbatol lib=The lib=coadministration lib=of la2=(1000 la2=mg/day) la2=for la2=10 la2=days la2=did la2=not la2=alter la2=the la2=pharmacokinetic la2=parameters la2=of la2=Cmax, la2=Cmin, la2=AUC, la2=CI/kg la2=or la2=tmax la2=at la2=felbamate la2=daily la2=doses la2=of la2=3000 la2=or la2=3600 la2=mg/day la2=in la2=10 la2=otherwise la2=healthy la2=subjects la2=with la2=epilepsy.
null dep=None lb1=Effects lb1=of lib=on lib=Felbatol lib=The lib=coadministration lib=of lib=erythromycin lib=(1000 lib=mg/day) lib=for lib=10 lib=days lib=did lib=not lib=alter lib=the lib=pharmacokinetic lib=parameters lib=of lib=Cmax, lib=Cmin, lib=AUC, lib=CI/kg lib=or lib=tmax lib=at la2=daily la2=doses la2=of la2=3000 la2=or la2=3600 la2=mg/day la2=in la2=10 la2=otherwise la2=healthy la2=subjects la2=with la2=epilepsy.
null dep=None lb1=Effects lb1=of lb1=Erythromycin lb1=on lib=The lib=coadministration lib=of la2=(1000 la2=mg/day) la2=for la2=10 la2=days la2=did la2=not la2=alter la2=the la2=pharmacokinetic la2=parameters la2=of la2=Cmax, la2=Cmin, la2=AUC, la2=CI/kg la2=or la2=tmax la2=at la2=felbamate la2=daily la2=doses la2=of la2=3000 la2=or la2=3600 la2=mg/day la2=in la2=10 la2=otherwise la2=healthy la2=subjects la2=with la2=epilepsy.
null dep=None lb1=Effects lb1=of lb1=Erythromycin lb1=on lib=The lib=coadministration lib=of lib=erythromycin lib=(1000 lib=mg/day) lib=for lib=10 lib=days lib=did lib=not lib=alter lib=the lib=pharmacokinetic lib=parameters lib=of lib=Cmax, lib=Cmin, lib=AUC, lib=CI/kg lib=or lib=tmax lib=at la2=daily la2=doses la2=of la2=3000 la2=or la2=3600 la2=mg/day la2=in la2=10 la2=otherwise la2=healthy la2=subjects la2=with la2=epilepsy.
null dep=None lb1=Effects lb1=of lb1=Erythromycin lb1=on lb1=Felbatol lb1=The lb1=coadministration lb1=of lib=(1000 lib=mg/day) lib=for lib=10 lib=days lib=did lib=not lib=alter lib=the lib=pharmacokinetic lib=parameters lib=of lib=Cmax, lib=Cmin, lib=AUC, lib=CI/kg lib=or lib=tmax lib=at la2=daily la2=doses la2=of la2=3000 la2=or la2=3600 la2=mg/day la2=in la2=10 la2=otherwise la2=healthy la2=subjects la2=with la2=epilepsy.
null dep=None lb1=Effects lb1=of lib=on lib=Low-Dose la2=A la2=group la2=of la2=24 la2=nonsmoking, la2=healthy la2=white la2=female la2=volunteers la2=established la2=on la2=an la2=oral la2=contraceptive la2=regimen la2=containing la2=30 la2=mg la2=ethinyl la2=estradiol la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lib=on lib=Low-Dose lib=Combination lib=Oral lib=Contraceptives lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral la2=regimen la2=containing la2=30 la2=mg la2=ethinyl la2=estradiol la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lib=on lib=Low-Dose lib=Combination lib=Oral lib=Contraceptives lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral lib=contraceptive lib=regimen lib=containing lib=30 lib=mg la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lib=on lib=Low-Dose lib=Combination lib=Oral lib=Contraceptives lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral lib=contraceptive lib=regimen lib=containing lib=30 lib=mg lib=ethinyl lib=estradiol lib=and lib=75 lib=mg la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lib=on lib=Low-Dose lib=Combination lib=Oral lib=Contraceptives lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral lib=contraceptive lib=regimen lib=containing lib=30 lib=mg lib=ethinyl lib=estradiol lib=and lib=75 lib=mg lib=gestodene lib=for lib=at lib=least lib=3 lib=months lib=received lib=2400 lib=mg/day lib=of la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lib=on lib=Low-Dose lib=Combination lib=Oral lib=Contraceptives lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral la2=regimen la2=containing la2=30 la2=mg la2=ethinyl la2=estradiol la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral la2=regimen la2=containing la2=30 la2=mg la2=ethinyl la2=estradiol la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral lib=contraceptive lib=regimen lib=containing lib=30 lib=mg la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral lib=contraceptive lib=regimen lib=containing lib=30 lib=mg lib=ethinyl lib=estradiol lib=and lib=75 lib=mg la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral lib=contraceptive lib=regimen lib=containing lib=30 lib=mg lib=ethinyl lib=estradiol lib=and lib=75 lib=mg lib=gestodene lib=for lib=at lib=least lib=3 lib=months lib=received lib=2400 lib=mg/day lib=of la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lib=A lib=group lib=of lib=24 lib=nonsmoking, lib=healthy lib=white lib=female lib=volunteers lib=established lib=on lib=an lib=oral la2=regimen la2=containing la2=30 la2=mg la2=ethinyl la2=estradiol la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lib=regimen lib=containing lib=30 lib=mg la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lib=regimen lib=containing lib=30 lib=mg lib=ethinyl lib=estradiol lib=and lib=75 lib=mg la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lib=regimen lib=containing lib=30 lib=mg lib=ethinyl lib=estradiol lib=and lib=75 lib=mg lib=gestodene lib=for lib=at lib=least lib=3 lib=months lib=received lib=2400 lib=mg/day lib=of la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lib=regimen lib=containing lib=30 lib=mg lib=ethinyl lib=estradiol lib=and lib=75 lib=mg lib=gestodene lib=for lib=at lib=least lib=3 lib=months lib=received lib=2400 lib=mg/day lib=of lib=felbamate lib=from lib=midcycle lib=(day lib=15) lib=to lib=midcycle lib=(day lib=14) lib=of lib=two lib=consecutive lib=oral la2=regimen la2=containing la2=30 la2=mg la2=ethinyl la2=estradiol la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=conj lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lb1=contraceptive lb1=regimen lb1=containing lb1=30 lb1=mg lib=and lib=75 lib=mg la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles. 2under1
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lb1=contraceptive lb1=regimen lb1=containing lb1=30 lb1=mg lib=and lib=75 lib=mg lib=gestodene lib=for lib=at lib=least lib=3 lib=months lib=received lib=2400 lib=mg/day lib=of la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lb1=contraceptive lb1=regimen lb1=containing lb1=30 lb1=mg lib=and lib=75 lib=mg lib=gestodene lib=for lib=at lib=least lib=3 lib=months lib=received lib=2400 lib=mg/day lib=of lib=felbamate lib=from lib=midcycle lib=(day lib=15) lib=to lib=midcycle lib=(day lib=14) lib=of lib=two lib=consecutive lib=oral la2=regimen la2=containing la2=30 la2=mg la2=ethinyl la2=estradiol la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lb1=contraceptive lb1=regimen lb1=containing lb1=30 lb1=mg lb1=ethinyl lb1=estradiol lb1=and lb1=75 lb1=mg lib=for lib=at lib=least lib=3 lib=months lib=received lib=2400 lib=mg/day lib=of la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lb1=contraceptive lb1=regimen lb1=containing lb1=30 lb1=mg lb1=ethinyl lb1=estradiol lb1=and lb1=75 lb1=mg lib=for lib=at lib=least lib=3 lib=months lib=received lib=2400 lib=mg/day lib=of lib=felbamate lib=from lib=midcycle lib=(day lib=15) lib=to lib=midcycle lib=(day lib=14) lib=of lib=two lib=consecutive lib=oral la2=regimen la2=containing la2=30 la2=mg la2=ethinyl la2=estradiol la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
null dep=None lb1=Effects lb1=of lb1=Felbatol lb1=on lb1=Low-Dose lb1=Combination lb1=Oral lb1=Contraceptives lb1=A lb1=group lb1=of lb1=24 lb1=nonsmoking, lb1=healthy lb1=white lb1=female lb1=volunteers lb1=established lb1=on lb1=an lb1=oral lb1=contraceptive lb1=regimen lb1=containing lb1=30 lb1=mg lb1=ethinyl lb1=estradiol lb1=and lb1=75 lb1=mg lb1=gestodene lb1=for lb1=at lb1=least lb1=3 lb1=months lb1=received lb1=2400 lb1=mg/day lb1=of lib=from lib=midcycle lib=(day lib=15) lib=to lib=midcycle lib=(day lib=14) lib=of lib=two lib=consecutive lib=oral la2=regimen la2=containing la2=30 la2=mg la2=ethinyl la2=estradiol la2=and la2=75 la2=mg la2=gestodene la2=for la2=at la2=least la2=3 la2=months la2=received la2=2400 la2=mg/day la2=of la2=felbamate la2=from la2=midcycle la2=(day la2=15) la2=to la2=midcycle la2=(day la2=14) la2=of la2=two la2=consecutive la2=oral la2=contraceptive la2=cycles.
mechanism dep=None lib=treatment lib=resulted lib=in lib=a lib=42% lib=decrease lib=in lib=the la2=AUC la2=0-24, la2=but la2=no la2=clinically la2=relevant la2=effect la2=was la2=observed la2=on la2=the la2=pharmacokinetic la2=parameters la2=of la2=ethinyl la2=estradiol.
null dep=None lib=treatment lib=resulted lib=in lib=a lib=42% lib=decrease lib=in lib=the lib=gestodene lib=AUC lib=0-24, lib=but lib=no lib=clinically lib=relevant lib=effect lib=was lib=observed lib=on lib=the lib=pharmacokinetic lib=parameters lib=of la2=.
null dep=None lb1=Felbamate lb1=treatment lb1=resulted lb1=in lb1=a lb1=42% lb1=decrease lb1=in lb1=the lib=AUC lib=0-24, lib=but lib=no lib=clinically lib=relevant lib=effect lib=was lib=observed lib=on lib=the lib=pharmacokinetic lib=parameters lib=of la2=.
null dep=conj lb1=No lb1=clinically lb1=significant lb1=adverse lb1=interactions lb1=with lb1=commonly lb1=used lb1=preanesthetic lb1=drugs, lb1=or lb1=drugs lb1=used lb1=during lb1=anesthesia lb1=( lib=, lib=intravenous lib=agents, lib=and lib=local la2=) la2=were la2=reported la2=in la2=clinical la2=trials.
null dep=None lb1=Like lib=, la2=does la2=not la2=predispose la2=to la2=premature la2=ventricular la2=arrhythmias la2=in la2=the la2=presence la2=of la2=exogenously la2=infused la2=epinephrine la2=in la2=swine.
null dep=case lb1=Like lib=, lib=desflurane lib=does lib=not lib=predispose lib=to lib=premature lib=ventricular lib=arrhythmias lib=in lib=the lib=presence lib=of lib=exogenously lib=infused la2=in la2=swine.
null dep=None lb1=Like lb1=isoflurane, lib=does lib=not lib=predispose lib=to lib=premature lib=ventricular lib=arrhythmias lib=in lib=the lib=presence lib=of lib=exogenously lib=infused la2=in la2=swine.
effect dep=case lib=potentiates lib=the lib=muscle lib=relaxant lib=effect lib=of lib=all la2=, la2=most la2=notably la2=nondepolarizing la2=muscle la2=relaxants, la2=and la2=MAC la2=(minimum la2=alveolar la2=concentration) la2=is la2=reduced la2=by la2=concomitant la2=administration la2=of la2=N la2=2O.
effect dep=case lib=potentiates lib=the lib=muscle lib=relaxant lib=effect lib=of lib=all lib=muscle lib=relaxants, lib=most lib=notably la2=, la2=and la2=MAC la2=(minimum la2=alveolar la2=concentration) la2=is la2=reduced la2=by la2=concomitant la2=administration la2=of la2=N la2=2O.
null dep=compound lb1=Isoflurane lb1=potentiates lb1=the lb1=muscle lb1=relaxant lb1=effect lb1=of lb1=all lib=, lib=most lib=notably la2=, la2=and la2=MAC la2=(minimum la2=alveolar la2=concentration) la2=is la2=reduced la2=by la2=concomitant la2=administration la2=of la2=N la2=2O.
null dep=appos lb1=Urinary lb1=acidifying lb1=agents lb1=These lb1=agents lb1=( lib=, la2=, la2=etc.) la2=increase la2=the la2=concentration la2=of la2=the la2=ionized la2=species la2=of la2=the la2=amphetamine la2=molecule, la2=thereby la2=increasing la2=urinary la2=excretion.
mechanism dep=None lb1=Urinary lb1=acidifying lb1=agents lb1=These lb1=agents lb1=( lib=, lib=sodium lib=acid lib=phosphate, lib=etc.) lib=increase lib=the lib=concentration lib=of lib=the lib=ionized lib=species lib=of lib=the la2=molecule, la2=thereby la2=increasing la2=urinary la2=excretion.
mechanism dep=None lb1=Urinary lb1=acidifying lb1=agents lb1=These lb1=agents lb1=(ammonium lb1=chloride, lib=, lib=etc.) lib=increase lib=the lib=concentration lib=of lib=the lib=ionized lib=species lib=of lib=the la2=molecule, la2=thereby la2=increasing la2=urinary la2=excretion.
null dep=amod la2=Adrenergic la2=blockers la2=are la2=inhibited la2=by la2=amphetamines.
null dep=None lib=Adrenergic lib=blockers lib=are lib=inhibited lib=by la2=.
effect dep=None lib=Adrenergic lib=blockers lib=are lib=inhibited lib=by la2=.
null dep=None lib=, la2=Amphetamines la2=may la2=enhance la2=the la2=activity la2=of la2=tricyclic la2=antidepressants la2=or la2=sympathomimetic la2=agents;
null dep=None lib=, lib=tricyclic la2=may la2=enhance la2=the la2=activity la2=of la2=tricyclic la2=antidepressants la2=or la2=sympathomimetic la2=agents;
null dep=None lib=, lib=tricyclic lib=Amphetamines lib=may lib=enhance lib=the lib=activity lib=of la2=or la2=sympathomimetic la2=agents;
null dep=None lib=, lib=tricyclic lib=Amphetamines lib=may lib=enhance lib=the lib=activity lib=of lib=tricyclic lib=antidepressants lib=or la2=;
null dep=amod lb1=Antidepressants, la2=may la2=enhance la2=the la2=activity la2=of la2=tricyclic la2=antidepressants la2=or la2=sympathomimetic la2=agents; 1under2
null dep=amod lb1=Antidepressants, lib=Amphetamines lib=may lib=enhance lib=the lib=activity lib=of la2=or la2=sympathomimetic la2=agents; 1under2
null dep=None lb1=Antidepressants, lib=Amphetamines lib=may lib=enhance lib=the lib=activity lib=of lib=tricyclic lib=antidepressants lib=or la2=;
effect dep=amod lb1=Antidepressants, lb1=tricyclic lib=may lib=enhance lib=the lib=activity lib=of la2=or la2=sympathomimetic la2=agents;
effect dep=None lb1=Antidepressants, lb1=tricyclic lib=may lib=enhance lib=the lib=activity lib=of lib=tricyclic lib=antidepressants lib=or la2=;
null dep=conj lb1=Antidepressants, lb1=tricyclic lb1=Amphetamines lb1=may lb1=enhance lb1=the lb1=activity lb1=of lib=or la2=;
mechanism dep=nmod lib=with la2=or la2=protriptyline la2=and la2=possibly la2=other la2=tricyclics la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain; 2under1
mechanism dep=None lib=with lib=desipramine lib=or la2=and la2=possibly la2=other la2=tricyclics la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain; 2under1
mechanism dep=None lib=with lib=desipramine lib=or lib=protriptyline lib=and lib=possibly lib=other la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain; 2under1
null dep=None lib=with lib=desipramine lib=or lib=protriptyline lib=and lib=possibly lib=other lib=tricyclics lib=cause lib=striking lib=and lib=sustained lib=increases lib=in lib=the lib=concentration lib=of la2=with la2=desipramine la2=or la2=protriptyline la2=and la2=possibly la2=other la2=tricyclics la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain;
null dep=conj lb1=d-amphetamine lb1=with lib=or la2=and la2=possibly la2=other la2=tricyclics la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain; 2under1
null dep=conj lb1=d-amphetamine lb1=with lib=or lib=protriptyline lib=and lib=possibly lib=other la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain; 2under1
null dep=nmod lb1=d-amphetamine lb1=with lib=or lib=protriptyline lib=and lib=possibly lib=other lib=tricyclics lib=cause lib=striking lib=and lib=sustained lib=increases lib=in lib=the lib=concentration lib=of la2=with la2=desipramine la2=or la2=protriptyline la2=and la2=possibly la2=other la2=tricyclics la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain; 1under2
null dep=None lb1=d-amphetamine lb1=with lb1=desipramine lb1=or lib=and lib=possibly lib=other la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain;
null dep=None lb1=d-amphetamine lb1=with lb1=desipramine lb1=or lib=and lib=possibly lib=other lib=tricyclics lib=cause lib=striking lib=and lib=sustained lib=increases lib=in lib=the lib=concentration lib=of la2=with la2=desipramine la2=or la2=protriptyline la2=and la2=possibly la2=other la2=tricyclics la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain; 1under2
null dep=None lb1=d-amphetamine lb1=with lb1=desipramine lb1=or lb1=protriptyline lb1=and lb1=possibly lb1=other lib=cause lib=striking lib=and lib=sustained lib=increases lib=in lib=the lib=concentration lib=of la2=with la2=desipramine la2=or la2=protriptyline la2=and la2=possibly la2=other la2=tricyclics la2=cause la2=striking la2=and la2=sustained la2=increases la2=in la2=the la2=concentration la2=of la2=d-amphetamine la2=in la2=the la2=brain; 1under2
null dep=compound la2=, la2=as la2=well la2=as la2=a la2=metabolite la2=of la2=furazolidone, la2=slow la2=amphetamine la2=metabolism.
null dep=None lib=MAOI lib=antidepressants, lib=as lib=well lib=as lib=a lib=metabolite lib=of la2=, la2=slow la2=amphetamine la2=metabolism. 2under1
null dep=None lib=MAOI lib=antidepressants, lib=as lib=well lib=as lib=a lib=metabolite lib=of lib=furazolidone, lib=slow la2=metabolism. 2under1
null dep=None lb1=MAO lb1=inhibitors lib=, lib=as lib=well lib=as lib=a lib=metabolite lib=of la2=, la2=slow la2=amphetamine la2=metabolism. 2under1
mechanism dep=None lb1=MAO lb1=inhibitors lib=, lib=as lib=well lib=as lib=a lib=metabolite lib=of lib=furazolidone, lib=slow la2=metabolism.
mechanism dep=None lb1=MAO lb1=inhibitors lb1=MAOI lb1=antidepressants, lb1=as lb1=well lb1=as lb1=a lb1=metabolite lb1=of lib=, lib=slow la2=metabolism.
null dep=None lib=: la2=may la2=counteract la2=the la2=sedative la2=effect la2=of la2=antihistamines. 2under1
null dep=None lib=: lib=Amphetamines lib=may lib=counteract lib=the lib=sedative lib=effect lib=of la2=. 2under1
effect dep=None lb1=Antihistamines: lib=may lib=counteract lib=the lib=sedative lib=effect lib=of la2=.
null dep=None lib=: la2=may la2=antagonize la2=the la2=hypotensive la2=effects la2=of la2=antihypertensives. 2under1
null dep=None lib=: lib=Amphetamines lib=may lib=antagonize lib=the lib=hypotensive lib=effects lib=of la2=. 2under1
effect dep=None lb1=Antihypertensives: lib=may lib=antagonize lib=the lib=hypotensive lib=effects lib=of la2=.
null dep=None lib=: la2=: la2=Chlorpromazine la2=blocks la2=dopamine la2=and la2=norepinephrine la2=receptors, la2=thus la2=inhibiting la2=the la2=central la2=stimulant la2=effects la2=of la2=amphetamines la2=and la2=can la2=be la2=used la2=to la2=treat la2=amphetamine la2=poisoning. 2under1
null dep=None lib=: lib=Chlorpromazine lib=blocks lib=dopamine lib=and lib=norepinephrine lib=receptors, lib=thus lib=inhibiting lib=the lib=central lib=stimulant lib=effects lib=of la2=and la2=can la2=be la2=used la2=to la2=treat la2=amphetamine la2=poisoning. 2under1
null dep=None lib=: lib=Chlorpromazine lib=blocks lib=dopamine lib=and lib=norepinephrine lib=receptors, lib=thus lib=inhibiting lib=the lib=central lib=stimulant lib=effects lib=of la2=s la2=and la2=can la2=be la2=used la2=to la2=treat la2=amphetamine la2=poisoning. 2under1
effect dep=None lib=: lib=Chlorpromazine lib=blocks lib=dopamine lib=and lib=norepinephrine lib=receptors, lib=thus lib=inhibiting lib=the lib=central lib=stimulant lib=effects lib=of la2=and la2=can la2=be la2=used la2=to la2=treat la2=amphetamine la2=poisoning. 2under1
null dep=None lib=: lib=Chlorpromazine lib=blocks lib=dopamine lib=and lib=norepinephrine lib=receptors, lib=thus lib=inhibiting lib=the lib=central lib=stimulant lib=effects lib=of la2=s la2=and la2=can la2=be la2=used la2=to la2=treat la2=amphetamine la2=poisoning. 2under1
null dep=None lb1=Chlorpromazine: lb1=Chlorpromazine lb1=blocks lb1=dopamine lb1=and lb1=norepinephrine lb1=receptors, lb1=thus lb1=inhibiting lb1=the lb1=central lb1=stimulant lb1=effects lb1=of lib=and lib=can lib=be lib=used lib=to lib=treat la2=s la2=and la2=can la2=be la2=used la2=to la2=treat la2=amphetamine la2=poisoning.
null dep=None lib=: la2=may la2=delay la2=intestinal la2=absorption la2=of la2=ethosuximide. 2under1
null dep=None lib=: lib=Amphetamines lib=may lib=delay lib=intestinal lib=absorption lib=of la2=. 2under1
mechanism dep=None lb1=Ethosuximide: lib=may lib=delay lib=intestinal lib=absorption lib=of la2=.
null dep=None lib=: la2=: la2=Haloperidol la2=blocks la2=dopamine la2=receptors, la2=thus la2=inhibiting la2=the la2=central la2=stimulant la2=effects la2=of la2=amphetamines. 2under1
null dep=None lib=: lib=Haloperidol lib=blocks lib=dopamine lib=receptors, lib=thus lib=inhibiting lib=the lib=central lib=stimulant lib=effects lib=of la2=. 2under1
effect dep=None lib=: lib=Haloperidol lib=blocks lib=dopamine lib=receptors, lib=thus lib=inhibiting lib=the lib=central lib=stimulant lib=effects lib=of la2=. 2under1
null dep=None lib=: lib=The lib=anorectic lib=and lib=stimulatory lib=effects lib=of la2=may la2=be la2=inhibited la2=by la2=lithium la2=carbonate. 2under1
null dep=compound lib=: lib=The lib=anorectic lib=and lib=stimulatory lib=effects lib=of lib=amphetamines lib=may lib=be lib=inhibited lib=by la2=.
effect dep=None lb1=Lithium lb1=carbonate: lb1=The lb1=anorectic lb1=and lb1=stimulatory lb1=effects lb1=of lib=may lib=be lib=inhibited lib=by la2=. 1under2
null dep=None lib=: la2=potentiate la2=the la2=analgesic la2=effect la2=of la2=meperidine. 2under1
null dep=None lib=: lib=Amphetamines lib=potentiate lib=the lib=analgesic lib=effect lib=of la2=. 2under1
effect dep=None lb1=Meperidine: lib=potentiate lib=the lib=analgesic lib=effect lib=of la2=.
null dep=None lib=therapy lib=Urinary lib=excretion lib=of la2=is la2=increased, la2=and la2=efficacy la2=is la2=reduced la2=by la2=acidifying la2=agents la2=used la2=in la2=methenamine la2=therapy.
null dep=None lib=therapy lib=Urinary lib=excretion lib=of lib=amphetamines lib=is lib=increased, lib=and lib=efficacy lib=is lib=reduced lib=by lib=acidifying lib=agents lib=used lib=in la2=therapy.
mechanism dep=None lb1=Methenamine lb1=therapy lb1=Urinary lb1=excretion lb1=of lib=is lib=increased, lib=and lib=efficacy lib=is lib=reduced lib=by lib=acidifying lib=agents lib=used lib=in la2=therapy.
null dep=None lib=: la2=enhance la2=the la2=adrenergic la2=effect la2=of la2=norepinephrine. 2under1
null dep=None lib=: lib=Amphetamines lib=enhance lib=the lib=adrenergic lib=effect lib=of la2=. 2under1
effect dep=None lb1=Norepinephrine: lib=enhance lib=the lib=adrenergic lib=effect lib=of la2=.
null dep=None lib=: la2=may la2=delay la2=intestinal la2=absorption la2=of la2=phenobarbital; 2under1
null dep=None lib=: lib=Amphetamines lib=may lib=delay lib=intestinal lib=absorption lib=of la2=; 2under1
mechanism dep=None lb1=Phenobarbital: lib=may lib=delay lib=intestinal lib=absorption lib=of la2=;
null dep=None lib=: la2=may la2=delay la2=intestinal la2=absorption la2=of la2=phenytoin; 2under1
null dep=None lib=: lib=Amphetamines lib=may lib=delay lib=intestinal lib=absorption lib=of la2=; 2under1
mechanism dep=None lb1=Phenytoin: lib=may lib=delay lib=intestinal lib=absorption lib=of la2=;
null dep=None lib=: lib=In lib=cases lib=of la2=overdosage, la2=amphetamine la2=CNS la2=stimulation la2=is la2=potentiated la2=and la2=fatal la2=convulsions la2=can la2=occur. 2under1
null dep=None lib=: lib=In lib=cases lib=of lib=propoxyphene lib=overdosage, la2=CNS la2=stimulation la2=is la2=potentiated la2=and la2=fatal la2=convulsions la2=can la2=occur. 2under1
effect dep=None lb1=Propoxyphene: lb1=In lb1=cases lb1=of lib=overdosage, la2=CNS la2=stimulation la2=is la2=potentiated la2=and la2=fatal la2=convulsions la2=can la2=occur.
null dep=None lib=: la2=inhibit la2=the la2=hypotensive la2=effect la2=of la2=veratrum la2=alkaloids. 2under1
null dep=compound lib=: lib=Amphetamines lib=inhibit lib=the lib=hypotensive lib=effect lib=of la2=.
effect dep=None lb1=Veratrum lb1=alkaloids: lib=inhibit lib=the lib=hypotensive lib=effect lib=of la2=. 1under2
null dep=None lb1=[Stimulation lb1=by lib=--an lib=analog lib=of lib=the lib=octapeptide lib=cholecystokinin--of la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lib=--an lib=analog lib=of lib=the lib=octapeptide lib=cholecystokinin--of lib=3H-spiroperidol lib=binding lib=after lib=the lib=long-term lib=administration lib=of la2=] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lib=--an lib=analog lib=of lib=the lib=octapeptide lib=cholecystokinin--of lib=3H-spiroperidol lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lib=--an lib=analog lib=of lib=the lib=octapeptide lib=cholecystokinin--of lib=3H-spiroperidol lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lib=--an lib=analog lib=of lib=the lib=octapeptide lib=cholecystokinin--of la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lib=--an lib=analog lib=of lib=the lib=octapeptide lib=cholecystokinin--of lib=3H-spiroperidol lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lib=--an lib=analog lib=of lib=the lib=octapeptide lib=cholecystokinin--of la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lib=--an lib=analog lib=of lib=the lib=octapeptide lib=cholecystokinin--of lib=3H-spiroperidol lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of la2=] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lib=] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lib=] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lib=] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lib=] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lib=] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lib=] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lib=(0.25 lib=mg/kg) lib=and la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lb1=haloperidol lb1=(0.25 lb1=mg/kg) lb1=and lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lb1=haloperidol lb1=(0.25 lb1=mg/kg) lb1=and lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lb1=haloperidol lb1=(0.25 lb1=mg/kg) lb1=and lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lb1=haloperidol lb1=(0.25 lb1=mg/kg) lb1=and lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lb1=haloperidol lb1=(0.25 lb1=mg/kg) lb1=and lb1=pyreneperone lb1=(0.25 lb1=mg/kg) lb1=resulted lb1=in lb1=the lb1=reduced lb1=interaction lb1=between lb1=3H-spiroperidol lb1=and lb1=low lb1=affinity lb1=binding lb1=sites lb1=for lib=in lib=subcortical lib=structures, lib=whereas la2=binding la2=after la2=the la2=long-term la2=administration la2=of la2=neuroleptics] la2=It la2=has la2=been la2=established la2=in la2=experiments la2=on la2=white la2=male la2=rats la2=that la2=prolonged la2=administration la2=(twice la2=a la2=day la2=for la2=14 la2=days) la2=of la2=haloperidol la2=(0.25 la2=mg/kg) la2=and la2=pyreneperone la2=(0.25 la2=mg/kg) la2=resulted la2=in la2=the la2=reduced la2=interaction la2=between la2=3H-spiroperidol la2=and la2=low la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lb1=3H-spiroperidol lb1=binding lb1=after lb1=the lb1=long-term lb1=administration lb1=of lb1=neuroleptics] lb1=It lb1=has lb1=been lb1=established lb1=in lb1=experiments lb1=on lb1=white lb1=male lb1=rats lb1=that lb1=prolonged lb1=administration lb1=(twice lb1=a lb1=day lb1=for lb1=14 lb1=days) lb1=of lb1=haloperidol lb1=(0.25 lb1=mg/kg) lb1=and lb1=pyreneperone lb1=(0.25 lb1=mg/kg) lb1=resulted lb1=in lb1=the lb1=reduced lb1=interaction lb1=between lb1=3H-spiroperidol lb1=and lb1=low lb1=affinity lb1=binding lb1=sites lb1=for lib=in lib=subcortical lib=structures, lib=whereas lib=3H-spiroperidol lib=binding lib=with lib=high lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=[Stimulation lb1=by lb1=cerulein--an lb1=analog lb1=of lb1=the lb1=octapeptide lb1=cholecystokinin--of lib=binding lib=after lib=the lib=long-term lib=administration lib=of lib=neuroleptics] lib=It lib=has lib=been lib=established lib=in lib=experiments lib=on lib=white lib=male lib=rats lib=that lib=prolonged lib=administration lib=(twice lib=a lib=day lib=for lib=14 lib=days) lib=of lib=haloperidol lib=(0.25 lib=mg/kg) lib=and lib=pyreneperone lib=(0.25 lib=mg/kg) lib=resulted lib=in lib=the lib=reduced lib=interaction lib=between lib=3H-spiroperidol lib=and lib=low lib=affinity lib=binding lib=sites lib=for la2=in la2=subcortical la2=structures, la2=whereas la2=3H-spiroperidol la2=binding la2=with la2=high la2=affinity la2=binding la2=sites la2=for la2=apomorphine la2=increased la2=both la2=in la2=the la2=frontal la2=cortex la2=and la2=subcortical la2=structures la2=of la2=the la2=forebrain.
null dep=None lb1=After lb1=prolonged lb1=administration lb1=of lib=the lib=displacing lib=effect lib=of la2=, la2=an la2=analog la2=of la2=cholecystokinin la2=octapeptide, la2=was la2=replaced la2=by la2=the la2=stimulant la2=action la2=on la2=3H-spiroperidol la2=binding.
null dep=None lb1=After lb1=prolonged lb1=administration lb1=of lib=the lib=displacing lib=effect lib=of lib=cerulein, lib=an lib=analog lib=of lib=cholecystokinin lib=octapeptide, lib=was lib=replaced lib=by lib=the lib=stimulant lib=action lib=on la2=binding.
null dep=None lb1=After lb1=prolonged lb1=administration lb1=of lb1=neuroleptics lb1=the lb1=displacing lb1=effect lb1=of lib=, lib=an lib=analog lib=of lib=cholecystokinin lib=octapeptide, lib=was lib=replaced lib=by lib=the lib=stimulant lib=action lib=on la2=binding.
null dep=None lb1=It lb1=is lb1=assumed lb1=that lb1=increased lb1=interaction lb1=between lib=and lib=high lib=affinity lib=binding lib=sites lib=for la2=on la2=dopamine2- la2=and la2=serotonin2-receptors la2=underlies la2=the la2=antipsychotic la2=action la2=of la2=neuroleptics la2=after la2=their la2=prolonged la2=administration.
null dep=None lb1=It lb1=is lb1=assumed lb1=that lb1=increased lb1=interaction lb1=between lib=and lib=high lib=affinity lib=binding lib=sites lib=for lib=apomorphine lib=on lib=dopamine2- lib=and lib=serotonin2-receptors lib=underlies lib=the lib=antipsychotic lib=action lib=of la2=after la2=their la2=prolonged la2=administration.
null dep=None lb1=It lb1=is lb1=assumed lb1=that lb1=increased lb1=interaction lb1=between lb1=3H-spiroperidol lb1=and lb1=high lb1=affinity lb1=binding lb1=sites lb1=for lib=on lib=dopamine2- lib=and lib=serotonin2-receptors lib=underlies lib=the lib=antipsychotic lib=action lib=of la2=after la2=their la2=prolonged la2=administration.
null dep=None lb1=The lb1=possibility lb1=of lb1=increased lb1=interaction lb1=should lb1=be lb1=kept lb1=in lb1=mind lb1=when lib=doses lib=greater lib=than lib=50 lib=mg lib=as lib=a lib=single lib=dose lib=or lib=200 lib=mg lib=of la2=per la2=day la2=are la2=used la2=concomitantly la2=with la2=highly la2=bound la2=drugs.
null dep=None lib=: lib=Concomitant lib=administration lib=of la2=and la2=aluminum la2=hydroxide la2=does la2=not la2=interfere la2=with la2=the la2=rate la2=or la2=extent la2=of la2=the la2=absorption la2=of la2=ketoprofen la2=administered la2=as la2=Orudis.
null dep=None lib=: lib=Concomitant lib=administration lib=of lib=magnesium lib=hydroxide lib=and la2=does la2=not la2=interfere la2=with la2=the la2=rate la2=or la2=extent la2=of la2=the la2=absorption la2=of la2=ketoprofen la2=administered la2=as la2=Orudis.
null dep=None lib=: lib=Concomitant lib=administration lib=of lib=magnesium lib=hydroxide lib=and lib=aluminum lib=hydroxide lib=does lib=not lib=interfere lib=with lib=the lib=rate lib=or lib=extent lib=of lib=the lib=absorption lib=of la2=administered la2=as la2=Orudis. 2under1
null dep=None lib=: lib=Concomitant lib=administration lib=of lib=magnesium lib=hydroxide lib=and lib=aluminum lib=hydroxide lib=does lib=not lib=interfere lib=with lib=the lib=rate lib=or lib=extent lib=of lib=the lib=absorption lib=of lib=ketoprofen lib=administered lib=as la2=. 2under1
null dep=compound lb1=Antacids: lb1=Concomitant lb1=administration lb1=of lib=and la2=does la2=not la2=interfere la2=with la2=the la2=rate la2=or la2=extent la2=of la2=the la2=absorption la2=of la2=ketoprofen la2=administered la2=as la2=Orudis.
null dep=case lb1=Antacids: lb1=Concomitant lb1=administration lb1=of lib=and lib=aluminum lib=hydroxide lib=does lib=not lib=interfere lib=with lib=the lib=rate lib=or lib=extent lib=of lib=the lib=absorption lib=of la2=administered la2=as la2=Orudis.
null dep=None lb1=Antacids: lb1=Concomitant lb1=administration lb1=of lib=and lib=aluminum lib=hydroxide lib=does lib=not lib=interfere lib=with lib=the lib=rate lib=or lib=extent lib=of lib=the lib=absorption lib=of lib=ketoprofen lib=administered lib=as la2=.
null dep=case lb1=Antacids: lb1=Concomitant lb1=administration lb1=of lb1=magnesium lb1=hydroxide lb1=and lib=does lib=not lib=interfere lib=with lib=the lib=rate lib=or lib=extent lib=of lib=the lib=absorption lib=of la2=administered la2=as la2=Orudis.
null dep=None lb1=Antacids: lb1=Concomitant lb1=administration lb1=of lb1=magnesium lb1=hydroxide lb1=and lib=does lib=not lib=interfere lib=with lib=the lib=rate lib=or lib=extent lib=of lib=the lib=absorption lib=of lib=ketoprofen lib=administered lib=as la2=.
null dep=None lb1=Antacids: lb1=Concomitant lb1=administration lb1=of lb1=magnesium lb1=hydroxide lb1=and lb1=aluminum lb1=hydroxide lb1=does lb1=not lb1=interfere lb1=with lb1=the lb1=rate lb1=or lb1=extent lb1=of lb1=the lb1=absorption lb1=of lib=administered lib=as la2=. 2under1
null dep=None lib=: la2=does la2=not la2=alter la2=aspirin la2=absorption; 2under1
null dep=None lib=: lib=Ketoprofen lib=does lib=not lib=alter la2=absorption; 2under1
null dep=None lb1=Aspirin: lib=does lib=not lib=alter la2=absorption;
mechanism dep=case lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lib=decreased la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
mechanism dep=case lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lib=decreased la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
null dep=None lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lib=decreased lib=ketoprofen lib=protein lib=binding lib=and lib=increased lib=ketoprofen lib=plasma lib=clearance lib=from lib=0.07 lib=L/kg/h lib=without la2=decreased la2=ketoprofen la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
null dep=None lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lib=decreased lib=ketoprofen lib=protein lib=binding lib=and lib=increased lib=ketoprofen lib=plasma lib=clearance lib=from lib=0.07 lib=L/kg/h lib=without la2=decreased la2=ketoprofen la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
null dep=None lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lb1=aspirin lb1=decreased lib=protein lib=binding lib=and lib=increased la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
null dep=case lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lb1=aspirin lb1=decreased lib=protein lib=binding lib=and lib=increased lib=ketoprofen lib=plasma lib=clearance lib=from lib=0.07 lib=L/kg/h lib=without la2=decreased la2=ketoprofen la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
null dep=case lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lb1=aspirin lb1=decreased lib=protein lib=binding lib=and lib=increased lib=ketoprofen lib=plasma lib=clearance lib=from lib=0.07 lib=L/kg/h lib=without la2=decreased la2=ketoprofen la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
null dep=case lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lb1=aspirin lb1=decreased lib=protein lib=binding lib=and lib=increased lib=ketoprofen lib=plasma lib=clearance lib=from lib=0.07 lib=L/kg/h lib=without la2=decreased la2=ketoprofen la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
null dep=case lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lb1=aspirin lb1=decreased lib=protein lib=binding lib=and lib=increased lib=ketoprofen lib=plasma lib=clearance lib=from lib=0.07 lib=L/kg/h lib=without la2=decreased la2=ketoprofen la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
null dep=None lb1=however, lb1=in lb1=a lb1=study lb1=of lb1=12 lb1=normal lb1=subjects, lb1=concurrent lb1=administration lb1=of lib=decreased lib=ketoprofen lib=protein lib=binding lib=and lib=increased lib=ketoprofen lib=plasma lib=clearance lib=from lib=0.07 lib=L/kg/h lib=without la2=decreased la2=ketoprofen la2=protein la2=binding la2=and la2=increased la2=ketoprofen la2=plasma la2=clearance la2=from la2=0.07 la2=L/kg/h la2=without la2=aspirin la2=to la2=0.11 la2=L/kg/h la2=with la2=aspirin.
advise dep=case lb1=Therefore, lb1=concurrent lb1=use lb1=of lib=and la2=is la2=not la2=recommended. 2under1
null dep=None lib=: la2=, la2=given la2=concomitantly la2=with la2=ketoprofen, la2=produces la2=a la2=reduction la2=in la2=urinary la2=potassium la2=and la2=chloride la2=excretion la2=compared la2=to la2=hydrochlorothiazide la2=alone. 2under1
null dep=None lib=: lib=Hydrochlorothiazide, lib=given lib=concomitantly lib=with la2=, la2=produces la2=a la2=reduction la2=in la2=urinary la2=potassium la2=and la2=chloride la2=excretion la2=compared la2=to la2=hydrochlorothiazide la2=alone. 2under1
null dep=None lib=: lib=Hydrochlorothiazide, lib=given lib=concomitantly lib=with lib=ketoprofen, lib=produces lib=a lib=reduction lib=in lib=urinary lib=potassium lib=and lib=chloride lib=excretion lib=compared lib=to la2=alone. 2under1
effect dep=None lb1=Diuretic: lib=, lib=given lib=concomitantly lib=with la2=, la2=produces la2=a la2=reduction la2=in la2=urinary la2=potassium la2=and la2=chloride la2=excretion la2=compared la2=to la2=hydrochlorothiazide la2=alone. 2under1
null dep=None lb1=Diuretic: lib=, lib=given lib=concomitantly lib=with lib=ketoprofen, lib=produces lib=a lib=reduction lib=in lib=urinary lib=potassium lib=and lib=chloride lib=excretion lib=compared lib=to la2=alone.
null dep=case lb1=Diuretic: lb1=Hydrochlorothiazide, lb1=given lb1=concomitantly lb1=with lib=, lib=produces lib=a lib=reduction lib=in lib=urinary lib=potassium lib=and lib=chloride lib=excretion lib=compared lib=to la2=alone.
null dep=None lib=: lib=In lib=a lib=study lib=in lib=12 lib=patients lib=with lib=congestive lib=heart lib=failure lib=where la2=and la2=digoxin la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin. 2under1
null dep=None lib=: lib=In lib=a lib=study lib=in lib=12 lib=patients lib=with lib=congestive lib=heart lib=failure lib=where lib=ketoprofen lib=and la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin. 2under1
null dep=None lib=: lib=In lib=a lib=study lib=in lib=12 lib=patients lib=with lib=congestive lib=heart lib=failure lib=where la2=and la2=digoxin la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin. 2under1
null dep=None lib=: lib=In lib=a lib=study lib=in lib=12 lib=patients lib=with lib=congestive lib=heart lib=failure lib=where lib=ketoprofen lib=and la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin. 2under1
null dep=conj lb1=Digoxin: lb1=In lb1=a lb1=study lb1=in lb1=12 lb1=patients lb1=with lb1=congestive lb1=heart lb1=failure lb1=where lib=and la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin. 2under1
null dep=None lb1=Digoxin: lb1=In lb1=a lb1=study lb1=in lb1=12 lb1=patients lb1=with lb1=congestive lb1=heart lb1=failure lb1=where lib=and lib=digoxin lib=were lib=concomitantly lib=administered, la2=and la2=digoxin la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin.
null dep=conj lb1=Digoxin: lb1=In lb1=a lb1=study lb1=in lb1=12 lb1=patients lb1=with lb1=congestive lb1=heart lb1=failure lb1=where lib=and la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin. 2under1
null dep=conj lb1=Digoxin: lb1=In lb1=a lb1=study lb1=in lb1=12 lb1=patients lb1=with lb1=congestive lb1=heart lb1=failure lb1=where lb1=ketoprofen lb1=and lib=were lib=concomitantly lib=administered, la2=and la2=digoxin la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin. 1under2
null dep=None lb1=Digoxin: lb1=In lb1=a lb1=study lb1=in lb1=12 lb1=patients lb1=with lb1=congestive lb1=heart lb1=failure lb1=where lb1=ketoprofen lb1=and lib=were lib=concomitantly lib=administered, lib=ketoprofen lib=did lib=not lib=alter lib=the lib=serum lib=levels lib=of la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin.
null dep=conj lb1=Digoxin: lb1=In lb1=a lb1=study lb1=in lb1=12 lb1=patients lb1=with lb1=congestive lb1=heart lb1=failure lb1=where lib=and la2=were la2=concomitantly la2=administered, la2=ketoprofen la2=did la2=not la2=alter la2=the la2=serum la2=levels la2=of la2=digoxin. 2under1
null dep=None lib=: lib=In lib=a lib=short-term lib=controlled lib=study lib=in lib=14 lib=normal lib=volunteers, la2=did la2=not la2=significantly la2=interfere la2=with la2=the la2=effect la2=of la2=warfarin la2=on la2=prothrombin la2=time. 2under1
null dep=None lib=: lib=In lib=a lib=short-term lib=controlled lib=study lib=in lib=14 lib=normal lib=volunteers, lib=ketoprofen lib=did lib=not lib=significantly lib=interfere lib=with lib=the lib=effect lib=of la2=on la2=prothrombin la2=time. 2under1
null dep=case lb1=Warfarin: lb1=In lb1=a lb1=short-term lb1=controlled lb1=study lb1=in lb1=14 lb1=normal lb1=volunteers, lib=did lib=not lib=significantly lib=interfere lib=with lib=the lib=effect lib=of la2=on la2=prothrombin la2=time.
null dep=None lb1=Bleeding lb1=from lb1=a lb1=number lb1=of lb1=sites lb1=may lb1=be lb1=a lb1=complication lb1=of lib=treatment lib=and lib=GI lib=bleeding lib=a lib=complication lib=of la2=treatment.
null dep=None lb1=Because lb1=prostaglandina lb1=play lb1=an lb1=important lb1=role lb1=in lb1=hemostasis lb1=and lib=has lib=an lib=effect lib=on lib=platelet lib=function lib=as lib=well, lib=concurent lib=therapy lib=with la2=has la2=an la2=effect la2=on la2=platelet la2=function la2=as la2=well, la2=concurent la2=therapy la2=with la2=ketoprofen la2=and la2=warfarin la2=requires la2=close la2=monitoring la2=of la2=patients la2=on la2=both la2=drugs.
null dep=conj lb1=Because lb1=prostaglandina lb1=play lb1=an lb1=important lb1=role lb1=in lb1=hemostasis lb1=and lib=has lib=an lib=effect lib=on lib=platelet lib=function lib=as lib=well, lib=concurent lib=therapy lib=with lib=ketoprofen lib=and la2=requires la2=close la2=monitoring la2=of la2=patients la2=on la2=both la2=drugs. 2under1
advise dep=conj lb1=Because lb1=prostaglandina lb1=play lb1=an lb1=important lb1=role lb1=in lb1=hemostasis lb1=and lib=has lib=an lib=effect lib=on lib=platelet lib=function lib=as lib=well, lib=concurent lib=therapy lib=with lib=ketoprofen lib=and la2=requires la2=close la2=monitoring la2=of la2=patients la2=on la2=both la2=drugs. 2under1
null dep=None lib=: la2=: la2=Probenecid la2=increases la2=both la2=free la2=and la2=bound la2=ketoprofen la2=by la2=reducing la2=the la2=plasma la2=clearance la2=of la2=ketoprofen la2=to la2=about la2=one-third, la2=as la2=well la2=as la2=decreasing la2=its la2=protein la2=binding. 2under1
null dep=None lib=: lib=Probenecid lib=increases lib=both lib=free lib=and lib=bound la2=by la2=reducing la2=the la2=plasma la2=clearance la2=of la2=ketoprofen la2=to la2=about la2=one-third, la2=as la2=well la2=as la2=decreasing la2=its la2=protein la2=binding. 2under1
null dep=None lib=: lib=Probenecid lib=increases lib=both lib=free lib=and lib=bound la2=by la2=reducing la2=the la2=plasma la2=clearance la2=of la2=ketoprofen la2=to la2=about la2=one-third, la2=as la2=well la2=as la2=decreasing la2=its la2=protein la2=binding. 2under1
mechanism dep=None lib=: lib=Probenecid lib=increases lib=both lib=free lib=and lib=bound la2=by la2=reducing la2=the la2=plasma la2=clearance la2=of la2=ketoprofen la2=to la2=about la2=one-third, la2=as la2=well la2=as la2=decreasing la2=its la2=protein la2=binding. 2under1
null dep=None lib=: lib=Probenecid lib=increases lib=both lib=free lib=and lib=bound la2=by la2=reducing la2=the la2=plasma la2=clearance la2=of la2=ketoprofen la2=to la2=about la2=one-third, la2=as la2=well la2=as la2=decreasing la2=its la2=protein la2=binding. 2under1
null dep=case lb1=Probenecid: lb1=Probenecid lb1=increases lb1=both lb1=free lb1=and lb1=bound lib=by lib=reducing lib=the lib=plasma lib=clearance lib=of la2=by la2=reducing la2=the la2=plasma la2=clearance la2=of la2=ketoprofen la2=to la2=about la2=one-third, la2=as la2=well la2=as la2=decreasing la2=its la2=protein la2=binding.
advise dep=conj lb1=Therefore, lb1=the lb1=combination lb1=of lib=and la2=is la2=not la2=recommended. 2under1
null dep=None lib=: la2=, la2=like la2=other la2=NSAIDs, la2=may la2=cause la2=changes la2=in la2=the la2=elimination la2=of la2=methotrexate la2=leading la2=to la2=elevated la2=serum la2=levels la2=of la2=the la2=drug la2=and la2=increased la2=toxicity. 2under1
null dep=None lib=: lib=Ketoprofen, lib=like lib=other la2=, la2=may la2=cause la2=changes la2=in la2=the la2=elimination la2=of la2=methotrexate la2=leading la2=to la2=elevated la2=serum la2=levels la2=of la2=the la2=drug la2=and la2=increased la2=toxicity. 2under1
null dep=None lib=: lib=Ketoprofen, lib=like lib=other lib=NSAIDs, lib=may lib=cause lib=changes lib=in lib=the lib=elimination lib=of la2=leading la2=to la2=elevated la2=serum la2=levels la2=of la2=the la2=drug la2=and la2=increased la2=toxicity. 2under1
null dep=nmod lb1=Methotrexate: lib=, lib=like lib=other la2=, la2=may la2=cause la2=changes la2=in la2=the la2=elimination la2=of la2=methotrexate la2=leading la2=to la2=elevated la2=serum la2=levels la2=of la2=the la2=drug la2=and la2=increased la2=toxicity. 2under1
mechanism dep=case lb1=Methotrexate: lib=, lib=like lib=other lib=NSAIDs, lib=may lib=cause lib=changes lib=in lib=the lib=elimination lib=of la2=leading la2=to la2=elevated la2=serum la2=levels la2=of la2=the la2=drug la2=and la2=increased la2=toxicity.
mechanism dep=None lb1=Methotrexate: lb1=Ketoprofen, lb1=like lb1=other lib=, lib=may lib=cause lib=changes lib=in lib=the lib=elimination lib=of la2=leading la2=to la2=elevated la2=serum la2=levels la2=of la2=the la2=drug la2=and la2=increased la2=toxicity.
null dep=None lib=: la2=have la2=been la2=reported la2=to la2=increase la2=steadystate la2=plasma la2=lithium la2=levels.
null dep=None lib=: lib=Nonsteroidal lib=anti-inflammatory lib=agents lib=have lib=been lib=reported lib=to lib=increase lib=steadystate lib=plasma la2=levels. 2under1
mechanism dep=None lb1=Lithium: lib=have lib=been lib=reported lib=to lib=increase lib=steadystate lib=plasma la2=levels.
null dep=None lb1=It lb1=is lb1=recommended lb1=that lb1=plasma lib=levels lib=be lib=monitored lib=when la2=is la2=coadministered la2=with la2=lithium.
null dep=None lb1=It lb1=is lb1=recommended lb1=that lb1=plasma lib=levels lib=be lib=monitored lib=when lib=ketoprofen lib=is lib=coadministered lib=with la2=levels la2=be la2=monitored la2=when la2=ketoprofen la2=is la2=coadministered la2=with la2=lithium.
advise dep=None lb1=It lb1=is lb1=recommended lb1=that lb1=plasma lb1=lithium lb1=levels lb1=be lb1=monitored lb1=when lib=is lib=coadministered lib=with la2=levels la2=be la2=monitored la2=when la2=ketoprofen la2=is la2=coadministered la2=with la2=lithium.
null dep=None lb1=Oral lib=CAUTION lib=SHOULD lib=BE lib=EXERCISED lib=WHEN la2=ARE la2=GIVEN la2=IN la2=CONJUNCTION la2=WITH la2=TRICOR.
null dep=None lb1=Oral lib=CAUTION lib=SHOULD lib=BE lib=EXERCISED lib=WHEN lib=COUMARIN lib=ANTICOAGULANTS lib=ARE lib=GIVEN lib=IN lib=CONJUNCTION lib=WITH la2=.
advise dep=None lb1=Oral lb1=Anticoagulants lb1=CAUTION lb1=SHOULD lb1=BE lb1=EXERCISED lb1=WHEN lib=ARE lib=GIVEN lib=IN lib=CONJUNCTION lib=WITH la2=.
null dep=conj lib=: lib=The lib=combined lib=use lib=of la2=and la2=HMG-CoA la2=reductase la2=inhibitors la2=should la2=be la2=avoided la2=unless la2=the la2=benefit la2=of la2=further la2=alterations la2=in la2=lipid la2=levels la2=is la2=likely la2=to la2=outweigh la2=the la2=increased la2=risk la2=of la2=this la2=drug la2=combination. 2under1
null dep=compound lib=: lib=The lib=combined lib=use lib=of lib=TRICOR lib=and la2=: la2=The la2=combined la2=use la2=of la2=TRICOR la2=and la2=HMG-CoA la2=reductase la2=inhibitors la2=should la2=be la2=avoided la2=unless la2=the la2=benefit la2=of la2=further la2=alterations la2=in la2=lipid la2=levels la2=is la2=likely la2=to la2=outweigh la2=the la2=increased la2=risk la2=of la2=this la2=drug la2=combination.
advise dep=conj lb1=HMG-CoA lb1=reductase lb1=inhibitors: lb1=The lb1=combined lb1=use lb1=of lib=and la2=: la2=The la2=combined la2=use la2=of la2=TRICOR la2=and la2=HMG-CoA la2=reductase la2=inhibitors la2=should la2=be la2=avoided la2=unless la2=the la2=benefit la2=of la2=further la2=alterations la2=in la2=lipid la2=levels la2=is la2=likely la2=to la2=outweigh la2=the la2=increased la2=risk la2=of la2=this la2=drug la2=combination. 1under2
null dep=None lib=: lib=Since la2=may la2=bind la2=other la2=drugs la2=given la2=concurrently, la2=patients la2=should la2=take la2=TRICOR la2=at la2=least la2=1 la2=hour la2=before la2=or la2=4-6 la2=hours la2=after la2=a la2=bile la2=acid la2=binding la2=resin la2=to la2=avoid la2=impeding la2=its la2=absorption.
null dep=None lib=: lib=Since lib=bile lib=acid lib=sequestrants lib=may lib=bind lib=other lib=drugs lib=given lib=concurrently, lib=patients lib=should lib=take la2=at la2=least la2=1 la2=hour la2=before la2=or la2=4-6 la2=hours la2=after la2=a la2=bile la2=acid la2=binding la2=resin la2=to la2=avoid la2=impeding la2=its la2=absorption. 2under1
null dep=None lib=: lib=Since lib=bile lib=acid lib=sequestrants lib=may lib=bind lib=other lib=drugs lib=given lib=concurrently, lib=patients lib=should lib=take lib=TRICOR lib=at lib=least lib=1 lib=hour lib=before lib=or lib=4-6 lib=hours lib=after lib=a la2=to la2=avoid la2=impeding la2=its la2=absorption.
null dep=None lb1=Resins: lb1=Since lib=may lib=bind lib=other lib=drugs lib=given lib=concurrently, lib=patients lib=should lib=take la2=at la2=least la2=1 la2=hour la2=before la2=or la2=4-6 la2=hours la2=after la2=a la2=bile la2=acid la2=binding la2=resin la2=to la2=avoid la2=impeding la2=its la2=absorption.
null dep=nsubj lb1=Resins: lb1=Since lib=may lib=bind lib=other lib=drugs lib=given lib=concurrently, lib=patients lib=should lib=take lib=TRICOR lib=at lib=least lib=1 lib=hour lib=before lib=or lib=4-6 lib=hours lib=after lib=a la2=to la2=avoid la2=impeding la2=its la2=absorption.
mechanism dep=None lb1=Resins: lb1=Since lb1=bile lb1=acid lb1=sequestrants lb1=may lb1=bind lb1=other lb1=drugs lb1=given lb1=concurrently, lb1=patients lb1=should lb1=take lib=at lib=least lib=1 lib=hour lib=before lib=or lib=4-6 lib=hours lib=after lib=a la2=to la2=avoid la2=impeding la2=its la2=absorption.
null dep=None lib=: lib=Because la2=can la2=produce la2=nephrotoxicity la2=with la2=decreases la2=in la2=creatinine la2=clearance la2=and la2=rises la2=in la2=serum la2=creatinine, la2=and la2=because la2=renal la2=excretion la2=is la2=the la2=primary la2=elimination la2=route la2=of la2=fibrate la2=drugs la2=including la2=TRICOR, la2=there la2=is la2=a la2=risk la2=that la2=an la2=interaction la2=will la2=lead la2=to la2=deterioration. 2under1
null dep=None lib=: lib=Because lib=cyclosporine lib=can lib=produce lib=nephrotoxicity lib=with lib=decreases lib=in lib=creatinine lib=clearance lib=and lib=rises lib=in lib=serum lib=creatinine, lib=and lib=because lib=renal lib=excretion lib=is lib=the lib=primary lib=elimination lib=route lib=of la2=including la2=TRICOR, la2=there la2=is la2=a la2=risk la2=that la2=an la2=interaction la2=will la2=lead la2=to la2=deterioration.
null dep=None lib=: lib=Because lib=cyclosporine lib=can lib=produce lib=nephrotoxicity lib=with lib=decreases lib=in lib=creatinine lib=clearance lib=and lib=rises lib=in lib=serum lib=creatinine, lib=and lib=because lib=renal lib=excretion lib=is lib=the lib=primary lib=elimination lib=route lib=of lib=fibrate lib=drugs lib=including la2=, la2=there la2=is la2=a la2=risk la2=that la2=an la2=interaction la2=will la2=lead la2=to la2=deterioration. 2under1
effect dep=None lb1=Cyclosporine: lb1=Because lib=can lib=produce lib=nephrotoxicity lib=with lib=decreases lib=in lib=creatinine lib=clearance lib=and lib=rises lib=in lib=serum lib=creatinine, lib=and lib=because lib=renal lib=excretion lib=is lib=the lib=primary lib=elimination lib=route lib=of la2=including la2=TRICOR, la2=there la2=is la2=a la2=risk la2=that la2=an la2=interaction la2=will la2=lead la2=to la2=deterioration.
effect dep=None lb1=Cyclosporine: lb1=Because lib=can lib=produce lib=nephrotoxicity lib=with lib=decreases lib=in lib=creatinine lib=clearance lib=and lib=rises lib=in lib=serum lib=creatinine, lib=and lib=because lib=renal lib=excretion lib=is lib=the lib=primary lib=elimination lib=route lib=of lib=fibrate lib=drugs lib=including la2=, la2=there la2=is la2=a la2=risk la2=that la2=an la2=interaction la2=will la2=lead la2=to la2=deterioration.
null dep=nmod lb1=Cyclosporine: lb1=Because lb1=cyclosporine lb1=can lb1=produce lb1=nephrotoxicity lb1=with lb1=decreases lb1=in lb1=creatinine lb1=clearance lb1=and lb1=rises lb1=in lb1=serum lb1=creatinine, lb1=and lb1=because lb1=renal lb1=excretion lb1=is lb1=the lb1=primary lb1=elimination lb1=route lb1=of lib=including la2=, la2=there la2=is la2=a la2=risk la2=that la2=an la2=interaction la2=will la2=lead la2=to la2=deterioration. 2under1
advise dep=None lb1=The lb1=benefits lb1=and lb1=risks lb1=of lb1=using lib=with la2=and la2=other la2=potentially la2=nephrotoxic la2=agents la2=should la2=be la2=carefully la2=considered, la2=and la2=the la2=lowest la2=effective la2=dose la2=employed
null dep=conj lb1=Drug-drug lb1=interactions lb1=In lb1=vitro lb1=studies lb1=using lb1=human lb1=liver lb1=microsomes lb1=indicate lb1=that lib=and la2=are la2=not la2=inhibitors la2=of la2=cytochrome la2=(CYP) la2=P450 la2=isoforms la2=CYP3A4, la2=CYP2D6, la2=CYP2E1, la2=or la2=CYP1A2.
advise dep=det lb1=Therefore, lib=should lib=be lib=taken lib=at lib=least lib=1 lib=hour lib=before lib=or lib=4-6 lib=hours lib=after lib=a la2=to la2=avoid la2=impeding la2=its la2=absorption la2=.
null dep=None lb1=Concomitant lb1=administration lb1=of lib=(equivalent lib=to lib=145mg la2=) la2=with la2=pravastatin la2=(40 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=has la2=been la2=shown la2=to la2=increase la2=the la2=mean la2=Cmax la2=and la2=AUC la2=values la2=for la2=pravastatin la2=by la2=36% la2=(range la2=from la2=69% la2=decrease la2=to la2=321% la2=increase) la2=and la2=28% la2=(range la2=from la2=54% la2=decrease la2=to la2=128% la2=increase), la2=respectively, la2=and la2=for la2=3 la2=-hydroxy-iso-pravastatin la2=by la2=55% la2=(range la2=from la2=32% la2=decrease la2=to la2=314% la2=increase) la2=and la2=39% la2=(range la2=from la2=24% la2=decrease la2=to la2=261% la2=increase), la2=respectively la2=in la2=23 la2=healthy la2=adults.
mechanism dep=None lb1=Concomitant lb1=administration lb1=of lib=(equivalent lib=to lib=145mg lib=TRICOR) lib=with la2=(40 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=has la2=been la2=shown la2=to la2=increase la2=the la2=mean la2=Cmax la2=and la2=AUC la2=values la2=for la2=pravastatin la2=by la2=36% la2=(range la2=from la2=69% la2=decrease la2=to la2=321% la2=increase) la2=and la2=28% la2=(range la2=from la2=54% la2=decrease la2=to la2=128% la2=increase), la2=respectively, la2=and la2=for la2=3 la2=-hydroxy-iso-pravastatin la2=by la2=55% la2=(range la2=from la2=32% la2=decrease la2=to la2=314% la2=increase) la2=and la2=39% la2=(range la2=from la2=24% la2=decrease la2=to la2=261% la2=increase), la2=respectively la2=in la2=23 la2=healthy la2=adults.
null dep=None lb1=Concomitant lb1=administration lb1=of lib=(equivalent lib=to lib=145mg lib=TRICOR) lib=with la2=(40 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=has la2=been la2=shown la2=to la2=increase la2=the la2=mean la2=Cmax la2=and la2=AUC la2=values la2=for la2=pravastatin la2=by la2=36% la2=(range la2=from la2=69% la2=decrease la2=to la2=321% la2=increase) la2=and la2=28% la2=(range la2=from la2=54% la2=decrease la2=to la2=128% la2=increase), la2=respectively, la2=and la2=for la2=3 la2=-hydroxy-iso-pravastatin la2=by la2=55% la2=(range la2=from la2=32% la2=decrease la2=to la2=314% la2=increase) la2=and la2=39% la2=(range la2=from la2=24% la2=decrease la2=to la2=261% la2=increase), la2=respectively la2=in la2=23 la2=healthy la2=adults.
mechanism dep=None lb1=Concomitant lb1=administration lb1=of lb1=fenofibrate lb1=(equivalent lb1=to lb1=145mg lib=) lib=with la2=(40 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=has la2=been la2=shown la2=to la2=increase la2=the la2=mean la2=Cmax la2=and la2=AUC la2=values la2=for la2=pravastatin la2=by la2=36% la2=(range la2=from la2=69% la2=decrease la2=to la2=321% la2=increase) la2=and la2=28% la2=(range la2=from la2=54% la2=decrease la2=to la2=128% la2=increase), la2=respectively, la2=and la2=for la2=3 la2=-hydroxy-iso-pravastatin la2=by la2=55% la2=(range la2=from la2=32% la2=decrease la2=to la2=314% la2=increase) la2=and la2=39% la2=(range la2=from la2=24% la2=decrease la2=to la2=261% la2=increase), la2=respectively la2=in la2=23 la2=healthy la2=adults.
null dep=None lb1=Concomitant lb1=administration lb1=of lb1=fenofibrate lb1=(equivalent lb1=to lb1=145mg lib=) lib=with la2=(40 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=has la2=been la2=shown la2=to la2=increase la2=the la2=mean la2=Cmax la2=and la2=AUC la2=values la2=for la2=pravastatin la2=by la2=36% la2=(range la2=from la2=69% la2=decrease la2=to la2=321% la2=increase) la2=and la2=28% la2=(range la2=from la2=54% la2=decrease la2=to la2=128% la2=increase), la2=respectively, la2=and la2=for la2=3 la2=-hydroxy-iso-pravastatin la2=by la2=55% la2=(range la2=from la2=32% la2=decrease la2=to la2=314% la2=increase) la2=and la2=39% la2=(range la2=from la2=24% la2=decrease la2=to la2=261% la2=increase), la2=respectively la2=in la2=23 la2=healthy la2=adults.
null dep=None lb1=Concomitant lb1=administration lb1=of lb1=fenofibrate lb1=(equivalent lb1=to lb1=145mg lb1=TRICOR) lb1=with lib=(40 lib=mg) lib=once lib=daily lib=for lib=10 lib=days lib=has lib=been lib=shown lib=to lib=increase lib=the lib=mean lib=Cmax lib=and lib=AUC lib=values lib=for la2=(40 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=has la2=been la2=shown la2=to la2=increase la2=the la2=mean la2=Cmax la2=and la2=AUC la2=values la2=for la2=pravastatin la2=by la2=36% la2=(range la2=from la2=69% la2=decrease la2=to la2=321% la2=increase) la2=and la2=28% la2=(range la2=from la2=54% la2=decrease la2=to la2=128% la2=increase), la2=respectively, la2=and la2=for la2=3 la2=-hydroxy-iso-pravastatin la2=by la2=55% la2=(range la2=from la2=32% la2=decrease la2=to la2=314% la2=increase) la2=and la2=39% la2=(range la2=from la2=24% la2=decrease la2=to la2=261% la2=increase), la2=respectively la2=in la2=23 la2=healthy la2=adults.
null dep=case lb1=A lb1=single lb1=dose lb1=of lib=had lib=no lib=clinically lib=important lib=effect lib=on lib=the lib=pharmacokinetics lib=of la2=.
null dep=None lb1=Concomitant lb1=administration lb1=of lib=(equivalent lib=to lib=145 lib=mg la2=) la2=with la2=atorvastatin la2=(20 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=resulted la2=in la2=approximately la2=17% la2=decrease la2=(range la2=from la2=67% la2=decrease la2=to la2=44% la2=increase) la2=in la2=atorvastatin la2=AUC la2=values la2=in la2=22 la2=healthy la2=males.
mechanism dep=None lb1=Concomitant lb1=administration lb1=of lib=(equivalent lib=to lib=145 lib=mg lib=TRICOR) lib=with la2=(20 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=resulted la2=in la2=approximately la2=17% la2=decrease la2=(range la2=from la2=67% la2=decrease la2=to la2=44% la2=increase) la2=in la2=atorvastatin la2=AUC la2=values la2=in la2=22 la2=healthy la2=males.
null dep=None lb1=Concomitant lb1=administration lb1=of lib=(equivalent lib=to lib=145 lib=mg lib=TRICOR) lib=with la2=(20 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=resulted la2=in la2=approximately la2=17% la2=decrease la2=(range la2=from la2=67% la2=decrease la2=to la2=44% la2=increase) la2=in la2=atorvastatin la2=AUC la2=values la2=in la2=22 la2=healthy la2=males.
mechanism dep=None lb1=Concomitant lb1=administration lb1=of lb1=fenofibrate lb1=(equivalent lb1=to lb1=145 lb1=mg lib=) lib=with la2=(20 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=resulted la2=in la2=approximately la2=17% la2=decrease la2=(range la2=from la2=67% la2=decrease la2=to la2=44% la2=increase) la2=in la2=atorvastatin la2=AUC la2=values la2=in la2=22 la2=healthy la2=males.
null dep=None lb1=Concomitant lb1=administration lb1=of lb1=fenofibrate lb1=(equivalent lb1=to lb1=145 lb1=mg lib=) lib=with la2=(20 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=resulted la2=in la2=approximately la2=17% la2=decrease la2=(range la2=from la2=67% la2=decrease la2=to la2=44% la2=increase) la2=in la2=atorvastatin la2=AUC la2=values la2=in la2=22 la2=healthy la2=males.
null dep=None lb1=Concomitant lb1=administration lb1=of lb1=fenofibrate lb1=(equivalent lb1=to lb1=145 lb1=mg lb1=TRICOR) lb1=with lib=(20 lib=mg) lib=once lib=daily lib=for lib=10 lib=days lib=resulted lib=in lib=approximately lib=17% lib=decrease lib=(range lib=from lib=67% lib=decrease lib=to lib=44% lib=increase) lib=in la2=(20 la2=mg) la2=once la2=daily la2=for la2=10 la2=days la2=resulted la2=in la2=approximately la2=17% la2=decrease la2=(range la2=from la2=67% la2=decrease la2=to la2=44% la2=increase) la2=in la2=atorvastatin la2=AUC la2=values la2=in la2=22 la2=healthy la2=males.
null dep=None lb1=The lib=Cmax lib=values lib=were lib=not lib=significantly lib=affected lib=by la2=.
null dep=None lb1=The lb1=pharmacokinetics lb1=of lib=were lib=not lib=significantly lib=affected lib=by
null dep=None lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lib=has lib=been lib=studied lib=in lib=combination lib=with la2=, la2=stavudine, la2=famciclovir, la2=and la2=tenofovir la2=disoproxil la2=fumarate.
null dep=None lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lib=has lib=been lib=studied lib=in lib=combination lib=with lib=indinavir, la2=, la2=famciclovir, la2=and la2=tenofovir la2=disoproxil la2=fumarate.
null dep=None lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lib=has lib=been lib=studied lib=in lib=combination lib=with lib=indinavir, lib=stavudine, la2=, la2=and la2=tenofovir la2=disoproxil la2=fumarate.
null dep=None lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lib=has lib=been lib=studied lib=in lib=combination lib=with lib=indinavir, lib=stavudine, lib=famciclovir, lib=and la2=.
null dep=conj lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lb1=EMTRIVA lb1=has lb1=been lb1=studied lb1=in lb1=combination lb1=with lib=, la2=, la2=famciclovir, la2=and la2=tenofovir la2=disoproxil la2=fumarate. 2under1
null dep=conj lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lb1=EMTRIVA lb1=has lb1=been lb1=studied lb1=in lb1=combination lb1=with lib=, lib=stavudine, la2=, la2=and la2=tenofovir la2=disoproxil la2=fumarate. 2under1
null dep=conj lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lb1=EMTRIVA lb1=has lb1=been lb1=studied lb1=in lb1=combination lb1=with lib=, lib=stavudine, lib=famciclovir, lib=and la2=.
null dep=None lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lb1=EMTRIVA lb1=has lb1=been lb1=studied lb1=in lb1=combination lb1=with lb1=indinavir, lib=, la2=, la2=and la2=tenofovir la2=disoproxil la2=fumarate.
null dep=None lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lb1=EMTRIVA lb1=has lb1=been lb1=studied lb1=in lb1=combination lb1=with lb1=indinavir, lib=, lib=famciclovir, lib=and la2=.
null dep=None lb1=The lb1=potential lb1=for lb1=drug lb1=interactions lb1=with lb1=EMTRIVA lb1=has lb1=been lb1=studied lb1=in lb1=combination lb1=with lb1=indinavir, lb1=stavudine, lib=, lib=and la2=.
effect dep=None lb1=Interactions lb1=attributed lb1=to lb1=the lb1=combined lb1=use lb1=of lib=injection lib=and lib=epidural la2=include la2=hypotension la2=and la2=dyspnea.
null dep=None lb1=SIDE lb1=EFFECTS lb1=( lib=) lib=The lib=most lib=common lib=adverse lib=reaction lib=during lib=treatment lib=with la2=is la2=transient la2=drowsiness la2=(10-63%).
null dep=None lb1=The lb1=adverse lb1=experience lb1=profile lb1=seen lb1=with lib=was lib=similar lib=to lib=that lib=seen lib=with la2=tablets.
null dep=None lib=dosed lib=as lib=a lib=1.0 lib=mg/kg lib=subcutaneous lib=injection lib=q12h lib=for lib=four lib=doses lib=did lib=not lib=alter lib=the lib=pharmacokinetics lib=of la2=or la2=the la2=level la2=of la2=platelet la2=aggregation la2=in la2=healthy la2=adults.
effect dep=None lib=may lib=enhance lib=the lib=effects lib=of la2=, la2=barbiturates, la2=alcohol, la2=and la2=other la2=CNS la2=depressants.
effect dep=None lib=may lib=enhance lib=the lib=effects lib=of lib=tricyclic lib=antidepressants, la2=, la2=alcohol, la2=and la2=other la2=CNS la2=depressants.
effect dep=None lib=may lib=enhance lib=the lib=effects lib=of lib=tricyclic lib=antidepressants, lib=barbiturates, la2=, la2=and la2=other la2=CNS la2=depressants.
effect dep=None lib=may lib=enhance lib=the lib=effects lib=of lib=tricyclic lib=antidepressants, lib=barbiturates, lib=alcohol, lib=and lib=other la2=.
null dep=conj lb1=Antihistamines lb1=may lb1=enhance lb1=the lb1=effects lb1=of lib=, la2=, la2=alcohol, la2=and la2=other la2=CNS la2=depressants. 2under1
null dep=conj lb1=Antihistamines lb1=may lb1=enhance lb1=the lb1=effects lb1=of lib=, lib=barbiturates, la2=, la2=and la2=other la2=CNS la2=depressants. 2under1
null dep=conj lb1=Antihistamines lb1=may lb1=enhance lb1=the lb1=effects lb1=of lib=, lib=barbiturates, lib=alcohol, lib=and lib=other la2=.
null dep=None lb1=Antihistamines lb1=may lb1=enhance lb1=the lb1=effects lb1=of lb1=tricyclic lb1=antidepressants, lib=, la2=, la2=and la2=other la2=CNS la2=depressants.
null dep=None lb1=Antihistamines lb1=may lb1=enhance lb1=the lb1=effects lb1=of lb1=tricyclic lb1=antidepressants, lib=, lib=alcohol, lib=and lib=other la2=.
null dep=None lb1=Antihistamines lb1=may lb1=enhance lb1=the lb1=effects lb1=of lb1=tricyclic lb1=antidepressants, lb1=barbiturates, lib=, lib=and lib=other la2=.
effect dep=None lib=prolong lib=and lib=intensify lib=the lib=anticholinergic lib=effects lib=of la2=.
effect dep=None lib=may lib=reduce lib=the lib=antihypertensive lib=effects lib=of la2=, la2=veratrum la2=alkaloids, la2=methyldopa la2=and la2=mecamylamine.
effect dep=None lib=may lib=reduce lib=the lib=antihypertensive lib=effects lib=of lib=reserpine, la2=, la2=methyldopa la2=and la2=mecamylamine.
effect dep=None lib=may lib=reduce lib=the lib=antihypertensive lib=effects lib=of lib=reserpine, lib=veratrum lib=alkaloids, la2=and la2=mecamylamine.
effect dep=None lib=may lib=reduce lib=the lib=antihypertensive lib=effects lib=of lib=reserpine, lib=veratrum lib=alkaloids, lib=methyldopa lib=and la2=.
null dep=conj lb1=Sympathomimetic lb1=amines lb1=may lb1=reduce lb1=the lb1=antihypertensive lb1=effects lb1=of lib=, la2=, la2=methyldopa la2=and la2=mecamylamine.
null dep=conj lb1=Sympathomimetic lb1=amines lb1=may lb1=reduce lb1=the lb1=antihypertensive lb1=effects lb1=of lib=, lib=veratrum lib=alkaloids, la2=and la2=mecamylamine. 2under1
null dep=conj lb1=Sympathomimetic lb1=amines lb1=may lb1=reduce lb1=the lb1=antihypertensive lb1=effects lb1=of lib=, lib=veratrum lib=alkaloids, lib=methyldopa lib=and la2=. 2under1
null dep=None lb1=Sympathomimetic lb1=amines lb1=may lb1=reduce lb1=the lb1=antihypertensive lb1=effects lb1=of lb1=reserpine, lib=, la2=and la2=mecamylamine.
null dep=None lb1=Sympathomimetic lb1=amines lb1=may lb1=reduce lb1=the lb1=antihypertensive lb1=effects lb1=of lb1=reserpine, lib=, lib=methyldopa lib=and la2=.
null dep=None lb1=Sympathomimetic lb1=amines lb1=may lb1=reduce lb1=the lb1=antihypertensive lb1=effects lb1=of lb1=reserpine, lb1=veratrum lb1=alkaloids, lib=and la2=.
effect dep=None lb1=Effects lb1=of lib=are lib=increased lib=with la2=and la2=beta la2=adrenergic la2=blockers.
effect dep=None lb1=Effects lb1=of lib=are lib=increased lib=with lib=MAO lib=inhibitors lib=and la2=.
null dep=conj lb1=Effects lb1=of lb1=sympathomimetics lb1=are lb1=increased lb1=with lib=and la2=.
null dep=None lb1=Few lb1=systemic lb1=data lb1=have lb1=been lb1=collected lb1=on lb1=the lb1=metabolism lb1=of lib=following lib=concomitant lib=administration lib=with lib=other lib=drugs lib=or, lib=alternatively, lib=the lib=effect lib=of lib=concomitant lib=administration lib=of la2=following la2=concomitant la2=administration la2=with la2=other la2=drugs la2=or, la2=alternatively, la2=the la2=effect la2=of la2=concomitant la2=administration la2=of la2=WELLBUTRIN la2=on la2=the la2=metabolism la2=of la2=other la2=drugs.
null dep=None lb1=In lb1=vitro lb1=studies lb1=indicate lb1=that lib=is lib=primarily lib=metabolized lib=to la2=by la2=the la2=CYP2B6 la2=isoenzyme.
int dep=None lb1=Therefore, lb1=the lb1=potential lb1=exists lb1=for lb1=a lb1=drug lb1=interaction lb1=between lib=and lib=drugs lib=that lib=affect lib=the lib=CYP2B6 lib=isoenzyme lib=(e.g., la2=and la2=cyclophosphamide).
int dep=None lb1=Therefore, lb1=the lb1=potential lb1=exists lb1=for lb1=a lb1=drug lb1=interaction lb1=between lib=and lib=drugs lib=that lib=affect lib=the lib=CYP2B6 lib=isoenzyme lib=(e.g., lib=orphenadrine lib=and la2=).
null dep=conj lb1=Therefore, lb1=the lb1=potential lb1=exists lb1=for lb1=a lb1=drug lb1=interaction lb1=between lb1=WELLBUTRIN lb1=and lb1=drugs lb1=that lb1=affect lb1=the lb1=CYP2B6 lb1=isoenzyme lb1=(e.g., lib=and la2=). 2under1
null dep=None lb1=The lib=metabolite lib=of la2=metabolite la2=of la2=bupropion la2=does la2=not la2=appear la2=to la2=be la2=produced la2=by la2=the la2=cytochrome la2=P450 la2=isoenzymes.
null dep=None lb1=The lb1=effects lb1=of lb1=concomitant lb1=administration lb1=of lib=on lib=the lib=pharmacokinetics lib=of la2=and la2=its la2=active la2=metabolites la2=were la2=studied la2=in la2=24 la2=healthy la2=young la2=male la2=volunteers.
null dep=None lb1=Following lb1=oral lb1=administration lb1=of lb1=two lb1=150-mg lb1=sustained-release lb1=tablets lb1=with lb1=and lb1=without lb1=800 lb1=mg lb1=of lib=, lib=the lib=pharmacokinetics lib=of la2=and la2=hydroxybupropion la2=were la2=unaffected.
null dep=None lb1=Following lb1=oral lb1=administration lb1=of lb1=two lb1=150-mg lb1=sustained-release lb1=tablets lb1=with lb1=and lb1=without lb1=800 lb1=mg lb1=of lib=, lib=the lib=pharmacokinetics lib=of lib=bupropion lib=and la2=were la2=unaffected.
null dep=conj lb1=Following lb1=oral lb1=administration lb1=of lb1=two lb1=150-mg lb1=sustained-release lb1=tablets lb1=with lb1=and lb1=without lb1=800 lb1=mg lb1=of lb1=cimetidine, lb1=the lb1=pharmacokinetics lb1=of lib=and la2=were la2=unaffected. 2under1
null dep=conj lb1=However, lb1=there lb1=were lb1=16% lb1=and lb1=32% lb1=increases lb1=in lb1=the lb1=AUC lb1=and lb1=Cmax, lb1=respectively, lb1=of lb1=the lb1=combined lb1=moieties lb1=of lib=and la2=. 2under1
mechanism dep=None lb1=While lb1=not lb1=systematically lb1=studied, lb1=certain lb1=drugs lb1=may lb1=induce lb1=the lb1=metabolism lb1=of lib=(e.g., la2=, la2=phenobarbital, la2=phenytoin).
mechanism dep=None lb1=While lb1=not lb1=systematically lb1=studied, lb1=certain lb1=drugs lb1=may lb1=induce lb1=the lb1=metabolism lb1=of lib=(e.g., lib=carbamazepine, la2=, la2=phenytoin).
mechanism dep=None lb1=While lb1=not lb1=systematically lb1=studied, lb1=certain lb1=drugs lb1=may lb1=induce lb1=the lb1=metabolism lb1=of lib=(e.g., lib=carbamazepine, lib=phenobarbital, la2=).
null dep=appos lb1=While lb1=not lb1=systematically lb1=studied, lb1=certain lb1=drugs lb1=may lb1=induce lb1=the lb1=metabolism lb1=of lb1=bupropion lb1=(e.g., lib=, la2=, la2=phenytoin). 2under1
null dep=appos lb1=While lb1=not lb1=systematically lb1=studied, lb1=certain lb1=drugs lb1=may lb1=induce lb1=the lb1=metabolism lb1=of lb1=bupropion lb1=(e.g., lib=, lib=phenobarbital, la2=). 2under1
null dep=None lb1=While lb1=not lb1=systematically lb1=studied, lb1=certain lb1=drugs lb1=may lb1=induce lb1=the lb1=metabolism lb1=of lb1=bupropion lb1=(e.g., lb1=carbamazepine, lib=, la2=).
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lib=(SSRIs, lib=many la2=), la2=beta-blockers, la2=antiarrhythmics, la2=and la2=antipsychotics la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme. 2under1
null dep=conj lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lib=(SSRIs, lib=many lib=tricyclics), la2=, la2=antiarrhythmics, la2=and la2=antipsychotics la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme. 2under1
null dep=conj lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lib=(SSRIs, lib=many lib=tricyclics), lib=beta-blockers, la2=, la2=and la2=antipsychotics la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme. 2under1
null dep=conj lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lib=(SSRIs, lib=many lib=tricyclics), lib=beta-blockers, lib=antiarrhythmics, lib=and la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme. 2under1
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lb1=antidepressants lb1=(SSRIs, lb1=many lib=), la2=, la2=antiarrhythmics, la2=and la2=antipsychotics la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lb1=antidepressants lb1=(SSRIs, lb1=many lib=), lib=beta-blockers, la2=, la2=and la2=antipsychotics la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lb1=antidepressants lb1=(SSRIs, lb1=many lib=), lib=beta-blockers, lib=antiarrhythmics, lib=and la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lb1=antidepressants lb1=(SSRIs, lb1=many lb1=tricyclics), lib=, la2=, la2=and la2=antipsychotics la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lb1=antidepressants lb1=(SSRIs, lb1=many lb1=tricyclics), lib=, lib=antiarrhythmics, lib=and la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450IID6 lb1=(CYP2D6): lb1=Many lb1=drugs, lb1=including lb1=most lb1=antidepressants lb1=(SSRIs, lb1=many lb1=tricyclics), lb1=beta-blockers, lib=, lib=and la2=are la2=metabolized la2=by la2=the la2=CYP2D6 la2=isoenzyme.
null dep=None lb1=Although lib=is lib=not lib=metabolized lib=by lib=this lib=isoenzyme, la2=is la2=not la2=metabolized la2=by la2=this la2=isoenzyme, la2=bupropion la2=and la2=hydroxybupropion la2=are la2=inhibitors la2=of la2=the la2=CYP2D6 la2=isoenzyme la2=in la2=vitro.
null dep=conj lb1=Although lib=is lib=not lib=metabolized lib=by lib=this lib=isoenzyme, lib=bupropion lib=and la2=are la2=inhibitors la2=of la2=the la2=CYP2D6 la2=isoenzyme la2=in la2=vitro. 2under1
null dep=conj lb1=Although lib=is lib=not lib=metabolized lib=by lib=this lib=isoenzyme, lib=bupropion lib=and la2=are la2=inhibitors la2=of la2=the la2=CYP2D6 la2=isoenzyme la2=in la2=vitro. 2under1
mechanism dep=None lb1=In lb1=a lb1=study lb1=of lb1=15 lb1=male lb1=subjects lb1=(ages lb1=19 lb1=to lb1=35 lb1=years) lb1=who lb1=were lb1=extensive lb1=metabolizers lb1=of lb1=the lb1=CYP2D6 lb1=isoenzyme, lb1=daily lb1=doses lb1=of lib=given lib=as lib=150 lib=mg lib=twice lib=daily lib=followed lib=by lib=a lib=single lib=dose lib=of lib=50 lib=mg la2=increased la2=the la2=Cmax, la2=AUC, la2=and la2=t1/2 la2=of la2=desipramine la2=by la2=an la2=average la2=of la2=approximately la2=2-, la2=5- la2=and la2=2-fold, la2=respectively.
null dep=None lb1=In lb1=a lb1=study lb1=of lb1=15 lb1=male lb1=subjects lb1=(ages lb1=19 lb1=to lb1=35 lb1=years) lb1=who lb1=were lb1=extensive lb1=metabolizers lb1=of lb1=the lb1=CYP2D6 lb1=isoenzyme, lb1=daily lb1=doses lb1=of lib=given lib=as lib=150 lib=mg lib=twice lib=daily lib=followed lib=by lib=a lib=single lib=dose lib=of lib=50 lib=mg la2=increased la2=the la2=Cmax, la2=AUC, la2=and la2=t1/2 la2=of la2=desipramine la2=by la2=an la2=average la2=of la2=approximately la2=2-, la2=5- la2=and la2=2-fold, la2=respectively.
null dep=None lb1=In lb1=a lb1=study lb1=of lb1=15 lb1=male lb1=subjects lb1=(ages lb1=19 lb1=to lb1=35 lb1=years) lb1=who lb1=were lb1=extensive lb1=metabolizers lb1=of lb1=the lb1=CYP2D6 lb1=isoenzyme, lb1=daily lb1=doses lb1=of lb1=bupropion lb1=given lb1=as lb1=150 lb1=mg lb1=twice lb1=daily lb1=followed lb1=by lb1=a lb1=single lb1=dose lb1=of lb1=50 lb1=mg lib=increased lib=the lib=Cmax, lib=AUC, lib=and lib=t1/2 lib=of la2=increased la2=the la2=Cmax, la2=AUC, la2=and la2=t1/2 la2=of la2=desipramine la2=by la2=an la2=average la2=of la2=approximately la2=2-, la2=5- la2=and la2=2-fold, la2=respectively.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain la2=(e.g., la2=nortriptyline, la2=imipramine, la2=desipramine, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., la2=, la2=imipramine, la2=desipramine, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, la2=, la2=desipramine, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, la2=, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, la2=, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, la2=, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, la2=), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., la2=, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
advise dep=None lb1=Therefore, lb1=co-administration lb1=of lib=with lib=drugs lib=that lib=are lib=metabolized lib=by lib=CYP2D6 lib=isoenzyme lib=including lib=certain lib=antidepressants lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=dep lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., la2=, la2=imipramine, la2=desipramine, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, la2=, la2=desipramine, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, la2=, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, la2=, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, la2=, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, la2=), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=conj lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., la2=, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=conj lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=conj lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lib=(e.g., lib=nortriptyline, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=conj lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, la2=, la2=desipramine, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=conj lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, la2=, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=conj lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, la2=, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=conj lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, la2=, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=appos lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, la2=), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., la2=, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lib=, lib=imipramine, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, la2=, la2=paroxetine, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, la2=, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, la2=, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, la2=), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., la2=, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lib=, lib=desipramine, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, la2=, la2=fluoxetine, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, la2=, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, la2=), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, lib=sertraline), la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., la2=, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lib=, lib=paroxetine, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, la2=, la2=sertraline), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, la2=), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, lib=sertraline), la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., la2=, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lib=, lib=fluoxetine, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, la2=), la2=antipsychotics la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, lib=sertraline), la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, lib=sertraline), lib=antipsychotics lib=(e.g., la2=, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lib=, lib=sertraline), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lib=), la2=(e.g., la2=haloperidol, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lib=), lib=antipsychotics lib=(e.g., la2=, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lib=), lib=antipsychotics lib=(e.g., lib=haloperidol, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lib=), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lib=), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lib=), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lib=), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lib=), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lib=), lib=antipsychotics lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=dep lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lib=(e.g., la2=, la2=risperidone, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lib=(e.g., lib=haloperidol, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lib=(e.g., lib=haloperidol, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lib=(e.g., lib=haloperidol, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=appos lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lib=, la2=, la2=thioridazine), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=appos lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lib=, lib=risperidone, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lib=, lib=risperidone, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lib=, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lib=, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lib=, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lib=, lib=risperidone, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lib=, la2=), la2=beta-blockers la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lib=, lib=thioridazine), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lib=, lib=thioridazine), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lib=, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lib=, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lib=, lib=thioridazine), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lib=), la2=(e.g., la2=metoprolol), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lib=), lib=beta-blockers lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lib=), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lib=), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lib=), lib=beta-blockers lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=dep lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lib=(e.g., la2=), la2=and la2=Type la2=1C la2=antiarrhythmics la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lib=(e.g., lib=metoprolol), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lib=(e.g., lib=metoprolol), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lb1=beta-blockers lb1=(e.g., lib=), lib=and la2=(e.g., la2=propafenone, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lb1=beta-blockers lb1=(e.g., lib=), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lb1=beta-blockers lb1=(e.g., lib=), lib=and lib=Type lib=1C lib=antiarrhythmics lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication.
null dep=dep lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lb1=beta-blockers lb1=(e.g., lb1=metoprolol), lb1=and lib=(e.g., la2=, la2=flecainide), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lb1=beta-blockers lb1=(e.g., lb1=metoprolol), lb1=and lib=(e.g., lib=propafenone, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=appos lb1=Therefore, lb1=co-administration lb1=of lb1=bupropion lb1=with lb1=drugs lb1=that lb1=are lb1=metabolized lb1=by lb1=CYP2D6 lb1=isoenzyme lb1=including lb1=certain lb1=antidepressants lb1=(e.g., lb1=nortriptyline, lb1=imipramine, lb1=desipramine, lb1=paroxetine, lb1=fluoxetine, lb1=sertraline), lb1=antipsychotics lb1=(e.g., lb1=haloperidol, lb1=risperidone, lb1=thioridazine), lb1=beta-blockers lb1=(e.g., lb1=metoprolol), lb1=and lb1=Type lb1=1C lb1=antiarrhythmics lb1=(e.g., lib=, la2=), la2=should la2=be la2=approached la2=with la2=caution la2=and la2=should la2=be la2=initiated la2=at la2=the la2=lower la2=end la2=of la2=the la2=dose la2=range la2=of la2=the la2=concomitant la2=medication. 2under1
null dep=None lib=: lib=Studies lib=in lib=animals lib=demonstrate lib=that lib=the lib=acute lib=toxicity lib=of la2=is la2=enhanced la2=by la2=the la2=MAO la2=inhibitor la2=phenelzine la2=. 2under1
null dep=compound lib=: lib=Studies lib=in lib=animals lib=demonstrate lib=that lib=the lib=acute lib=toxicity lib=of lib=bupropion lib=is lib=enhanced lib=by lib=the la2=phenelzine la2=.
null dep=compound lib=: lib=Studies lib=in lib=animals lib=demonstrate lib=that lib=the lib=acute lib=toxicity lib=of lib=bupropion lib=is lib=enhanced lib=by lib=the lib=MAO lib=inhibitor la2=. 2under1
null dep=None lb1=MAO lb1=Inhibitors: lb1=Studies lb1=in lb1=animals lb1=demonstrate lb1=that lb1=the lb1=acute lb1=toxicity lb1=of lib=is lib=enhanced lib=by lib=the la2=phenelzine la2=.
effect dep=None lb1=MAO lb1=Inhibitors: lb1=Studies lb1=in lb1=animals lb1=demonstrate lb1=that lb1=the lb1=acute lb1=toxicity lb1=of lib=is lib=enhanced lib=by lib=the lib=MAO lib=inhibitor la2=.
null dep=compound lb1=MAO lb1=Inhibitors: lb1=Studies lb1=in lb1=animals lb1=demonstrate lb1=that lb1=the lb1=acute lb1=toxicity lb1=of lb1=bupropion lb1=is lb1=enhanced lb1=by lb1=the la2=.
null dep=conj lib=and la2=: la2=Limited la2=clinical la2=data la2=suggest la2=a la2=higher la2=incidence la2=of la2=adverse la2=experiences la2=in la2=patients la2=receiving la2=bupropion la2=concurrently la2=with la2=either la2=levodopa la2=or la2=amantadine. 2under1
null dep=None lib=and lib=Amantadine: lib=Limited lib=clinical lib=data lib=suggest lib=a lib=higher lib=incidence lib=of lib=adverse lib=experiences lib=in lib=patients lib=receiving la2=concurrently la2=with la2=either la2=levodopa la2=or la2=amantadine. 2under1
null dep=None lib=and lib=Amantadine: lib=Limited lib=clinical lib=data lib=suggest lib=a lib=higher lib=incidence lib=of lib=adverse lib=experiences lib=in lib=patients lib=receiving lib=bupropion lib=concurrently lib=with lib=either la2=or la2=amantadine. 2under1
null dep=None lib=and lib=Amantadine: lib=Limited lib=clinical lib=data lib=suggest lib=a lib=higher lib=incidence lib=of lib=adverse lib=experiences lib=in lib=patients lib=receiving lib=bupropion lib=concurrently lib=with lib=either lib=levodopa lib=or la2=. 2under1
null dep=None lb1=Levodopa lb1=and lib=: lib=Limited lib=clinical lib=data lib=suggest lib=a lib=higher lib=incidence lib=of lib=adverse lib=experiences lib=in lib=patients lib=receiving la2=concurrently la2=with la2=either la2=levodopa la2=or la2=amantadine.
null dep=None lb1=Levodopa lb1=and lib=: lib=Limited lib=clinical lib=data lib=suggest lib=a lib=higher lib=incidence lib=of lib=adverse lib=experiences lib=in lib=patients lib=receiving lib=bupropion lib=concurrently lib=with lib=either la2=or la2=amantadine.
null dep=None lb1=Levodopa lb1=and lib=: lib=Limited lib=clinical lib=data lib=suggest lib=a lib=higher lib=incidence lib=of lib=adverse lib=experiences lib=in lib=patients lib=receiving lib=bupropion lib=concurrently lib=with lib=either lib=levodopa lib=or la2=.
effect dep=None lb1=Levodopa lb1=and lb1=Amantadine: lb1=Limited lb1=clinical lb1=data lb1=suggest lb1=a lb1=higher lb1=incidence lb1=of lb1=adverse lb1=experiences lb1=in lb1=patients lb1=receiving lib=concurrently lib=with lib=either la2=or la2=amantadine.
effect dep=None lb1=Levodopa lb1=and lb1=Amantadine: lb1=Limited lb1=clinical lb1=data lb1=suggest lb1=a lb1=higher lb1=incidence lb1=of lb1=adverse lb1=experiences lb1=in lb1=patients lb1=receiving lib=concurrently lib=with lib=either lib=levodopa lib=or la2=.
null dep=conj lb1=Levodopa lb1=and lb1=Amantadine: lb1=Limited lb1=clinical lb1=data lb1=suggest lb1=a lb1=higher lb1=incidence lb1=of lb1=adverse lb1=experiences lb1=in lb1=patients lb1=receiving lb1=bupropion lb1=concurrently lb1=with lb1=either lib=or la2=. 2under1
advise dep=None lb1=Administration lb1=of lib=Tablets lib=to lib=patients lib=receiving lib=either la2=or la2=amantadine la2=concurrently la2=should la2=be la2=undertaken la2=with la2=caution, la2=using la2=small la2=initial la2=doses la2=and la2=small la2=gradual la2=dose la2=increases.
advise dep=None lb1=Administration lb1=of lib=Tablets lib=to lib=patients lib=receiving lib=either lib=levodopa lib=or la2=concurrently la2=should la2=be la2=undertaken la2=with la2=caution, la2=using la2=small la2=initial la2=doses la2=and la2=small la2=gradual la2=dose la2=increases.
null dep=conj lb1=Administration lb1=of lb1=WELLBUTRIN lb1=Tablets lb1=to lb1=patients lb1=receiving lb1=either lib=or la2=concurrently la2=should la2=be la2=undertaken la2=with la2=caution, la2=using la2=small la2=initial la2=doses la2=and la2=small la2=gradual la2=dose la2=increases. 2under1
advise dep=None lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lib=and lib=agents lib=(e.g., la2=, la2=other la2=antidepressants, la2=theophylline, la2=systemic la2=steroids, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution.
advise dep=None lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lib=and lib=agents lib=(e.g., lib=antipsychotics, lib=other la2=, la2=theophylline, la2=systemic la2=steroids, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution.
advise dep=None lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lib=and lib=agents lib=(e.g., lib=antipsychotics, lib=other lib=antidepressants, la2=, la2=systemic la2=steroids, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution.
advise dep=None lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lib=and lib=agents lib=(e.g., lib=antipsychotics, lib=other lib=antidepressants, lib=theophylline, lib=systemic la2=, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution.
null dep=conj lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lb1=WELLBUTRIN lb1=and lb1=agents lb1=(e.g., lib=, lib=other la2=, la2=theophylline, la2=systemic la2=steroids, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution. 2under1
null dep=conj lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lb1=WELLBUTRIN lb1=and lb1=agents lb1=(e.g., lib=, lib=other lib=antidepressants, la2=, la2=systemic la2=steroids, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution. 2under1
null dep=conj lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lb1=WELLBUTRIN lb1=and lb1=agents lb1=(e.g., lib=, lib=other lib=antidepressants, lib=theophylline, lib=systemic la2=, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution. 2under1
null dep=None lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lb1=WELLBUTRIN lb1=and lb1=agents lb1=(e.g., lb1=antipsychotics, lb1=other lib=, la2=, la2=systemic la2=steroids, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution.
null dep=None lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lb1=WELLBUTRIN lb1=and lb1=agents lb1=(e.g., lb1=antipsychotics, lb1=other lib=, lib=theophylline, lib=systemic la2=, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution.
null dep=None lb1=Drugs lb1=that lb1=Lower lb1=Seizure lb1=Threshold: lb1=Concurrent lb1=administration lb1=of lb1=WELLBUTRIN lb1=and lb1=agents lb1=(e.g., lb1=antipsychotics, lb1=other lb1=antidepressants, lib=, lib=systemic la2=, la2=etc.) la2=that la2=lower la2=seizure la2=threshold la2=should la2=be la2=undertaken la2=only la2=with la2=extreme la2=caution.
null dep=None lib=: lib=In lib=post-marketing lib=experience, lib=there lib=have lib=been lib=rare lib=reports lib=of lib=adverse lib=neuropsychiatric lib=events lib=or lib=reduced la2=tolerance la2=in la2=patients la2=who la2=were la2=drinking la2=alcohol la2=during la2=treatment la2=with la2=WELLBUTRIN. 2under1
null dep=None lib=: lib=In lib=post-marketing lib=experience, lib=there lib=have lib=been lib=rare lib=reports lib=of lib=adverse lib=neuropsychiatric lib=events lib=or lib=reduced la2=tolerance la2=in la2=patients la2=who la2=were la2=drinking la2=alcohol la2=during la2=treatment la2=with la2=WELLBUTRIN. 2under1
null dep=None lib=: lib=In lib=post-marketing lib=experience, lib=there lib=have lib=been lib=rare lib=reports lib=of lib=adverse lib=neuropsychiatric lib=events lib=or lib=reduced lib=alcohol lib=tolerance lib=in lib=patients lib=who lib=were lib=drinking lib=alcohol lib=during lib=treatment lib=with la2=. 2under1
null dep=None lb1=Alcohol: lb1=In lb1=post-marketing lb1=experience, lb1=there lb1=have lb1=been lb1=rare lb1=reports lb1=of lb1=adverse lb1=neuropsychiatric lb1=events lb1=or lb1=reduced lib=tolerance lib=in lib=patients lib=who lib=were lib=drinking la2=tolerance la2=in la2=patients la2=who la2=were la2=drinking la2=alcohol la2=during la2=treatment la2=with la2=WELLBUTRIN.
null dep=None lb1=Alcohol: lb1=In lb1=post-marketing lb1=experience, lb1=there lb1=have lb1=been lb1=rare lb1=reports lb1=of lb1=adverse lb1=neuropsychiatric lb1=events lb1=or lb1=reduced lib=tolerance lib=in lib=patients lib=who lib=were lib=drinking lib=alcohol lib=during lib=treatment lib=with la2=.
effect dep=None lb1=Alcohol: lb1=In lb1=post-marketing lb1=experience, lb1=there lb1=have lb1=been lb1=rare lb1=reports lb1=of lb1=adverse lb1=neuropsychiatric lb1=events lb1=or lb1=reduced lib=tolerance lib=in lib=patients lib=who lib=were lib=drinking lib=alcohol lib=during lib=treatment lib=with la2=.
advise dep=None lb1=The lb1=consumption lb1=of lib=during lib=treatment lib=with la2=should la2=be la2=minimized la2=or la2=avoided la2=(also la2=see la2=a la2=href= la2=bupropz_od.htm#CI la2=CONTRAINDICATIONS)
null dep=None lb1=There lb1=is lb1=no lb1=information lb1=regarding lb1=the lb1=effect lb1=on lib=pharmacokinetics lib=of lib=higher lib=doses lib=of la2=/SMX la2=such la2=as la2=those la2=used la2=to la2=treat la2=Pneumocystis la2=carinii la2=pneumonia.
null dep=None lb1=There lb1=is lb1=no lb1=information lb1=regarding lb1=the lb1=effect lb1=on lib=pharmacokinetics lib=of lib=higher lib=doses lib=of lib=TMP/ la2=such la2=as la2=those la2=used la2=to la2=treat la2=Pneumocystis la2=carinii la2=pneumonia.
null dep=None lb1=There lb1=is lb1=no lb1=information lb1=regarding lb1=the lb1=effect lb1=on lb1=lamivudine lb1=pharmacokinetics lb1=of lb1=higher lb1=doses lb1=of lib=/ la2=such la2=as la2=those la2=used la2=to la2=treat la2=Pneumocystis la2=carinii la2=pneumonia.
effect dep=conj lib=and la2=may la2=inhibit la2=the la2=intracellular la2=phosphorylation la2=of la2=one la2=another. 2under1
advise dep=None lb1=Therefore, lb1=use lb1=of lib=in lib=combination lib=with la2=is la2=not la2=recommended
null dep=None lb1=The lib=are lib=a lib=rapidly lib=growing lib=class lib=of la2=with la2=a la2=broad la2=spectrum la2=of la2=activity la2=against la2=gram-negative la2=and la2=some la2=gram-positive la2=aerobic la2=bacteria.
null dep=conj lb1=These lb1=agents, lb1=including lib=, la2=, la2=ofloxacin, la2=enoxacin, la2=and la2=lomefloxacin, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis. 2under1
null dep=conj lb1=These lb1=agents, lb1=including lib=, lib=cipr la2=, la2=ofloxacin, la2=enoxacin, la2=and la2=lomefloxacin, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis. 2under1
null dep=conj lb1=These lb1=agents, lb1=including lib=, lib=ciprofloxacin, lib=ofloxacin, la2=, la2=and la2=lomefloxacin, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis. 2under1
null dep=conj lb1=These lb1=agents, lb1=including lib=, lib=ciprofloxacin, lib=ofloxacin, lib=enoxacin, lib=and la2=, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis. 2under1
null dep=None lb1=These lb1=agents, lb1=including lb1=norfloxacin, lib=, la2=, la2=ofloxacin, la2=enoxacin, la2=and la2=lomefloxacin, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis.
null dep=None lb1=These lb1=agents, lb1=including lb1=norfloxacin, lib=, lib=ofloxacin, la2=, la2=and la2=lomefloxacin, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis.
null dep=None lb1=These lb1=agents, lb1=including lb1=norfloxacin, lib=, lib=ofloxacin, lib=enoxacin, lib=and la2=, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis.
null dep=None lb1=These lb1=agents, lb1=including lb1=norfloxacin, lb1=cipr lib=, lib=ofloxacin, la2=, la2=and la2=lomefloxacin, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis.
null dep=None lb1=These lb1=agents, lb1=including lb1=norfloxacin, lb1=cipr lib=, lib=ofloxacin, lib=enoxacin, lib=and la2=, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis.
null dep=None lb1=These lb1=agents, lb1=including lb1=norfloxacin, lb1=ciprofloxacin, lb1=ofloxacin, lib=, lib=and la2=, la2=have la2=been la2=extensively la2=studied la2=and la2=have la2=demonstrated la2=efficacy la2=and la2=safety la2=profiles la2=comparable la2=to la2=those la2=of la2=other la2=traditional la2=agents la2=for la2=the la2=treatment la2=of la2=complicated la2=or la2=uncomplicated la2=urinary la2=tract la2=infections la2=and la2=prostatitis.
null dep=None lb1=Advantages lb1=offered lb1=by lb1=this lb1=class lb1=of lib=include lib=optimal lib=pharmacokinetics, lib=effectiveness lib=against lib=multidrug-resistant lib=organisms, lib=and lib=oral lib=administration lib=even lib=when lib=parenteral la2=include la2=optimal la2=pharmacokinetics, la2=effectiveness la2=against la2=multidrug-resistant la2=organisms, la2=and la2=oral la2=administration la2=even la2=when la2=parenteral la2=antibiotics la2=are la2=generally la2=used.
null dep=None lb1=Differential lb1=actions lb1=of lb1=intrathecal lib=on lib=blocking lib=the lib=tail-flick lib=inhibition lib=induced lib=by lib=intraventricular la2=and la2=morphine la2=in la2=rats.
null dep=None lb1=Differential lb1=actions lb1=of lb1=intrathecal lib=on lib=blocking lib=the lib=tail-flick lib=inhibition lib=induced lib=by lib=intraventricular lib=beta-endorphin lib=and la2=in la2=rats.
null dep=conj lb1=Differential lb1=actions lb1=of lb1=intrathecal lb1=naloxone lb1=on lb1=blocking lb1=the lb1=tail-flick lb1=inhibition lb1=induced lb1=by lb1=intraventricular lib=and la2=in la2=rats. 2under1
null dep=None lb1=The lb1=blockade lb1=of lb1=the lb1=spinal lb1=endorphinergic lb1=system lb1=by lb1=intrathecal lib=on lib=the lib=production lib=of lib=tail-flick lib=inhibition lib=induced lib=by lib=intraventricular la2=and la2=morphine la2=was la2=then la2=studied.
null dep=None lb1=The lb1=blockade lb1=of lb1=the lb1=spinal lb1=endorphinergic lb1=system lb1=by lb1=intrathecal lib=on lib=the lib=production lib=of lib=tail-flick lib=inhibition lib=induced lib=by lib=intraventricular lib=beta-endorphin lib=and la2=was la2=then la2=studied.
null dep=conj lb1=The lb1=blockade lb1=of lb1=the lb1=spinal lb1=endorphinergic lb1=system lb1=by lb1=intrathecal lb1=naloxone lb1=on lb1=the lb1=production lb1=of lb1=tail-flick lb1=inhibition lb1=induced lb1=by lb1=intraventricular lib=and la2=was la2=then la2=studied. 2under1
null dep=conj lb1=Intraventricular lb1=injection lb1=of lib=and la2=produced la2=an la2=inhibition la2=of la2=the la2=tail-flick la2=response la2=to la2=the la2=heat la2=stimulus la2=in la2=rats. 2under1
effect dep=None lb1=Intrathecal lb1=injection lb1=of lib=at lib=doses lib=of lib=0.4 lib=to lib=40 lib=micrograms lib=caused lib=a lib=dose-related lib=blockade lib=of lib=the lib=inhibition lib=of lib=the lib=tail-flick lib=response lib=induced lib=by lib=intraventricular lib=injection lib=of la2=, la2=and la2=a la2=high la2=dose la2=of la2=naloxone la2=(40 la2=micrograms) la2=completely la2=blocked la2=the la2=tail-flick la2=inhibition la2=induced la2=by la2=intraventricular la2=beta-endorphin la2=(16 la2=micrograms).
null dep=None lb1=Intrathecal lb1=injection lb1=of lib=at lib=doses lib=of lib=0.4 lib=to lib=40 lib=micrograms lib=caused lib=a lib=dose-related lib=blockade lib=of lib=the lib=inhibition lib=of lib=the lib=tail-flick lib=response lib=induced lib=by lib=intraventricular lib=injection lib=of lib=beta-endorphin, lib=and lib=a lib=high lib=dose lib=of la2=at la2=doses la2=of la2=0.4 la2=to la2=40 la2=micrograms la2=caused la2=a la2=dose-related la2=blockade la2=of la2=the la2=inhibition la2=of la2=the la2=tail-flick la2=response la2=induced la2=by la2=intraventricular la2=injection la2=of la2=beta-endorphin, la2=and la2=a la2=high la2=dose la2=of la2=naloxone la2=(40 la2=micrograms) la2=completely la2=blocked la2=the la2=tail-flick la2=inhibition la2=induced la2=by la2=intraventricular la2=beta-endorphin la2=(16 la2=micrograms).
null dep=None lb1=Intrathecal lb1=injection lb1=of lib=at lib=doses lib=of lib=0.4 lib=to lib=40 lib=micrograms lib=caused lib=a lib=dose-related lib=blockade lib=of lib=the lib=inhibition lib=of lib=the lib=tail-flick lib=response lib=induced lib=by lib=intraventricular lib=injection lib=of la2=, la2=and la2=a la2=high la2=dose la2=of la2=naloxone la2=(40 la2=micrograms) la2=completely la2=blocked la2=the la2=tail-flick la2=inhibition la2=induced la2=by la2=intraventricular la2=beta-endorphin la2=(16 la2=micrograms).
null dep=None lb1=Intrathecal lb1=injection lb1=of lb1=naloxone lb1=at lb1=doses lb1=of lb1=0.4 lb1=to lb1=40 lb1=micrograms lb1=caused lb1=a lb1=dose-related lb1=blockade lb1=of lb1=the lb1=inhibition lb1=of lb1=the lb1=tail-flick lb1=response lb1=induced lb1=by lb1=intraventricular lb1=injection lb1=of lib=, lib=and lib=a lib=high lib=dose lib=of la2=at la2=doses la2=of la2=0.4 la2=to la2=40 la2=micrograms la2=caused la2=a la2=dose-related la2=blockade la2=of la2=the la2=inhibition la2=of la2=the la2=tail-flick la2=response la2=induced la2=by la2=intraventricular la2=injection la2=of la2=beta-endorphin, la2=and la2=a la2=high la2=dose la2=of la2=naloxone la2=(40 la2=micrograms) la2=completely la2=blocked la2=the la2=tail-flick la2=inhibition la2=induced la2=by la2=intraventricular la2=beta-endorphin la2=(16 la2=micrograms).
null dep=None lb1=Intrathecal lb1=injection lb1=of lb1=naloxone lb1=at lb1=doses lb1=of lb1=0.4 lb1=to lb1=40 lb1=micrograms lb1=caused lb1=a lb1=dose-related lb1=blockade lb1=of lb1=the lb1=inhibition lb1=of lb1=the lb1=tail-flick lb1=response lb1=induced lb1=by lb1=intraventricular lb1=injection lb1=of lib=, lib=and lib=a lib=high lib=dose lib=of lib=naloxone lib=(40 lib=micrograms) lib=completely lib=blocked lib=the lib=tail-flick lib=inhibition lib=induced lib=by lib=intraventricular la2=, la2=and la2=a la2=high la2=dose la2=of la2=naloxone la2=(40 la2=micrograms) la2=completely la2=blocked la2=the la2=tail-flick la2=inhibition la2=induced la2=by la2=intraventricular la2=beta-endorphin la2=(16 la2=micrograms).
effect dep=None lb1=Intrathecal lb1=injection lb1=of lib=at lib=doses lib=of lib=0.4 lib=to lib=40 lib=micrograms lib=caused lib=a lib=dose-related lib=blockade lib=of lib=the lib=inhibition lib=of lib=the lib=tail-flick lib=response lib=induced lib=by lib=intraventricular lib=injection lib=of la2=, la2=and la2=a la2=high la2=dose la2=of la2=naloxone la2=(40 la2=micrograms) la2=completely la2=blocked la2=the la2=tail-flick la2=inhibition la2=induced la2=by la2=intraventricular la2=beta-endorphin la2=(16 la2=micrograms).
effect dep=None lb1=On lb1=the lb1=other lb1=hand, lb1=intrathecal lib=(12-120 lib=micrograms) lib=had lib=only lib=a lib=very lib=weak lib=effect lib=on lib=the lib=tail-flick lib=inhibition lib=induced lib=by lib=intraventricular la2=(40 la2=micrograms).
effect dep=None lb1=Intraventricular lb1=injection lb1=of lib=at lib=doses lib=of lib=1.2 lib=to lib=12 lib=micrograms lib=equally lib=antagonized lib=in lib=a lib=dose-dependent lib=manner lib=the lib=tail-flick lib=inhibition lib=induced lib=by lib=intraventricular la2=and la2=morphine.
effect dep=None lb1=Intraventricular lb1=injection lb1=of lib=at lib=doses lib=of lib=1.2 lib=to lib=12 lib=micrograms lib=equally lib=antagonized lib=in lib=a lib=dose-dependent lib=manner lib=the lib=tail-flick lib=inhibition lib=induced lib=by lib=intraventricular lib=beta-endorphin lib=and la2=.
null dep=conj lb1=Intraventricular lb1=injection lb1=of lb1=naloxone lb1=at lb1=doses lb1=of lb1=1.2 lb1=to lb1=12 lb1=micrograms lb1=equally lb1=antagonized lb1=in lb1=a lb1=dose-dependent lb1=manner lb1=the lb1=tail-flick lb1=inhibition lb1=induced lb1=by lb1=intraventricular lib=and la2=. 2under1
null dep=None lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lib=-sensitive lib=endorphinergic lib=system lib=is lib=involved lib=in lib=the lib=production lib=of la2=but la2=not la2=morphine-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=None lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lib=-sensitive lib=endorphinergic lib=system lib=is lib=involved lib=in lib=the lib=production lib=of lib=beta-endorphin lib=but lib=not la2=-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=None lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lib=-sensitive lib=endorphinergic lib=system lib=is lib=involved lib=in lib=the lib=production lib=of la2=but la2=not la2=morphine-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=None lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lib=-sensitive lib=endorphinergic lib=system lib=is lib=involved lib=in lib=the lib=production lib=of lib=beta-endorphin lib=but lib=not la2=-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=conj lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lb1=naloxone-sensitive lb1=endorphinergic lb1=system lb1=is lb1=involved lb1=in lb1=the lb1=production lb1=of lib=but lib=not la2=-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=None lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lb1=naloxone-sensitive lb1=endorphinergic lb1=system lb1=is lb1=involved lb1=in lb1=the lb1=production lb1=of lib=but lib=not lib=morphine-induced lib=tail-flick lib=inhibition, lib=and lib=suggest lib=that lib=intraventricular la2=but la2=not la2=morphine-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=conj lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lb1=naloxone-sensitive lb1=endorphinergic lb1=system lb1=is lb1=involved lb1=in lb1=the lb1=production lb1=of lib=but lib=not la2=-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=conj lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lb1=naloxone-sensitive lb1=endorphinergic lb1=system lb1=is lb1=involved lb1=in lb1=the lb1=production lb1=of lb1=beta-endorphin lb1=but lb1=not lib=-induced lib=tail-flick lib=inhibition, lib=and lib=suggest lib=that lib=intraventricular la2=but la2=not la2=morphine-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=None lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lb1=naloxone-sensitive lb1=endorphinergic lb1=system lb1=is lb1=involved lb1=in lb1=the lb1=production lb1=of lb1=beta-endorphin lb1=but lb1=not lib=-induced lib=tail-flick lib=inhibition, lib=and lib=suggest lib=that lib=intraventricular lib=beta-endorphin lib=and la2=-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=conj lb1=The lb1=results lb1=indicate lb1=that lb1=a lb1=spinal lb1=naloxone-sensitive lb1=endorphinergic lb1=system lb1=is lb1=involved lb1=in lb1=the lb1=production lb1=of lib=but lib=not la2=-induced la2=tail-flick la2=inhibition, la2=and la2=suggest la2=that la2=intraventricular la2=beta-endorphin la2=and la2=morphine la2=elicit la2=their la2=pharmacological la2=actions la2=via la2=the la2=activation la2=of la2=different la2=descending la2=pain la2=inhibitory la2=systems;
null dep=conj lb1=descending lb1=epsilon lb1=and lb1=mu lb1=systems lb1=for lib=and la2=, la2=respectively, la2=are la2=proposed. 2under1
effect dep=None lb1=The lb1=use lb1=of lib=may lib=result lib=in lib=additive lib=CNS lib=depressant lib=effects lib=when lib=coadministered lib=with la2=, la2=antihistamines, la2=psychotropics la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression.
effect dep=None lb1=The lb1=use lb1=of lib=may lib=result lib=in lib=additive lib=CNS lib=depressant lib=effects lib=when lib=coadministered lib=with lib=alcohol, la2=, la2=psychotropics la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression.
effect dep=None lb1=The lb1=use lb1=of lib=may lib=result lib=in lib=additive lib=CNS lib=depressant lib=effects lib=when lib=coadministered lib=with lib=alcohol, lib=antihistamines, la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression.
null dep=conj lb1=The lb1=use lb1=of lb1=codeine lb1=may lb1=result lb1=in lb1=additive lb1=CNS lb1=depressant lb1=effects lb1=when lb1=coadministered lb1=with lib=, la2=, la2=psychotropics la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression. 2under1
null dep=conj lb1=The lb1=use lb1=of lb1=codeine lb1=may lb1=result lb1=in lb1=additive lb1=CNS lb1=depressant lb1=effects lb1=when lb1=coadministered lb1=with lib=, lib=antihistamines, la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression. 2under1
null dep=None lb1=The lb1=use lb1=of lb1=codeine lb1=may lb1=result lb1=in lb1=additive lb1=CNS lb1=depressant lb1=effects lb1=when lb1=coadministered lb1=with lb1=alcohol, lib=, la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression.
effect dep=None lb1=Serious lb1=toxicity lb1=may lb1=result lb1=if lib=is lib=coadministered lib=with la2=(MAOIs).
effect dep=None lb1=Serious lb1=toxicity lb1=may lb1=result lb1=if lib=is lib=coadministered lib=with lib=monoamine lib=oxidase lib=inhibitors lib=( la2=).
null dep=appos lb1=Serious lb1=toxicity lb1=may lb1=result lb1=if lb1=dextromethorphan lb1=is lb1=coadministered lb1=with lib=( la2=). 2under1
effect dep=cc lb1=The lb1=use lb1=of lib=may lib=result lib=in lib=additive lib=CNS lib=depressant lib=effects lib=when lib=coadministered lib=with la2=, la2=antihistamines, la2=psychotropics la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression.
effect dep=None lb1=The lb1=use lb1=of lib=may lib=result lib=in lib=additive lib=CNS lib=depressant lib=effects lib=when lib=coadministered lib=with lib=alcohol, la2=, la2=psychotropics la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression.
effect dep=None lb1=The lb1=use lb1=of lib=may lib=result lib=in lib=additive lib=CNS lib=depressant lib=effects lib=when lib=coadministered lib=with lib=alcohol, lib=antihistamines, la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression.
null dep=conj lb1=The lb1=use lb1=of lb1=dextromethorphan lb1=hydrobromide lb1=may lb1=result lb1=in lb1=additive lb1=CNS lb1=depressant lb1=effects lb1=when lb1=coadministered lb1=with lib=, la2=, la2=psychotropics la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression. 2under1
null dep=conj lb1=The lb1=use lb1=of lb1=dextromethorphan lb1=hydrobromide lb1=may lb1=result lb1=in lb1=additive lb1=CNS lb1=depressant lb1=effects lb1=when lb1=coadministered lb1=with lib=, lib=antihistamines, la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression. 2under1
null dep=None lb1=The lb1=use lb1=of lb1=dextromethorphan lb1=hydrobromide lb1=may lb1=result lb1=in lb1=additive lb1=CNS lb1=depressant lb1=effects lb1=when lb1=coadministered lb1=with lb1=alcohol, lib=, la2=or la2=other la2=drugs la2=that la2=produce la2=CNS la2=depression.
null dep=punct lib=- lib=Concomitant lib=use lib=of la2=and la2=human la2=growth la2=hormone la2=may la2=enhance la2=nutrient la2=absorption la2=in la2=those la2=with la2=severe la2=short la2=bowel la2=syndrome. 2under1
null dep=amod lib=- lib=Concomitant lib=use lib=of lib=L-glutamine lib=and la2=may la2=enhance la2=nutrient la2=absorption la2=in la2=those la2=with la2=severe la2=short la2=bowel la2=syndrome.
mechanism dep=punct lb1=Human lb1=growth lb1=hormone lb1=- lb1=Concomitant lb1=use lb1=of lib=and la2=may la2=enhance la2=nutrient la2=absorption la2=in la2=those la2=with la2=severe la2=short la2=bowel la2=syndrome. 1under2
null dep=punct lib=- lib=Concomitant lib=use lib=of la2=and la2=indomethacin la2=may la2=ameliorate la2=increased la2=intestinal la2=permeability la2=caused la2=by la2=indomethacin. 2under1
null dep=None lib=- lib=Concomitant lib=use lib=of lib=L-glutamine lib=and la2=may la2=ameliorate la2=increased la2=intestinal la2=permeability la2=caused la2=by la2=indomethacin. 2under1
null dep=None lib=- lib=Concomitant lib=use lib=of lib=L-glutamine lib=and la2=may la2=ameliorate la2=increased la2=intestinal la2=permeability la2=caused la2=by la2=indomethacin. 2under1
effect dep=conj lb1=Indomethacin lb1=- lb1=Concomitant lb1=use lb1=of lib=and la2=may la2=ameliorate la2=increased la2=intestinal la2=permeability la2=caused la2=by la2=indomethacin. 2under1
null dep=conj lb1=Indomethacin lb1=- lb1=Concomitant lb1=use lb1=of lib=and la2=may la2=ameliorate la2=increased la2=intestinal la2=permeability la2=caused la2=by la2=indomethacin. 2under1
null dep=None lb1=Indomethacin lb1=- lb1=Concomitant lb1=use lb1=of lb1=L-glutamine lb1=and lib=may lib=ameliorate lib=increased lib=intestinal lib=permeability lib=caused lib=by la2=may la2=ameliorate la2=increased la2=intestinal la2=permeability la2=caused la2=by la2=indomethacin.
null dep=None lib=- lib=There lib=is lib=one lib=report lib=that la2=may la2=decrease la2=the la2=possible la2=effectiveness la2=of la2=supplemental la2=L-glutamine la2=for la2=chemotherapy-induced la2=mucositis.
null dep=punct lib=- lib=There lib=is lib=one lib=report lib=that lib=methotrexate lib=may lib=decrease lib=the lib=possible lib=effectiveness lib=of lib=supplemental la2=for la2=chemotherapy-induced la2=mucositis.
effect dep=None lb1=Methotrexate lb1=- lb1=There lb1=is lb1=one lb1=report lb1=that lib=may lib=decrease lib=the lib=possible lib=effectiveness lib=of lib=supplemental la2=for la2=chemotherapy-induced la2=mucositis.
effect dep=None lb1=In lb1=another lb1=report, lb1=nine lb1=patients lb1=with lb1=breast lb1=cancer lb1=were lb1=reported lb1=to lb1=have lb1=decreased lb1=symptoms lb1=of lib=-related lib=toxicity lib=when lib=given lib=supplemental la2=at la2=a la2=dose la2=of la2=0.5 la2=gram/kilogram/day.
null dep=None lib=- lib=In lib=one lib=report, la2=at la2=a la2=dose la2=of la2=10 la2=grams la2=three la2=times la2=daily, la2=given la2=24 la2=hours la2=after la2=receiving la2=paclitaxel, la2=appeared la2=to la2=prevent la2=the la2=development la2=of la2=myalgia la2=and la2=arthralgia, la2=adverse la2=reactions la2=of la2=paclitaxel.
null dep=None lib=- lib=In lib=one lib=report, lib=L-glutamine lib=at lib=a lib=dose lib=of lib=10 lib=grams lib=three lib=times lib=daily, lib=given lib=24 lib=hours lib=after lib=receiving la2=, la2=appeared la2=to la2=prevent la2=the la2=development la2=of la2=myalgia la2=and la2=arthralgia, la2=adverse la2=reactions la2=of la2=paclitaxel.
null dep=None lib=- lib=In lib=one lib=report, lib=L-glutamine lib=at lib=a lib=dose lib=of lib=10 lib=grams lib=three lib=times lib=daily, lib=given lib=24 lib=hours lib=after lib=receiving la2=, la2=appeared la2=to la2=prevent la2=the la2=development la2=of la2=myalgia la2=and la2=arthralgia, la2=adverse la2=reactions la2=of la2=paclitaxel.
effect dep=None lb1=Paclitaxel lb1=- lb1=In lb1=one lb1=report, lib=at lib=a lib=dose lib=of lib=10 lib=grams lib=three lib=times lib=daily, lib=given lib=24 lib=hours lib=after lib=receiving la2=, la2=appeared la2=to la2=prevent la2=the la2=development la2=of la2=myalgia la2=and la2=arthralgia, la2=adverse la2=reactions la2=of la2=paclitaxel. 2under1
null dep=None lb1=Paclitaxel lb1=- lb1=In lb1=one lb1=report, lib=at lib=a lib=dose lib=of lib=10 lib=grams lib=three lib=times lib=daily, lib=given lib=24 lib=hours lib=after lib=receiving la2=, la2=appeared la2=to la2=prevent la2=the la2=development la2=of la2=myalgia la2=and la2=arthralgia, la2=adverse la2=reactions la2=of la2=paclitaxel. 2under1
null dep=None lb1=Paclitaxel lb1=- lb1=In lb1=one lb1=report, lb1=L-glutamine lb1=at lb1=a lb1=dose lb1=of lb1=10 lb1=grams lb1=three lb1=times lb1=daily, lb1=given lb1=24 lb1=hours lb1=after lb1=receiving lib=, lib=appeared lib=to lib=prevent lib=the lib=development lib=of lib=myalgia lib=and lib=arthralgia, lib=adverse lib=reactions lib=of la2=, la2=appeared la2=to la2=prevent la2=the la2=development la2=of la2=myalgia la2=and la2=arthralgia, la2=adverse la2=reactions la2=of la2=paclitaxel.
null dep=case lb1=In lb1=vitro lb1=activity lb1=of lib=, lib=either lib=singly lib=or lib=in lib=combination lib=with la2=, la2=against la2=Mycobacterium la2=ulcerans.
null dep=conj lb1=The lb1=antimicrobial lb1=effect lb1=of lb1=a lib=, la2=, la2=either la2=alone la2=or la2=in la2=combination la2=with la2=ofloxacin, la2=was la2=evaluated la2=in la2=vitro la2=against la2=two la2=type la2=strains la2=and la2=six la2=clinical la2=isolates la2=of la2=Mycobacterium la2=ulcerans. 2under1
null dep=dep lb1=The lb1=antimicrobial lb1=effect lb1=of lb1=a lib=, lib=KRM-1648, lib=either lib=alone lib=or lib=in lib=combination lib=with la2=, la2=was la2=evaluated la2=in la2=vitro la2=against la2=two la2=type la2=strains la2=and la2=six la2=clinical la2=isolates la2=of la2=Mycobacterium la2=ulcerans. 2under1
null dep=None lb1=The lb1=antimicrobial lb1=effect lb1=of lb1=a lb1=benzoxazinorifamycin, lib=, lib=either lib=alone lib=or lib=in lib=combination lib=with la2=, la2=was la2=evaluated la2=in la2=vitro la2=against la2=two la2=type la2=strains la2=and la2=six la2=clinical la2=isolates la2=of la2=Mycobacterium la2=ulcerans.
null dep=conj lb1=ulcerans lb1=was lb1=between lb1=0.012 lb1=and lb1=0.025 lb1=mg/l, lb1=while lb1=corresponding lb1=values lb1=for lib=and la2=were la2=in la2=the la2=range la2=of la2=0.1-0.8 la2=mg/l la2=and la2=0.1-0.4 la2=mg/l la2=respectively. 2under1
effect dep=None lb1=When lb1=combined lb1=with lib=, la2=exhibited la2=strong la2=synergistic la2=activity la2=while la2=only la2=additive la2=effects la2=were la2=observed la2=with la2=the la2=combination la2=of la2=rifampicin la2=(or la2=rifabutin) la2=and la2=ofloxacin.
null dep=case lb1=When lb1=combined lb1=with lib=, lib=KRM-1648 lib=exhibited lib=strong lib=synergistic lib=activity lib=while lib=only lib=additive lib=effects lib=were lib=observed lib=with lib=the lib=combination lib=of la2=(or la2=rifabutin) la2=and la2=ofloxacin. 1under2
null dep=None lb1=When lb1=combined lb1=with lib=, lib=KRM-1648 lib=exhibited lib=strong lib=synergistic lib=activity lib=while lib=only lib=additive lib=effects lib=were lib=observed lib=with lib=the lib=combination lib=of lib=rifampicin lib=(or la2=) la2=and la2=ofloxacin.
null dep=None lb1=When lb1=combined lb1=with lib=, lib=KRM-1648 lib=exhibited lib=strong lib=synergistic lib=activity lib=while lib=only lib=additive lib=effects lib=were lib=observed lib=with lib=the lib=combination lib=of lib=rifampicin lib=(or lib=rifabutin) lib=and la2=, la2=KRM-1648 la2=exhibited la2=strong la2=synergistic la2=activity la2=while la2=only la2=additive la2=effects la2=were la2=observed la2=with la2=the la2=combination la2=of la2=rifampicin la2=(or la2=rifabutin) la2=and la2=ofloxacin.
null dep=None lb1=When lb1=combined lb1=with lb1=ofloxacin, lib=exhibited lib=strong lib=synergistic lib=activity lib=while lib=only lib=additive lib=effects lib=were lib=observed lib=with lib=the lib=combination lib=of la2=(or la2=rifabutin) la2=and la2=ofloxacin.
null dep=None lb1=When lb1=combined lb1=with lb1=ofloxacin, lib=exhibited lib=strong lib=synergistic lib=activity lib=while lib=only lib=additive lib=effects lib=were lib=observed lib=with lib=the lib=combination lib=of lib=rifampicin lib=(or la2=) la2=and la2=ofloxacin.
null dep=None lb1=When lb1=combined lb1=with lb1=ofloxacin, lib=exhibited lib=strong lib=synergistic lib=activity lib=while lib=only lib=additive lib=effects lib=were lib=observed lib=with lib=the lib=combination lib=of lib=rifampicin lib=(or lib=rifabutin) lib=and la2=, la2=KRM-1648 la2=exhibited la2=strong la2=synergistic la2=activity la2=while la2=only la2=additive la2=effects la2=were la2=observed la2=with la2=the la2=combination la2=of la2=rifampicin la2=(or la2=rifabutin) la2=and la2=ofloxacin.
null dep=appos lb1=When lb1=combined lb1=with lb1=ofloxacin, lb1=KRM-1648 lb1=exhibited lb1=strong lb1=synergistic lb1=activity lb1=while lb1=only lb1=additive lb1=effects lb1=were lb1=observed lb1=with lb1=the lb1=combination lb1=of lib=(or la2=) la2=and la2=ofloxacin. 2under1
effect dep=case lb1=When lb1=combined lb1=with lb1=ofloxacin, lb1=KRM-1648 lb1=exhibited lb1=strong lb1=synergistic lb1=activity lb1=while lb1=only lb1=additive lb1=effects lb1=were lb1=observed lb1=with lb1=the lb1=combination lb1=of lib=(or lib=rifabutin) lib=and la2=, la2=KRM-1648 la2=exhibited la2=strong la2=synergistic la2=activity la2=while la2=only la2=additive la2=effects la2=were la2=observed la2=with la2=the la2=combination la2=of la2=rifampicin la2=(or la2=rifabutin) la2=and la2=ofloxacin. 2under1
effect dep=None lb1=When lb1=combined lb1=with lb1=ofloxacin, lb1=KRM-1648 lb1=exhibited lb1=strong lb1=synergistic lb1=activity lb1=while lb1=only lb1=additive lb1=effects lb1=were lb1=observed lb1=with lb1=the lb1=combination lb1=of lb1=rifampicin lb1=(or lib=) lib=and la2=, la2=KRM-1648 la2=exhibited la2=strong la2=synergistic la2=activity la2=while la2=only la2=additive la2=effects la2=were la2=observed la2=with la2=the la2=combination la2=of la2=rifampicin la2=(or la2=rifabutin) la2=and la2=ofloxacin.
null dep=appos lb1=Synergism lb1=between lib=(e.g., la2=), la2=ephedrine, la2=and la2=other la2=sympathomimetic la2=bronchodilators la2=has la2=been la2=reported. 2under1
null dep=conj lb1=Synergism lb1=between lib=(e.g., lib=theophylline), la2=, la2=and la2=other la2=sympathomimetic la2=bronchodilators la2=has la2=been la2=reported. 2under1
effect dep=compound lb1=Synergism lb1=between lib=(e.g., lib=theophylline), lib=ephedrine, lib=and lib=other la2=has la2=been la2=reported.
null dep=None lb1=Synergism lb1=between lb1=xanthine lb1=bronchodilators lb1=(e.g., lib=), la2=, la2=and la2=other la2=sympathomimetic la2=bronchodilators la2=has la2=been la2=reported.
effect dep=appos lb1=Synergism lb1=between lb1=xanthine lb1=bronchodilators lb1=(e.g., lib=), lib=ephedrine, lib=and lib=other la2=has la2=been la2=reported. 1under2
effect dep=conj lb1=Synergism lb1=between lb1=xanthine lb1=bronchodilators lb1=(e.g., lb1=theophylline), lib=, lib=and lib=other la2=has la2=been la2=reported. 1under2
mechanism dep=conj lb1=Concurrent lb1=administration lb1=of lib=and la2=, la2=which la2=competes la2=for la2=tubular la2=secretion, la2=has la2=been la2=shown la2=to la2=increase la2=the la2=plasma la2=half-life la2=of la2=dyphylline la2=. 2under1
null dep=None lb1=Concurrent lb1=administration lb1=of lib=and lib=probenecid, lib=which lib=competes lib=for lib=tubular lib=secretion, lib=has lib=been lib=shown lib=to lib=increase lib=the lib=plasma lib=half-life lib=of la2=and la2=probenecid, la2=which la2=competes la2=for la2=tubular la2=secretion, la2=has la2=been la2=shown la2=to la2=increase la2=the la2=plasma la2=half-life la2=of la2=dyphylline la2=.
null dep=conj lb1=Concurrent lb1=administration lb1=of lb1=dyphylline lb1=and lib=, lib=which lib=competes lib=for lib=tubular lib=secretion, lib=has lib=been lib=shown lib=to lib=increase lib=the lib=plasma lib=half-life lib=of la2=and la2=probenecid, la2=which la2=competes la2=for la2=tubular la2=secretion, la2=has la2=been la2=shown la2=to la2=increase la2=the la2=plasma la2=half-life la2=of la2=dyphylline la2=. 1under2
null dep=None lib=overdose lib=recognized lib=by lib=a la2=assay.
effect dep=None lb1=We lb1=report lb1=the lb1=case lb1=of lb1=an lb1=adolescent lb1=with lb1=altered lb1=consciousness lb1=caused lb1=by lib=overdose lib=with lib=a lib=positive la2=level la2=to la2=alert la2=clinicians la2=to la2=the la2=cross-reactivity la2=of la2=carbamazepine la2=with la2=a la2=toxicology la2=screen la2=for la2=tricyclic la2=antidepressants.
null dep=None lb1=We lb1=report lb1=the lb1=case lb1=of lb1=an lb1=adolescent lb1=with lb1=altered lb1=consciousness lb1=caused lb1=by lib=overdose lib=with lib=a lib=positive lib=tricyclic lib=antidepressant lib=level lib=to lib=alert lib=clinicians lib=to lib=the lib=cross-reactivity lib=of la2=overdose la2=with la2=a la2=positive la2=tricyclic la2=antidepressant la2=level la2=to la2=alert la2=clinicians la2=to la2=the la2=cross-reactivity la2=of la2=carbamazepine la2=with la2=a la2=toxicology la2=screen la2=for la2=tricyclic la2=antidepressants.
null dep=None lb1=We lb1=report lb1=the lb1=case lb1=of lb1=an lb1=adolescent lb1=with lb1=altered lb1=consciousness lb1=caused lb1=by lib=overdose lib=with lib=a lib=positive lib=tricyclic lib=antidepressant lib=level lib=to lib=alert lib=clinicians lib=to lib=the lib=cross-reactivity lib=of lib=carbamazepine lib=with lib=a lib=toxicology lib=screen lib=for la2=.
null dep=None lb1=We lb1=report lb1=the lb1=case lb1=of lb1=an lb1=adolescent lb1=with lb1=altered lb1=consciousness lb1=caused lb1=by lb1=carbamazepine lb1=overdose lb1=with lb1=a lb1=positive lib=level lib=to lib=alert lib=clinicians lib=to lib=the lib=cross-reactivity lib=of la2=overdose la2=with la2=a la2=positive la2=tricyclic la2=antidepressant la2=level la2=to la2=alert la2=clinicians la2=to la2=the la2=cross-reactivity la2=of la2=carbamazepine la2=with la2=a la2=toxicology la2=screen la2=for la2=tricyclic la2=antidepressants.
null dep=amod lb1=We lb1=report lb1=the lb1=case lb1=of lb1=an lb1=adolescent lb1=with lb1=altered lb1=consciousness lb1=caused lb1=by lb1=carbamazepine lb1=overdose lb1=with lb1=a lb1=positive lib=level lib=to lib=alert lib=clinicians lib=to lib=the lib=cross-reactivity lib=of lib=carbamazepine lib=with lib=a lib=toxicology lib=screen lib=for la2=.
advise dep=None lb1=We lb1=report lb1=the lb1=case lb1=of lb1=an lb1=adolescent lb1=with lb1=altered lb1=consciousness lb1=caused lb1=by lib=overdose lib=with lib=a lib=positive lib=tricyclic lib=antidepressant lib=level lib=to lib=alert lib=clinicians lib=to lib=the lib=cross-reactivity lib=of lib=carbamazepine lib=with lib=a lib=toxicology lib=screen lib=for la2=.
effect dep=cc lb1=Animal lb1=experience lb1=indicates lb1=that lib=prolongs lib=the lib=sleeping lib=time lib=after la2=or la2=after la2=ethyl la2=alcohol, la2=increases la2=the la2=inhibitory la2=effects la2=of la2=chlorpromazine, la2=but la2=does la2=not la2=exhibit la2=monoamine la2=oxidase la2=inhibition.
effect dep=None lb1=Animal lb1=experience lb1=indicates lb1=that lib=prolongs lib=the lib=sleeping lib=time lib=after lib=hexobarbital lib=or lib=after la2=, la2=increases la2=the la2=inhibitory la2=effects la2=of la2=chlorpromazine, la2=but la2=does la2=not la2=exhibit la2=monoamine la2=oxidase la2=inhibition.
effect dep=None lb1=Animal lb1=experience lb1=indicates lb1=that lib=prolongs lib=the lib=sleeping lib=time lib=after lib=hexobarbital lib=or lib=after lib=ethyl lib=alcohol, lib=increases lib=the lib=inhibitory lib=effects lib=of la2=, la2=but la2=does la2=not la2=exhibit la2=monoamine la2=oxidase la2=inhibition.
null dep=conj lb1=Animal lb1=experience lb1=indicates lb1=that lb1=clorazepate lb1=dipotassium lb1=prolongs lb1=the lb1=sleeping lb1=time lb1=after lib=or lib=after la2=, la2=increases la2=the la2=inhibitory la2=effects la2=of la2=chlorpromazine, la2=but la2=does la2=not la2=exhibit la2=monoamine la2=oxidase la2=inhibition.
null dep=cc lb1=Animal lb1=experience lb1=indicates lb1=that lb1=clorazepate lb1=dipotassium lb1=prolongs lb1=the lb1=sleeping lb1=time lb1=after lib=or lib=after lib=ethyl lib=alcohol, lib=increases lib=the lib=inhibitory lib=effects lib=of la2=, la2=but la2=does la2=not la2=exhibit la2=monoamine la2=oxidase la2=inhibition.
null dep=None lb1=Animal lb1=experience lb1=indicates lb1=that lb1=clorazepate lb1=dipotassium lb1=prolongs lb1=the lb1=sleeping lb1=time lb1=after lb1=hexobarbital lb1=or lb1=after lib=, lib=increases lib=the lib=inhibitory lib=effects lib=of la2=, la2=but la2=does la2=not la2=exhibit la2=monoamine la2=oxidase la2=inhibition.
effect dep=None lb1=The lb1=actions lb1=of lb1=the lib=may lib=be lib=potentiated lib=by la2=, la2=narcotics, la2=phenothiazines, la2=monoamine la2=oxidase la2=inhibitors la2=or la2=other la2=antidepressants.
effect dep=None lb1=The lb1=actions lb1=of lb1=the lib=may lib=be lib=potentiated lib=by lib=barbiturates, la2=, la2=phenothiazines, la2=monoamine la2=oxidase la2=inhibitors la2=or la2=other la2=antidepressants.
effect dep=None lb1=The lb1=actions lb1=of lb1=the lib=may lib=be lib=potentiated lib=by lib=barbiturates, lib=narcotics, la2=, la2=monoamine la2=oxidase la2=inhibitors la2=or la2=other la2=antidepressants.
effect dep=None lb1=The lb1=actions lb1=of lb1=the lib=may lib=be lib=potentiated lib=by lib=barbiturates, lib=narcotics, lib=phenothiazines, la2=or la2=other la2=antidepressants.
effect dep=None lb1=The lb1=actions lb1=of lb1=the lib=may lib=be lib=potentiated lib=by lib=barbiturates, lib=narcotics, lib=phenothiazines, lib=monoamine lib=oxidase lib=inhibitors lib=or lib=other la2=.
null dep=conj lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lib=, la2=, la2=phenothiazines, la2=monoamine la2=oxidase la2=inhibitors la2=or la2=other la2=antidepressants. 2under1
null dep=conj lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lib=, lib=narcotics, la2=, la2=monoamine la2=oxidase la2=inhibitors la2=or la2=other la2=antidepressants. 2under1
null dep=conj lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lib=, lib=narcotics, lib=phenothiazines, la2=or la2=other la2=antidepressants.
null dep=conj lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lib=, lib=narcotics, lib=phenothiazines, lib=monoamine lib=oxidase lib=inhibitors lib=or lib=other la2=. 2under1
null dep=None lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lb1=barbiturates, lib=, la2=, la2=monoamine la2=oxidase la2=inhibitors la2=or la2=other la2=antidepressants.
null dep=None lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lb1=barbiturates, lib=, lib=phenothiazines, la2=or la2=other la2=antidepressants.
null dep=None lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lb1=barbiturates, lib=, lib=phenothiazines, lib=monoamine lib=oxidase lib=inhibitors lib=or lib=other la2=.
null dep=None lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lb1=barbiturates, lb1=narcotics, lib=, la2=or la2=other la2=antidepressants.
null dep=None lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lb1=barbiturates, lb1=narcotics, lib=, lib=monoamine lib=oxidase lib=inhibitors lib=or lib=other la2=.
null dep=None lb1=The lb1=actions lb1=of lb1=the lb1=benzodiazepines lb1=may lb1=be lb1=potentiated lb1=by lb1=barbiturates, lb1=narcotics, lb1=phenothiazines, lib=or lib=other la2=.
null dep=None lb1=In lb1=bioavailability lb1=studies lb1=with lb1=normal lb1=subjects, lb1=the lb1=concurrent lb1=administration lb1=of lib=at lib=therapeutic lib=levels lib=did lib=not lib=significantly lib=influence lib=the lib=bioavailability lib=of la2=tablets.
null dep=conj lib=, la2=, la2=Metal la2=Cations, la2=Multivitamins la2=Quinolones la2=form la2=chelates la2=with la2=alkaline la2=earth la2=and la2=transition la2=metal la2=cations. 2under1
null dep=None lib=, lib=Sucralfate, lib=Metal lib=Cations, la2=Quinolones la2=form la2=chelates la2=with la2=alkaline la2=earth la2=and la2=transition la2=metal la2=cations. 2under1
null dep=appos lib=, lib=Sucralfate, lib=Metal lib=Cations, lib=Multivitamins la2=form la2=chelates la2=with la2=alkaline la2=earth la2=and la2=transition la2=metal la2=cations. 2under1
null dep=None lb1=Antacids, lib=, lib=Metal lib=Cations, la2=Quinolones la2=form la2=chelates la2=with la2=alkaline la2=earth la2=and la2=transition la2=metal la2=cations.
null dep=None lb1=Antacids, lib=, lib=Metal lib=Cations, lib=Multivitamins la2=form la2=chelates la2=with la2=alkaline la2=earth la2=and la2=transition la2=metal la2=cations.
null dep=compound lb1=Antacids, lb1=Sucralfate, lb1=Metal lb1=Cations, la2=form la2=chelates la2=with la2=alkaline la2=earth la2=and la2=transition la2=metal la2=cations. 1under2
null dep=None lb1=Administration lb1=of lib=with la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing la2=, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, la2=, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, lib=magnesium, lib=or la2=, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with la2=, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or la2=, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
mechanism dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lib=with lib=antacids lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing la2=, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, la2=, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, lib=magnesium, lib=or la2=, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with la2=, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or la2=, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lib=containing lib=aluminum, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=conj lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, la2=, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=conj lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, lib=magnesium, lib=or la2=, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, lib=magnesium, lib=or lib=calcium, lib=with la2=, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or la2=, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lib=, lib=magnesium, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lib=, lib=or la2=, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lib=, lib=or lib=calcium, lib=with la2=, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lib=, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lib=, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lib=, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lib=, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or la2=, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lib=, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lib=, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lib=, lib=or lib=calcium, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lib=, lib=with la2=, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lib=, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lib=, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lib=, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lib=, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or la2=, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lib=, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lib=, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lib=, lib=with lib=sucralfate, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lib=, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lib=, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lib=, lib=with lib=metal lib=cations lib=such lib=as la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lib=, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or la2=, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lib=, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lib=, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lib=, lib=with lib=metal lib=cations lib=such lib=as lib=iron, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=conj lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with lib=multivitamins lib=containing la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=conj lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or la2=, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=conj lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lib=containing la2=, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lib=containing lib=iron lib=or la2=, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=conj lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or la2=, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lib=, lib=or lib=with lib=multivitamins lib=containing lib=iron lib=or lib=zinc, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lb1=multivitamins lb1=containing lb1=iron lb1=or lib=, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lb1=multivitamins lb1=containing lb1=iron lb1=or lib=, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lb1=multivitamins lb1=containing lb1=iron lb1=or lib=, lib=or lib=with lib=formulations lib=containing lib=divalent lib=and lib=trivalent lib=cations lib=such lib=as lib=VIDEX lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=appos lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lb1=multivitamins lb1=containing lb1=iron lb1=or lb1=zinc, lb1=or lb1=with lb1=formulations lb1=containing lb1=divalent lb1=and lb1=trivalent lb1=cations lb1=such lb1=as lib=( la2=) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired. 2under1
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lb1=multivitamins lb1=containing lb1=iron lb1=or lb1=zinc, lb1=or lb1=with lb1=formulations lb1=containing lb1=divalent lb1=and lb1=trivalent lb1=cations lb1=such lb1=as lib=(didanosine) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None lb1=Administration lb1=of lb1=quinolones lb1=with lb1=antacids lb1=containing lb1=aluminum, lb1=magnesium, lb1=or lb1=calcium, lb1=with lb1=sucralfate, lb1=with lb1=metal lb1=cations lb1=such lb1=as lb1=iron, lb1=or lb1=with lb1=multivitamins lb1=containing lb1=iron lb1=or lb1=zinc, lb1=or lb1=with lb1=formulations lb1=containing lb1=divalent lb1=and lb1=trivalent lb1=cations lb1=such lb1=as lb1=VIDEX lb1=( lib=) lib=chewable/buffered lib=tablets lib=or lib=the lib=pediatric lib=powder lib=for lib=oral lib=solution, lib=may lib=substantially lib=interfere lib=with lib=the lib=absorption lib=of la2=with la2=antacids la2=containing la2=aluminum, la2=magnesium, la2=or la2=calcium, la2=with la2=sucralfate, la2=with la2=metal la2=cations la2=such la2=as la2=iron, la2=or la2=with la2=multivitamins la2=containing la2=iron la2=or la2=zinc, la2=or la2=with la2=formulations la2=containing la2=divalent la2=and la2=trivalent la2=cations la2=such la2=as la2=VIDEX la2=(didanosine) la2=chewable/buffered la2=tablets la2=or la2=the la2=pediatric la2=powder la2=for la2=oral la2=solution, la2=may la2=substantially la2=interfere la2=with la2=the la2=absorption la2=of la2=quinolones, la2=resulting la2=in la2=systemic la2=concentrations la2=considerably la2=lower la2=than la2=desired.
null dep=None la2=Grepafloxacin, la2=like la2=other la2=quinolones, la2=may la2=inhibit la2=the la2=metabolism la2=of la2=caffeine la2=and la2=theobromine.
null dep=compound lib=Theobromine la2=, la2=like la2=other la2=quinolones, la2=may la2=inhibit la2=the la2=metabolism la2=of la2=caffeine la2=and la2=theobromine. 1under2
null dep=None lib=Theobromine lib=Grepafloxacin, lib=like lib=other la2=, la2=may la2=inhibit la2=the la2=metabolism la2=of la2=caffeine la2=and la2=theobromine.
null dep=None lib=Theobromine lib=Grepafloxacin, lib=like lib=other lib=quinolones, lib=may lib=inhibit lib=the lib=metabolism lib=of la2=and la2=theobromine.
null dep=None lib=Theobromine lib=Grepafloxacin, lib=like lib=other lib=quinolones, lib=may lib=inhibit lib=the lib=metabolism lib=of lib=caffeine lib=and la2=.
null dep=compound lb1=Caffeine la2=, la2=like la2=other la2=quinolones, la2=may la2=inhibit la2=the la2=metabolism la2=of la2=caffeine la2=and la2=theobromine. 1under2
null dep=None lb1=Caffeine lib=Grepafloxacin, lib=like lib=other la2=, la2=may la2=inhibit la2=the la2=metabolism la2=of la2=caffeine la2=and la2=theobromine.
null dep=None lb1=Caffeine lib=Grepafloxacin, lib=like lib=other lib=quinolones, lib=may lib=inhibit lib=the lib=metabolism lib=of la2=and la2=theobromine.
null dep=None lb1=Caffeine lib=Grepafloxacin, lib=like lib=other lib=quinolones, lib=may lib=inhibit lib=the lib=metabolism lib=of lib=caffeine lib=and la2=.
null dep=nmod lb1=Caffeine lb1=Theobromine lib=, lib=like lib=other la2=, la2=may la2=inhibit la2=the la2=metabolism la2=of la2=caffeine la2=and la2=theobromine. 2under1
mechanism dep=None lb1=Caffeine lb1=Theobromine lib=, lib=like lib=other lib=quinolones, lib=may lib=inhibit lib=the lib=metabolism lib=of la2=and la2=theobromine.
mechanism dep=None lb1=Caffeine lb1=Theobromine lib=, lib=like lib=other lib=quinolones, lib=may lib=inhibit lib=the lib=metabolism lib=of lib=caffeine lib=and la2=.
mechanism dep=None lb1=Caffeine lb1=Theobromine lb1=Grepafloxacin, lb1=like lb1=other lib=, lib=may lib=inhibit lib=the lib=metabolism lib=of la2=and la2=theobromine.
mechanism dep=None lb1=Caffeine lb1=Theobromine lb1=Grepafloxacin, lb1=like lb1=other lib=, lib=may lib=inhibit lib=the lib=metabolism lib=of lib=caffeine lib=and la2=.
null dep=conj lb1=Caffeine lb1=Theobromine lb1=Grepafloxacin, lb1=like lb1=other lb1=quinolones, lb1=may lb1=inhibit lb1=the lb1=metabolism lb1=of lib=and la2=. 2under1
null dep=conj lb1=In lb1=some lb1=patients, lb1=this lb1=may lb1=lead lb1=to lb1=reduced lb1=clearance, lb1=prolongation lb1=of lb1=plasma lb1=half-life, lb1=and lb1=enhanced lb1=effects lb1=of lib=and la2=. 2under1
null dep=None lib=: la2=is la2=a la2=competitive la2=inhibitor la2=of la2=the la2=metabolism la2=of la2=theophylline. 2under1
null dep=None lib=: lib=Grepafloxacin lib=is lib=a lib=competitive lib=inhibitor lib=of lib=the lib=metabolism lib=of la2=. 2under1
mechanism dep=None lb1=Theophylline: lib=is lib=a lib=competitive lib=inhibitor lib=of lib=the lib=metabolism lib=of la2=.
null dep=None lb1=Serum lib=concentrations lib=increase lib=when la2=is la2=initiated la2=in la2=a la2=patient la2=maintained la2=on la2=theophylline.
null dep=None lb1=Serum lib=concentrations lib=increase lib=when lib=grepafloxacin lib=is lib=initiated lib=in lib=a lib=patient lib=maintained lib=on la2=concentrations la2=increase la2=when la2=grepafloxacin la2=is la2=initiated la2=in la2=a la2=patient la2=maintained la2=on la2=theophylline.
mechanism dep=None lb1=Serum lb1=theophylline lb1=concentrations lb1=increase lb1=when lib=is lib=initiated lib=in lib=a lib=patient lib=maintained lib=on la2=concentrations la2=increase la2=when la2=grepafloxacin la2=is la2=initiated la2=in la2=a la2=patient la2=maintained la2=on la2=theophylline.
null dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lib=in lib=a lib=patient lib=maintained lib=on la2=, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
null dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lib=in lib=a lib=patient lib=maintained lib=on la2=, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
null dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lib=in lib=a lib=patient lib=maintained lib=on lib=theophylline, lib=the lib=theophylline lib=maintenance lib=dose lib=should lib=be lib=halved lib=for lib=the lib=period lib=of lib=concurrent lib=use lib=of la2=in la2=a la2=patient la2=maintained la2=on la2=theophylline, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
null dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lib=in lib=a lib=patient lib=maintained lib=on la2=, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
null dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lb1=grepafloxacin lb1=in lb1=a lb1=patient lb1=maintained lb1=on lib=, lib=the la2=, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
null dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lb1=grepafloxacin lb1=in lb1=a lb1=patient lb1=maintained lb1=on lib=, lib=the lib=theophylline lib=maintenance lib=dose lib=should lib=be lib=halved lib=for lib=the lib=period lib=of lib=concurrent lib=use lib=of la2=in la2=a la2=patient la2=maintained la2=on la2=theophylline, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
null dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lb1=grepafloxacin lb1=in lb1=a lb1=patient lb1=maintained lb1=on lib=, lib=the la2=, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
advise dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lb1=grepafloxacin lb1=in lb1=a lb1=patient lb1=maintained lb1=on lib=, lib=the lib=theophylline lib=maintenance lib=dose lib=should lib=be lib=halved lib=for lib=the lib=period lib=of lib=concurrent lib=use lib=of la2=in la2=a la2=patient la2=maintained la2=on la2=theophylline, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
null dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lb1=grepafloxacin lb1=in lb1=a lb1=patient lb1=maintained lb1=on lib=, lib=the la2=, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
null dep=None lb1=When lb1=initiating lb1=a lb1=multi-day lb1=course lb1=of lib=in lib=a lib=patient lib=maintained lib=on la2=, la2=the la2=theophylline la2=maintenance la2=dose la2=should la2=be la2=halved la2=for la2=the la2=period la2=of la2=concurrent la2=use la2=of la2=grepafloxacin la2=and la2=monitoring la2=of la2=serum la2=theophylline la2=concentrations la2=should la2=be la2=initiated la2=as la2=a la2=guide la2=to la2=further la2=dosage la2=adjustments.
null dep=None lib=: lib=In lib=subjects lib=receiving la2=, la2=no la2=significant la2=change la2=in la2=clotting la2=time la2=was la2=observed la2=when la2=grepafloxacin la2=was la2=coadministered. 2under1
null dep=None lib=: lib=In lib=subjects lib=receiving lib=warfarin, lib=no lib=significant lib=change lib=in lib=clotting lib=time lib=was lib=observed lib=when la2=was la2=coadministered. 2under1
null dep=None lb1=Warfarin: lb1=In lb1=subjects lb1=receiving lib=, lib=no lib=significant lib=change lib=in lib=clotting lib=time lib=was lib=observed lib=when la2=was la2=coadministered.
effect dep=None lb1=However, lb1=because lb1=some lib=have lib=been lib=reported lib=to lib=enhance lib=the lib=effects lib=of la2=or la2=its la2=derivatives, la2=prothrombin la2=time la2=or la2=other la2=suitable la2=anticoagulation la2=test la2=should la2=be la2=monitored la2=closely la2=if la2=a la2=quinolone la2=antimicrobial la2=is la2=administered la2=with la2=warfarin la2=or la2=its la2=derivatives.
null dep=amod lb1=However, lb1=because lb1=some lib=have lib=been lib=reported lib=to lib=enhance lib=the lib=effects lib=of lib=warfarin lib=or lib=its lib=derivatives, lib=prothrombin lib=time lib=or lib=other lib=suitable lib=anticoagulation lib=test lib=should lib=be lib=monitored lib=closely lib=if lib=a la2=is la2=administered la2=with la2=warfarin la2=or la2=its la2=derivatives.
null dep=None lb1=However, lb1=because lb1=some lib=have lib=been lib=reported lib=to lib=enhance lib=the lib=effects lib=of la2=or la2=its la2=derivatives, la2=prothrombin la2=time la2=or la2=other la2=suitable la2=anticoagulation la2=test la2=should la2=be la2=monitored la2=closely la2=if la2=a la2=quinolone la2=antimicrobial la2=is la2=administered la2=with la2=warfarin la2=or la2=its la2=derivatives.
null dep=det lb1=However, lb1=because lb1=some lb1=quinolones lb1=have lb1=been lb1=reported lb1=to lb1=enhance lb1=the lb1=effects lb1=of lib=or lib=its lib=derivatives, lib=prothrombin lib=time lib=or lib=other lib=suitable lib=anticoagulation lib=test lib=should lib=be lib=monitored lib=closely lib=if lib=a la2=is la2=administered la2=with la2=warfarin la2=or la2=its la2=derivatives.
null dep=None lb1=However, lb1=because lb1=some lb1=quinolones lb1=have lb1=been lb1=reported lb1=to lb1=enhance lb1=the lb1=effects lb1=of lib=or lib=its lib=derivatives, lib=prothrombin lib=time lib=or lib=other lib=suitable lib=anticoagulation lib=test lib=should lib=be lib=monitored lib=closely lib=if lib=a lib=quinolone lib=antimicrobial lib=is lib=administered lib=with la2=or la2=its la2=derivatives, la2=prothrombin la2=time la2=or la2=other la2=suitable la2=anticoagulation la2=test la2=should la2=be la2=monitored la2=closely la2=if la2=a la2=quinolone la2=antimicrobial la2=is la2=administered la2=with la2=warfarin la2=or la2=its la2=derivatives.
advise dep=det lb1=However, lb1=because lb1=some lb1=quinolones lb1=have lb1=been lb1=reported lb1=to lb1=enhance lb1=the lb1=effects lb1=of lb1=warfarin lb1=or lb1=its lb1=derivatives, lb1=prothrombin lb1=time lb1=or lb1=other lb1=suitable lb1=anticoagulation lb1=test lb1=should lb1=be lb1=monitored lb1=closely lb1=if lb1=a lib=is lib=administered lib=with la2=or la2=its la2=derivatives, la2=prothrombin la2=time la2=or la2=other la2=suitable la2=anticoagulation la2=test la2=should la2=be la2=monitored la2=closely la2=if la2=a la2=quinolone la2=antimicrobial la2=is la2=administered la2=with la2=warfarin la2=or la2=its la2=derivatives.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450 lb1=Enzymes lb1=The lb1=drug lb1=interaction lb1=study lb1=evaluating lb1=the lb1=effect lb1=of lib=on la2=indicates la2=that la2=grepafloxacin la2=inhibits la2=theophylline la2=metabolism, la2=which la2=is la2=mediated la2=by la2=CYP1A2.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450 lb1=Enzymes lb1=The lb1=drug lb1=interaction lb1=study lb1=evaluating lb1=the lb1=effect lb1=of lib=on lib=theophylline lib=indicates lib=that la2=on la2=theophylline la2=indicates la2=that la2=grepafloxacin la2=inhibits la2=theophylline la2=metabolism, la2=which la2=is la2=mediated la2=by la2=CYP1A2.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450 lb1=Enzymes lb1=The lb1=drug lb1=interaction lb1=study lb1=evaluating lb1=the lb1=effect lb1=of lib=on la2=indicates la2=that la2=grepafloxacin la2=inhibits la2=theophylline la2=metabolism, la2=which la2=is la2=mediated la2=by la2=CYP1A2.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450 lb1=Enzymes lb1=The lb1=drug lb1=interaction lb1=study lb1=evaluating lb1=the lb1=effect lb1=of lb1=grepafloxacin lb1=on lib=indicates lib=that la2=on la2=theophylline la2=indicates la2=that la2=grepafloxacin la2=inhibits la2=theophylline la2=metabolism, la2=which la2=is la2=mediated la2=by la2=CYP1A2.
null dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450 lb1=Enzymes lb1=The lb1=drug lb1=interaction lb1=study lb1=evaluating lb1=the lb1=effect lb1=of lb1=grepafloxacin lb1=on lib=indicates lib=that lib=grepafloxacin lib=inhibits la2=indicates la2=that la2=grepafloxacin la2=inhibits la2=theophylline la2=metabolism, la2=which la2=is la2=mediated la2=by la2=CYP1A2.
mechanism dep=None lb1=Drugs lb1=Metabolized lb1=by lb1=Cytochrome lb1=P450 lb1=Enzymes lb1=The lb1=drug lb1=interaction lb1=study lb1=evaluating lb1=the lb1=effect lb1=of lib=on la2=indicates la2=that la2=grepafloxacin la2=inhibits la2=theophylline la2=metabolism, la2=which la2=is la2=mediated la2=by la2=CYP1A2.
null dep=None lb1=substrates, lb1=in lb1=vitro lb1=data lb1=suggest lb1=similar lb1=effects lb1=of lib=in lib=CYP3A4 lib=mediated lib=metabolism lib=and la2=metabolism.
mechanism dep=None lb1=In lb1=addition, lb1=other lib=have lib=been lib=reported lib=to lib=decrease lib=the lib=CYP3A4-mediated lib=metabolism lib=of la2=.
null dep=conj lb1=include lib=, la2=, la2=cisapride, la2=midazolam, la2=and la2=triazolam. 2under1
null dep=conj lb1=include lib=, lib=astemizole, la2=, la2=midazolam, la2=and la2=triazolam. 2under1
null dep=conj lb1=include lib=, lib=astemizole, lib=cisapride, la2=, la2=and la2=triazolam. 2under1
null dep=conj lb1=include lib=, lib=astemizole, lib=cisapride, lib=midazolam, lib=and la2=. 2under1
null dep=None lb1=include lb1=terfenadine, lib=, la2=, la2=midazolam, la2=and la2=triazolam.
null dep=None lb1=include lb1=terfenadine, lib=, lib=cisapride, la2=, la2=and la2=triazolam.
null dep=None lb1=include lb1=terfenadine, lib=, lib=cisapride, lib=midazolam, lib=and la2=.
null dep=None lb1=include lb1=terfenadine, lb1=astemizole, lib=, la2=, la2=and la2=triazolam.
null dep=None lb1=include lb1=terfenadine, lb1=astemizole, lib=, lib=midazolam, lib=and la2=.
null dep=None lb1=include lb1=terfenadine, lb1=astemizole, lb1=cisapride, lib=, lib=and la2=.
null dep=appos lib=( la2=): la2=The la2=concomitant la2=administration la2=of la2=a la2=nonsteroidal la2=anti la2=inflammatory la2=drug la2=with la2=a la2=quinolone la2=may la2=increase la2=the la2=risks la2=of la2=CNS la2=stimulation la2=and la2=convulsions. 2under1
null dep=det lib=(NSAIDs): lib=The lib=concomitant lib=administration lib=of lib=a la2=with la2=a la2=quinolone la2=may la2=increase la2=the la2=risks la2=of la2=CNS la2=stimulation la2=and la2=convulsions.
null dep=det lib=(NSAIDs): lib=The lib=concomitant lib=administration lib=of lib=a lib=nonsteroidal lib=anti lib=inflammatory lib=drug lib=with lib=a la2=may la2=increase la2=the la2=risks la2=of la2=CNS la2=stimulation la2=and la2=convulsions. 2under1
null dep=None lb1=Nonsteroidal lb1=Anti-inflammatory lb1=Drugs lb1=( lib=): lib=The lib=concomitant lib=administration lib=of lib=a la2=with la2=a la2=quinolone la2=may la2=increase la2=the la2=risks la2=of la2=CNS la2=stimulation la2=and la2=convulsions.
null dep=None lb1=Nonsteroidal lb1=Anti-inflammatory lb1=Drugs lb1=( lib=): lib=The lib=concomitant lib=administration lib=of lib=a lib=nonsteroidal lib=anti lib=inflammatory lib=drug lib=with lib=a la2=may la2=increase la2=the la2=risks la2=of la2=CNS la2=stimulation la2=and la2=convulsions.
effect dep=nmod lb1=Nonsteroidal lb1=Anti-inflammatory lb1=Drugs lb1=(NSAIDs): lb1=The lb1=concomitant lb1=administration lb1=of lb1=a lib=with lib=a la2=may la2=increase la2=the la2=risks la2=of la2=CNS la2=stimulation la2=and la2=convulsions. 2under1
null dep=None lib=: lib=Disturbances lib=of lib=blood lib=glucose, lib=including lib=hyperglycemia lib=and lib=hypoglycemia, lib=have lib=been lib=reported lib=in lib=patients lib=treated lib=concomitantly lib=with la2=and la2=an la2=antidiabetic la2=agent. 2under1
null dep=None lib=: lib=Disturbances lib=of lib=blood lib=glucose, lib=including lib=hyperglycemia lib=and lib=hypoglycemia, lib=have lib=been lib=reported lib=in lib=patients lib=treated lib=concomitantly lib=with lib=quinolones lib=and lib=an la2=.
effect dep=conj lb1=Antidiabetic lb1=Agents: lb1=Disturbances lb1=of lb1=blood lb1=glucose, lb1=including lb1=hyperglycemia lb1=and lb1=hypoglycemia, lb1=have lb1=been lb1=reported lb1=in lb1=patients lb1=treated lb1=concomitantly lb1=with lib=and lib=an la2=.
null dep=None lb1=In lb1=normal lb1=volunteers lb1=receiving lib=, lib=the lib=administration lib=of la2=decreased la2=the la2=renal la2=clearance la2=and la2=significantly la2=increased la2=the la2=plasma la2=levels la2=of la2=indomethacin.
null dep=None lb1=In lb1=normal lb1=volunteers lb1=receiving lib=, lib=the lib=administration lib=of lib=diflunisal lib=decreased lib=the lib=renal lib=clearance lib=and lib=significantly lib=increased lib=the lib=plasma lib=levels lib=of la2=, la2=the la2=administration la2=of la2=diflunisal la2=decreased la2=the la2=renal la2=clearance la2=and la2=significantly la2=increased la2=the la2=plasma la2=levels la2=of la2=indomethacin.
mechanism dep=None lb1=In lb1=normal lb1=volunteers lb1=receiving lb1=indomethacin, lb1=the lb1=administration lb1=of lib=decreased lib=the lib=renal lib=clearance lib=and lib=significantly lib=increased lib=the lib=plasma lib=levels lib=of la2=, la2=the la2=administration la2=of la2=diflunisal la2=decreased la2=the la2=renal la2=clearance la2=and la2=significantly la2=increased la2=the la2=plasma la2=levels la2=of la2=indomethacin.
effect dep=conj lb1=In lb1=some lb1=patients, lb1=combined lb1=use lb1=of lib=and la2=has la2=been la2=associated la2=with la2=fatal la2=gastrointestinal la2=hemorrhage. 2under1
advise dep=conj lb1=Therefore, lib=and la2=should la2=not la2=be la2=used la2=concomitantly. 2under1
mechanism dep=None lb1=In lb1=a lb1=study lb1=in lb1=normal lb1=volunteers, lb1=it lb1=was lb1=found lb1=that lb1=chronic lb1=concurrent lb1=administration lb1=of lb1=3.6 lb1=g lb1=of lib=per lib=day lib=decreases la2=blood la2=levels la2=approximately la2=20%.
advise dep=None lb1=The lb1=concomitant lb1=use lb1=of lib=with lib=other la2=is la2=not la2=recommended la2=due la2=to la2=the la2=increased la2=possibility la2=of la2=gastrointestinal la2=toxicity, la2=with la2=little la2=or la2=no la2=increase la2=in la2=efficacy.
null dep=None lb1=Clinical lb1=studies lb1=have lb1=shown lb1=that lib=does lib=not lib=influence lib=the lib=hypoprothrombinemia lib=produced lib=by la2=.
advise dep=None lb1=However, lb1=when lb1=any lb1=additional lb1=drug, lb1=including lib=, lib=is lib=added lib=to lib=the lib=treatment lib=of lib=patients lib=on la2=therapy, la2=the la2=patients la2=should la2=be la2=observed la2=for la2=alterations la2=of la2=the la2=prothrombin la2=time.
effect dep=conj lb1=In lb1=post-marketing lb1=experience, lb1=bleeding lb1=has lb1=been lb1=reported lb1=in lb1=patients lb1=on lb1=concomitant lb1=treatment lb1=with lib=and la2=. 2under1
advise dep=conj lb1=Caution lb1=should lb1=be lb1=exercised lb1=when lib=and la2=are la2=administered la2=concomitantly. 2under1
mechanism dep=None lb1=When lib=is lib=given lib=to lib=patients lib=receiving la2=, la2=the la2=plasma la2=levels la2=of la2=indomethacin la2=are la2=likely la2=to la2=be la2=increased.
null dep=None lb1=When lib=is lib=given lib=to lib=patients lib=receiving lib=probenecid, lib=the lib=plasma lib=levels lib=of la2=are la2=likely la2=to la2=be la2=increased.
null dep=None lb1=When lb1=INDOCIN lb1=is lb1=given lb1=to lb1=patients lb1=receiving lib=, lib=the lib=plasma lib=levels lib=of la2=are la2=likely la2=to la2=be la2=increased.
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=if lib=is lib=administered lib=simultaneously lib=with la2=.
mechanism dep=None lib=has lib=been lib=reported lib=to lib=decrease lib=the lib=tubular lib=secretion lib=of la2=and la2=to la2=potentiate la2=its la2=toxicity.
effect dep=None lb1=Administration lb1=of lib=concomitantly lib=with la2=has la2=been la2=associated la2=with la2=an la2=increase la2=in la2=cyclosporine-induced la2=toxicity, la2=possibly la2=due la2=to la2=decreased la2=synthesis la2=of la2=renal la2=prostacyclin.
null dep=None lb1=Administration lb1=of lib=concomitantly lib=with la2=has la2=been la2=associated la2=with la2=an la2=increase la2=in la2=cyclosporine-induced la2=toxicity, la2=possibly la2=due la2=to la2=decreased la2=synthesis la2=of la2=renal la2=prostacyclin.
null dep=None lb1=Administration lb1=of lb1=non-steroidal lb1=anti-inflammatory lb1=drugs lb1=concomitantly lb1=with lib=has lib=been lib=associated lib=with lib=an lib=increase lib=in la2=has la2=been la2=associated la2=with la2=an la2=increase la2=in la2=cyclosporine-induced la2=toxicity, la2=possibly la2=due la2=to la2=decreased la2=synthesis la2=of la2=renal la2=prostacyclin.
advise dep=None lib=should lib=be lib=used lib=with lib=caution lib=in lib=patients lib=taking la2=, la2=and la2=renal la2=function la2=should la2=be la2=carefully la2=monitored.
mechanism dep=None lb1=Capsules lib=50 lib=mg lib=t.i.d. lib=produced lib=a lib=clinically lib=relevant lib=elevation lib=of lib=plasma la2=and la2=reduction la2=in la2=renal la2=lithium la2=clearance la2=in la2=psychiatric la2=patients la2=and la2=normal la2=subjects la2=with la2=steady la2=state la2=plasma la2=lithium la2=concentrations.
null dep=None lb1=Capsules lib=50 lib=mg lib=t.i.d. lib=produced lib=a lib=clinically lib=relevant lib=elevation lib=of lib=plasma la2=and la2=reduction la2=in la2=renal la2=lithium la2=clearance la2=in la2=psychiatric la2=patients la2=and la2=normal la2=subjects la2=with la2=steady la2=state la2=plasma la2=lithium la2=concentrations.
null dep=None lb1=Capsules lib=50 lib=mg lib=t.i.d. lib=produced lib=a lib=clinically lib=relevant lib=elevation lib=of lib=plasma la2=and la2=reduction la2=in la2=renal la2=lithium la2=clearance la2=in la2=psychiatric la2=patients la2=and la2=normal la2=subjects la2=with la2=steady la2=state la2=plasma la2=lithium la2=concentrations.
null dep=None lb1=Capsules lb1=INDOCIN lb1=50 lb1=mg lb1=t.i.d. lb1=produced lb1=a lb1=clinically lb1=relevant lb1=elevation lb1=of lb1=plasma lib=and lib=reduction lib=in lib=renal la2=and la2=reduction la2=in la2=renal la2=lithium la2=clearance la2=in la2=psychiatric la2=patients la2=and la2=normal la2=subjects la2=with la2=steady la2=state la2=plasma la2=lithium la2=concentrations.
null dep=None lb1=Capsules lb1=INDOCIN lb1=50 lb1=mg lb1=t.i.d. lb1=produced lb1=a lb1=clinically lb1=relevant lb1=elevation lb1=of lb1=plasma lib=and lib=reduction lib=in lib=renal la2=and la2=reduction la2=in la2=renal la2=lithium la2=clearance la2=in la2=psychiatric la2=patients la2=and la2=normal la2=subjects la2=with la2=steady la2=state la2=plasma la2=lithium la2=concentrations.
null dep=None lb1=Capsules lb1=INDOCIN lb1=50 lb1=mg lb1=t.i.d. lb1=produced lb1=a lb1=clinically lb1=relevant lb1=elevation lb1=of lb1=plasma lib=and lib=reduction lib=in lib=renal la2=and la2=reduction la2=in la2=renal la2=lithium la2=clearance la2=in la2=psychiatric la2=patients la2=and la2=normal la2=subjects la2=with la2=steady la2=state la2=plasma la2=lithium la2=concentrations.
advise dep=conj lb1=As lb1=a lb1=consequence, lb1=when lib=and la2=are la2=given la2=concomitantly, la2=the la2=patient la2=should la2=be la2=carefully la2=observed la2=for la2=signs la2=of la2=lithium la2=toxicity. 2under1
null dep=conj lb1=As lb1=a lb1=consequence, lb1=when lib=and la2=are la2=given la2=concomitantly, la2=the la2=patient la2=should la2=be la2=carefully la2=observed la2=for la2=signs la2=of la2=lithium la2=toxicity. 2under1
null dep=None lb1=As lb1=a lb1=consequence, lb1=when lb1=INDOCIN lb1=and lib=are lib=given lib=concomitantly, lib=the lib=patient lib=should lib=be lib=carefully lib=observed lib=for lib=signs lib=of la2=are la2=given la2=concomitantly, la2=the la2=patient la2=should la2=be la2=carefully la2=observed la2=for la2=signs la2=of la2=lithium la2=toxicity.
mechanism dep=None lib=given lib=concomitantly lib=with la2=has la2=been la2=reported la2=to la2=increase la2=the la2=serum la2=concentration la2=and la2=prolong la2=the la2=half-life la2=of la2=digoxin.
null dep=None lib=given lib=concomitantly lib=with la2=has la2=been la2=reported la2=to la2=increase la2=the la2=serum la2=concentration la2=and la2=prolong la2=the la2=half-life la2=of la2=digoxin.
null dep=None lb1=INDOCIN lb1=given lb1=concomitantly lb1=with lib=has lib=been lib=reported lib=to lib=increase lib=the lib=serum lib=concentration lib=and lib=prolong lib=the lib=half-life lib=of la2=has la2=been la2=reported la2=to la2=increase la2=the la2=serum la2=concentration la2=and la2=prolong la2=the la2=half-life la2=of la2=digoxin.
advise dep=conj lb1=Therefore, lb1=when lib=and la2=are la2=used la2=concomitantly, la2=serum la2=digoxin la2=levels la2=should la2=be la2=closely la2=monitored. 2under1
null dep=conj lb1=Therefore, lb1=when lib=and la2=are la2=used la2=concomitantly, la2=serum la2=digoxin la2=levels la2=should la2=be la2=closely la2=monitored. 2under1
null dep=None lb1=Therefore, lb1=when lb1=INDOCIN lb1=and lib=are lib=used lib=concomitantly, lib=serum la2=are la2=used la2=concomitantly, la2=serum la2=digoxin la2=levels la2=should la2=be la2=closely la2=monitored.
effect dep=None lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of
effect dep=None lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of
effect dep=None lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lib=can lib=reduce lib=the lib=diuretic, lib=natriuretic, lib=and lib=antihypertensive lib=effects lib=of lib=loop, lib=potassium-sparing, lib=and la2=.
null dep=conj lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lb1=INDOCIN lb1=can lb1=reduce lb1=the lb1=diuretic, lb1=natriuretic, lb1=and lb1=antihypertensive lb1=effects lb1=of lb1=loop, lb1=potassium-sparing, lb1=and lb1=thiazide lb1=diuretics.
null dep=conj lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lb1=INDOCIN lb1=can lb1=reduce lb1=the lb1=diuretic, lb1=natriuretic, lb1=and lb1=antihypertensive lb1=effects lb1=of lb1=loop, lb1=potassium-sparing, lb1=and lb1=thiazide lb1=diuretics. la2=.
null dep=amod lb1=In lb1=some lb1=patients, lb1=the lb1=administration lb1=of lb1=INDOCIN lb1=can lb1=reduce lb1=the lb1=diuretic, lb1=natriuretic, lb1=and lb1=antihypertensive lb1=effects lb1=of lb1=loop, lb1=potassium-sparing, lb1=and lb1=thiazide lb1=diuretics. la2=.
null dep=conj lb1=Therefore, lb1=when lib=and la2=and la2=INDOCIN. 2under1
null dep=compound lb1=( lib=) la2=are la2=used la2=concomitantly, la2=the la2=patient la2=should la2=be la2=observed la2=closely la2=to la2=determine la2=if la2=the la2=desired la2=effect la2=of la2=the la2=diuretic la2=is la2=obtained. 1under2
null dep=None lb1=( lib=) la2=s la2=are la2=used la2=concomitantly, la2=the la2=patient la2=should la2=be la2=observed la2=closely la2=to la2=determine la2=if la2=the la2=desired la2=effect la2=of la2=the la2=diuretic la2=is la2=obtained.
null dep=None lb1=(Indomethacin) lib=are lib=used lib=concomitantly, lib=the lib=patient lib=should lib=be lib=observed lib=closely lib=to lib=determine lib=if lib=the lib=desired lib=effect lib=of lib=the la2=s la2=are la2=used la2=concomitantly, la2=the la2=patient la2=should la2=be la2=observed la2=closely la2=to la2=determine la2=if la2=the la2=desired la2=effect la2=of la2=the la2=diuretic la2=is la2=obtained.
null dep=None lib=reduces lib=basal lib=plasma lib=renin lib=activity lib=(PRA), lib=as lib=well lib=as lib=those lib=elevations lib=of lib=PRA lib=induced lib=by la2=administration, la2=or la2=salt la2=or la2=volume la2=depletion.
effect dep=None lb1=It lb1=has lb1=been lb1=reported lb1=that lb1=the lb1=addition lb1=of lib=to lib=a lib=maintenance lib=schedule lib=of la2=resulted la2=in la2=reversible la2=acute la2=renal la2=failure la2=in la2=two la2=of la2=four la2=healthy la2=volunteers.
advise dep=conj lib=and la2=should la2=not la2=be la2=administered la2=together. 2under1
null dep=compound lib=and la2=each la2=may la2=be la2=associated la2=with la2=increased la2=serum la2=potassium la2=levels. 1under2
effect dep=conj lb1=The lb1=potential lb1=effects lb1=of lib=and la2=on la2=potassium la2=kinetics la2=and la2=renal la2=function la2=should la2=be la2=considered la2=when la2=these la2=agents la2=are la2=administered la2=concurrently.
effect dep=None lb1=Most lb1=of lb1=the lb1=above lb1=effects lb1=concerning lib=have lib=been lib=attributed, lib=at lib=least lib=in lib=part, lib=to lib=mechanisms lib=involving lib=inhibition lib=of lib=prostaglandin lib=synthesis lib=by la2=.
effect dep=None lb1=Blunting lb1=of lb1=the lb1=antihypertensive lb1=effect lb1=of lib=by la2=including la2=INDOCIN la2=has la2=been la2=reported.
effect dep=None lb1=Blunting lb1=of lb1=the lb1=antihypertensive lb1=effect lb1=of lib=by lib=non-steroidal lib=antiinflammatory lib=drugs lib=including la2=has la2=been la2=reported.
null dep=nmod lb1=Blunting lb1=of lb1=the lb1=antihypertensive lb1=effect lb1=of lb1=beta-adrenoceptor lb1=blocking lb1=agents lb1=by lib=including la2=has la2=been la2=reported. 2under1
effect dep=None lib=can lib=reduce lib=the lib=antihypertensive lib=effects lib=of la2=and la2=losartan.
effect dep=None lib=can lib=reduce lib=the lib=antihypertensive lib=effects lib=of lib=captopril lib=and la2=.
null dep=conj lb1=INDOCIN lb1=can lb1=reduce lb1=the lb1=antihypertensive lb1=effects lb1=of lib=and la2=. 2under1
null dep=None lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lib=and lib=other lib=highly lib=bound lib=drugs, lib=such lib=as la2=, la2=salicylic la2=acid, la2=phenylbutazone, la2=and la2=diazepam. 2under1
null dep=None lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lib=and lib=other lib=highly lib=bound lib=drugs, lib=such lib=as lib=warfarin, la2=, la2=phenylbutazone, la2=and la2=diazepam.
null dep=None lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lib=and lib=other lib=highly lib=bound lib=drugs, lib=such lib=as lib=warfarin, lib=salicylic lib=acid, la2=, la2=and la2=diazepam. 2under1
null dep=None lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lib=and lib=other lib=highly lib=bound lib=drugs, lib=such lib=as lib=warfarin, lib=salicylic lib=acid, lib=phenylbutazone, lib=and la2=. 2under1
null dep=conj lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lb1=entacapone lb1=and lb1=other lb1=highly lb1=bound lb1=drugs, lb1=such lb1=as lib=, la2=, la2=phenylbutazone, la2=and la2=diazepam.
null dep=conj lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lb1=entacapone lb1=and lb1=other lb1=highly lb1=bound lb1=drugs, lb1=such lb1=as lib=, lib=salicylic lib=acid, la2=, la2=and la2=diazepam. 2under1
null dep=conj lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lb1=entacapone lb1=and lb1=other lb1=highly lb1=bound lb1=drugs, lb1=such lb1=as lib=, lib=salicylic lib=acid, lib=phenylbutazone, lib=and la2=. 2under1
null dep=None lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lb1=entacapone lb1=and lb1=other lb1=highly lb1=bound lb1=drugs, lb1=such lb1=as lb1=warfarin, lib=, la2=, la2=and la2=diazepam.
null dep=None lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lb1=entacapone lb1=and lb1=other lb1=highly lb1=bound lb1=drugs, lb1=such lb1=as lb1=warfarin, lib=, lib=phenylbutazone, lib=and la2=.
null dep=None lb1=In lb1=vitro lb1=studies lb1=have lb1=shown lb1=no lb1=binding lb1=displacement lb1=between lb1=entacapone lb1=and lb1=other lb1=highly lb1=bound lb1=drugs, lb1=such lb1=as lb1=warfarin, lb1=salicylic lb1=acid, lib=, lib=and la2=.
null dep=None lb1=Treatment lb1=with lib=coadministered lib=with la2=/dopa la2=decarboxylase la2=inhibitor la2=does la2=not la2=change la2=these la2=effects.
null dep=None lb1=Treatment lb1=with lib=coadministered lib=with lib=levodopa/ la2=does la2=not la2=change la2=these la2=effects.
null dep=None lb1=Treatment lb1=with lb1=entacapone lb1=coadministered lb1=with lib=/ la2=does la2=not la2=change la2=these la2=effects.
null dep=compound lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the la2=in la2=two la2=multiple-dose la2=interaction la2=studies la2=when la2=entacapone la2=was la2=coadministered la2=with la2=a la2=levodopa/dopa la2=decarboxylase la2=inhibitor la2=(n=29).
null dep=det lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the lib=selegiline lib=in lib=two lib=multiple-dose lib=interaction lib=studies lib=when la2=was la2=coadministered la2=with la2=a la2=levodopa/dopa la2=decarboxylase la2=inhibitor la2=(n=29).
null dep=det lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the lib=selegiline lib=in lib=two lib=multiple-dose lib=interaction lib=studies lib=when lib=entacapone lib=was lib=coadministered lib=with lib=a la2=/dopa la2=decarboxylase la2=inhibitor la2=(n=29).
null dep=det lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the lib=selegiline lib=in lib=two lib=multiple-dose lib=interaction lib=studies lib=when lib=entacapone lib=was lib=coadministered lib=with lib=a lib=levodopa/ la2=(n=29).
null dep=None lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the lb1=MAO-B lb1=inhibitor lib=in lib=two lib=multiple-dose lib=interaction lib=studies lib=when la2=was la2=coadministered la2=with la2=a la2=levodopa/dopa la2=decarboxylase la2=inhibitor la2=(n=29).
null dep=None lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the lb1=MAO-B lb1=inhibitor lib=in lib=two lib=multiple-dose lib=interaction lib=studies lib=when lib=entacapone lib=was lib=coadministered lib=with lib=a la2=/dopa la2=decarboxylase la2=inhibitor la2=(n=29).
null dep=compound lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the lb1=MAO-B lb1=inhibitor lib=in lib=two lib=multiple-dose lib=interaction lib=studies lib=when lib=entacapone lib=was lib=coadministered lib=with lib=a lib=levodopa/ la2=(n=29).
null dep=None lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the lb1=MAO-B lb1=inhibitor lb1=selegiline lb1=in lb1=two lb1=multiple-dose lb1=interaction lb1=studies lb1=when lib=was lib=coadministered lib=with lib=a la2=/dopa la2=decarboxylase la2=inhibitor la2=(n=29).
null dep=det lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the lb1=MAO-B lb1=inhibitor lb1=selegiline lb1=in lb1=two lb1=multiple-dose lb1=interaction lb1=studies lb1=when lib=was lib=coadministered lib=with lib=a lib=levodopa/ la2=(n=29).
null dep=det lb1=No lb1=interaction lb1=was lb1=noted lb1=with lb1=the lb1=MAO-B lb1=inhibitor lb1=selegiline lb1=in lb1=two lb1=multiple-dose lb1=interaction lb1=studies lb1=when lb1=entacapone lb1=was lb1=coadministered lb1=with lb1=a lib=/ la2=(n=29).
null dep=None lb1=More lb1=than lb1=600 lb1=Parkinsons lb1=disease lb1=patients lb1=in lb1=clinical lb1=trials lb1=have lb1=used lib=in lib=combination lib=with la2=and la2=levodopa/dopa la2=decarboxylase la2=inhibitor.
null dep=None lb1=More lb1=than lb1=600 lb1=Parkinsons lb1=disease lb1=patients lb1=in lb1=clinical lb1=trials lb1=have lb1=used lib=in lib=combination lib=with lib=entacapone lib=and la2=/dopa la2=decarboxylase la2=inhibitor.
null dep=None lb1=More lb1=than lb1=600 lb1=Parkinsons lb1=disease lb1=patients lb1=in lb1=clinical lb1=trials lb1=have lb1=used lib=in lib=combination lib=with lib=entacapone lib=and lib=levodopa/ la2=.
null dep=None lb1=More lb1=than lb1=600 lb1=Parkinsons lb1=disease lb1=patients lb1=in lb1=clinical lb1=trials lb1=have lb1=used lb1=selegiline lb1=in lb1=combination lb1=with lib=and la2=/dopa la2=decarboxylase la2=inhibitor.
null dep=conj lb1=More lb1=than lb1=600 lb1=Parkinsons lb1=disease lb1=patients lb1=in lb1=clinical lb1=trials lb1=have lb1=used lb1=selegiline lb1=in lb1=combination lb1=with lib=and lib=levodopa/ la2=.
null dep=None lb1=More lb1=than lb1=600 lb1=Parkinsons lb1=disease lb1=patients lb1=in lb1=clinical lb1=trials lb1=have lb1=used lb1=selegiline lb1=in lb1=combination lb1=with lb1=entacapone lb1=and lib=/ la2=.
null dep=None lb1=As lb1=most lib=excretion lib=is lib=via lib=the lib=bile, lib=caution lib=should lib=be lib=exercised lib=when lib=drugs lib=known lib=to lib=interfere lib=with lib=biliary lib=excretion, lib=glucuronidation, lib=and lib=intestinal lib=beta-glucuronidase lib=are lib=given lib=concurrently lib=with la2=excretion la2=is la2=via la2=the la2=bile, la2=caution la2=should la2=be la2=exercised la2=when la2=drugs la2=known la2=to la2=interfere la2=with la2=biliary la2=excretion, la2=glucuronidation, la2=and la2=intestinal la2=beta-glucuronidase la2=are la2=given la2=concurrently la2=with la2=entacapone.
null dep=conj lb1=These lb1=include lib=, la2=, la2=and la2=some la2=antibiotics la2=(e.g. la2=erythromycin, la2=rifamipicin, la2=ampicillin la2=and la2=chloramphenicol). 2under1
null dep=conj lb1=These lb1=include lib=, lib=cholestyramine, lib=and lib=some la2=(e.g. la2=erythromycin, la2=rifamipicin, la2=ampicillin la2=and la2=chloramphenicol). 2under1
null dep=None lb1=These lb1=include lib=, lib=cholestyramine, lib=and lib=some lib=antibiotics lib=(e.g. la2=, la2=rifamipicin, la2=ampicillin la2=and la2=chloramphenicol). 2under1
null dep=None lb1=These lb1=include lib=, lib=cholestyramine, lib=and lib=some lib=antibiotics lib=(e.g. lib=erythromycin, lib=rifamipicin, la2=and la2=chloramphenicol). 2under1
null dep=None lb1=These lb1=include lib=, lib=cholestyramine, lib=and lib=some lib=antibiotics lib=(e.g. lib=erythromycin, lib=rifamipicin, lib=ampicillin lib=and la2=). 2under1
null dep=None lb1=These lb1=include lb1=probenecid, lib=, lib=and lib=some la2=(e.g. la2=erythromycin, la2=rifamipicin, la2=ampicillin la2=and la2=chloramphenicol).
null dep=None lb1=These lb1=include lb1=probenecid, lib=, lib=and lib=some lib=antibiotics lib=(e.g. la2=, la2=rifamipicin, la2=ampicillin la2=and la2=chloramphenicol).
null dep=None lb1=These lb1=include lb1=probenecid, lib=, lib=and lib=some lib=antibiotics lib=(e.g. lib=erythromycin, lib=rifamipicin, la2=and la2=chloramphenicol).
null dep=None lb1=These lb1=include lb1=probenecid, lib=, lib=and lib=some lib=antibiotics lib=(e.g. lib=erythromycin, lib=rifamipicin, lib=ampicillin lib=and la2=).
null dep=None lb1=These lb1=include lb1=probenecid, lb1=cholestyramine, lb1=and lb1=some lib=(e.g. la2=, la2=rifamipicin, la2=ampicillin la2=and la2=chloramphenicol). 2under1
null dep=None lb1=These lb1=include lb1=probenecid, lb1=cholestyramine, lb1=and lb1=some lib=(e.g. lib=erythromycin, lib=rifamipicin, la2=and la2=chloramphenicol). 2under1
null dep=None lb1=These lb1=include lb1=probenecid, lb1=cholestyramine, lb1=and lb1=some lib=(e.g. lib=erythromycin, lib=rifamipicin, lib=ampicillin lib=and la2=). 2under1
null dep=conj lb1=These lb1=include lb1=probenecid, lb1=cholestyramine, lb1=and lb1=some lb1=antibiotics lb1=(e.g. lib=, lib=rifamipicin, la2=and la2=chloramphenicol). 2under1
null dep=conj lb1=These lb1=include lb1=probenecid, lb1=cholestyramine, lb1=and lb1=some lb1=antibiotics lb1=(e.g. lib=, lib=rifamipicin, lib=ampicillin lib=and la2=). 2under1
null dep=None lb1=These lb1=include lb1=probenecid, lb1=cholestyramine, lb1=and lb1=some lb1=antibiotics lb1=(e.g. lb1=erythromycin, lb1=rifamipicin, lib=and la2=).
null dep=amod lb1=No lb1=interaction lb1=with lb1=the la2=was la2=shown la2=in la2=a la2=single-dose la2=study la2=with la2=entacapone la2=without la2=coadministered la2=levodopa/dopa-decarboxylase la2=inhibitor.
null dep=None lb1=No lb1=interaction lb1=with lb1=the lib=imipramine lib=was lib=shown lib=in lib=a lib=single-dose lib=study lib=with la2=without la2=coadministered la2=levodopa/dopa-decarboxylase la2=inhibitor.
null dep=None lb1=No lb1=interaction lb1=with lb1=the lib=imipramine lib=was lib=shown lib=in lib=a lib=single-dose lib=study lib=with lib=entacapone lib=without lib=coadministered la2=/dopa-decarboxylase la2=inhibitor.
null dep=None lb1=No lb1=interaction lb1=with lb1=the lib=imipramine lib=was lib=shown lib=in lib=a lib=single-dose lib=study lib=with lib=entacapone lib=without lib=coadministered lib=levodopa/ la2=.
null dep=None lb1=No lb1=interaction lb1=with lb1=the lb1=tricyclic lb1=antidepressant lib=was lib=shown lib=in lib=a lib=single-dose lib=study lib=with la2=without la2=coadministered la2=levodopa/dopa-decarboxylase la2=inhibitor.
null dep=None lb1=No lb1=interaction lb1=with lb1=the lb1=tricyclic lb1=antidepressant lib=was lib=shown lib=in lib=a lib=single-dose lib=study lib=with lib=entacapone lib=without lib=coadministered la2=/dopa-decarboxylase la2=inhibitor.
null dep=None lb1=No lb1=interaction lb1=with lb1=the lb1=tricyclic lb1=antidepressant lib=was lib=shown lib=in lib=a lib=single-dose lib=study lib=with lib=entacapone lib=without lib=coadministered lib=levodopa/ la2=.
null dep=None lb1=No lb1=interaction lb1=with lb1=the lb1=tricyclic lb1=antidepressant lb1=imipramine lb1=was lb1=shown lb1=in lb1=a lb1=single-dose lb1=study lb1=with lib=without lib=coadministered la2=/dopa-decarboxylase la2=inhibitor.
null dep=None lb1=No lb1=interaction lb1=with lb1=the lb1=tricyclic lb1=antidepressant lb1=imipramine lb1=was lb1=shown lb1=in lb1=a lb1=single-dose lb1=study lb1=with lib=without lib=coadministered lib=levodopa/ la2=.
null dep=None lb1=No lb1=interaction lb1=with lb1=the lb1=tricyclic lb1=antidepressant lb1=imipramine lb1=was lb1=shown lb1=in lb1=a lb1=single-dose lb1=study lb1=with lb1=entacapone lb1=without lb1=coadministered lib=/ la2=.
effect dep=None lb1=Use lb1=of lib=in lib=a lib=patient lib=who lib=has lib=previously lib=received la2=increases la2=the la2=risk la2=of la2=cardiotoxicity.
advise dep=conj lib=should lib=not lib=be lib=used lib=in lib=patients lib=who lib=have lib=previously lib=received lib=the lib=recommended lib=maximum lib=cumulative lib=doses lib=of la2=or la2=Cerubidine. 1under2
null dep=None lib=should lib=not lib=be lib=used lib=in lib=patients lib=who lib=have lib=previously lib=received lib=the lib=recommended lib=maximum lib=cumulative lib=doses lib=of lib=doxorubicin lib=or la2=should la2=not la2=be la2=used la2=in la2=patients la2=who la2=have la2=previously la2=received la2=the la2=recommended la2=maximum la2=cumulative la2=doses la2=of la2=doxorubicin la2=or la2=Cerubidine.
null dep=conj lb1=Cerubidine lb1=should lb1=not lb1=be lb1=used lb1=in lb1=patients lb1=who lb1=have lb1=previously lb1=received lb1=the lb1=recommended lb1=maximum lb1=cumulative lb1=doses lb1=of lib=or la2=should la2=not la2=be la2=used la2=in la2=patients la2=who la2=have la2=previously la2=received la2=the la2=recommended la2=maximum la2=cumulative la2=doses la2=of la2=doxorubicin la2=or la2=Cerubidine. 2under1
effect dep=None lib=used lib=concurrently lib=with la2=may la2=also la2=result la2=in la2=increased la2=cardiotoxicity.
null dep=None lb1=[The lb1=effect lb1=of lib=on lib=the lib=activity lib=of lib=mixed-function lib=mono-oxidases lib=in lib=the lib=liver lib=microsomes] lib=The lib=effects lib=of lib=the la2=--the la2=drug la2=sandimmune--on la2=hepatic la2=microsomal la2=monooxygenase la2=activities la2=were la2=studied.
null dep=None lb1=[The lb1=effect lb1=of lib=on lib=the lib=activity lib=of lib=mixed-function lib=mono-oxidases lib=in lib=the lib=liver lib=microsomes] lib=The lib=effects lib=of lib=the lib=immunodepressant--the lib=drug la2=on la2=the la2=activity la2=of la2=mixed-function la2=mono-oxidases la2=in la2=the la2=liver la2=microsomes] la2=The la2=effects la2=of la2=the la2=immunodepressant--the la2=drug la2=sandimmune--on la2=hepatic la2=microsomal la2=monooxygenase la2=activities la2=were la2=studied.
null dep=None lb1=[The lb1=effect lb1=of lb1=sandimmune lb1=on lb1=the lb1=activity lb1=of lb1=mixed-function lb1=mono-oxidases lb1=in lb1=the lb1=liver lb1=microsomes] lb1=The lb1=effects lb1=of lb1=the lib=--the lib=drug la2=on la2=the la2=activity la2=of la2=mixed-function la2=mono-oxidases la2=in la2=the la2=liver la2=microsomes] la2=The la2=effects la2=of la2=the la2=immunodepressant--the la2=drug la2=sandimmune--on la2=hepatic la2=microsomal la2=monooxygenase la2=activities la2=were la2=studied.
effect dep=case lb1=- lib=may lib=enhance lib=the lib=CNS lib=depressive lib=effects lib=of la2=, la2=barbiturates la2=and la2=other la2=sedatives
effect dep=None lb1=- lib=may lib=enhance lib=the lib=CNS lib=depressive lib=effects lib=of lib=alcohol, la2=and la2=other la2=sedatives
effect dep=None lb1=- lib=may lib=enhance lib=the lib=CNS lib=depressive lib=effects lib=of lib=alcohol, lib=barbiturates lib=and lib=other
null dep=conj lb1=- lb1=Lofexidine lb1=may lb1=enhance lb1=the lb1=CNS lb1=depressive lb1=effects lb1=of lib=, la2=and la2=other la2=sedatives 2under1
null dep=conj lb1=- lb1=Lofexidine lb1=may lb1=enhance lb1=the lb1=CNS lb1=depressive lb1=effects lb1=of lib=, lib=barbiturates lib=and lib=other 2under1
null dep=None lb1=- lb1=Lofexidine lb1=may lb1=enhance lb1=the lb1=CNS lb1=depressive lb1=effects lb1=of lb1=alcohol, lib=and lib=other
effect dep=None lb1=- lib=may lib=enhance lib=the lib=effects lib=of la2=therapy
effect dep=case lb1=- lb1=Concomitant lb1=use lb1=of lib=may lib=reduce lib=the lib=efficacy lib=of la2=.
null dep=conj lb1=Combinations lb1=of lib=and la2=: la2=effects la2=on la2=drug la2=discrimination la2=and la2=behavioral la2=inhibition la2=in la2=rats. 2under1
null dep=appos lib=( la2=) la2=produces la2=psychotomimetic la2=effects la2=in la2=humans la2=that la2=resemble la2=schizophrenia la2=symptoms. 2under1
null dep=amod lb1=In lb1=the lb1=present lb1=study, lb1=the la2=was la2=tested la2=in la2=combination la2=with la2=an la2=active la2=dose la2=of la2=PCP la2=in la2=two-lever la2=drug la2=discrimination la2=and la2=mixed la2=signalled-unsignalled la2=differential-reinforcement-of-low-rates la2=(DRL) la2=procedures.
null dep=None lb1=In lb1=the lb1=present lb1=study, lb1=the lib=clozapine lib=was lib=tested lib=in lib=combination lib=with lib=an lib=active lib=dose lib=of la2=in la2=two-lever la2=drug la2=discrimination la2=and la2=mixed la2=signalled-unsignalled la2=differential-reinforcement-of-low-rates la2=(DRL) la2=procedures.
null dep=None lb1=In lb1=the lb1=present lb1=study, lb1=the lb1=atypical lb1=antipsychotic lib=was lib=tested lib=in lib=combination lib=with lib=an lib=active lib=dose lib=of la2=in la2=two-lever la2=drug la2=discrimination la2=and la2=mixed la2=signalled-unsignalled la2=differential-reinforcement-of-low-rates la2=(DRL) la2=procedures.
null dep=None lib=produced lib=distinctive lib=effects lib=in lib=each lib=task: lib=it lib=substituted lib=for lib=the lib=training lib=dose lib=in la2=produced la2=distinctive la2=effects la2=in la2=each la2=task: la2=it la2=substituted la2=for la2=the la2=training la2=dose la2=in la2=PCP la2=discrimination la2=and la2=it la2=increased la2=the la2=number la2=of la2=responses la2=with la2=short la2=(<3 la2=s) la2=interresponse la2=times la2=as la2=well la2=as la2=increasing la2=overall la2=response la2=rates la2=in la2=the la2=DRL la2=schedule.
null dep=None lb1=Acute lb1=dosing lb1=with lib=failed lib=to lib=alter lib=the lib=behavioral lib=effects lib=of la2=in la2=either la2=procedure la2=even la2=when la2=tested la2=up la2=to la2=doses la2=that la2=produced la2=pharmacological la2=effects la2=alone.
null dep=None lb1=These lb1=results lb1=suggest lb1=that lb1=acute lb1=dosing lb1=with lib=would lib=not lib=affect lib=behaviors lib=most lib=closely lib=associated lib=with la2=intoxication.
null dep=None lb1=Since lb1=chronic lb1=dosing lb1=is lb1=required lb1=for lb1=therapeutic lb1=efficacy lb1=of lib=, lib=future lib=studies lib=should lib=focus lib=on lib=investigation lib=of lib=chronic lib=dosing lib=effects lib=of lib=these lib=drugs lib=in lib=combination lib=with la2=. 2under1
effect dep=None lb1=Therapeutic lb1=drug lb1=monitoring lb1=can lb1=avoid lb1=iatrogenic lb1=alterations lb1=caused lb1=by lib=(MDP)- la2=interaction. 2under1
null dep=nsubj lib=is lib=an la2=used la2=to la2=treat la2=a la2=wide la2=variety la2=of la2=infections la2=caused la2=by la2=gram-negative la2=organisms, la2=but la2=it la2=is la2=potentially la2=toxic la2=to la2=the la2=kidneys. 1under2
mechanism dep=None lb1=Due lb1=to lb1=its lb1=nephrotoxicity, lib=may lib=cause lib=abnormal lib=renal lib=uptake lib=to lib=be lib=seen lib=on la2=bone la2=scintigraphy.
null dep=None lb1=Therapeutic lb1=drug lb1=monitoring lb1=(TDM) lb1=of lib=therapy, lib=and lib=bone lib=scintigraphy lib=employing la2=as la2=the la2=radiopharmaceutical la2=was la2=carried la2=out la2=in la2=22 la2=patients.
null dep=None lb1=Therapeutic lb1=drug lb1=monitoring lb1=(TDM) lb1=of lib=therapy, lib=and lib=bone lib=scintigraphy lib=employing lib=99mTc-MDP lib=as lib=the la2=was la2=carried la2=out la2=in la2=22 la2=patients.
null dep=None lb1=Therapeutic lb1=drug lb1=monitoring lb1=(TDM) lb1=of lb1=gentamicin lb1=therapy, lb1=and lb1=bone lb1=scintigraphy lb1=employing lib=as lib=the la2=was la2=carried la2=out la2=in la2=22 la2=patients.
null dep=None lb1=The lb1=data lb1=presented lb1=here lb1=demonstrate lb1=that lb1=with lb1=serial lb1=pharmacokinetic lb1=dosing lb1=of lib=, lib=the lib=iatrogenic lib=alteration lib=caused lib=by la2=, la2=the la2=iatrogenic la2=alteration la2=caused la2=by la2=gentamicin la2=therapy la2=can la2=be la2=avoided.
null dep=compound lb1=Interactions lb1=for lib=( la2=, la2=Vitamin la2=D3, la2=Calcitriol, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=compound lb1=Interactions lb1=for lib=(Vitamin lib=D2, la2=, la2=Calcitriol, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lib=(Vitamin lib=D2, lib=Vitamin lib=D3, la2=, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins; 2under1
null dep=None lb1=Interactions lb1=for lib=(Vitamin lib=D2, lib=Vitamin lib=D3, lib=Calcitriol, lib=and la2=): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins; 2under1
null dep=None lb1=Interactions lb1=for lib=(Vitamin lib=D2, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lib=(Vitamin lib=D2, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=compound lb1=Interactions lb1=for lib=(Vitamin lib=D2, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=compound lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, la2=, la2=Calcitriol, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=conj lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, la2=, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins; 2under1
null dep=conj lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, lib=Calcitriol, lib=and la2=): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins; 2under1
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, la2=, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, lib=Calcitriol, lib=and la2=): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, lib=Calcitriol, lib=and lib=Calcidiol): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lib=, lib=and la2=): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lib=, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lib=, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lib=, lib=and lib=Calcidiol): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lib=): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lib=): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lib=): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lb1=Calcidiol): lib=: la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins; 2under1
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lb1=Calcidiol): lib=: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
mechanism dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lb1=Calcidiol): lib=: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lib=/ la2=: la2=The la2=coadministration la2=of la2=phenytoin la2=or la2=phenobarbital la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lib=/Phenobarbital: lib=The lib=coadministration lib=of la2=or la2=phenobarbital la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lib=/Phenobarbital: lib=The lib=coadministration lib=of lib=phenytoin lib=or la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lib=/Phenobarbital: lib=The lib=coadministration lib=of lib=phenytoin lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of la2=, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lib=/Phenobarbital: lib=The lib=coadministration lib=of lib=phenytoin lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of lib=vitamin lib=D, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/ lib=: lib=The lib=coadministration lib=of la2=or la2=phenobarbital la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/ lib=: lib=The lib=coadministration lib=of lib=phenytoin lib=or la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/ lib=: lib=The lib=coadministration lib=of lib=phenytoin lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of la2=, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/ lib=: lib=The lib=coadministration lib=of lib=phenytoin lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of lib=vitamin lib=D, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=conj lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lib=or la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism. 2under1
null dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of la2=, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
mechanism dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of lib=vitamin lib=D, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lb1=phenytoin lb1=or lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of la2=, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
mechanism dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lb1=phenytoin lb1=or lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of lib=vitamin lib=D, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lb1=phenytoin lb1=or lb1=phenobarbital lb1=will lb1=not lb1=affect lb1=plasma lb1=concentrations lb1=of lib=, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Since lb1=blood lb1=level lb1=of lib=/ergocalcitriol lib=will lib=be lib=reduced, lib=higher lib=doses lib=of la2=may la2=be la2=necessary la2=if la2=these la2=drugs la2=are la2=administered la2=simultaneously.
null dep=None lib=: la2=: la2=Thiazides la2=are la2=known la2=to la2=induce la2=hypercalcemia la2=by la2=the la2=reduction la2=of la2=calcium la2=excretion la2=in la2=urine. 2under1
effect dep=None lb1=Some lb1=reports lb1=have lb1=shown lb1=that lb1=the lb1=concomitant lb1=administration lb1=of lib=with la2=causes la2=hypercalcemia.
null dep=None lib=: la2=dosage la2=must la2=be la2=determined la2=with la2=care la2=in la2=patients la2=undergoing la2=treatment la2=with la2=digitalis, la2=as la2=hypercalcemia la2=in la2=such la2=patients la2=may la2=precipitate la2=cardiac la2=arrhythmias.
null dep=None lib=: lib=Vitamin lib=D lib=dosage lib=must lib=be lib=determined lib=with lib=care lib=in lib=patients lib=undergoing lib=treatment lib=with la2=, la2=as la2=hypercalcemia la2=in la2=such la2=patients la2=may la2=precipitate la2=cardiac la2=arrhythmias. 2under1
advise dep=None lb1=Digitalis: lib=dosage lib=must lib=be lib=determined lib=with lib=care lib=in lib=patients lib=undergoing lib=treatment lib=with la2=, la2=as la2=hypercalcemia la2=in la2=such la2=patients la2=may la2=precipitate la2=cardiac la2=arrhythmias.
null dep=None lib=: la2=: la2=Ketoconazole la2=may la2=inhibit la2=both la2=synthetic la2=and la2=catabolic la2=enzymes la2=of la2=vitamin la2=D. 2under1
null dep=None lib=: lib=Ketoconazole lib=may lib=inhibit lib=both lib=synthetic lib=and lib=catabolic lib=enzymes lib=of la2=.
mechanism dep=None lib=: lib=Ketoconazole lib=may lib=inhibit lib=both lib=synthetic lib=and lib=catabolic lib=enzymes lib=of la2=.
null dep=nmod lb1=However, lb1=in lb1=vivo lb1=drug lb1=interaction lb1=studies lb1=of lib=with la2=have la2=not la2=been la2=investigated.
null dep=None lib=: lib=A lib=relationship lib=of lib=functional lib=antagonism lib=exists lib=between la2=, la2=which la2=promote la2=calcium la2=absorption, la2=and la2=corticosteroids, la2=which la2=inhibit la2=calcium la2=absorption.
null dep=None lib=: lib=A lib=relationship lib=of lib=functional lib=antagonism lib=exists lib=between lib=vitamin lib=D lib=analogues, lib=which lib=promote lib=calcium lib=absorption, lib=and la2=, la2=which la2=inhibit la2=calcium la2=absorption. 2under1
mechanism dep=conj lb1=Corticosteroids: lb1=A lb1=relationship lb1=of lb1=functional lb1=antagonism lb1=exists lb1=between lib=, lib=which lib=promote lib=calcium lib=absorption, lib=and la2=, la2=which la2=inhibit la2=calcium la2=absorption. 2under1
null dep=compound lib=: lib=The lib=coadministration lib=of lib=any lib=of lib=the la2=should la2=be la2=avoided la2=as la2=this la2=could la2=create la2=possible la2=additive la2=effects la2=and la2=hypercalcemia.
null dep=None lib=Supplements: lib=Uncontrolled lib=intake lib=of lib=additional la2=-containing la2=preparations la2=should la2=be la2=avoided.
null dep=None lib=: la2=: la2=Magnesium-containing la2=preparations la2=(eg, la2=antacids) la2=may la2=cause la2=hypermagnesemia la2=and la2=should la2=therefore la2=not la2=be la2=taken la2=during la2=therapy la2=with la2=vitamin la2=D la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis.
null dep=None lib=: lib=Magnesium-containing lib=preparations lib=(eg, la2=) la2=may la2=cause la2=hypermagnesemia la2=and la2=should la2=therefore la2=not la2=be la2=taken la2=during la2=therapy la2=with la2=vitamin la2=D la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis. 2under1
null dep=None lib=: lib=Magnesium-containing lib=preparations lib=(eg, lib=antacids) lib=may lib=cause lib=hypermagnesemia lib=and lib=should lib=therefore lib=not lib=be lib=taken lib=during lib=therapy lib=with la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis.
null dep=None lib=: lib=Magnesium-containing lib=preparations lib=(eg, la2=) la2=may la2=cause la2=hypermagnesemia la2=and la2=should la2=therefore la2=not la2=be la2=taken la2=during la2=therapy la2=with la2=vitamin la2=D la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis. 2under1
advise dep=None lib=: lib=Magnesium-containing lib=preparations lib=(eg, lib=antacids) lib=may lib=cause lib=hypermagnesemia lib=and lib=should lib=therefore lib=not lib=be lib=taken lib=during lib=therapy lib=with la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis.
advise dep=None lb1=Magnesium: lb1=Magnesium-containing lb1=preparations lb1=(eg, lib=) lib=may lib=cause lib=hypermagnesemia lib=and lib=should lib=therefore lib=not lib=be lib=taken lib=during lib=therapy lib=with la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis.
null dep=appos lib=( la2=) la2=blood la2=levels la2=may la2=be la2=increased la2=and la2=prolonged la2=by la2=concurrent la2=administration la2=of la2=probenecid.
mechanism dep=None lib=(carbenicillin lib=indanyl lib=sodium) lib=blood lib=levels lib=may lib=be lib=increased lib=and lib=prolonged lib=by lib=concurrent lib=administration lib=of la2=.
mechanism dep=None lb1=Geocillin lb1=( lib=) lib=blood lib=levels lib=may lib=be lib=increased lib=and lib=prolonged lib=by lib=concurrent lib=administration lib=of la2=.
null dep=None lib=was lib=found lib=to lib=have lib=no lib=significant lib=effect lib=on lib=the lib=bioavailability lib=of la2=, la2=lovastatin, la2=metoprolol, la2=quinidine, la2=valproic la2=acid, la2=and la2=warfarin.
null dep=None lib=was lib=found lib=to lib=have lib=no lib=significant lib=effect lib=on lib=the lib=bioavailability lib=of lib=digoxin, la2=, la2=metoprolol, la2=quinidine, la2=valproic la2=acid, la2=and la2=warfarin.
null dep=None lib=was lib=found lib=to lib=have lib=no lib=significant lib=effect lib=on lib=the lib=bioavailability lib=of lib=digoxin, lib=lovastatin, la2=, la2=quinidine, la2=valproic la2=acid, la2=and la2=warfarin.
null dep=None lib=was lib=found lib=to lib=have lib=no lib=significant lib=effect lib=on lib=the lib=bioavailability lib=of lib=digoxin, lib=lovastatin, lib=metoprolol, la2=, la2=valproic la2=acid, la2=and la2=warfarin.
null dep=None lib=was lib=found lib=to lib=have lib=no lib=significant lib=effect lib=on lib=the lib=bioavailability lib=of lib=digoxin, lib=lovastatin, lib=metoprolol, lib=quinidine, la2=, la2=and la2=warfarin.
null dep=None lib=was lib=found lib=to lib=have lib=no lib=significant lib=effect lib=on lib=the lib=bioavailability lib=of lib=digoxin, lib=lovastatin, lib=metoprolol, lib=quinidine, lib=valproic lib=acid, lib=and la2=.
null dep=conj lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lib=, la2=, la2=metoprolol, la2=quinidine, la2=valproic la2=acid, la2=and la2=warfarin. 2under1
null dep=conj lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lib=, lib=lovastatin, la2=, la2=quinidine, la2=valproic la2=acid, la2=and la2=warfarin. 2under1
null dep=conj lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lib=, lib=lovastatin, lib=metoprolol, la2=, la2=valproic la2=acid, la2=and la2=warfarin. 2under1
null dep=conj lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lib=, lib=lovastatin, lib=metoprolol, lib=quinidine, la2=, la2=and la2=warfarin.
null dep=conj lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lib=, lib=lovastatin, lib=metoprolol, lib=quinidine, lib=valproic lib=acid, lib=and la2=. 2under1
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lib=, la2=, la2=quinidine, la2=valproic la2=acid, la2=and la2=warfarin.
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lib=, lib=metoprolol, la2=, la2=valproic la2=acid, la2=and la2=warfarin.
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lib=, lib=metoprolol, lib=quinidine, la2=, la2=and la2=warfarin.
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lib=, lib=metoprolol, lib=quinidine, lib=valproic lib=acid, lib=and la2=.
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lb1=lovastatin, lib=, la2=, la2=valproic la2=acid, la2=and la2=warfarin.
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lb1=lovastatin, lib=, lib=quinidine, la2=, la2=and la2=warfarin.
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lb1=lovastatin, lib=, lib=quinidine, lib=valproic lib=acid, lib=and la2=.
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lb1=lovastatin, lb1=metoprolol, lib=, la2=, la2=and la2=warfarin.
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lb1=lovastatin, lb1=metoprolol, lib=, lib=valproic lib=acid, lib=and la2=.
null dep=None lb1=WelChol lb1=was lb1=found lb1=to lb1=have lb1=no lb1=significant lb1=effect lb1=on lb1=the lb1=bioavailability lb1=of lb1=digoxin, lb1=lovastatin, lb1=metoprolol, lb1=quinidine, lib=, lib=and la2=.
mechanism dep=None lib=decreased lib=the lib=Cmax lib=and lib=AUC lib=of lib=sustained-release la2=(Calan la2=SR la2=) la2=by la2=approximately la2=31% la2=and la2=11%, la2=respectively.
mechanism dep=None lib=decreased lib=the lib=Cmax lib=and lib=AUC lib=of lib=sustained-release lib=verapamil lib=( la2=) la2=by la2=approximately la2=31% la2=and la2=11%, la2=respectively.
null dep=appos lb1=WelChol lb1=decreased lb1=the lb1=Cmax lb1=and lb1=AUC lb1=of lb1=sustained-release lib=( la2=) la2=by la2=approximately la2=31% la2=and la2=11%, la2=respectively.
null dep=None lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lib=with la2=, la2=lovastatin, la2=or la2=simvastatin la2=did la2=not la2=interfere la2=with la2=the la2=lipid-lowering la2=activity la2=of la2=the la2=HMG-CoA la2=reductase la2=inhibitor.
null dep=None lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lib=with lib=atorvastatin, la2=, la2=or la2=simvastatin la2=did la2=not la2=interfere la2=with la2=the la2=lipid-lowering la2=activity la2=of la2=the la2=HMG-CoA la2=reductase la2=inhibitor.
null dep=None lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lib=with lib=atorvastatin, lib=lovastatin, lib=or la2=did la2=not la2=interfere la2=with la2=the la2=lipid-lowering la2=activity la2=of la2=the la2=HMG-CoA la2=reductase la2=inhibitor.
null dep=None lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lib=with lib=atorvastatin, lib=lovastatin, lib=or lib=simvastatin lib=did lib=not lib=interfere lib=with lib=the lib=lipid-lowering lib=activity lib=of lib=the la2=.
null dep=conj lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lb1=WelChol lb1=with lib=, la2=, la2=or la2=simvastatin la2=did la2=not la2=interfere la2=with la2=the la2=lipid-lowering la2=activity la2=of la2=the la2=HMG-CoA la2=reductase la2=inhibitor. 2under1
null dep=conj lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lb1=WelChol lb1=with lib=, lib=lovastatin, lib=or la2=did la2=not la2=interfere la2=with la2=the la2=lipid-lowering la2=activity la2=of la2=the la2=HMG-CoA la2=reductase la2=inhibitor. 2under1
null dep=cc lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lb1=WelChol lb1=with lib=, lib=lovastatin, lib=or lib=simvastatin lib=did lib=not lib=interfere lib=with lib=the lib=lipid-lowering lib=activity lib=of lib=the la2=.
null dep=None lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lb1=WelChol lb1=with lb1=atorvastatin, lib=, lib=or la2=did la2=not la2=interfere la2=with la2=the la2=lipid-lowering la2=activity la2=of la2=the la2=HMG-CoA la2=reductase la2=inhibitor.
null dep=None lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lb1=WelChol lb1=with lb1=atorvastatin, lib=, lib=or lib=simvastatin lib=did lib=not lib=interfere lib=with lib=the lib=lipid-lowering lib=activity lib=of lib=the la2=.
null dep=None lb1=In lb1=clinical lb1=studies, lb1=coadministration lb1=of lb1=WelChol lb1=with lb1=atorvastatin, lb1=lovastatin, lb1=or lib=did lib=not lib=interfere lib=with lib=the lib=lipid-lowering lib=activity lib=of lib=the la2=.
null dep=None lib=: lib=Patients lib=on la2=, la2=especially la2=those la2=with la2=intravascular la2=volume la2=depletion, la2=may la2=occasionally la2=experience la2=an la2=excessive la2=reduction la2=of la2=blood la2=pressure la2=after la2=initiation la2=of la2=therapy la2=with la2=fosinopril la2=sodium. 2under1
null dep=None lib=: lib=Patients lib=on lib=diuretics, lib=especially lib=those lib=with lib=intravascular lib=volume lib=depletion, lib=may lib=occasionally lib=experience lib=an lib=excessive lib=reduction lib=of lib=blood lib=pressure lib=after lib=initiation lib=of lib=therapy lib=with la2=.
effect dep=None lb1=Diuretics: lb1=Patients lb1=on lib=, lib=especially lib=those lib=with lib=intravascular lib=volume lib=depletion, lib=may lib=occasionally lib=experience lib=an lib=excessive lib=reduction lib=of lib=blood lib=pressure lib=after lib=initiation lib=of lib=therapy lib=with la2=.
effect dep=None lb1=The lb1=possibility lb1=of lb1=hypotensive lb1=effects lb1=can lb1=be lb1=minimized lb1=by lb1=either lb1=discontinuing lb1=the lib=or lib=increasing lib=salt lib=intake lib=prior lib=to lib=initiation lib=of lib=treatment lib=with la2=.
null dep=None lib=Supplements lib=and la2=: la2=Fosinopril la2=sodium la2=can la2=attenuate la2=potassium la2=loss la2=caused la2=by la2=thiazide la2=diuretics.
null dep=None lib=Supplements lib=and lib=Potassium-Sparing lib=Diuretics: la2=can la2=attenuate la2=potassium la2=loss la2=caused la2=by la2=thiazide la2=diuretics.
null dep=None lib=Supplements lib=and lib=Potassium-Sparing lib=Diuretics: lib=Fosinopril lib=sodium lib=can lib=attenuate lib=potassium lib=loss lib=caused lib=by la2=.
null dep=None lb1=Potassium lb1=Supplements lb1=and lib=: la2=can la2=attenuate la2=potassium la2=loss la2=caused la2=by la2=thiazide la2=diuretics.
null dep=None lb1=Potassium lb1=Supplements lb1=and lib=: lib=Fosinopril lib=sodium lib=can lib=attenuate lib=potassium lib=loss lib=caused lib=by la2=.
effect dep=None lb1=Potassium lb1=Supplements lb1=and lb1=Potassium-Sparing lb1=Diuretics: lib=can lib=attenuate lib=potassium lib=loss lib=caused lib=by la2=.
null dep=dep lib=( la2=, la2=amiloride,triamterene, la2=and la2=others) la2=or la2=potassium la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia. 2under1
null dep=cc lib=(spironolactone, la2=,triamterene, la2=and la2=others) la2=or la2=potassium la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia. 2under1
null dep=None lib=(spironolactone, lib=amiloride, la2=, la2=and la2=others) la2=or la2=potassium la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia. 2under1
null dep=None lib=(spironolactone, lib=amiloride,triamterene, lib=and lib=others) lib=or la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia. 2under1
null dep=conj lb1=Potassium-sparing lb1=diuretics lb1=( lib=, la2=,triamterene, la2=and la2=others) la2=or la2=potassium la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia. 2under1
null dep=conj lb1=Potassium-sparing lb1=diuretics lb1=( lib=, lib=amiloride, la2=, la2=and la2=others) la2=or la2=potassium la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia. 2under1
null dep=None lb1=Potassium-sparing lb1=diuretics lb1=( lib=, lib=amiloride,triamterene, lib=and lib=others) lib=or la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia.
null dep=None lb1=Potassium-sparing lb1=diuretics lb1=(spironolactone, lib=, la2=, la2=and la2=others) la2=or la2=potassium la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia.
null dep=None lb1=Potassium-sparing lb1=diuretics lb1=(spironolactone, lib=,triamterene, lib=and lib=others) lib=or la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia.
null dep=None lb1=Potassium-sparing lb1=diuretics lb1=(spironolactone, lb1=amiloride, lib=, lib=and lib=others) lib=or la2=supplements la2=can la2=increase la2=the la2=risk la2=of la2=hyperkalemia.
null dep=None lib=: lib=Increased lib=serum la2=levels la2=and la2=symptoms la2=of la2=lithium la2=toxicity la2=have la2=been la2=reported la2=in la2=patients la2=receiving la2=ACE la2=inhibitors la2=during la2=therapy la2=with la2=lithium. 2under1
null dep=None lib=: lib=Increased lib=serum la2=levels la2=and la2=symptoms la2=of la2=lithium la2=toxicity la2=have la2=been la2=reported la2=in la2=patients la2=receiving la2=ACE la2=inhibitors la2=during la2=therapy la2=with la2=lithium. 2under1
null dep=None lib=: lib=Increased lib=serum lib=lithium lib=levels lib=and lib=symptoms lib=of lib=lithium lib=toxicity lib=have lib=been lib=reported lib=in lib=patients lib=receiving la2=during la2=therapy la2=with la2=lithium.
null dep=None lib=: lib=Increased lib=serum la2=levels la2=and la2=symptoms la2=of la2=lithium la2=toxicity la2=have la2=been la2=reported la2=in la2=patients la2=receiving la2=ACE la2=inhibitors la2=during la2=therapy la2=with la2=lithium. 2under1
null dep=None lb1=Lithium: lb1=Increased lb1=serum lib=levels lib=and lib=symptoms lib=of la2=levels la2=and la2=symptoms la2=of la2=lithium la2=toxicity la2=have la2=been la2=reported la2=in la2=patients la2=receiving la2=ACE la2=inhibitors la2=during la2=therapy la2=with la2=lithium.
null dep=None lb1=Lithium: lb1=Increased lb1=serum lib=levels lib=and lib=symptoms lib=of lib=lithium lib=toxicity lib=have lib=been lib=reported lib=in lib=patients lib=receiving la2=during la2=therapy la2=with la2=lithium.
null dep=None lb1=Lithium: lb1=Increased lb1=serum lib=levels lib=and lib=symptoms lib=of la2=levels la2=and la2=symptoms la2=of la2=lithium la2=toxicity la2=have la2=been la2=reported la2=in la2=patients la2=receiving la2=ACE la2=inhibitors la2=during la2=therapy la2=with la2=lithium.
null dep=None lb1=Lithium: lb1=Increased lb1=serum lib=levels lib=and lib=symptoms lib=of lib=lithium lib=toxicity lib=have lib=been lib=reported lib=in lib=patients lib=receiving la2=during la2=therapy la2=with la2=lithium.
null dep=None lb1=Lithium: lb1=Increased lb1=serum lib=levels lib=and lib=symptoms lib=of la2=levels la2=and la2=symptoms la2=of la2=lithium la2=toxicity la2=have la2=been la2=reported la2=in la2=patients la2=receiving la2=ACE la2=inhibitors la2=during la2=therapy la2=with la2=lithium.
effect dep=None lb1=Lithium: lb1=Increased lb1=serum lb1=lithium lb1=levels lb1=and lb1=symptoms lb1=of lb1=lithium lb1=toxicity lb1=have lb1=been lb1=reported lb1=in lb1=patients lb1=receiving lib=during lib=therapy lib=with la2=levels la2=and la2=symptoms la2=of la2=lithium la2=toxicity la2=have la2=been la2=reported la2=in la2=patients la2=receiving la2=ACE la2=inhibitors la2=during la2=therapy la2=with la2=lithium.
null dep=None lib=: lib=In lib=a lib=clinical lib=pharmacology lib=study, lib=coadministration lib=of lib=an la2=(aluminum la2=hydroxide, la2=magnesium la2=hydroxide, la2=and la2=simethicone) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril. 2under1
null dep=None lib=: lib=In lib=a lib=clinical lib=pharmacology lib=study, lib=coadministration lib=of lib=an lib=antacid lib=( la2=, la2=magnesium la2=hydroxide, la2=and la2=simethicone) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lib=: lib=In lib=a lib=clinical lib=pharmacology lib=study, lib=coadministration lib=of lib=an lib=antacid lib=(aluminum lib=hydroxide, la2=, la2=and la2=simethicone) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lib=: lib=In lib=a lib=clinical lib=pharmacology lib=study, lib=coadministration lib=of lib=an lib=antacid lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and la2=) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril. 2under1
null dep=None lib=: lib=In lib=a lib=clinical lib=pharmacology lib=study, lib=coadministration lib=of lib=an lib=antacid lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril. 2under1
null dep=None lib=: lib=In lib=a lib=clinical lib=pharmacology lib=study, lib=coadministration lib=of lib=an lib=antacid lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril. 2under1
null dep=None lib=: lib=In lib=a lib=clinical lib=pharmacology lib=study, lib=coadministration lib=of lib=an lib=antacid lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril. 2under1
null dep=None lib=: lib=In lib=a lib=clinical lib=pharmacology lib=study, lib=coadministration lib=of lib=an lib=antacid lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of lib=fosinoprilat lib=as lib=compared lib=with lib=fosinopril lib=administered lib=alone, lib=suggesting lib=that la2=may la2=impair la2=absorption la2=of la2=fosinopril. 2under1
null dep=None lib=: lib=In lib=a lib=clinical lib=pharmacology lib=study, lib=coadministration lib=of lib=an lib=antacid lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril. 2under1
null dep=det lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lib=( la2=, la2=magnesium la2=hydroxide, la2=and la2=simethicone) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril. 1under2
null dep=det lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lib=(aluminum lib=hydroxide, la2=, la2=and la2=simethicone) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril. 1under2
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and la2=) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
mechanism dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of lib=fosinoprilat lib=as lib=compared lib=with lib=fosinopril lib=administered lib=alone, lib=suggesting lib=that la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lib=(aluminum lib=hydroxide, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=compound lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=( lib=, la2=, la2=and la2=simethicone) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=( lib=, lib=magnesium lib=hydroxide, lib=and la2=) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
mechanism dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=( lib=, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=( lib=, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=( lib=, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=det lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=( lib=, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of lib=fosinoprilat lib=as lib=compared lib=with lib=fosinopril lib=administered lib=alone, lib=suggesting lib=that la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=( lib=, lib=magnesium lib=hydroxide, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lib=, lib=and la2=) la2=with la2=fosinopril la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
mechanism dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lib=, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lib=, lib=and lib=simethicone) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lib=, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=det lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lib=, lib=and lib=simethicone) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of lib=fosinoprilat lib=as lib=compared lib=with lib=fosinopril lib=administered lib=alone, lib=suggesting lib=that la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lib=, lib=and lib=simethicone) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
mechanism dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lib=) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lib=) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lib=) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lib=) lib=with lib=fosinopril lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of lib=fosinoprilat lib=as lib=compared lib=with lib=fosinopril lib=administered lib=alone, lib=suggesting lib=that la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lib=) lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of lib=fosinoprilat lib=as lib=compared lib=with lib=fosinopril lib=administered lib=alone, lib=suggesting lib=that la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lb1=fosinopril lb1=reduced lb1=serum lb1=levels lb1=and lb1=urinary lb1=excretion lb1=of lib=as lib=compared lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lb1=fosinopril lb1=reduced lb1=serum lb1=levels lb1=and lb1=urinary lb1=excretion lb1=of lib=as lib=compared lib=with lib=fosinopril lib=administered lib=alone, lib=suggesting lib=that la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lb1=fosinopril lb1=reduced lb1=serum lb1=levels lb1=and lb1=urinary lb1=excretion lb1=of lib=as lib=compared lib=with la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of lib=fosinoprilat lib=as lib=compared lib=with lib=fosinopril lib=administered lib=alone, lib=suggesting lib=that la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lib=reduced lib=serum lib=levels lib=and lib=urinary lib=excretion lib=of la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
mechanism dep=None lb1=Antacids: lb1=In lb1=a lb1=clinical lb1=pharmacology lb1=study, lb1=coadministration lb1=of lb1=an lb1=antacid lb1=(aluminum lb1=hydroxide, lb1=magnesium lb1=hydroxide, lb1=and lb1=simethicone) lb1=with lb1=fosinopril lb1=reduced lb1=serum lb1=levels lb1=and lb1=urinary lb1=excretion lb1=of lb1=fosinoprilat lb1=as lb1=compared lb1=with lb1=fosinopril lb1=administered lb1=alone, lb1=suggesting lb1=that lib=may lib=impair lib=absorption lib=of la2=reduced la2=serum la2=levels la2=and la2=urinary la2=excretion la2=of la2=fosinoprilat la2=as la2=compared la2=with la2=fosinopril la2=administered la2=alone, la2=suggesting la2=that la2=antacids la2=may la2=impair la2=absorption la2=of la2=fosinopril.
null dep=conj lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, la2=, la2=propanolol, la2=hydrochlorothiazide, la2=cimetidine, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs. 2under1
null dep=conj lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, lib=nifedipine, la2=, la2=hydrochlorothiazide, la2=cimetidine, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs. 2under1
null dep=conj lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, lib=nifedipine, lib=propanolol, la2=, la2=cimetidine, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs. 2under1
null dep=conj lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, lib=nifedipine, lib=propanolol, lib=hydrochlorothiazide, la2=, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs. 2under1
null dep=conj lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, lib=nifedipine, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, la2=, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs. 2under1
null dep=conj lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, lib=nifedipine, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, la2=, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs. 2under1
null dep=conj lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, lib=nifedipine, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, la2=, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs. 2under1
null dep=conj lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, lib=nifedipine, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and la2=, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs. 2under1
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, lib=nifedipine, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lib=, lib=nifedipine, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lib=, la2=, la2=hydrochlorothiazide, la2=cimetidine, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lib=, lib=propanolol, la2=, la2=cimetidine, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lib=, lib=propanolol, lib=hydrochlorothiazide, la2=, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lib=, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, la2=, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lib=, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, la2=, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lib=, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, la2=, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lib=, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and la2=, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lib=, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lib=, lib=propanolol, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lib=, la2=, la2=cimetidine, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lib=, lib=hydrochlorothiazide, la2=, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lib=, lib=hydrochlorothiazide, lib=cimetidine, la2=, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lib=, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, la2=, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lib=, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, la2=, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lib=, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and la2=, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lib=, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lib=, lib=hydrochlorothiazide, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lib=, la2=, la2=metoclopramide, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lib=, lib=cimetidine, la2=, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lib=, lib=cimetidine, lib=metoclopramide, la2=, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lib=, lib=cimetidine, lib=metoclopramide, lib=propantheline, la2=, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lib=, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and la2=, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lib=, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lib=, lib=cimetidine, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lib=, la2=, la2=propantheline, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lib=, lib=metoclopramide, la2=, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lib=, lib=metoclopramide, lib=propantheline, la2=, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lib=, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and la2=, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lib=, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lib=, lib=metoclopramide, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lib=, la2=, la2=digoxin, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lib=, lib=propantheline, la2=, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lib=, lib=propantheline, lib=digoxin, lib=and la2=, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lib=, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lib=, lib=propantheline, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lib=, la2=, la2=and la2=warfarin, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lib=, lib=digoxin, lib=and la2=, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lib=, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lib=, lib=digoxin, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lb1=propantheline, lib=, lib=and la2=, la2=the la2=bioavailability la2=of la2=fosinoprilat la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lb1=propantheline, lib=, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lb1=propantheline, lib=, lib=and lib=warfarin, lib=the lib=bioavailability lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lb1=propantheline, lb1=digoxin, lb1=and lib=, lib=the lib=bioavailability lib=of la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lb1=propantheline, lb1=digoxin, lb1=and lib=, lib=the lib=bioavailability lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=None lb1=In lb1=separate lb1=single lb1=or lb1=multiple lb1=dose lb1=pharmacokinetic lb1=interaction lb1=studies lb1=with lb1=chlorthalidone, lb1=nifedipine, lb1=propanolol, lb1=hydrochlorothiazide, lb1=cimetidine, lb1=metoclopramide, lb1=propantheline, lb1=digoxin, lb1=and lb1=warfarin, lb1=the lb1=bioavailability lb1=of lib=was lib=not lib=altered lib=by lib=coadministration lib=of la2=at la2=was la2=not la2=altered la2=by la2=coadministration la2=of la2=fosinopril la2=with la2=any la2=one la2=of la2=these la2=drugs.
null dep=conj lb1=In lb1=a lb1=study lb1=with lb1=concomitant lb1=administration lb1=of lib=and la2=, la2=the la2=bioavailability la2=of la2=unbound la2=fosinoprilat la2=was la2=not la2=altered.
null dep=None lb1=In lb1=a lb1=study lb1=with lb1=concomitant lb1=administration lb1=of lib=and lib=fosinopril lib=sodium, lib=the lib=bioavailability lib=of lib=unbound la2=was la2=not la2=altered.
null dep=compound lb1=In lb1=a lb1=study lb1=with lb1=concomitant lb1=administration lb1=of lb1=aspirin lb1=and lib=, lib=the lib=bioavailability lib=of lib=unbound la2=was la2=not la2=altered.
null dep=None lb1=In lb1=a lb1=pharmacokinetic lb1=interaction lb1=study lb1=with lib=, lib=bioavailability lib=parameters, lib=the lib=degree lib=of lib=protein lib=binding, lib=and lib=the lib=anticoagulant lib=effect lib=(measured lib=by lib=prothrombin lib=time) lib=of la2=, la2=bioavailability la2=parameters, la2=the la2=degree la2=of la2=protein la2=binding, la2=and la2=the la2=anticoagulant la2=effect la2=(measured la2=by la2=prothrombin la2=time) la2=of la2=warfarin la2=were la2=not la2=significantly la2=changed.
null dep=None lb1=Drug/Laboratory lb1=Test lb1=Interaction lib=may lib=cause lib=a lib=false lib=low lib=measurement lib=of lib=serum la2=levels la2=with la2=the la2=Digi- la2=Tab la2=RIA la2=Kit la2=for la2=Digoxin.
null dep=None lb1=Drug/Laboratory lb1=Test lb1=Interaction lib=may lib=cause lib=a lib=false lib=low lib=measurement lib=of lib=serum lib=digoxin lib=levels lib=with lib=the lib=Digi- lib=Tab lib=RIA lib=Kit lib=for la2=.
null dep=None lb1=Drug/Laboratory lb1=Test lb1=Interaction lb1=Fosinopril lb1=may lb1=cause lb1=a lb1=false lb1=low lb1=measurement lb1=of lb1=serum lib=levels lib=with lib=the lib=Digi- lib=Tab lib=RIA lib=Kit lib=for la2=.
null dep=appos lib=, lib=a la2=, la2=has la2=been la2=reported la2=to la2=inactivate la2=the la2=antifungal la2=activity la2=of la2=flucytosine la2=by la2=competitive la2=inhibition.
effect dep=None lib=, lib=a lib=cytostatic lib=agent, lib=has lib=been lib=reported lib=to lib=inactivate lib=the lib=antifungal lib=activity lib=of la2=by la2=competitive la2=inhibition.
null dep=None lb1=Cytosine lb1=arabinoside, lb1=a lib=, lib=has lib=been lib=reported lib=to lib=inactivate lib=the lib=antifungal lib=activity lib=of la2=by la2=competitive la2=inhibition.
null dep=conj lb1=Induction lb1=of lb1=apoptosis lb1=in lb1=breast lb1=cancer lb1=cells lb1=in lb1=response lb1=to lib=and la2=. 2under1
null dep=appos lb1=1, lib=( la2=), la2=the la2=active la2=metabolite la2=of la2=vitamin la2=D, la2=is la2=a la2=potent la2=inhibitor la2=of la2=breast la2=cancer la2=cell la2=growth la2=both la2=in la2=vivo la2=and la2=in la2=vitro.
null dep=compound lb1=1, lib=(1,25(OH)2D3), lib=the lib=active lib=metabolite lib=of la2=, la2=is la2=a la2=potent la2=inhibitor la2=of la2=breast la2=cancer la2=cell la2=growth la2=both la2=in la2=vivo la2=and la2=in la2=vitro.
null dep=compound lb1=1,25-Dihydroxycholecalciferol lb1=D3 lb1=( lib=), lib=the lib=active lib=metabolite lib=of la2=, la2=is la2=a la2=potent la2=inhibitor la2=of la2=breast la2=cancer la2=cell la2=growth la2=both la2=in la2=vivo la2=and la2=in la2=vitro.
null dep=None lb1=In lb1=the lb1=experiments lb1=reported lb1=here, lb1=we lb1=examined lb1=the lb1=interactions lb1=between lib=and lib=the la2=4-hydroxytamoxifen la2=(TAM), la2=which la2=also la2=induces la2=apoptosis la2=in la2=MCF-7 la2=cells.
null dep=conj lb1=In lb1=the lb1=experiments lb1=reported lb1=here, lb1=we lb1=examined lb1=the lb1=interactions lb1=between lib=and lib=the lib=antiestrogen la2=(TAM), la2=which la2=also la2=induces la2=apoptosis la2=in la2=MCF-7 la2=cells.
null dep=None lb1=In lb1=the lb1=experiments lb1=reported lb1=here, lb1=we lb1=examined lb1=the lb1=interactions lb1=between lib=and lib=the lib=antiestrogen lib=4-hydroxytamoxifen lib=( la2=), la2=which la2=also la2=induces la2=apoptosis la2=in la2=MCF-7 la2=cells.
null dep=amod lb1=In lb1=the lb1=experiments lb1=reported lb1=here, lb1=we lb1=examined lb1=the lb1=interactions lb1=between lb1=1,25(OH)2D3 lb1=and lb1=the la2=(TAM), la2=which la2=also la2=induces la2=apoptosis la2=in la2=MCF-7 la2=cells. 1under2
null dep=None lb1=In lb1=the lb1=experiments lb1=reported lb1=here, lb1=we lb1=examined lb1=the lb1=interactions lb1=between lb1=1,25(OH)2D3 lb1=and lb1=the lib=4-hydroxytamoxifen lib=( la2=), la2=which la2=also la2=induces la2=apoptosis la2=in la2=MCF-7 la2=cells.
null dep=appos lb1=In lb1=the lb1=experiments lb1=reported lb1=here, lb1=we lb1=examined lb1=the lb1=interactions lb1=between lb1=1,25(OH)2D3 lb1=and lb1=the lb1=antiestrogen lib=( la2=), la2=which la2=also la2=induces la2=apoptosis la2=in la2=MCF-7 la2=cells. 2under1
effect dep=None lb1=Our lb1=data lb1=suggest lb1=that lib=significantly lib=potentiates lib=the lib=reduction lib=in lib=cell lib=number lib=induced lib=by la2=alone.
effect dep=conj lb1=Combined lb1=treatment lb1=with lib=and la2=enhances la2=the la2=degree la2=of la2=apoptosis la2=assessed la2=using la2=morphological la2=markers la2=that la2=identify la2=chromatin la2=and la2=nuclear la2=matrix la2=protein la2=condensation.
null dep=None lb1=These lb1=data lb1=emphasize lb1=that lb1=apoptosis lb1=can lb1=be lb1=induced lb1=in lb1=MCF-7 lb1=cells lb1=either lb1=by lb1=activation lb1=of lib=-mediated lib=signalling lib=or lib=disruption lib=of la2=-dependent la2=signalling.
null dep=conj lb1=Drug-Drug lb1=Interactions: lb1=The lb1=pharmacokinetic lb1=and lb1=pharmacodynamic lb1=interactions lb1=between lib=and lib=other la2=have la2=not la2=been la2=determined. 2under1
advise dep=None lb1=However, lb1=interactions lb1=may lb1=be lb1=expected, lb1=and lib=should lib=NOT lib=be lib=used lib=in lib=combination lib=with lib=other la2=.
null dep=None lib=: lib=Based lib=on lib=reports lib=of lib=profound lib=hypotension lib=and lib=loss lib=of lib=consciousness lib=when la2=was la2=administered la2=with la2=ondansetron, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lib=: lib=Based lib=on lib=reports lib=of lib=profound lib=hypotension lib=and lib=loss lib=of lib=consciousness lib=when lib=apomorphine lib=was lib=administered lib=with la2=, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lib=: lib=Based lib=on lib=reports lib=of lib=profound lib=hypotension lib=and lib=loss lib=of lib=consciousness lib=when la2=was la2=administered la2=with la2=ondansetron, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=compound lib=: lib=Based lib=on lib=reports lib=of lib=profound lib=hypotension lib=and lib=loss lib=of lib=consciousness lib=when lib=apomorphine lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lib=: lib=Based lib=on lib=reports lib=of lib=profound lib=hypotension lib=and lib=loss lib=of lib=consciousness lib=when lib=apomorphine lib=was lib=administered lib=with la2=, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lib=: lib=Based lib=on lib=reports lib=of lib=profound lib=hypotension lib=and lib=loss lib=of lib=consciousness lib=when lib=apomorphine lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, la2=, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lib=: lib=Based lib=on lib=reports lib=of lib=profound lib=hypotension lib=and lib=loss lib=of lib=consciousness lib=when lib=apomorphine lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, la2=, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lib=: lib=Based lib=on lib=reports lib=of lib=profound lib=hypotension lib=and lib=loss lib=of lib=consciousness lib=when lib=apomorphine lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, la2=, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lib=: lib=Based lib=on lib=reports lib=of lib=profound lib=hypotension lib=and lib=loss lib=of lib=consciousness lib=when lib=apomorphine lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, lib=palonosetron, lib=and la2=) la2=is la2=contraindicated la2=. 2under1
effect dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with la2=, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of la2=was la2=administered la2=with la2=ondansetron, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with la2=, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, la2=, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, la2=, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, la2=, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, lib=palonosetron, lib=and la2=) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of la2=was la2=administered la2=with la2=ondansetron, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 1under2
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, la2=, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, la2=, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, la2=, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, la2=, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, lib=palonosetron, lib=and la2=) la2=is la2=contraindicated la2=.
advise dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
advise dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with la2=, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
advise dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, la2=, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
advise dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, la2=, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
advise dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, la2=, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
advise dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lib=was lib=administered lib=with lib=ondansetron, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, lib=palonosetron, lib=and la2=) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lib=(including, lib=for lib=example, la2=, la2=the la2=concomitant la2=use la2=of la2=apomorphine la2=with la2=drugs la2=of la2=the la2=5HT3 la2=antagonist la2=class la2=(including, la2=for la2=example, la2=ondansetron, la2=granisetron, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lib=(including, lib=for lib=example, lib=ondansetron, la2=, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, la2=, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, la2=, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, lib=palonosetron, lib=and la2=) la2=is la2=contraindicated la2=. 2under1
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, la2=, la2=dolasetron, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, la2=, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, la2=, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lib=, lib=the lib=concomitant lib=use lib=of lib=apomorphine lib=with lib=drugs lib=of lib=the lib=5HT3 lib=antagonist lib=class lib=(including, lib=for lib=example, lib=ondansetron, lib=granisetron, lib=dolasetron, lib=palonosetron, lib=and la2=) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lb1=5HT3 lb1=antagonist lb1=class lb1=(including, lb1=for lb1=example, lb1=ondansetron, lib=, la2=, la2=palonosetron, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lb1=5HT3 lb1=antagonist lb1=class lb1=(including, lb1=for lb1=example, lb1=ondansetron, lib=, lib=dolasetron, la2=, la2=and la2=alosetron) la2=is la2=contraindicated la2=.
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lb1=5HT3 lb1=antagonist lb1=class lb1=(including, lb1=for lb1=example, lb1=ondansetron, lib=, lib=dolasetron, lib=palonosetron, lib=and la2=) la2=is la2=contraindicated la2=.
null dep=conj lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lb1=5HT3 lb1=antagonist lb1=class lb1=(including, lb1=for lb1=example, lb1=ondansetron, lb1=granisetron, lib=, la2=, la2=and la2=alosetron) la2=is la2=contraindicated la2=. 2under1
null dep=conj lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lb1=5HT3 lb1=antagonist lb1=class lb1=(including, lb1=for lb1=example, lb1=ondansetron, lb1=granisetron, lib=, lib=palonosetron, lib=and la2=) la2=is la2=contraindicated la2=. 2under1
null dep=None lb1=5HT3 lb1=Antagonists: lb1=Based lb1=on lb1=reports lb1=of lb1=profound lb1=hypotension lb1=and lb1=loss lb1=of lb1=consciousness lb1=when lb1=apomorphine lb1=was lb1=administered lb1=with lb1=ondansetron, lb1=the lb1=concomitant lb1=use lb1=of lb1=apomorphine lb1=with lb1=drugs lb1=of lb1=the lb1=5HT3 lb1=antagonist lb1=class lb1=(including, lb1=for lb1=example, lb1=ondansetron, lb1=granisetron, lb1=dolasetron, lib=, lib=and la2=) la2=is la2=contraindicated la2=.
null dep=None lib=s lib=and la2=: la2=The la2=following la2=adverse la2=events la2=were la2=experienced la2=more la2=commonly la2=in la2=patients la2=receiving la2=concomitant la2=antihypertensive la2=medications la2=or la2=vasodilators la2=(n la2== la2=94) la2=compared la2=to la2=patients la2=not la2=receiving la2=these la2=concomitant la2=drugs la2=(n la2== la2=456): la2=hypotension la2=10% la2=vs la2=4%, la2=myocardial la2=infarction la2=3% la2=vs la2=1%, la2=serious la2=pneumonia la2=5% la2=vs la2=3%, la2=serious la2=falls la2=9% la2=vs la2=3%, la2=and la2=bone la2=and la2=joint la2=injuries la2=6% la2=vs la2=2%.
null dep=None lib=s lib=and lib=Vasodilators: lib=The lib=following lib=adverse lib=events lib=were lib=experienced lib=more lib=commonly lib=in lib=patients lib=receiving lib=concomitant la2=or la2=vasodilators la2=(n la2== la2=94) la2=compared la2=to la2=patients la2=not la2=receiving la2=these la2=concomitant la2=drugs la2=(n la2== la2=456): la2=hypotension la2=10% la2=vs la2=4%, la2=myocardial la2=infarction la2=3% la2=vs la2=1%, la2=serious la2=pneumonia la2=5% la2=vs la2=3%, la2=serious la2=falls la2=9% la2=vs la2=3%, la2=and la2=bone la2=and la2=joint la2=injuries la2=6% la2=vs la2=2%.
null dep=dep lib=s lib=and lib=Vasodilators: lib=The lib=following lib=adverse lib=events lib=were lib=experienced lib=more lib=commonly lib=in lib=patients lib=receiving lib=concomitant lib=antihypertensive lib=medications lib=or la2=(n la2== la2=94) la2=compared la2=to la2=patients la2=not la2=receiving la2=these la2=concomitant la2=drugs la2=(n la2== la2=456): la2=hypotension la2=10% la2=vs la2=4%, la2=myocardial la2=infarction la2=3% la2=vs la2=1%, la2=serious la2=pneumonia la2=5% la2=vs la2=3%, la2=serious la2=falls la2=9% la2=vs la2=3%, la2=and la2=bone la2=and la2=joint la2=injuries la2=6% la2=vs la2=2%.
null dep=cc lb1=Antihypertensive lb1=Medications lb1=and lib=: lib=The lib=following lib=adverse lib=events lib=were lib=experienced lib=more lib=commonly lib=in lib=patients lib=receiving lib=concomitant la2=or la2=vasodilators la2=(n la2== la2=94) la2=compared la2=to la2=patients la2=not la2=receiving la2=these la2=concomitant la2=drugs la2=(n la2== la2=456): la2=hypotension la2=10% la2=vs la2=4%, la2=myocardial la2=infarction la2=3% la2=vs la2=1%, la2=serious la2=pneumonia la2=5% la2=vs la2=3%, la2=serious la2=falls la2=9% la2=vs la2=3%, la2=and la2=bone la2=and la2=joint la2=injuries la2=6% la2=vs la2=2%.
null dep=None lb1=Antihypertensive lb1=Medications lb1=and lib=: lib=The lib=following lib=adverse lib=events lib=were lib=experienced lib=more lib=commonly lib=in lib=patients lib=receiving lib=concomitant lib=antihypertensive lib=medications lib=or la2=(n la2== la2=94) la2=compared la2=to la2=patients la2=not la2=receiving la2=these la2=concomitant la2=drugs la2=(n la2== la2=456): la2=hypotension la2=10% la2=vs la2=4%, la2=myocardial la2=infarction la2=3% la2=vs la2=1%, la2=serious la2=pneumonia la2=5% la2=vs la2=3%, la2=serious la2=falls la2=9% la2=vs la2=3%, la2=and la2=bone la2=and la2=joint la2=injuries la2=6% la2=vs la2=2%.
effect dep=cc lb1=Antihypertensive lb1=Medications lb1=and lb1=Vasodilators: lb1=The lb1=following lb1=adverse lb1=events lb1=were lb1=experienced lb1=more lb1=commonly lb1=in lb1=patients lb1=receiving lb1=concomitant lib=or la2=(n la2== la2=94) la2=compared la2=to la2=patients la2=not la2=receiving la2=these la2=concomitant la2=drugs la2=(n la2== la2=456): la2=hypotension la2=10% la2=vs la2=4%, la2=myocardial la2=infarction la2=3% la2=vs la2=1%, la2=serious la2=pneumonia la2=5% la2=vs la2=3%, la2=serious la2=falls la2=9% la2=vs la2=3%, la2=and la2=bone la2=and la2=joint la2=injuries la2=6% la2=vs la2=2%. 2under1
null dep=nsubj lib=: lib=Since la2=is la2=a la2=dopamine la2=agonist, la2=it la2=is la2=possible la2=that la2=dopamine la2=antagonists, la2=such la2=as la2=the la2=neuroleptics la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=cop lib=: lib=Since lib=apomorphine lib=is lib=a la2=, la2=it la2=is la2=possible la2=that la2=dopamine la2=antagonists, la2=such la2=as la2=the la2=neuroleptics la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=cop lib=: lib=Since lib=apomorphine lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that la2=, la2=such la2=as la2=the la2=neuroleptics la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lib=: lib=Since lib=apomorphine lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=det lib=: lib=Since lib=apomorphine lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=( la2=, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=None lib=: lib=Since lib=apomorphine lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, la2=, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=det lib=: lib=Since lib=apomorphine lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, la2=) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=det lib=: lib=Since lib=apomorphine lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or la2=, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=None lib=: lib=Since lib=apomorphine lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or lib=metoclopramide, lib=may lib=diminish lib=the lib=effectiveness lib=of la2=. 2under1
null dep=nsubj lb1=Dopamine lb1=Antagonists: lb1=Since lib=is lib=a la2=, la2=it la2=is la2=possible la2=that la2=dopamine la2=antagonists, la2=such la2=as la2=the la2=neuroleptics la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 1under2
null dep=nsubj lb1=Dopamine lb1=Antagonists: lb1=Since lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that la2=, la2=such la2=as la2=the la2=neuroleptics la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=cc lb1=Dopamine lb1=Antagonists: lb1=Since lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=( la2=, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, la2=, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, la2=) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or la2=, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lib=is lib=a lib=dopamine lib=agonist, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or lib=metoclopramide, lib=may lib=diminish lib=the lib=effectiveness lib=of la2=.
null dep=cop lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lib=, lib=it lib=is lib=possible lib=that la2=, la2=such la2=as la2=the la2=neuroleptics la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lib=, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=det lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lib=, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=( la2=, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lib=, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, la2=, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=det lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lib=, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, la2=) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=det lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lib=, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or la2=, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lib=, lib=it lib=is lib=possible lib=that lib=dopamine lib=antagonists, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or lib=metoclopramide, lib=may lib=diminish lib=the lib=effectiveness lib=of la2=.
null dep=nmod lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lib=, lib=such lib=as lib=the la2=(phenothiazines, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=det lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lib=, lib=such lib=as lib=the lib=neuroleptics lib=( la2=, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lib=, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, la2=, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=det lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lib=, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, la2=) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
effect dep=det lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lib=, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or la2=, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lib=, lib=such lib=as lib=the lib=neuroleptics lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or lib=metoclopramide, lib=may lib=diminish lib=the lib=effectiveness lib=of la2=.
null dep=dep lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lib=( la2=, la2=butyrophenones, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lib=(phenothiazines, la2=, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=det lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lib=(phenothiazines, lib=butyrophenones, la2=) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=conj lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or la2=, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lib=(phenothiazines, lib=butyrophenones, lib=thioxanthenes) lib=or lib=metoclopramide, lib=may lib=diminish lib=the lib=effectiveness lib=of la2=.
null dep=conj lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=( lib=, la2=, la2=thioxanthenes) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=conj lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=( lib=, lib=butyrophenones, la2=) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN. 2under1
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=( lib=, lib=butyrophenones, lib=thioxanthenes) lib=or la2=, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
effect dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=( lib=, lib=butyrophenones, lib=thioxanthenes) lib=or lib=metoclopramide, lib=may lib=diminish lib=the lib=effectiveness lib=of la2=.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=(phenothiazines, lib=, la2=) la2=or la2=metoclopramide, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=(phenothiazines, lib=, lib=thioxanthenes) lib=or la2=, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
effect dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=(phenothiazines, lib=, lib=thioxanthenes) lib=or lib=metoclopramide, lib=may lib=diminish lib=the lib=effectiveness lib=of la2=.
null dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=(phenothiazines, lb1=butyrophenones, lib=) lib=or la2=, la2=may la2=diminish la2=the la2=effectiveness la2=of la2=APOKYN.
effect dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=(phenothiazines, lb1=butyrophenones, lib=) lib=or lib=metoclopramide, lib=may lib=diminish lib=the lib=effectiveness lib=of la2=.
effect dep=None lb1=Dopamine lb1=Antagonists: lb1=Since lb1=apomorphine lb1=is lb1=a lb1=dopamine lb1=agonist, lb1=it lb1=is lb1=possible lb1=that lb1=dopamine lb1=antagonists, lb1=such lb1=as lb1=the lb1=neuroleptics lb1=(phenothiazines, lb1=butyrophenones, lb1=thioxanthenes) lb1=or lib=, lib=may lib=diminish lib=the lib=effectiveness lib=of la2=.
advise dep=None lb1=Patients lb1=with lb1=major lb1=psychotic lb1=disorders, lb1=treated lb1=with lib=, lib=should lib=be lib=treated lib=with la2=only la2=if la2=the la2=potential la2=benefits la2=outweigh la2=the la2=risks.
null dep=None lb1=Interactions lb1=for lib=analogues lib=( la2=, la2=Vitamin la2=D3, la2=Calcitriol, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lib=analogues lib=(Vitamin lib=D2, la2=, la2=Calcitriol, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lib=analogues lib=(Vitamin lib=D2, lib=Vitamin lib=D3, la2=, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lib=analogues lib=(Vitamin lib=D2, lib=Vitamin lib=D3, lib=Calcitriol, lib=and la2=): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lib=analogues lib=(Vitamin lib=D2, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lib=analogues lib=(Vitamin lib=D2, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lib=analogues lib=(Vitamin lib=D2, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=compound lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, la2=, la2=Calcitriol, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=conj lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, la2=, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins; 2under1
null dep=conj lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, lib=Calcitriol, lib=and la2=): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins; 2under1
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=( lib=, lib=Vitamin lib=D3, lib=Calcitriol, lib=and lib=Calcidiol): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, la2=, la2=and la2=Calcidiol): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, lib=Calcitriol, lib=and la2=): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, lib=Calcitriol, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lib=, lib=Calcitriol, lib=and lib=Calcidiol): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lib=, lib=and la2=): la2=Cholestyramine: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lib=, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lib=, lib=and lib=Calcidiol): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lib=, lib=and lib=Calcidiol): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lib=): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lib=): la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lib=): lib=Cholestyramine: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lb1=Calcidiol): lib=: la2=: la2=Cholestyramine la2=has la2=been la2=reported la2=to la2=reduce la2=intestinal la2=absorption la2=of la2=fat la2=soluble la2=vitamins; 2under1
null dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lb1=Calcidiol): lib=: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
mechanism dep=None lb1=Interactions lb1=for lb1=vitamin lb1=D lb1=analogues lb1=(Vitamin lb1=D2, lb1=Vitamin lb1=D3, lb1=Calcitriol, lb1=and lb1=Calcidiol): lib=: lib=Cholestyramine lib=has lib=been lib=reported lib=to lib=reduce lib=intestinal lib=absorption lib=of la2=;
null dep=None lib=/ la2=: la2=The la2=coadministration la2=of la2=phenytoin la2=or la2=phenobarbital la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lib=/Phenobarbital: lib=The lib=coadministration lib=of la2=or la2=phenobarbital la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lib=/Phenobarbital: lib=The lib=coadministration lib=of lib=phenytoin lib=or la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lib=/Phenobarbital: lib=The lib=coadministration lib=of lib=phenytoin lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of la2=, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lib=/Phenobarbital: lib=The lib=coadministration lib=of lib=phenytoin lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of lib=vitamin lib=D, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/ lib=: lib=The lib=coadministration lib=of la2=or la2=phenobarbital la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/ lib=: lib=The lib=coadministration lib=of lib=phenytoin lib=or la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/ lib=: lib=The lib=coadministration lib=of lib=phenytoin lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of la2=, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/ lib=: lib=The lib=coadministration lib=of lib=phenytoin lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of lib=vitamin lib=D, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=conj lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lib=or la2=will la2=not la2=affect la2=plasma la2=concentrations la2=of la2=vitamin la2=D, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism. 2under1
null dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of la2=, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lib=or lib=phenobarbital lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of lib=vitamin lib=D, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lb1=phenytoin lb1=or lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of la2=, la2=but la2=may la2=reduce la2=endogenous la2=plasma la2=levels la2=of la2=calcitriol/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lb1=phenytoin lb1=or lib=will lib=not lib=affect lib=plasma lib=concentrations lib=of lib=vitamin lib=D, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Phenytoin/Phenobarbital: lb1=The lb1=coadministration lb1=of lb1=phenytoin lb1=or lb1=phenobarbital lb1=will lb1=not lb1=affect lb1=plasma lb1=concentrations lb1=of lib=, lib=but lib=may lib=reduce lib=endogenous lib=plasma lib=levels lib=of la2=/ergocalcitriol la2=by la2=accelerating la2=metabolism.
null dep=None lb1=Since lb1=blood lb1=level lb1=of lib=/ergocalcitriol lib=will lib=be lib=reduced, lib=higher lib=doses lib=of la2=may la2=be la2=necessary la2=if la2=these la2=drugs la2=are la2=administered la2=simultaneously.
null dep=None lib=: la2=: la2=Thiazides la2=are la2=known la2=to la2=induce la2=hypercalcemia la2=by la2=the la2=reduction la2=of la2=calcium la2=excretion la2=in la2=urine. 2under1
effect dep=None lb1=Some lb1=reports lb1=have lb1=shown lb1=that lb1=the lb1=concomitant lb1=administration lb1=of lib=with la2=causes la2=hypercalcemia.
null dep=None lib=: la2=dosage la2=must la2=be la2=determined la2=with la2=care la2=in la2=patients la2=undergoing la2=treatment la2=with la2=digitalis, la2=as la2=hypercalcemia la2=in la2=such la2=patients la2=may la2=precipitate la2=cardiac la2=arrhythmias.
null dep=None lib=: lib=Vitamin lib=D lib=dosage lib=must lib=be lib=determined lib=with lib=care lib=in lib=patients lib=undergoing lib=treatment lib=with la2=, la2=as la2=hypercalcemia la2=in la2=such la2=patients la2=may la2=precipitate la2=cardiac la2=arrhythmias. 2under1
advise dep=None lb1=Digitalis: lib=dosage lib=must lib=be lib=determined lib=with lib=care lib=in lib=patients lib=undergoing lib=treatment lib=with la2=, la2=as la2=hypercalcemia la2=in la2=such la2=patients la2=may la2=precipitate la2=cardiac la2=arrhythmias.
null dep=None lib=: la2=: la2=Ketoconazole la2=may la2=inhibit la2=both la2=synthetic la2=and la2=catabolic la2=enzymes la2=of la2=vitamin la2=D. 2under1
null dep=None lib=: lib=Ketoconazole lib=may lib=inhibit lib=both lib=synthetic lib=and lib=catabolic lib=enzymes lib=of la2=.
mechanism dep=None lib=: lib=Ketoconazole lib=may lib=inhibit lib=both lib=synthetic lib=and lib=catabolic lib=enzymes lib=of la2=.
null dep=nmod lb1=However, lb1=in lb1=vivo lb1=drug lb1=interaction lb1=studies lb1=of lib=with la2=have la2=not la2=been la2=investigated.
null dep=None lib=: lib=A lib=relationship lib=of lib=functional lib=antagonism lib=exists lib=between la2=analogues, la2=which la2=promote la2=calcium la2=absorption, la2=and la2=corticosteroids, la2=which la2=inhibit la2=calcium la2=absorption.
null dep=None lib=: lib=A lib=relationship lib=of lib=functional lib=antagonism lib=exists lib=between lib=vitamin lib=D lib=analogues, lib=which lib=promote lib=calcium lib=absorption, lib=and la2=, la2=which la2=inhibit la2=calcium la2=absorption. 2under1
effect dep=None lb1=Corticosteroids: lb1=A lb1=relationship lb1=of lb1=functional lb1=antagonism lb1=exists lb1=between lib=analogues, lib=which lib=promote lib=calcium lib=absorption, lib=and la2=, la2=which la2=inhibit la2=calcium la2=absorption.
null dep=compound lib=: lib=The lib=coadministration lib=of lib=any lib=of lib=the la2=analogues la2=should la2=be la2=avoided la2=as la2=this la2=could la2=create la2=possible la2=additive la2=effects la2=and la2=hypercalcemia.
null dep=None lib=Supplements: lib=Uncontrolled lib=intake lib=of lib=additional la2=-containing la2=preparations la2=should la2=be la2=avoided.
null dep=None lib=: la2=: la2=Magnesium-containing la2=preparations la2=(eg, la2=antacids) la2=may la2=cause la2=hypermagnesemia la2=and la2=should la2=therefore la2=not la2=be la2=taken la2=during la2=therapy la2=with la2=vitamin la2=D la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis.
null dep=None lib=: lib=Magnesium-containing lib=preparations lib=(eg, la2=) la2=may la2=cause la2=hypermagnesemia la2=and la2=should la2=therefore la2=not la2=be la2=taken la2=during la2=therapy la2=with la2=vitamin la2=D la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis. 2under1
null dep=None lib=: lib=Magnesium-containing lib=preparations lib=(eg, lib=antacids) lib=may lib=cause lib=hypermagnesemia lib=and lib=should lib=therefore lib=not lib=be lib=taken lib=during lib=therapy lib=with la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis.
null dep=None lib=: lib=Magnesium-containing lib=preparations lib=(eg, la2=) la2=may la2=cause la2=hypermagnesemia la2=and la2=should la2=therefore la2=not la2=be la2=taken la2=during la2=therapy la2=with la2=vitamin la2=D la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis. 2under1
effect dep=None lib=: lib=Magnesium-containing lib=preparations lib=(eg, lib=antacids) lib=may lib=cause lib=hypermagnesemia lib=and lib=should lib=therefore lib=not lib=be lib=taken lib=during lib=therapy lib=with la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis.
effect dep=None lb1=Magnesium: lb1=Magnesium-containing lb1=preparations lb1=(eg, lib=) lib=may lib=cause lib=hypermagnesemia lib=and lib=should lib=therefore lib=not lib=be lib=taken lib=during lib=therapy lib=with la2=by la2=patients la2=on la2=chronic la2=renal la2=dialysis.
null dep=nmod lib=, lib=such lib=as la2=, la2=diltiazem la2=and la2=nifedipine, la2=inhibit la2=platelet la2=activation la2=in la2=vitro, la2=and la2=decrease la2=platelet la2=adhesion la2=intravascularly. 2under1
null dep=None lib=, lib=such lib=as lib=verapamil, la2=and la2=nifedipine, la2=inhibit la2=platelet la2=activation la2=in la2=vitro, la2=and la2=decrease la2=platelet la2=adhesion la2=intravascularly. 2under1
null dep=None lib=, lib=such lib=as lib=verapamil, lib=diltiazem lib=and la2=, la2=inhibit la2=platelet la2=activation la2=in la2=vitro, la2=and la2=decrease la2=platelet la2=adhesion la2=intravascularly. 2under1
null dep=conj lb1=Slow-channel lb1=calcium lb1=blockers, lb1=such lb1=as lib=, la2=and la2=nifedipine, la2=inhibit la2=platelet la2=activation la2=in la2=vitro, la2=and la2=decrease la2=platelet la2=adhesion la2=intravascularly. 2under1
null dep=conj lb1=Slow-channel lb1=calcium lb1=blockers, lb1=such lb1=as lib=, lib=diltiazem lib=and la2=, la2=inhibit la2=platelet la2=activation la2=in la2=vitro, la2=and la2=decrease la2=platelet la2=adhesion la2=intravascularly. 2under1
null dep=None lb1=Slow-channel lb1=calcium lb1=blockers, lb1=such lb1=as lb1=verapamil, lib=and la2=, la2=inhibit la2=platelet la2=activation la2=in la2=vitro, la2=and la2=decrease la2=platelet la2=adhesion la2=intravascularly.
null dep=None lib=: la2=, la2=erythromycins, la2=sulfonamides, la2=or la2=tetracyclines la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins. 2under1
null dep=None lib=: lib=Chloramphenicol, la2=, la2=sulfonamides, la2=or la2=tetracyclines la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins. 2under1
null dep=None lib=: lib=Chloramphenicol, lib=erythromycins, la2=, la2=or la2=tetracyclines la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins. 2under1
null dep=None lib=: lib=Chloramphenicol, lib=erythromycins, lib=sulfonamides, lib=or la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins. 2under1
null dep=None lib=: lib=Chloramphenicol, lib=erythromycins, lib=sulfonamides, lib=or lib=tetracyclines lib=may lib=interfere lib=with lib=the lib=bactericidal lib=effect lib=of la2=. 2under1
null dep=conj lb1=Bacteriostatic lb1=Antibiotics: lib=, la2=, la2=sulfonamides, la2=or la2=tetracyclines la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins. 2under1
null dep=conj lb1=Bacteriostatic lb1=Antibiotics: lib=, lib=erythromycins, la2=, la2=or la2=tetracyclines la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins. 2under1
null dep=conj lb1=Bacteriostatic lb1=Antibiotics: lib=, lib=erythromycins, lib=sulfonamides, lib=or la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins. 2under1
effect dep=None lb1=Bacteriostatic lb1=Antibiotics: lib=, lib=erythromycins, lib=sulfonamides, lib=or lib=tetracyclines lib=may lib=interfere lib=with lib=the lib=bactericidal lib=effect lib=of la2=.
null dep=None lb1=Bacteriostatic lb1=Antibiotics: lb1=Chloramphenicol, lib=, la2=, la2=or la2=tetracyclines la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins.
null dep=None lb1=Bacteriostatic lb1=Antibiotics: lb1=Chloramphenicol, lib=, lib=sulfonamides, lib=or la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins.
effect dep=None lb1=Bacteriostatic lb1=Antibiotics: lb1=Chloramphenicol, lib=, lib=sulfonamides, lib=or lib=tetracyclines lib=may lib=interfere lib=with lib=the lib=bactericidal lib=effect lib=of la2=.
null dep=None lb1=Bacteriostatic lb1=Antibiotics: lb1=Chloramphenicol, lb1=erythromycins, lib=, lib=or la2=may la2=interfere la2=with la2=the la2=bactericidal la2=effect la2=of la2=penicillins.
effect dep=None lb1=Bacteriostatic lb1=Antibiotics: lb1=Chloramphenicol, lb1=erythromycins, lib=, lib=or lib=tetracyclines lib=may lib=interfere lib=with lib=the lib=bactericidal lib=effect lib=of la2=.
effect dep=None lb1=Bacteriostatic lb1=Antibiotics: lb1=Chloramphenicol, lb1=erythromycins, lb1=sulfonamides, lb1=or lib=may lib=interfere lib=with lib=the lib=bactericidal lib=effect lib=of la2=.
mechanism dep=None lib=: lib=May lib=decrease lib=renal lib=tubular lib=secretion lib=of la2=resulting la2=in la2=increased la2=blood la2=levels la2=and/or la2=ampicillin la2=toxicity. 2under1
null dep=None lib=: lib=May lib=decrease lib=renal lib=tubular lib=secretion lib=of la2=resulting la2=in la2=increased la2=blood la2=levels la2=and/or la2=ampicillin la2=toxicity. 2under1
null dep=None lb1=Probenecid: lb1=May lb1=decrease lb1=renal lb1=tubular lb1=secretion lb1=of lib=resulting lib=in lib=increased lib=blood lib=levels lib=and/or la2=resulting la2=in la2=increased la2=blood la2=levels la2=and/or la2=ampicillin la2=toxicity.
null dep=None lb1=Drug/Laboratory lb1=Test lb1=Interaction lb1=After lb1=treatment lb1=with lib=, lib=a lib=false-positive lib=reaction lib=for lib=glucose lib=in lib=the lib=urine lib=may lib=occur lib=with la2=tests la2=(Benedicts la2=solution, la2=Fehlings la2=solution, la2=or la2=Clinitest la2=tablets) la2=but la2=not la2=with la2=enzyme la2=based la2=tests la2=such la2=as la2=Clinistix la2=and la2=Glucose la2=Enzymatic la2=Test la2=Strip la2=USP.
null dep=None lb1=The lb1=EC50 lb1=values lb1=for lib=, lib=which lib=is lib=not lib=a lib=substrate lib=for la2=uptake-1, la2=were la2=reduced la2=in la2=myocardium la2=in la2=functional la2=classes la2=II la2=to la2=III la2=and la2=IV la2=compared la2=with la2=those la2=in la2=nonfailing la2=myocardium. 2under1
null dep=conj lb1=The lb1=uptake lb1=inhibitors lib=and la2=(3 la2=mumol/liter) la2=potentiated la2=the la2=positive la2=inotropic la2=effects la2=of la2=norepinephrine la2=in la2=nonfailing la2=myocardium la2=(p la2=< la2=0.05) la2=but la2=not la2=in la2=functional la2=class la2=IV la2=myocardium. 2under1
effect dep=None lb1=The lb1=uptake lb1=inhibitors lib=and lib=desipramine lib=(3 lib=mumol/liter) lib=potentiated lib=the lib=positive lib=inotropic lib=effects lib=of la2=in la2=nonfailing la2=myocardium la2=(p la2=< la2=0.05) la2=but la2=not la2=in la2=functional la2=class la2=IV la2=myocardium.
effect dep=None lb1=The lb1=uptake lb1=inhibitors lb1=cocaine lb1=and lib=(3 lib=mumol/liter) lib=potentiated lib=the lib=positive lib=inotropic lib=effects lib=of la2=in la2=nonfailing la2=myocardium la2=(p la2=< la2=0.05) la2=but la2=not la2=in la2=functional la2=class la2=IV la2=myocardium.
null dep=None lb1=Radioligand lb1=binding lb1=experiments lb1=using lb1=the lb1=uptake lb1=inhibitor lb1=hydrogen-3 lib=revealed lib=a lib=significant lib=decrease lib=by lib=approximately lib=30% lib=in la2=uptake-1 la2=carrier la2=density la2=in la2=functional la2=classes la2=II la2=to la2=III la2=and la2=IV la2=myocardium la2=versus la2=nonfailing la2=myocardium la2=(p la2=< la2=0.05).
null dep=conj lb1=This lb1=defect lb1=in lb1=the lb1=failing lb1=heart lb1=can lb1=be lb1=mimicked lb1=by lb1=the lb1=effects lb1=of lb1=uptake lb1=blocking lb1=agents, lb1=such lb1=as lib=and la2=, la2=in la2=the la2=nonfailing la2=heart la2=only. 2under1
null dep=None lb1=Compromised lib=uptake-1 lib=in lib=functional lib=class lib=IV lib=cannot lib=be lib=further lib=increased lib=by la2=and la2=desipramine.
null dep=None lb1=Compromised lib=uptake-1 lib=in lib=functional lib=class lib=IV lib=cannot lib=be lib=further lib=increased lib=by lib=cocaine lib=and la2=.
null dep=conj lb1=Compromised lb1=norepinephrine lb1=uptake-1 lb1=in lb1=functional lb1=class lb1=IV lb1=cannot lb1=be lb1=further lb1=increased lb1=by lib=and la2=. 2under1
effect dep=None lb1=Taking lib=after lib=drinking la2=may la2=worsen la2=side la2=effects la2=and la2=may la2=cause la2=severe la2=hypotension la2=and la2=cardiovascular la2=collapse.
null dep=conj lb1=By lb1=contrast, lib=(1 lib=mM) lib=and la2=(1 la2=mM) la2=had la2=no la2=significant la2=effect la2=on la2=the la2=translocation la2=when la2=added la2=alone. 2under1
null dep=None lib=, lib=and lib=to lib=a lib=lesser lib=extent, la2=, la2=enhanced la2=the la2=translocating la2=action la2=of la2=oleate la2=and la2=increased la2=its la2=effectiveness la2=in la2=transferring la2=the la2=phosphohydrolase la2=from la2=the la2=soluble la2=to la2=the la2=microsomal la2=fraction. 2under1
null dep=conj lb1=For lb1=information lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=and la2=in la2=combination, la2=see la2=Drug la2=Interactions la2=under la2=CLINICAL la2=PHARMACOLOGY la2=section. 2under1
null dep=conj lb1=The lb1=risk lb1=of lb1=a lb1=potential lb1=interaction lb1=between lib=and la2=concentrates la2=has la2=not la2=been la2=adequately la2=evaluated la2=in la2=preclinical la2=or la2=clinical la2=studies.
null dep=amod lb1=Simultaneous lb1=use lb1=of lib=or la2=or la2=prothrombin la2=complex la2=concentrates la2=should la2=be la2=avoided.
null dep=amod lb1=Although lb1=the lb1=specific lb1=drug lb1=interaction lb1=was lb1=not lb1=studied lb1=in lb1=a lb1=clinical lb1=trial, lb1=there lb1=have lb1=been lb1=more lb1=than lb1=50 lb1=episodes lb1=of lb1=concomitant lb1=use lb1=of lb1=antifibrinolytic lb1=therapies lb1=(i.e., lib=, la2=) la2=and la2=NovoSeven.
null dep=None lb1=Although lb1=the lb1=specific lb1=drug lb1=interaction lb1=was lb1=not lb1=studied lb1=in lb1=a lb1=clinical lb1=trial, lb1=there lb1=have lb1=been lb1=more lb1=than lb1=50 lb1=episodes lb1=of lb1=concomitant lb1=use lb1=of lb1=antifibrinolytic lb1=therapies lb1=(i.e., lib=, lib=aminocaproic lib=acid) lib=and la2=.
null dep=None lb1=Although lb1=the lb1=specific lb1=drug lb1=interaction lb1=was lb1=not lb1=studied lb1=in lb1=a lb1=clinical lb1=trial, lb1=there lb1=have lb1=been lb1=more lb1=than lb1=50 lb1=episodes lb1=of lb1=concomitant lb1=use lb1=of lb1=antifibrinolytic lb1=therapies lb1=(i.e., lb1=tranexamic lb1=acid, lib=) lib=and la2=.
null dep=None lb1=Co-administration lb1=of lib=at lib=steady-state lib=with lib=a lib=single lib=dose lib=of la2=.
effect dep=None lb1=Co-administration lb1=of lib=at lib=steady-state lib=with lib=a lib=single lib=dose lib=of la2=(2 la2=x la2=600 la2=mg la2=tablets) la2=results la2=in la2=increased la2=azithromycin la2=serum la2=concentrations.
null dep=None lb1=Co-administration lb1=of lib=at lib=steady-state lib=with lib=a lib=single lib=dose lib=of la2=(2 la2=x la2=600 la2=mg la2=tablets) la2=results la2=in la2=increased la2=azithromycin la2=serum la2=concentrations.
null dep=None lb1=Co-administration lb1=of lb1=nelfinavir lb1=at lb1=steady-state lb1=with lb1=a lb1=single lb1=dose lb1=of lib=(2 lib=x lib=600 lib=mg lib=tablets) lib=results lib=in lib=increased la2=(2 la2=x la2=600 la2=mg la2=tablets) la2=results la2=in la2=increased la2=azithromycin la2=serum la2=concentrations.
advise dep=None lb1=Although lb1=a lb1=dose lb1=adjustment lb1=of lib=is lib=not lib=recommended lib=when lib=administered lib=in lib=combination lib=with la2=, la2=close la2=monitoring la2=for la2=known la2=side la2=effects la2=of la2=azithromycin, la2=such la2=as la2=liver la2=enzyme la2=abnormalities la2=and la2=hearing la2=impairment, la2=is la2=warranted. 1under2
null dep=None lb1=Although lb1=a lb1=dose lb1=adjustment lb1=of lib=is lib=not lib=recommended lib=when lib=administered lib=in lib=combination lib=with lib=nelfinavir, lib=close lib=monitoring lib=for lib=known lib=side lib=effects lib=of la2=is la2=not la2=recommended la2=when la2=administered la2=in la2=combination la2=with la2=nelfinavir, la2=close la2=monitoring la2=for la2=known la2=side la2=effects la2=of la2=azithromycin, la2=such la2=as la2=liver la2=enzyme la2=abnormalities la2=and la2=hearing la2=impairment, la2=is la2=warranted.
null dep=None lb1=Although lb1=a lb1=dose lb1=adjustment lb1=of lb1=azithromycin lb1=is lb1=not lb1=recommended lb1=when lb1=administered lb1=in lb1=combination lb1=with lib=, lib=close lib=monitoring lib=for lib=known lib=side lib=effects lib=of la2=is la2=not la2=recommended la2=when la2=administered la2=in la2=combination la2=with la2=nelfinavir, la2=close la2=monitoring la2=for la2=known la2=side la2=effects la2=of la2=azithromycin, la2=such la2=as la2=liver la2=enzyme la2=abnormalities la2=and la2=hearing la2=impairment, la2=is la2=warranted. 2under1
null dep=None lib=did lib=not lib=affect lib=the lib=prothrombin lib=time lib=response lib=to lib=a lib=single lib=dose lib=of la2=.
advise dep=conj lb1=However, lb1=prudent lb1=medical lb1=practice lb1=dictates lb1=careful lb1=monitoring lb1=of lb1=prothrombin lb1=time lb1=in lb1=all lb1=patients lb1=treated lb1=with lib=and la2=concomitantly. 2under1
effect dep=conj lb1=Concurrent lb1=use lb1=of lib=and la2=in la2=clinical la2=practice la2=has la2=been la2=associated la2=with la2=increased la2=anticoagulant la2=effects. 2under1
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of la2=, la2=carbamazepine, la2=cetirizine, la2=didanosine, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, la2=, la2=cetirizine, la2=didanosine, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, la2=, la2=didanosine, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, la2=, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, la2=, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, la2=, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, la2=, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, la2=, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, la2=, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
mechanism dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of lib=atorvastatin, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, la2=, la2=cetirizine, la2=didanosine, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, la2=, la2=didanosine, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, la2=, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, la2=, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, la2=, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, la2=, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, la2=, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, la2=, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine. 2under1
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=conj lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lib=, lib=carbamazepine, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=. 2under1
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, la2=, la2=didanosine, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, la2=, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, la2=, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, la2=, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, la2=, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, la2=, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, la2=, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lib=, lib=cetirizine, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, la2=, la2=efavirenz, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, la2=, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, la2=, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, lib=fluconazole, la2=, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, la2=, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, la2=, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lib=, lib=didanosine, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, la2=, la2=fluconazole, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, la2=, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, lib=fluconazole, la2=, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, lib=fluconazole, lib=indinavir, la2=, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, la2=, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lib=, lib=efavirenz, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, la2=, la2=indinavir, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, lib=fluconazole, la2=, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, lib=fluconazole, lib=indinavir, la2=, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, lib=fluconazole, lib=indinavir, lib=midazolam, la2=, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lib=, lib=fluconazole, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lib=, la2=, la2=midazolam, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lib=, lib=indinavir, la2=, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lib=, lib=indinavir, lib=midazolam, la2=, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lib=, lib=indinavir, lib=midazolam, lib=rifabutin, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lib=, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lib=, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lib=, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lib=, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lib=, lib=indinavir, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lib=, la2=, la2=rifabutin, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lib=, lib=midazolam, la2=, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lib=, lib=midazolam, lib=rifabutin, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lib=, lib=midazolam, lib=rifabutin, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lib=, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lib=, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lib=, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lib=, lib=midazolam, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lib=, la2=, la2=sildenafil, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lib=, lib=rifabutin, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lib=, lib=rifabutin, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lib=, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lib=, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lib=, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lib=, lib=rifabutin, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lib=, la2=, la2=theophylline la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lib=, lib=sildenafil, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lib=, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lib=, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lib=, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lib=, lib=sildenafil, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lib=, la2=(intravenous la2=and la2=oral), la2=triazolam, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lib=, lib=theophylline lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lib=, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lib=, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lib=, lib=theophylline lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lib=(intravenous lib=and lib=oral), la2=, la2=trimethoprim/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lib=(intravenous lib=and lib=oral), lib=triazolam, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lib=(intravenous lib=and lib=oral), lib=triazolam, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lb1=theophylline lb1=(intravenous lb1=and lb1=oral), lib=, la2=/sulfamethoxazole la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lb1=theophylline lb1=(intravenous lb1=and lb1=oral), lib=, lib=trimethoprim/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lb1=theophylline lb1=(intravenous lb1=and lb1=oral), lib=, lib=trimethoprim/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lb1=theophylline lb1=(intravenous lb1=and lb1=oral), lb1=triazolam, lib=/ la2=or la2=zidovudine.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lb1=theophylline lb1=(intravenous lb1=and lb1=oral), lb1=triazolam, lib=/sulfamethoxazole lib=or la2=.
null dep=None lb1=When lb1=used lb1=in lb1=therapeutic lb1=doses, lb1=azithromycin lb1=had lb1=a lb1=modest lb1=effect lb1=on lb1=the lb1=pharmacokinetics lb1=of lb1=atorvastatin, lb1=carbamazepine, lb1=cetirizine, lb1=didanosine, lb1=efavirenz, lb1=fluconazole, lb1=indinavir, lb1=midazolam, lb1=rifabutin, lb1=sildenafil, lb1=theophylline lb1=(intravenous lb1=and lb1=oral), lb1=triazolam, lb1=trimethoprim/ lib=or la2=.
null dep=conj lb1=Co-administration lb1=with lib=or la2=had la2=a la2=modest la2=effect la2=on la2=the la2=pharmacokinetics la2=of la2=azithromycin. 2under1
mechanism dep=None lb1=Co-administration lb1=with lib=or lib=fluconazole lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of la2=.
mechanism dep=None lb1=Co-administration lb1=with lb1=efavirenz lb1=or lib=had lib=a lib=modest lib=effect lib=on lib=the lib=pharmacokinetics lib=of la2=.
null dep=None lb1=Until lb1=further lb1=data lb1=are lb1=developed lb1=regarding lb1=drug lb1=interactions lb1=when lib=and lib=these lib=drugs lib=are lib=used lib=concomitantly, lib=careful lib=monitoring lib=of lib=patients lib=is lib=advised: la2=elevated la2=digoxin la2=concentrations.
null dep=None lb1=Until lb1=further lb1=data lb1=are lb1=developed lb1=regarding lb1=drug lb1=interactions lb1=when lib=and lib=these lib=drugs lib=are lib=used lib=concomitantly, lib=careful lib=monitoring lib=of lib=patients lib=is lib=advised: lib=Digoxin lib=elevated la2=concentrations.
null dep=None lb1=Until lb1=further lb1=data lb1=are lb1=developed lb1=regarding lb1=drug lb1=interactions lb1=when lb1=azithromycin lb1=and lb1=these lb1=drugs lb1=are lb1=used lb1=concomitantly, lb1=careful lb1=monitoring lb1=of lb1=patients lb1=is lb1=advised: lib=elevated la2=concentrations.
null dep=conj lib=or la2=acute la2=ergot la2=toxicity la2=characterized la2=by la2=severe la2=peripheral la2=vasospasm la2=and la2=dysesthesia. 2under1
null dep=conj lib=, la2=and la2=phenytoin la2=concentrations. 2under1
null dep=conj lib=, lib=hexobarbital lib=and la2=concentrations. 2under1
null dep=None lb1=Cyclosporine, lib=and la2=concentrations.
effect dep=None lb1=Catecholamine-depleting lb1=drugs lb1=(eg, lib=) lib=may lib=have lib=an lib=additive lib=effect lib=when lib=given lib=with la2=s.
effect dep=None lib=may lib=also lib=have lib=an lib=additive lib=effect lib=when lib=given lib=with la2=.
effect dep=None lib=may lib=exacerbate lib=the lib=rebound lib=hypertension lib=which lib=can lib=follow lib=the lib=withdrawal lib=of la2=.
advise dep=None lb1=If lb1=the lb1=two lb1=drugs lb1=are lb1=coadministered, lb1=the lib=should lib=be lib=withdrawn lib=several lib=days lib=before lib=the lib=gradual lib=withdrawal lib=of la2=.
null dep=None lb1=If lb1=replacing lib=by la2=therapy, la2=the la2=introduction la2=of la2=beta la2=blockers la2=should la2=be la2=delayed la2=for la2=several la2=days la2=after la2=clonidine la2=administration la2=has la2=stopped.
null dep=None lb1=If lb1=replacing lib=by lib=beta-blocker lib=therapy, lib=the lib=introduction lib=of la2=should la2=be la2=delayed la2=for la2=several la2=days la2=after la2=clonidine la2=administration la2=has la2=stopped.
null dep=None lb1=If lb1=replacing lib=by lib=beta-blocker lib=therapy, lib=the lib=introduction lib=of lib=beta lib=blockers lib=should lib=be lib=delayed lib=for lib=several lib=days lib=after la2=by la2=beta-blocker la2=therapy, la2=the la2=introduction la2=of la2=beta la2=blockers la2=should la2=be la2=delayed la2=for la2=several la2=days la2=after la2=clonidine la2=administration la2=has la2=stopped.
null dep=compound lb1=If lb1=replacing lb1=clonidine lb1=by lib=therapy, lib=the lib=introduction lib=of la2=should la2=be la2=delayed la2=for la2=several la2=days la2=after la2=clonidine la2=administration la2=has la2=stopped.
null dep=None lb1=If lb1=replacing lb1=clonidine lb1=by lib=therapy, lib=the lib=introduction lib=of lib=beta lib=blockers lib=should lib=be lib=delayed lib=for lib=several lib=days lib=after la2=by la2=beta-blocker la2=therapy, la2=the la2=introduction la2=of la2=beta la2=blockers la2=should la2=be la2=delayed la2=for la2=several la2=days la2=after la2=clonidine la2=administration la2=has la2=stopped.
advise dep=None lb1=If lb1=replacing lb1=clonidine lb1=by lb1=beta-blocker lb1=therapy, lb1=the lb1=introduction lb1=of lib=should lib=be lib=delayed lib=for lib=several lib=days lib=after la2=by la2=beta-blocker la2=therapy, la2=the la2=introduction la2=of la2=beta la2=blockers la2=should la2=be la2=delayed la2=for la2=several la2=days la2=after la2=clonidine la2=administration la2=has la2=stopped.
effect dep=None lb1=Concomitant lb1=use lb1=of lb1=prostaglandin lb1=synthase lb1=inhibiting lb1=drugs, lb1=eg, lib=, lib=may lib=decrease lib=the lib=hypotensive lib=effects lib=of la2=.
null dep=conj lb1=Information lb1=on lb1=concurrent lb1=usage lb1=of lib=and la2=is la2=limited. 2under1
null dep=conj lb1=Data lb1=from lb1=several lb1=studies, lb1=ie, lb1=TIMI-II, lb1=ISIS-2, lb1=currently lb1=do lb1=not lb1=suggest lb1=any lb1=clinical lb1=interaction lb1=between lib=and la2=in la2=the la2=acute la2=myocardial la2=infarction la2=setting.
mechanism dep=None lb1=Co-administration lb1=of lib=with la2=has la2=been la2=shown la2=to la2=increase la2=the la2=mean la2=half-life la2=and la2=the la2=area la2=under la2=the la2=concentration-time la2=curve.
null dep=nmod lib=including la2=, la2=phenelzine la2=sulfate, la2=and la2=pargyline la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension.
null dep=nmod lib=including lib=tranylcypromine lib=sulfate, la2=, la2=and la2=pargyline la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension.
null dep=None lib=including lib=tranylcypromine lib=sulfate, lib=phenelzine lib=sulfate, lib=and la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension. 2under1
null dep=conj lib=including lib=tranylcypromine lib=sulfate, lib=phenelzine lib=sulfate, lib=and lib=pargyline lib=HC1: lib=Concomitant lib=use lib=of la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension. 2under1
null dep=amod lib=including lib=tranylcypromine lib=sulfate, lib=phenelzine lib=sulfate, lib=and lib=pargyline lib=HC1: lib=Concomitant lib=use lib=of lib=L-tyrosine lib=and lib=non-selective la2=including la2=tranylcypromine la2=sulfate, la2=phenelzine la2=sulfate, la2=and la2=pargyline la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension.
null dep=compound lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lib=, la2=, la2=and la2=pargyline la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension.
null dep=None lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lib=, lib=phenelzine lib=sulfate, lib=and la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension. 2under1
null dep=None lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lib=, lib=phenelzine lib=sulfate, lib=and lib=pargyline lib=HC1: lib=Concomitant lib=use lib=of la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension.
null dep=nmod lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lib=, lib=phenelzine lib=sulfate, lib=and lib=pargyline lib=HC1: lib=Concomitant lib=use lib=of lib=L-tyrosine lib=and lib=non-selective la2=including la2=tranylcypromine la2=sulfate, la2=phenelzine la2=sulfate, la2=and la2=pargyline la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension.
null dep=None lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lb1=tranylcypromine lb1=sulfate, lib=, lib=and la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension. 2under1
null dep=None lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lb1=tranylcypromine lb1=sulfate, lib=, lib=and lib=pargyline lib=HC1: lib=Concomitant lib=use lib=of la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension.
null dep=nmod lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lb1=tranylcypromine lb1=sulfate, lib=, lib=and lib=pargyline lib=HC1: lib=Concomitant lib=use lib=of lib=L-tyrosine lib=and lib=non-selective la2=including la2=tranylcypromine la2=sulfate, la2=phenelzine la2=sulfate, la2=and la2=pargyline la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension.
null dep=None lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lb1=tranylcypromine lb1=sulfate, lb1=phenelzine lb1=sulfate, lb1=and lib=HC1: lib=Concomitant lib=use lib=of la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension.
null dep=None lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lb1=tranylcypromine lb1=sulfate, lb1=phenelzine lb1=sulfate, lb1=and lib=HC1: lib=Concomitant lib=use lib=of lib=L-tyrosine lib=and lib=non-selective la2=including la2=tranylcypromine la2=sulfate, la2=phenelzine la2=sulfate, la2=and la2=pargyline la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension. 1under2
effect dep=conj lb1=Non-selective lb1=MAO lb1=inhibitors lb1=including lb1=tranylcypromine lb1=sulfate, lb1=phenelzine lb1=sulfate, lb1=and lb1=pargyline lb1=HC1: lb1=Concomitant lb1=use lb1=of lib=and lib=non-selective la2=including la2=tranylcypromine la2=sulfate, la2=phenelzine la2=sulfate, la2=and la2=pargyline la2=HC1: la2=Concomitant la2=use la2=of la2=L-tyrosine la2=and la2=non-selective la2=MAO la2=inhibitors la2=may la2=cause la2=hypertension. 1under2
null dep=None lb1=Potential lb1=drug lb1=interactions lb1=between lib=( la2=cream) la2=Cream, la2=1%, la2=and la2=other la2=drugs la2=have la2=not la2=been la2=systematically la2=evaluated.
effect dep=None lb1=The lb1=use lb1=of lib=in lib=patients lib=who lib=are lib=receiving la2=may la2=potentiate la2=renal la2=disease la2=states.
null dep=det lb1=Similarly, lb1=patients lb1=receiving lb1=the lb1=drug lb1=and lb1=a lib=, la2=or la2=sulfonylurea la2=should la2=be la2=observed la2=for la2=signs la2=of la2=toxicity la2=to la2=these la2=drugs. 2under1
null dep=det lb1=Similarly, lb1=patients lb1=receiving lb1=the lb1=drug lb1=and lb1=a lib=, lib=sulfonamide lib=or la2=should la2=be la2=observed la2=for la2=signs la2=of la2=toxicity la2=to la2=these la2=drugs. 2under1
null dep=None lb1=Similarly, lb1=patients lb1=receiving lb1=the lb1=drug lb1=and lb1=a lb1=hydantoin, lib=or la2=should la2=be la2=observed la2=for la2=signs la2=of la2=toxicity la2=to la2=these la2=drugs.
advise dep=conj lb1=Concomitant lb1=administration lb1=of lib=and la2=is la2=not la2=recommended la2=because la2=naproxen la2=is la2=displaced la2=from la2=its la2=binding la2=sites la2=during la2=the la2=concomitant la2=administration la2=of la2=aspirin, la2=resulting la2=in la2=lower la2=plasma la2=concentrations la2=and la2=peak la2=plasma la2=levels. 2under1
null dep=None lb1=Concomitant lb1=administration lb1=of lib=and lib=aspirin lib=is lib=not lib=recommended lib=because la2=and la2=aspirin la2=is la2=not la2=recommended la2=because la2=naproxen la2=is la2=displaced la2=from la2=its la2=binding la2=sites la2=during la2=the la2=concomitant la2=administration la2=of la2=aspirin, la2=resulting la2=in la2=lower la2=plasma la2=concentrations la2=and la2=peak la2=plasma la2=levels.
null dep=conj lb1=Concomitant lb1=administration lb1=of lib=and la2=is la2=not la2=recommended la2=because la2=naproxen la2=is la2=displaced la2=from la2=its la2=binding la2=sites la2=during la2=the la2=concomitant la2=administration la2=of la2=aspirin, la2=resulting la2=in la2=lower la2=plasma la2=concentrations la2=and la2=peak la2=plasma la2=levels. 2under1
null dep=conj lb1=Concomitant lb1=administration lb1=of lb1=naproxen lb1=and lib=is lib=not lib=recommended lib=because la2=and la2=aspirin la2=is la2=not la2=recommended la2=because la2=naproxen la2=is la2=displaced la2=from la2=its la2=binding la2=sites la2=during la2=the la2=concomitant la2=administration la2=of la2=aspirin, la2=resulting la2=in la2=lower la2=plasma la2=concentrations la2=and la2=peak la2=plasma la2=levels. 1under2
null dep=None lb1=Concomitant lb1=administration lb1=of lb1=naproxen lb1=and lib=is lib=not lib=recommended lib=because lib=naproxen lib=is lib=displaced lib=from lib=its lib=binding lib=sites lib=during lib=the lib=concomitant lib=administration lib=of la2=is la2=not la2=recommended la2=because la2=naproxen la2=is la2=displaced la2=from la2=its la2=binding la2=sites la2=during la2=the la2=concomitant la2=administration la2=of la2=aspirin, la2=resulting la2=in la2=lower la2=plasma la2=concentrations la2=and la2=peak la2=plasma la2=levels.
advise dep=conj lb1=Concomitant lb1=administration lb1=of lib=and la2=is la2=not la2=recommended la2=because la2=naproxen la2=is la2=displaced la2=from la2=its la2=binding la2=sites la2=during la2=the la2=concomitant la2=administration la2=of la2=aspirin, la2=resulting la2=in la2=lower la2=plasma la2=concentrations la2=and la2=peak la2=plasma la2=levels. 2under1
null dep=None lb1=Inhibition lb1=of lb1=renal lib=clearance lib=leading lib=to lib=increases lib=in lib=plasma la2=clearance la2=leading la2=to la2=increases la2=in la2=plasma la2=lithium la2=concentrations la2=has la2=also la2=been la2=reported.
null dep=conj lib=and lib=other la2=can la2=reduce la2=the la2=antihypertensive la2=effect la2=of la2=propranolol la2=and la2=other la2=beta-blockers. 2under1
effect dep=None lib=and lib=other lib=NSAIDs lib=can lib=reduce lib=the lib=antihypertensive lib=effect lib=of la2=and la2=other la2=beta-blockers.
effect dep=None lib=and lib=other lib=NSAIDs lib=can lib=reduce lib=the lib=antihypertensive lib=effect lib=of lib=propranolol lib=and lib=other la2=.
effect dep=None lb1=Naproxen lb1=and lb1=other lib=can lib=reduce lib=the lib=antihypertensive lib=effect lib=of la2=and la2=other la2=beta-blockers.
effect dep=None lb1=Naproxen lb1=and lb1=other lib=can lib=reduce lib=the lib=antihypertensive lib=effect lib=of lib=propranolol lib=and lib=other la2=.
null dep=conj lb1=Naproxen lb1=and lb1=other lb1=NSAIDs lb1=can lb1=reduce lb1=the lb1=antihypertensive lb1=effect lb1=of lib=and lib=other la2=. 2under1
mechanism dep=None lib=given lib=concurrently lib=increases la2=anion la2=plasma la2=levels la2=and la2=extends la2=its la2=plasma la2=half-life la2=significantly. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=if lib=is lib=administered lib=concomitantly lib=with la2=.
null dep=conj lib=, la2=and la2=other la2=NSAIDs la2=have la2=been la2=reported la2=to la2=reduce la2=the la2=tubular la2=secretion la2=of la2=methotrexate la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate.
null dep=conj lib=, lib=naproxen lib=sodium lib=and lib=other la2=have la2=been la2=reported la2=to la2=reduce la2=the la2=tubular la2=secretion la2=of la2=methotrexate la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate. 2under1
mechanism dep=None lib=, lib=naproxen lib=sodium lib=and lib=other lib=NSAIDs lib=have lib=been lib=reported lib=to lib=reduce lib=the lib=tubular lib=secretion lib=of la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate.
null dep=None lib=, lib=naproxen lib=sodium lib=and lib=other lib=NSAIDs lib=have lib=been lib=reported lib=to lib=reduce lib=the lib=tubular lib=secretion lib=of la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate.
null dep=None lb1=Naproxen, lib=and lib=other la2=have la2=been la2=reported la2=to la2=reduce la2=the la2=tubular la2=secretion la2=of la2=methotrexate la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate.
mechanism dep=None lb1=Naproxen, lib=and lib=other lib=NSAIDs lib=have lib=been lib=reported lib=to lib=reduce lib=the lib=tubular lib=secretion lib=of la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate.
null dep=None lb1=Naproxen, lib=and lib=other lib=NSAIDs lib=have lib=been lib=reported lib=to lib=reduce lib=the lib=tubular lib=secretion lib=of la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate.
mechanism dep=None lb1=Naproxen, lb1=naproxen lb1=sodium lb1=and lb1=other lib=have lib=been lib=reported lib=to lib=reduce lib=the lib=tubular lib=secretion lib=of la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate.
null dep=None lb1=Naproxen, lb1=naproxen lb1=sodium lb1=and lb1=other lib=have lib=been lib=reported lib=to lib=reduce lib=the lib=tubular lib=secretion lib=of la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate.
null dep=None lb1=Naproxen, lb1=naproxen lb1=sodium lb1=and lb1=other lb1=NSAIDs lb1=have lb1=been lb1=reported lb1=to lb1=reduce lb1=the lb1=tubular lb1=secretion lb1=of lib=in lib=an lib=animal lib=model, lib=possibly lib=increasing lib=the lib=toxicity lib=of la2=in la2=an la2=animal la2=model, la2=possibly la2=increasing la2=the la2=toxicity la2=of la2=methotrexate.
mechanism dep=None lb1=The lb1=absorption lb1=of lib=may lib=be lib=affected lib=by lib=the lib=simultaneous lib=administration lib=of lib=indigestion lib=remedies, la2=or la2=zinc la2=supplements.
mechanism dep=None lb1=The lb1=absorption lb1=of lib=may lib=be lib=affected lib=by lib=the lib=simultaneous lib=administration lib=of lib=indigestion lib=remedies, lib=iron lib=or la2=supplements.
null dep=None lb1=The lb1=absorption lb1=of lb1=lymecycline lb1=may lb1=be lb1=affected lb1=by lb1=the lb1=simultaneous lb1=administration lb1=of lb1=indigestion lb1=remedies, lib=or la2=supplements.
effect dep=None lb1=Oral lib=may lib=be lib=less lib=effective lib=while lib=you lib=are lib=taking la2=.
mechanism dep=None lb1=Co-treatment lb1=with lb1=the lb1=potent lb1=CYP3A4 lb1=inhibitor lib=increases la2=AUC la2=by la2=2/3.
advise dep=nmod lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with la2=and la2=other la2=strong la2=CYP3A4 la2=inhibitors la2=such la2=as, la2=but la2=not la2=limited la2=to, la2=atazanavir, la2=clarithromycin, la2=indinavir, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, la2=, la2=clarithromycin, la2=indinavir, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, la2=, la2=indinavir, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, la2=, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, la2=, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, la2=, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, la2=, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, la2=, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, la2=, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
advise dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lib=with lib=ketoconazole lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, la2=, la2=clarithromycin, la2=indinavir, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, la2=, la2=indinavir, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, la2=, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, la2=, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, la2=, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, la2=, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, la2=, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, la2=, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=cc lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lib=and lib=other lib=strong lib=CYP3A4 lib=inhibitors lib=such lib=as, lib=but lib=not lib=limited lib=to, lib=atazanavir, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, la2=, la2=indinavir, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, la2=, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, lib=indinavir, la2=, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, lib=indinavir, lib=itraconazole, la2=, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, la2=, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, la2=, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, la2=, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lib=, lib=clarithromycin, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, la2=, la2=itraconazole, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, lib=indinavir, la2=, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, lib=indinavir, lib=itraconazole, la2=, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, lib=indinavir, lib=itraconazole, lib=nefazodone, la2=, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, la2=, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, la2=, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lib=, lib=indinavir, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lib=, la2=, la2=nefazodone, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lib=, lib=itraconazole, la2=, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lib=, lib=itraconazole, lib=nefazodone, la2=, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lib=, lib=itraconazole, lib=nefazodone, lib=nelfinavir, la2=, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lib=, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, la2=, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lib=, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lib=, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lib=, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lib=, lib=itraconazole, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lib=, la2=, la2=nelfinavir, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lib=, lib=nefazodone, la2=, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lib=, lib=nefazodone, lib=nelfinavir, la2=, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lib=, lib=nefazodone, lib=nelfinavir, lib=ritonavir, la2=, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lib=, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lib=, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lib=, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lib=, lib=nefazodone, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lib=, la2=, la2=ritonavir, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lib=, lib=nelfinavir, la2=, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lib=, lib=nelfinavir, lib=ritonavir, la2=, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lib=, lib=nelfinavir, lib=ritonavir, lib=saquinavir, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lib=, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lib=, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lib=, lib=nelfinavir, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lib=, la2=, la2=saquinavir, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lib=, lib=ritonavir, la2=, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lib=, lib=ritonavir, lib=saquinavir, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lib=, lib=ritonavir, lib=saquinavir, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lib=, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lib=, lib=ritonavir, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lib=, la2=, la2=telithromycin, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lib=, lib=saquinavir, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lib=, lib=saquinavir, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lib=, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lib=, lib=saquinavir, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lib=, la2=, la2=troleandomycin la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lib=, lib=telithromycin, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lib=, lib=telithromycin, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lib=, lib=telithromycin, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lb1=saquinavir, lib=, la2=(TAO), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lb1=saquinavir, lib=, lib=troleandomycin lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lb1=saquinavir, lib=, lib=troleandomycin lib=(TAO), lib=and la2=. 2under1
null dep=appos lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lb1=saquinavir, lb1=telithromycin, lib=( la2=), la2=and la2=voriconazole la2=. 2under1
null dep=conj lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lb1=saquinavir, lb1=telithromycin, lib=(TAO), lib=and la2=. 2under1
null dep=None lb1=Caution lb1=should lb1=be lb1=used lb1=when lb1=administering lb1=or lb1=taking lb1=TARCEVA lb1=with lb1=ketoconazole lb1=and lb1=other lb1=strong lb1=CYP3A4 lb1=inhibitors lb1=such lb1=as, lb1=but lb1=not lb1=limited lb1=to, lb1=atazanavir, lb1=clarithromycin, lb1=indinavir, lb1=itraconazole, lb1=nefazodone, lb1=nelfinavir, lb1=ritonavir, lb1=saquinavir, lb1=telithromycin, lb1=troleandomycin lb1=( lib=), lib=and la2=.
mechanism dep=None lb1=Pre-treatment lb1=with lb1=the lb1=CYP3A4 lb1=inducer lib=decreased la2=AUC la2=by la2=about la2=2/3.
advise dep=None lb1=If lb1=the lib=dose lib=is lib=adjusted lib=upward, lib=the lib=dose lib=will lib=need lib=to lib=be lib=reduced lib=upon lib=discontinuation lib=of la2=or la2=other la2=inducers.
null dep=None lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lib=, la2=, la2=phenytoin, la2=carbamazepine, la2=phenobarbital la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=None lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lib=, lib=rifapentine, la2=, la2=carbamazepine, la2=phenobarbital la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=None lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lib=, lib=rifapentine, lib=phenytoin, la2=, la2=phenobarbital la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=None lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lib=, lib=rifapentine, lib=phenytoin, lib=carbamazepine, la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=None lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lb1=rifabutin, lib=, la2=, la2=carbamazepine, la2=phenobarbital la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=None lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lb1=rifabutin, lib=, lib=phenytoin, la2=, la2=phenobarbital la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=None lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lb1=rifabutin, lib=, lib=phenytoin, lib=carbamazepine, la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=None lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lb1=rifabutin, lb1=rifapentine, lib=, la2=, la2=phenobarbital la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=None lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lb1=rifabutin, lb1=rifapentine, lib=, lib=carbamazepine, la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=conj lb1=Other lb1=CYP3A4 lb1=inducers lb1=include, lb1=but lb1=are lb1=not lb1=limited lb1=to, lb1=rifabutin, lb1=rifapentine, lb1=phenytoin, lib=, la2=and la2=St. la2=Johns la2=Wort. 2under1
null dep=conj lb1=Patients lb1=taking lib=or lib=other la2=should la2=be la2=monitored la2=regularly la2=for la2=changes la2=in la2=prothrombin la2=time la2=or la2=INR
null dep=conj lib=, la2=, la2=Niacin la2=(Nicotinic la2=Acid, la2=Erythromycin, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle.
null dep=appos lib=, lib=Fibric lib=Acid lib=Derivatives, la2=(Nicotinic la2=Acid, la2=Erythromycin, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle. 2under1
null dep=None lib=, lib=Fibric lib=Acid lib=Derivatives, lib=Niacin lib=( la2=, la2=Erythromycin, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle.
null dep=None lib=, lib=Fibric lib=Acid lib=Derivatives, lib=Niacin lib=(Nicotinic lib=Acid, la2=, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle. 2under1
null dep=None lib=, lib=Fibric lib=Acid lib=Derivatives, lib=Niacin lib=(Nicotinic lib=Acid, lib=Erythromycin, la2=: la2=Skeletal la2=Muscle.
null dep=dep lb1=Immunosuppressive lb1=Drugs, lib=, la2=(Nicotinic la2=Acid, la2=Erythromycin, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle.
null dep=compound lb1=Immunosuppressive lb1=Drugs, lib=, lib=Niacin lib=( la2=, la2=Erythromycin, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle.
null dep=conj lb1=Immunosuppressive lb1=Drugs, lib=, lib=Niacin lib=(Nicotinic lib=Acid, la2=, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle. 2under1
null dep=appos lb1=Immunosuppressive lb1=Drugs, lib=, lib=Niacin lib=(Nicotinic lib=Acid, lib=Erythromycin, la2=: la2=Skeletal la2=Muscle.
null dep=dep lb1=Immunosuppressive lb1=Drugs, lb1=Fibric lb1=Acid lb1=Derivatives, lib=( la2=, la2=Erythromycin, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle.
null dep=None lb1=Immunosuppressive lb1=Drugs, lb1=Fibric lb1=Acid lb1=Derivatives, lib=(Nicotinic lib=Acid, la2=, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle. 2under1
null dep=None lb1=Immunosuppressive lb1=Drugs, lb1=Fibric lb1=Acid lb1=Derivatives, lib=(Nicotinic lib=Acid, lib=Erythromycin, la2=: la2=Skeletal la2=Muscle.
null dep=conj lb1=Immunosuppressive lb1=Drugs, lb1=Fibric lb1=Acid lb1=Derivatives, lb1=Niacin lb1=( lib=, la2=, la2=Azole la2=Antifungals: la2=Skeletal la2=Muscle. 2under1
null dep=appos lb1=Immunosuppressive lb1=Drugs, lb1=Fibric lb1=Acid lb1=Derivatives, lb1=Niacin lb1=( lib=, lib=Erythromycin, la2=: la2=Skeletal la2=Muscle.
null dep=None lb1=Immunosuppressive lb1=Drugs, lb1=Fibric lb1=Acid lb1=Derivatives, lb1=Niacin lb1=(Nicotinic lb1=Acid, lib=, la2=: la2=Skeletal la2=Muscle.
null dep=appos lib=( la2=): la2=Cerivastatin la2=plasma la2=concentrations la2=were la2=not la2=affected la2=by la2=co-administration la2=of la2=antacid.
null dep=None lib=(Magnesium-Aluminum lib=Hydroxide): la2=plasma la2=concentrations la2=were la2=not la2=affected la2=by la2=co-administration la2=of la2=antacid. 2under1
null dep=None lib=(Magnesium-Aluminum lib=Hydroxide): lib=Cerivastatin lib=plasma lib=concentrations lib=were lib=not lib=affected lib=by lib=co-administration lib=of la2=. 2under1
null dep=None lb1=ANTACID lb1=( lib=): la2=plasma la2=concentrations la2=were la2=not la2=affected la2=by la2=co-administration la2=of la2=antacid.
null dep=None lb1=ANTACID lb1=( lib=): lib=Cerivastatin lib=plasma lib=concentrations lib=were lib=not lib=affected lib=by lib=co-administration lib=of la2=.
null dep=None lb1=ANTACID lb1=(Magnesium-Aluminum lb1=Hydroxide): lib=plasma lib=concentrations lib=were lib=not lib=affected lib=by lib=co-administration lib=of la2=.
null dep=None lib=: la2=plasma la2=concentrations la2=were la2=not la2=affected la2=by la2=co-administration la2=of la2=cimetidine. 2under1
null dep=None lib=: lib=Cerivastatin lib=plasma lib=concentrations lib=were lib=not lib=affected lib=by lib=co-administration lib=of la2=. 2under1
null dep=None lb1=CIMETlDINE: lib=plasma lib=concentrations lib=were lib=not lib=affected lib=by lib=co-administration lib=of la2=.
null dep=None lib=: lib=The lib=influence lib=of lib=the lib=bile-acidsequestering lib=agent la2=on la2=the la2=pharmacokinetits la2=of la2=cerivastatin la2=sodium la2=was la2=evaluated la2=in la2=12 la2=healthy la2=males la2=in la2=2 la2=separate la2=randomized la2=crossover la2=studies. 2under1
null dep=None lib=: lib=The lib=influence lib=of lib=the lib=bile-acidsequestering lib=agent lib=cholestyramine lib=on lib=the lib=pharmacokinetits lib=of la2=was la2=evaluated la2=in la2=12 la2=healthy la2=males la2=in la2=2 la2=separate la2=randomized la2=crossover la2=studies.
null dep=None lb1=CHOLESTYRAMINE: lb1=The lb1=influence lb1=of lb1=the lb1=bile-acidsequestering lb1=agent lib=on lib=the lib=pharmacokinetits lib=of la2=was la2=evaluated la2=in la2=12 la2=healthy la2=males la2=in la2=2 la2=separate la2=randomized la2=crossover la2=studies.
mechanism dep=conj lb1=In lb1=the lb1=first lb1=study, lb1=concomitant lb1=administration lb1=of lb1=0.2 lb1=mg lib=and lib=12 lib=g la2=resulted la2=in la2=decreases la2=of la2=more la2=than la2=22% la2=for la2=AUC la2=and la2=40% la2=for la2=Cmax la2=when la2=compared la2=to la2=dosing la2=cerivastatin la2=sodium la2=alone. 2under1
null dep=compound lb1=In lb1=the lb1=first lb1=study, lb1=concomitant lb1=administration lb1=of lb1=0.2 lb1=mg lib=and lib=12 lib=g lib=cholestyramine lib=resulted lib=in lib=decreases lib=of lib=more lib=than lib=22% lib=for lib=AUC lib=and lib=40% lib=for lib=Cmax lib=when lib=compared lib=to lib=dosing la2=and la2=12 la2=g la2=cholestyramine la2=resulted la2=in la2=decreases la2=of la2=more la2=than la2=22% la2=for la2=AUC la2=and la2=40% la2=for la2=Cmax la2=when la2=compared la2=to la2=dosing la2=cerivastatin la2=sodium la2=alone.
null dep=conj lb1=In lb1=the lb1=first lb1=study, lb1=concomitant lb1=administration lb1=of lb1=0.2 lb1=mg lb1=cerivastatin lb1=sodium lb1=and lb1=12 lb1=g lib=resulted lib=in lib=decreases lib=of lib=more lib=than lib=22% lib=for lib=AUC lib=and lib=40% lib=for lib=Cmax lib=when lib=compared lib=to lib=dosing la2=and la2=12 la2=g la2=cholestyramine la2=resulted la2=in la2=decreases la2=of la2=more la2=than la2=22% la2=for la2=AUC la2=and la2=40% la2=for la2=Cmax la2=when la2=compared la2=to la2=dosing la2=cerivastatin la2=sodium la2=alone. 1under2
mechanism dep=None lb1=However, lb1=in lb1=the lb1=second lb1=study, lb1=administration lb1=of lb1=12 lb1=g lib=1 lib=hour lib=before lib=the lib=evening lib=meal lib=and lib=0.3 lib=mg la2=approximately la2=4 la2=hours la2=after la2=the la2=same la2=evening la2=meal la2=resulted la2=in la2=a la2=decrease la2=in la2=the la2=cerivastatin la2=AUC la2=of la2=less la2=than la2=8%, la2=and la2=a la2=decrease la2=in la2=Cmax la2=of la2=about la2=30% la2=when la2=compared la2=to la2=dosing la2=cerivastatin la2=sodium la2=alone.
null dep=None lb1=However, lb1=in lb1=the lb1=second lb1=study, lb1=administration lb1=of lb1=12 lb1=g lib=1 lib=hour lib=before lib=the lib=evening lib=meal lib=and lib=0.3 lib=mg la2=sodium la2=approximately la2=4 la2=hours la2=after la2=the la2=same la2=evening la2=meal la2=resulted la2=in la2=a la2=decrease la2=in la2=the la2=cerivastatin la2=AUC la2=of la2=less la2=than la2=8%, la2=and la2=a la2=decrease la2=in la2=Cmax la2=of la2=about la2=30% la2=when la2=compared la2=to la2=dosing la2=cerivastatin la2=sodium la2=alone.
null dep=None lb1=However, lb1=in lb1=the lb1=second lb1=study, lb1=administration lb1=of lb1=12 lb1=g lib=1 lib=hour lib=before lib=the lib=evening lib=meal lib=and lib=0.3 lib=mg la2=approximately la2=4 la2=hours la2=after la2=the la2=same la2=evening la2=meal la2=resulted la2=in la2=a la2=decrease la2=in la2=the la2=cerivastatin la2=AUC la2=of la2=less la2=than la2=8%, la2=and la2=a la2=decrease la2=in la2=Cmax la2=of la2=about la2=30% la2=when la2=compared la2=to la2=dosing la2=cerivastatin la2=sodium la2=alone.
null dep=compound lb1=However, lb1=in lb1=the lb1=second lb1=study, lb1=administration lb1=of lb1=12 lb1=g lb1=cholestyramine lb1=1 lb1=hour lb1=before lb1=the lb1=evening lb1=meal lb1=and lb1=0.3 lb1=mg lib=approximately lib=4 lib=hours lib=after lib=the lib=same lib=evening lib=meal lib=resulted lib=in lib=a lib=decrease lib=in lib=the la2=sodium la2=approximately la2=4 la2=hours la2=after la2=the la2=same la2=evening la2=meal la2=resulted la2=in la2=a la2=decrease la2=in la2=the la2=cerivastatin la2=AUC la2=of la2=less la2=than la2=8%, la2=and la2=a la2=decrease la2=in la2=Cmax la2=of la2=about la2=30% la2=when la2=compared la2=to la2=dosing la2=cerivastatin la2=sodium la2=alone. 2under1
null dep=compound lb1=However, lb1=in lb1=the lb1=second lb1=study, lb1=administration lb1=of lb1=12 lb1=g lb1=cholestyramine lb1=1 lb1=hour lb1=before lb1=the lb1=evening lb1=meal lb1=and lb1=0.3 lb1=mg lib=approximately lib=4 lib=hours lib=after lib=the lib=same lib=evening lib=meal lib=resulted lib=in lib=a lib=decrease lib=in lib=the lib=cerivastatin lib=AUC lib=of lib=less lib=than lib=8%, lib=and lib=a lib=decrease lib=in lib=Cmax lib=of lib=about lib=30% lib=when lib=compared lib=to lib=dosing la2=approximately la2=4 la2=hours la2=after la2=the la2=same la2=evening la2=meal la2=resulted la2=in la2=a la2=decrease la2=in la2=the la2=cerivastatin la2=AUC la2=of la2=less la2=than la2=8%, la2=and la2=a la2=decrease la2=in la2=Cmax la2=of la2=about la2=30% la2=when la2=compared la2=to la2=dosing la2=cerivastatin la2=sodium la2=alone.
null dep=compound lb1=However, lb1=in lb1=the lb1=second lb1=study, lb1=administration lb1=of lb1=12 lb1=g lb1=cholestyramine lb1=1 lb1=hour lb1=before lb1=the lb1=evening lb1=meal lb1=and lb1=0.3 lb1=mg lib=sodium lib=approximately lib=4 lib=hours lib=after lib=the lib=same lib=evening lib=meal lib=resulted lib=in lib=a lib=decrease lib=in lib=the lib=cerivastatin lib=AUC lib=of lib=less lib=than lib=8%, lib=and lib=a lib=decrease lib=in lib=Cmax lib=of lib=about lib=30% lib=when lib=compared lib=to lib=dosing la2=approximately la2=4 la2=hours la2=after la2=the la2=same la2=evening la2=meal la2=resulted la2=in la2=a la2=decrease la2=in la2=the la2=cerivastatin la2=AUC la2=of la2=less la2=than la2=8%, la2=and la2=a la2=decrease la2=in la2=Cmax la2=of la2=about la2=30% la2=when la2=compared la2=to la2=dosing la2=cerivastatin la2=sodium la2=alone. 1under2
null dep=None lb1=Therefore, lb1=it lb1=would lb1=be lb1=expected lb1=that lb1=a lb1=dosing lb1=schedule lb1=of lib=given lib=at lib=bedtime lib=and la2=given la2=before la2=the la2=evening la2=meal la2=would la2=not la2=result la2=in la2=a la2=significant la2=decrease la2=in la2=the la2=clinical la2=effect la2=of la2=cerivastatin la2=sodium.
null dep=compound lb1=Therefore, lb1=it lb1=would lb1=be lb1=expected lb1=that lb1=a lb1=dosing lb1=schedule lb1=of lib=given lib=at lib=bedtime lib=and lib=cholestyramine lib=given lib=before lib=the lib=evening lib=meal lib=would lib=not lib=result lib=in lib=a lib=significant lib=decrease lib=in lib=the lib=clinical lib=effect lib=of la2=given la2=at la2=bedtime la2=and la2=cholestyramine la2=given la2=before la2=the la2=evening la2=meal la2=would la2=not la2=result la2=in la2=a la2=significant la2=decrease la2=in la2=the la2=clinical la2=effect la2=of la2=cerivastatin la2=sodium.
null dep=None lb1=Therefore, lb1=it lb1=would lb1=be lb1=expected lb1=that lb1=a lb1=dosing lb1=schedule lb1=of lb1=cerivastatin lb1=sodium lb1=given lb1=at lb1=bedtime lb1=and lib=given lib=before lib=the lib=evening lib=meal lib=would lib=not lib=result lib=in lib=a lib=significant lib=decrease lib=in lib=the lib=clinical lib=effect lib=of la2=given la2=at la2=bedtime la2=and la2=cholestyramine la2=given la2=before la2=the la2=evening la2=meal la2=would la2=not la2=result la2=in la2=a la2=significant la2=decrease la2=in la2=the la2=clinical la2=effect la2=of la2=cerivastatin la2=sodium.
null dep=None lib=: lib=Plasma la2=levels la2=and la2=digoxin la2=clearance la2=at la2=steady-state la2=were la2=not la2=affected la2=by la2=co-administration la2=of la2=0.2 la2=mg la2=cerivastatin la2=sodium. 2under1
null dep=None lib=: lib=Plasma la2=levels la2=and la2=digoxin la2=clearance la2=at la2=steady-state la2=were la2=not la2=affected la2=by la2=co-administration la2=of la2=0.2 la2=mg la2=cerivastatin la2=sodium. 2under1
null dep=None lib=: lib=Plasma lib=digoxin lib=levels lib=and lib=digoxin lib=clearance lib=at lib=steady-state lib=were lib=not lib=affected lib=by lib=co-administration lib=of lib=0.2 lib=mg la2=.
null dep=None lb1=DIGOXIN: lb1=Plasma lib=levels lib=and la2=levels la2=and la2=digoxin la2=clearance la2=at la2=steady-state la2=were la2=not la2=affected la2=by la2=co-administration la2=of la2=0.2 la2=mg la2=cerivastatin la2=sodium.
null dep=None lb1=DIGOXIN: lb1=Plasma lib=levels lib=and lib=digoxin lib=clearance lib=at lib=steady-state lib=were lib=not lib=affected lib=by lib=co-administration lib=of lib=0.2 lib=mg la2=.
null dep=None lb1=DIGOXIN: lb1=Plasma lib=levels lib=and lib=digoxin lib=clearance lib=at lib=steady-state lib=were lib=not lib=affected lib=by lib=co-administration lib=of lib=0.2 lib=mg la2=.
null dep=None lib=plasma lib=concentrations lib=were lib=also lib=not lib=affected lib=by lib=co-administration lib=of la2=.
null dep=None lib=: lib=Co- lib=administration lib=of la2=and la2=cerivastatin la2=to la2=healthy la2=volunteers la2=did la2=not la2=result la2=in la2=any la2=changes la2=in la2=prothrombin la2=time la2=or la2=clotting la2=factor la2=VII la2=when la2=compared la2=to la2=co-administration la2=of la2=warfarin la2=and la2=placebo. 2under1
null dep=None lib=: lib=Co- lib=administration lib=of lib=warfarin lib=and la2=to la2=healthy la2=volunteers la2=did la2=not la2=result la2=in la2=any la2=changes la2=in la2=prothrombin la2=time la2=or la2=clotting la2=factor la2=VII la2=when la2=compared la2=to la2=co-administration la2=of la2=warfarin la2=and la2=placebo. 2under1
null dep=None lib=: lib=Co- lib=administration lib=of la2=and la2=cerivastatin la2=to la2=healthy la2=volunteers la2=did la2=not la2=result la2=in la2=any la2=changes la2=in la2=prothrombin la2=time la2=or la2=clotting la2=factor la2=VII la2=when la2=compared la2=to la2=co-administration la2=of la2=warfarin la2=and la2=placebo. 2under1
null dep=conj lb1=WARFARIN: lb1=Co- lb1=administration lb1=of lib=and la2=to la2=healthy la2=volunteers la2=did la2=not la2=result la2=in la2=any la2=changes la2=in la2=prothrombin la2=time la2=or la2=clotting la2=factor la2=VII la2=when la2=compared la2=to la2=co-administration la2=of la2=warfarin la2=and la2=placebo. 2under1
null dep=None lb1=WARFARIN: lb1=Co- lb1=administration lb1=of lib=and lib=cerivastatin lib=to lib=healthy lib=volunteers lib=did lib=not lib=result lib=in lib=any lib=changes lib=in lib=prothrombin lib=time lib=or lib=clotting lib=factor lib=VII lib=when lib=compared lib=to lib=co-administration lib=of la2=and la2=cerivastatin la2=to la2=healthy la2=volunteers la2=did la2=not la2=result la2=in la2=any la2=changes la2=in la2=prothrombin la2=time la2=or la2=clotting la2=factor la2=VII la2=when la2=compared la2=to la2=co-administration la2=of la2=warfarin la2=and la2=placebo.
null dep=conj lb1=WARFARIN: lb1=Co- lb1=administration lb1=of lb1=warfarin lb1=and lib=to lib=healthy lib=volunteers lib=did lib=not lib=result lib=in lib=any lib=changes lib=in lib=prothrombin lib=time lib=or lib=clotting lib=factor lib=VII lib=when lib=compared lib=to lib=co-administration lib=of la2=and la2=cerivastatin la2=to la2=healthy la2=volunteers la2=did la2=not la2=result la2=in la2=any la2=changes la2=in la2=prothrombin la2=time la2=or la2=clotting la2=factor la2=VII la2=when la2=compared la2=to la2=co-administration la2=of la2=warfarin la2=and la2=placebo. 1under2
null dep=None lb1=The lb1=AUC lb1=and lb1=Cmax lb1=of lb1=both lb1=the lb1=(R) lb1=and lb1=(S) lb1=isomers lb1=of lib=were lib=unaffected lib=by lib=concurrent lib=dosing lib=of lib=0.3 lib=mg la2=.
null dep=conj lb1=Co-administration lb1=of lib=and la2=did la2=not la2=alter la2=the la2=pharmacokinetics la2=of la2=cerivastatin la2=sodium. 2under1
null dep=conj lb1=Co-administration lb1=of lib=and lib=cerivastatin lib=did lib=not lib=alter lib=the lib=pharmacokinetics lib=of la2=.
null dep=compound lb1=Co-administration lb1=of lb1=warfarin lb1=and lib=did lib=not lib=alter lib=the lib=pharmacokinetics lib=of la2=. 1under2
null dep=None lib=: lib=In lib=hypercholesterolemic lib=patients, lib=steady-state la2=AUC la2=and la2=Cmax la2=increased la2=approximately la2=50% la2=and la2=24% la2=respectively la2=after la2=10 la2=days la2=with la2=co-administration la2=of la2=erythromycin, la2=a la2=known la2=inhibitor la2=of la2=cytochrome la2=P450 la2=3A4. 2under1
null dep=None lib=: lib=In lib=hypercholesterolemic lib=patients, lib=steady-state lib=cerivastatin lib=AUC lib=and lib=Cmax lib=increased lib=approximately lib=50% lib=and lib=24% lib=respectively lib=after lib=10 lib=days lib=with lib=co-administration lib=of la2=, la2=a la2=known la2=inhibitor la2=of la2=cytochrome la2=P450 la2=3A4. 2under1
mechanism dep=None lb1=ERYTHROMYCIN: lb1=In lb1=hypercholesterolemic lb1=patients, lb1=steady-state lib=AUC lib=and lib=Cmax lib=increased lib=approximately lib=50% lib=and lib=24% lib=respectively lib=after lib=10 lib=days lib=with lib=co-administration lib=of la2=, la2=a la2=known la2=inhibitor la2=of la2=cytochrome la2=P450 la2=3A4.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lib=was lib=used lib=concomitantly lib=with la2=, la2=betablockers, la2=calcium-channel la2=blockers, la2=diuretics, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lib=was lib=used lib=concomitantly lib=with lib=angiotensin- lib=converting lib=enzyme lib=(ACE) lib=inhibitors, la2=, la2=calcium-channel la2=blockers, la2=diuretics, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lib=was lib=used lib=concomitantly lib=with lib=angiotensin- lib=converting lib=enzyme lib=(ACE) lib=inhibitors, lib=betablockers, la2=, la2=diuretics, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lib=was lib=used lib=concomitantly lib=with lib=angiotensin- lib=converting lib=enzyme lib=(ACE) lib=inhibitors, lib=betablockers, lib=calcium-channel lib=blockers, la2=, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lib=was lib=used lib=concomitantly lib=with lib=angiotensin- lib=converting lib=enzyme lib=(ACE) lib=inhibitors, lib=betablockers, lib=calcium-channel lib=blockers, lib=diuretics, lib=and la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lib=was lib=used lib=concomitantly lib=with lib=angiotensin- lib=converting lib=enzyme lib=(ACE) lib=inhibitors, lib=betablockers, lib=calcium-channel lib=blockers, lib=diuretics, lib=and lib=nonsteroidal lib=anti-inflammatory lib=drugs lib=( la2=) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=conj lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lib=, la2=, la2=calcium-channel la2=blockers, la2=diuretics, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions. 2under1
null dep=conj lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lib=, lib=betablockers, la2=, la2=diuretics, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=conj lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lib=, lib=betablockers, lib=calcium-channel lib=blockers, la2=, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions. 2under1
null dep=conj lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lib=, lib=betablockers, lib=calcium-channel lib=blockers, lib=diuretics, lib=and la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lib=, lib=betablockers, lib=calcium-channel lib=blockers, lib=diuretics, lib=and lib=nonsteroidal lib=anti-inflammatory lib=drugs lib=( la2=) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions. 2under1
null dep=compound lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lib=, la2=, la2=diuretics, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lib=, lib=calcium-channel lib=blockers, la2=, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lib=, lib=calcium-channel lib=blockers, lib=diuretics, lib=and la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lib=, lib=calcium-channel lib=blockers, lib=diuretics, lib=and lib=nonsteroidal lib=anti-inflammatory lib=drugs lib=( la2=) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lb1=betablockers, lib=, la2=, la2=and la2=nonsteroidal la2=anti-inflammatory la2=drugs la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lb1=betablockers, lib=, lib=diuretics, lib=and la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lb1=betablockers, lib=, lib=diuretics, lib=and lib=nonsteroidal lib=anti-inflammatory lib=drugs lib=( la2=) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lb1=betablockers, lb1=calcium-channel lb1=blockers, lib=, lib=and la2=(NSAIDs) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=None lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lb1=betablockers, lb1=calcium-channel lb1=blockers, lib=, lib=and lib=nonsteroidal lib=anti-inflammatory lib=drugs lib=( la2=) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions.
null dep=appos lb1=OTHER lb1=CONCOMITANT lb1=THERAPY: lb1=Although lb1=specific lb1=interaction lb1=studies lb1=were lb1=not lb1=performed, lb1=in lb1=clinical lb1=studies, lb1=cerivastatin lb1=sodium lb1=was lb1=used lb1=concomitantly lb1=with lb1=angiotensin- lb1=converting lb1=enzyme lb1=(ACE) lb1=inhibitors, lb1=betablockers, lb1=calcium-channel lb1=blockers, lb1=diuretics, lb1=and lib=( la2=) la2=without la2=evidence la2=of la2=clinically la2=significant la2=adverse la2=interactions. 2under1
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase la2=plasma la2=concentrations la2=Drugs la2=that la2=may la2=increase la2=imatinib la2=plasma la2=concentrations: la2=Caution la2=is la2=recommended la2=when la2=administering la2=Gleevec la2=with la2=inhibitors la2=of la2=the la2=CYP3A4 la2=family la2=(e.g., la2=ketoconazole, la2=itraconazole, la2=erythromycin, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering la2=with la2=inhibitors la2=of la2=the la2=CYP3A4 la2=family la2=(e.g., la2=ketoconazole, la2=itraconazole, la2=erythromycin, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering lib=Gleevec lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., la2=, la2=itraconazole, la2=erythromycin, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering lib=Gleevec lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., lib=ketoconazole, la2=, la2=erythromycin, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering lib=Gleevec lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., lib=ketoconazole, lib=itraconazole, la2=, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering lib=Gleevec lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., lib=ketoconazole, lib=itraconazole, lib=erythromycin, la2=).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering la2=with la2=inhibitors la2=of la2=the la2=CYP3A4 la2=family la2=(e.g., la2=ketoconazole, la2=itraconazole, la2=erythromycin, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering lib=Gleevec lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., la2=, la2=itraconazole, la2=erythromycin, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering lib=Gleevec lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., lib=ketoconazole, la2=, la2=erythromycin, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering lib=Gleevec lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., lib=ketoconazole, lib=itraconazole, la2=, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lib=plasma lib=concentrations lib=Drugs lib=that lib=may lib=increase lib=imatinib lib=plasma lib=concentrations: lib=Caution lib=is lib=recommended lib=when lib=administering lib=Gleevec lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., lib=ketoconazole, lib=itraconazole, lib=erythromycin, la2=).
advise dep=None lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., la2=, la2=itraconazole, la2=erythromycin, la2=clarithromycin).
advise dep=None lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., lib=ketoconazole, la2=, la2=erythromycin, la2=clarithromycin).
advise dep=None lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., lib=ketoconazole, lib=itraconazole, la2=, la2=clarithromycin).
advise dep=None lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lib=with lib=inhibitors lib=of lib=the lib=CYP3A4 lib=family lib=(e.g., lib=ketoconazole, lib=itraconazole, lib=erythromycin, la2=).
null dep=conj lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lb1=Gleevec lb1=with lb1=inhibitors lb1=of lb1=the lb1=CYP3A4 lb1=family lb1=(e.g., lib=, la2=, la2=erythromycin, la2=clarithromycin). 2under1
null dep=conj lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lb1=Gleevec lb1=with lb1=inhibitors lb1=of lb1=the lb1=CYP3A4 lb1=family lb1=(e.g., lib=, lib=itraconazole, la2=, la2=clarithromycin). 2under1
null dep=appos lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lb1=Gleevec lb1=with lb1=inhibitors lb1=of lb1=the lb1=CYP3A4 lb1=family lb1=(e.g., lib=, lib=itraconazole, lib=erythromycin, la2=). 2under1
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lb1=Gleevec lb1=with lb1=inhibitors lb1=of lb1=the lb1=CYP3A4 lb1=family lb1=(e.g., lb1=ketoconazole, lib=, la2=, la2=clarithromycin).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lb1=Gleevec lb1=with lb1=inhibitors lb1=of lb1=the lb1=CYP3A4 lb1=family lb1=(e.g., lb1=ketoconazole, lib=, lib=erythromycin, la2=).
null dep=None lb1=Drugs lb1=that lb1=may lb1=alter lb1=imatinib lb1=plasma lb1=concentrations lb1=Drugs lb1=that lb1=may lb1=increase lb1=imatinib lb1=plasma lb1=concentrations: lb1=Caution lb1=is lb1=recommended lb1=when lb1=administering lb1=Gleevec lb1=with lb1=inhibitors lb1=of lb1=the lb1=CYP3A4 lb1=family lb1=(e.g., lb1=ketoconazole, lb1=itraconazole, lib=, la2=).
null dep=None lb1=There lb1=is lb1=a lb1=significant lb1=increase lb1=in lb1=exposure lb1=to lib=when la2=is la2=coadministered la2=with la2=ketoconazole la2=(CYP3A4 la2=inhibitor).
null dep=case lb1=There lb1=is lb1=a lb1=significant lb1=increase lb1=in lb1=exposure lb1=to lib=when lib=Gleevec lib=is lib=coadministered lib=with la2=(CYP3A4 la2=inhibitor).
mechanism dep=None lb1=There lb1=is lb1=a lb1=significant lb1=increase lb1=in lb1=exposure lb1=to lb1=imatinib lb1=when lib=is lib=coadministered lib=with la2=(CYP3A4 la2=inhibitor).
null dep=None lb1=Drugs lb1=that lb1=may lb1=decrease lib=plasma lib=concentrations: lib=Substances lib=that lib=are lib=inducers lib=of lib=CYP3A4 lib=activity lib=may lib=increase lib=metabolism lib=and lib=decrease la2=plasma la2=concentrations: la2=Substances la2=that la2=are la2=inducers la2=of la2=CYP3A4 la2=activity la2=may la2=increase la2=metabolism la2=and la2=decrease la2=imatinib la2=plasma la2=concentrations.
null dep=conj lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lib=, la2=, la2=carbamazepine, la2=rifampin, la2=phenobarbital la2=or la2=St. 2under1
null dep=conj lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lib=, lib=phenytoin, la2=, la2=rifampin, la2=phenobarbital la2=or la2=St. 2under1
null dep=conj lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lib=, lib=phenytoin, lib=carbamazepine, la2=, la2=phenobarbital la2=or la2=St. 2under1
null dep=conj lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lib=, lib=phenytoin, lib=carbamazepine, lib=rifampin, la2=or la2=St. 2under1
null dep=None lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lb1=dexamethasone, lib=, la2=, la2=rifampin, la2=phenobarbital la2=or la2=St.
null dep=None lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lb1=dexamethasone, lib=, lib=carbamazepine, la2=, la2=phenobarbital la2=or la2=St.
null dep=None lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lb1=dexamethasone, lib=, lib=carbamazepine, lib=rifampin, la2=or la2=St.
null dep=None lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lb1=dexamethasone, lb1=phenytoin, lib=, la2=, la2=phenobarbital la2=or la2=St.
null dep=None lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lb1=dexamethasone, lb1=phenytoin, lib=, lib=rifampin, la2=or la2=St.
null dep=None lb1=Co-medications lb1=that lb1=induce lb1=CYP3A4 lb1=(e.g., lb1=dexamethasone, lb1=phenytoin, lb1=carbamazepine, lib=, la2=or la2=St.
mechanism dep=None lb1=Pretreatment lb1=of lb1=healthy lb1=volunteers lb1=with lb1=multiple lb1=doses lb1=of lib=followed lib=by lib=a lib=single lib=dose lib=of la2=, la2=increased la2=Gleevec la2=oral-dose la2=clearance la2=by la2=3.8-fold, la2=which la2=significantly la2=(p la2=0.05) la2=decreased la2=mean la2=cmax la2=and la2=AUC(0-8).
null dep=None lb1=Pretreatment lb1=of lb1=healthy lb1=volunteers lb1=with lb1=multiple lb1=doses lb1=of lib=followed lib=by lib=a lib=single lib=dose lib=of la2=, la2=increased la2=Gleevec la2=oral-dose la2=clearance la2=by la2=3.8-fold, la2=which la2=significantly la2=(p la2=0.05) la2=decreased la2=mean la2=cmax la2=and la2=AUC(0-8).
null dep=None lb1=Pretreatment lb1=of lb1=healthy lb1=volunteers lb1=with lb1=multiple lb1=doses lb1=of lb1=rifampin lb1=followed lb1=by lb1=a lb1=single lb1=dose lb1=of lib=, lib=increased la2=, la2=increased la2=Gleevec la2=oral-dose la2=clearance la2=by la2=3.8-fold, la2=which la2=significantly la2=(p la2=0.05) la2=decreased la2=mean la2=cmax la2=and la2=AUC(0-8).
null dep=compound lb1=Drugs lb1=that lb1=may lb1=have lb1=their lb1=plasma lb1=concentration lb1=altered lb1=by la2=Gleevec la2=increases la2=the la2=mean la2=cmax la2=and la2=AUC la2=of la2=simvastatin la2=(CYP3A4 la2=substrate) la2=2- la2=and la2=3.5-fold, la2=respectively, la2=suggesting la2=an la2=inhibition la2=of la2=the la2=CYP3A4 la2=by la2=Gleevec. 2under1
null dep=None lb1=Drugs lb1=that lb1=may lb1=have lb1=their lb1=plasma lb1=concentration lb1=altered lb1=by lib=Gleevec lib=increases lib=the lib=mean lib=cmax lib=and lib=AUC lib=of la2=(CYP3A4 la2=substrate) la2=2- la2=and la2=3.5-fold, la2=respectively, la2=suggesting la2=an la2=inhibition la2=of la2=the la2=CYP3A4 la2=by la2=Gleevec.
null dep=compound lb1=Drugs lb1=that lb1=may lb1=have lb1=their lb1=plasma lb1=concentration lb1=altered lb1=by la2=Gleevec la2=increases la2=the la2=mean la2=cmax la2=and la2=AUC la2=of la2=simvastatin la2=(CYP3A4 la2=substrate) la2=2- la2=and la2=3.5-fold, la2=respectively, la2=suggesting la2=an la2=inhibition la2=of la2=the la2=CYP3A4 la2=by la2=Gleevec. 2under1
mechanism dep=None lb1=Drugs lb1=that lb1=may lb1=have lb1=their lb1=plasma lb1=concentration lb1=altered lb1=by lib=Gleevec lib=increases lib=the lib=mean lib=cmax lib=and lib=AUC lib=of la2=(CYP3A4 la2=substrate) la2=2- la2=and la2=3.5-fold, la2=respectively, la2=suggesting la2=an la2=inhibition la2=of la2=the la2=CYP3A4 la2=by la2=Gleevec.
null dep=compound lb1=Drugs lb1=that lb1=may lb1=have lb1=their lb1=plasma lb1=concentration lb1=altered lb1=by la2=Gleevec la2=increases la2=the la2=mean la2=cmax la2=and la2=AUC la2=of la2=simvastatin la2=(CYP3A4 la2=substrate) la2=2- la2=and la2=3.5-fold, la2=respectively, la2=suggesting la2=an la2=inhibition la2=of la2=the la2=CYP3A4 la2=by la2=Gleevec. 2under1
null dep=None lb1=Drugs lb1=that lb1=may lb1=have lb1=their lb1=plasma lb1=concentration lb1=altered lb1=by lb1=Gleevec lb1=Gleevec lb1=increases lb1=the lb1=mean lb1=cmax lb1=and lb1=AUC lb1=of lib=(CYP3A4 lib=substrate) lib=2- lib=and lib=3.5-fold, lib=respectively, lib=suggesting lib=an lib=inhibition lib=of lib=the lib=CYP3A4 lib=by la2=Gleevec la2=increases la2=the la2=mean la2=cmax la2=and la2=AUC la2=of la2=simvastatin la2=(CYP3A4 la2=substrate) la2=2- la2=and la2=3.5-fold, la2=respectively, la2=suggesting la2=an la2=inhibition la2=of la2=the la2=CYP3A4 la2=by la2=Gleevec.
advise dep=None lb1=Particular lb1=caution lb1=is lb1=recommended lb1=when lb1=administering lib=with lib=CYP3A4 lib=substrates lib=that lib=have lib=a lib=narrow lib=therapeutic lib=window lib=(e.g., la2=or la2=pimozide).
advise dep=None lb1=Particular lb1=caution lb1=is lb1=recommended lb1=when lb1=administering lib=with lib=CYP3A4 lib=substrates lib=that lib=have lib=a lib=narrow lib=therapeutic lib=window lib=(e.g., lib=cyclosporine lib=or la2=).
null dep=conj lb1=Particular lb1=caution lb1=is lb1=recommended lb1=when lb1=administering lb1=Gleevec lb1=with lb1=CYP3A4 lb1=substrates lb1=that lb1=have lb1=a lb1=narrow lb1=therapeutic lb1=window lb1=(e.g., lib=or la2=). 2under1
mechanism dep=None lib=will lib=increase lib=plasmaconcentration lib=of lib=other lib=CYP3A4 lib=metabolized lib=drugs lib=(e.g., lib=triazolo- la2=, la2=dihydropyridine la2=calcium la2=channel la2=blockers, la2=certain la2=HMG-CoA la2=reductase la2=inhibitors, la2=etc.).
mechanism dep=None lib=will lib=increase lib=plasmaconcentration lib=of lib=other lib=CYP3A4 lib=metabolized lib=drugs lib=(e.g., lib=triazolo-benzodiazepines, la2=, la2=certain la2=HMG-CoA la2=reductase la2=inhibitors, la2=etc.).
mechanism dep=None lib=will lib=increase lib=plasmaconcentration lib=of lib=other lib=CYP3A4 lib=metabolized lib=drugs lib=(e.g., lib=triazolo-benzodiazepines, lib=dihydropyridine lib=calcium lib=channel lib=blockers, lib=certain la2=, la2=etc.).
null dep=None lb1=Gleevec lb1=will lb1=increase lb1=plasmaconcentration lb1=of lb1=other lb1=CYP3A4 lb1=metabolized lb1=drugs lb1=(e.g., lb1=triazolo- lib=, la2=, la2=certain la2=HMG-CoA la2=reductase la2=inhibitors, la2=etc.).
null dep=None lb1=Gleevec lb1=will lb1=increase lb1=plasmaconcentration lb1=of lb1=other lb1=CYP3A4 lb1=metabolized lb1=drugs lb1=(e.g., lb1=triazolo- lib=, lib=dihydropyridine lib=calcium lib=channel lib=blockers, lib=certain la2=, la2=etc.).
null dep=None lb1=Gleevec lb1=will lb1=increase lb1=plasmaconcentration lb1=of lb1=other lb1=CYP3A4 lb1=metabolized lb1=drugs lb1=(e.g., lb1=triazolo-benzodiazepines, lib=, lib=certain la2=, la2=etc.).
null dep=None lb1=Because lib=is lib=metabolized lib=by lib=CYP2C9 lib=and lib=CYP3A4, lib=patients lib=who lib=require lib=anticoagulation lib=should lib=receive lib=low-molecular lib=weight lib=or lib=standard la2=.
mechanism dep=None lb1=Systemic lb1=exposure lb1=to lib=is lib=expected lib=to lib=be lib=increased lib=when lib=coadministered lib=with la2=.
